<SEC-DOCUMENT>0001213900-25-060421.txt : 20250701
<SEC-HEADER>0001213900-25-060421.hdr.sgml : 20250701
<ACCEPTANCE-DATETIME>20250701165051
ACCESSION NUMBER:		0001213900-25-060421
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		17
CONFORMED PERIOD OF REPORT:	20250625
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250701
DATE AS OF CHANGE:		20250701

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Launch One Acquisition Corp.
		CENTRAL INDEX KEY:			0002015502
		STANDARD INDUSTRIAL CLASSIFICATION:	BLANK CHECKS [6770]
		ORGANIZATION NAME:           	05 Real Estate & Construction
		EIN:				000000000
		STATE OF INCORPORATION:			E9
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-42173
		FILM NUMBER:		251097124

	BUSINESS ADDRESS:	
		STREET 1:		180 GRAND AVENUE  SUITE 1530
		CITY:			OAKLAND
		STATE:			CA
		ZIP:			94612
		BUSINESS PHONE:		5106929600

	MAIL ADDRESS:	
		STREET 1:		180 GRAND AVENUE  SUITE 1530
		CITY:			OAKLAND
		STATE:			CA
		ZIP:			94612
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ea0247612-8k425_launch.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:us-roles="http://fasb.org/us-roles/2025" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:LPAA="http://launchoneacquisitioncorp.com/20250625">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02E_US%2DGAAP%2D2025 -->
<!-- Field: Set; Name: xdx; ID: xdx_032_LPAA_launchoneacquisitioncorp.com_20250625 -->
<!-- Field: Set; Name: xdx; ID: xdx_04E_20250625_20250625 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_05D_edei%2D%2DEntityCentralIndexKey_0002015502 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2025-06-25" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-06-25" id="Fact000004" name="dei:EntityCentralIndexKey">0002015502</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="lpaa-20250625.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2025-06-25">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0002015502</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-06-25</xbrli:startDate>
        <xbrli:endDate>2025-06-25</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-06-252025-06-25_custom_UnitsEachConsistingOfOneClassOrdinaryShareAndOnehalfOfOneRedeemableWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0002015502</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">LPAA:UnitsEachConsistingOfOneClassOrdinaryShareAndOnehalfOfOneRedeemableWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-06-25</xbrli:startDate>
        <xbrli:endDate>2025-06-25</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-06-252025-06-25_custom_ClassOrdinarySharesParValue0.0001PerShareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0002015502</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">LPAA:ClassOrdinarySharesParValue0.0001PerShareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-06-25</xbrli:startDate>
        <xbrli:endDate>2025-06-25</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-06-252025-06-25_custom_WarrantsEachWholeWarrantExercisableForOneClassOrdinaryShareAtExercisePriceOf11.50PerShareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0002015502</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">LPAA:WarrantsEachWholeWarrantExercisableForOneClassOrdinaryShareAtExercisePriceOf11.50PerShareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-06-25</xbrli:startDate>
        <xbrli:endDate>2025-06-25</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Washington, D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM <span id="xdx_900_edei--DocumentType_c20250625__20250625_zbr51fBqFSzj"><ix:nonNumeric contextRef="AsOf2025-06-25" id="Fact000009" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PURSUANT TO SECTION 13 OR 15(d) OF THE</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITIES EXCHANGE ACT OF 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Date of Report (Date of earliest event reported):
<b><span id="xdx_901_edei--DocumentPeriodEndDate_c20250625__20250625_zWXOXnOAesVf"><ix:nonNumeric contextRef="AsOf2025-06-25" format="ixt:datemonthdayyearen" id="Fact000010" name="dei:DocumentPeriodEndDate">June 25, 2025</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_902_edei--EntityRegistrantName_c20250625__20250625_zh3iB8y0i274"><ix:nonNumeric contextRef="AsOf2025-06-25" id="Fact000011" name="dei:EntityRegistrantName">LAUNCH ONE ACQUISITION CORP.</ix:nonNumeric></span> </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact name of registrant as specified in its charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_903_edei--EntityIncorporationStateCountryCode_c20250625__20250625_zMtDskkNBt98"><ix:nonNumeric contextRef="AsOf2025-06-25" format="ixt-sec:edgarprovcountryen" id="Fact000012" name="dei:EntityIncorporationStateCountryCode">Cayman Islands</ix:nonNumeric></span></b></span></td>
    <td style="width: 2%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_908_edei--EntityFileNumber_c20250625__20250625_zG2HGgfmWJg9"><ix:nonNumeric contextRef="AsOf2025-06-25" id="Fact000013" name="dei:EntityFileNumber">001-42173</ix:nonNumeric></span></b></span></td>
    <td style="width: 2%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_904_edei--EntityTaxIdentificationNumber_c20250625__20250625_zXoU4XHlkcZ2"><ix:nonNumeric contextRef="AsOf2025-06-25" id="Fact000014" name="dei:EntityTaxIdentificationNumber">98-1781481</ix:nonNumeric></span></b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State or other jurisdiction<br/>
of incorporation)</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Commission File Number)</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(IRS Employer<br/>
Identification No.)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr>
    <td style="border-bottom: black 1.5pt solid; vertical-align: top; width: 49%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_901_edei--EntityAddressAddressLine1_c20250625__20250625_zj7tXMOw0V34"><ix:nonNumeric contextRef="AsOf2025-06-25" id="Fact000015" name="dei:EntityAddressAddressLine1">180 Grand Avenue</ix:nonNumeric></span>, <span id="xdx_90B_edei--EntityAddressAddressLine2_c20250625__20250625_zAj4TuPiE7o8"><ix:nonNumeric contextRef="AsOf2025-06-25" id="Fact000016" name="dei:EntityAddressAddressLine2">Suite 153</ix:nonNumeric></span><br/>
<span id="xdx_904_edei--EntityAddressCityOrTown_c20250625__20250625_zXTjeEUuvPB"><ix:nonNumeric contextRef="AsOf2025-06-25" id="Fact000017" name="dei:EntityAddressCityOrTown">Oakland</ix:nonNumeric></span>, <span id="xdx_90C_edei--EntityAddressStateOrProvince_c20250625__20250625_zq6y3nDS6a5b"><ix:nonNumeric contextRef="AsOf2025-06-25" id="Fact000018" name="dei:EntityAddressStateOrProvince">CA</ix:nonNumeric> </span></b></span></td>
    <td style="vertical-align: top; width: 2%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; vertical-align: bottom; width: 49%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_905_edei--EntityAddressPostalZipCode_c20250625__20250625_zF3Xm7DiGdee"><ix:nonNumeric contextRef="AsOf2025-06-25" id="Fact000019" name="dei:EntityAddressPostalZipCode">94612</ix:nonNumeric></span></b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address of principal executive offices)</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Zip Code)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Registrant&#8217;s telephone number, including
area code: <b>(<span id="xdx_907_edei--CityAreaCode_c20250625__20250625_zteW0RzXIFK2"><ix:nonNumeric contextRef="AsOf2025-06-25" id="Fact000020" name="dei:CityAreaCode">510</ix:nonNumeric></span>) <span id="xdx_904_edei--LocalPhoneNumber_c20250625__20250625_ziX8e1aPWnua"><ix:nonNumeric contextRef="AsOf2025-06-25" id="Fact000021" name="dei:LocalPhoneNumber">692-9600</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Not Applicable<br/>
</b>(Former name or former address, if changed since last report)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_edei--WrittenCommunications_c20250625__20250625_z39PNngOj228"><ix:nonNumeric contextRef="AsOf2025-06-25" format="ixt:booleantrue" id="Fact000022" name="dei:WrittenCommunications">&#9746;</ix:nonNumeric></span></span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_edei--SolicitingMaterial_c20250625__20250625_zUsDCkNpKfxk"><ix:nonNumeric contextRef="AsOf2025-06-25" format="ixt:booleanfalse" id="Fact000023" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_edei--PreCommencementTenderOffer_c20250625__20250625_zgInR3OjNhSc"><ix:nonNumeric contextRef="AsOf2025-06-25" format="ixt:booleanfalse" id="Fact000024" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_edei--PreCommencementIssuerTenderOffer_c20250625__20250625_z9zVjcErHeAc"><ix:nonNumeric contextRef="AsOf2025-06-25" format="ixt:booleanfalse" id="Fact000025" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Securities registered pursuant to Section&#160;12(b)
of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title of Each Class</b></span></td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Trading Symbol(s)</b></span></td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name of Each Exchange on Which<br/>
Registered</b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_906_edei--Security12bTitle_c20250625__20250625__us-gaap--StatementClassOfStockAxis__custom--UnitsEachConsistingOfOneClassOrdinaryShareAndOnehalfOfOneRedeemableWarrantMember_zOqJAddyvlX9"><ix:nonNumeric contextRef="From2025-06-252025-06-25_custom_UnitsEachConsistingOfOneClassOrdinaryShareAndOnehalfOfOneRedeemableWarrantMember" id="Fact000026" name="dei:Security12bTitle">Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant</ix:nonNumeric></span></b></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_903_edei--TradingSymbol_c20250625__20250625__us-gaap--StatementClassOfStockAxis__custom--UnitsEachConsistingOfOneClassOrdinaryShareAndOnehalfOfOneRedeemableWarrantMember_zUtr6fG4zK73"><ix:nonNumeric contextRef="From2025-06-252025-06-25_custom_UnitsEachConsistingOfOneClassOrdinaryShareAndOnehalfOfOneRedeemableWarrantMember" id="Fact000027" name="dei:TradingSymbol">LPAAU</ix:nonNumeric></span></b></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The <span id="xdx_905_edei--SecurityExchangeName_c20250625__20250625__us-gaap--StatementClassOfStockAxis__custom--UnitsEachConsistingOfOneClassOrdinaryShareAndOnehalfOfOneRedeemableWarrantMember_zD7SJDQDgZhc"><ix:nonNumeric contextRef="From2025-06-252025-06-25_custom_UnitsEachConsistingOfOneClassOrdinaryShareAndOnehalfOfOneRedeemableWarrantMember" format="ixt-sec:exchnameen" id="Fact000028" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Stock Market LLC</b></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_907_edei--Security12bTitle_c20250625__20250625__us-gaap--StatementClassOfStockAxis__custom--ClassOrdinarySharesParValue0.0001PerShareMember_z32G83ghX1Ih"><ix:nonNumeric contextRef="From2025-06-252025-06-25_custom_ClassOrdinarySharesParValue0.0001PerShareMember" id="Fact000029" name="dei:Security12bTitle">Class A ordinary shares, par value $0.0001 per share</ix:nonNumeric></span></b></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><br/>
<b><span id="xdx_90E_edei--TradingSymbol_c20250625__20250625__us-gaap--StatementClassOfStockAxis__custom--ClassOrdinarySharesParValue0.0001PerShareMember_z4edeqciUii2"><ix:nonNumeric contextRef="From2025-06-252025-06-25_custom_ClassOrdinarySharesParValue0.0001PerShareMember" id="Fact000030" name="dei:TradingSymbol">LPAA</ix:nonNumeric></span></b></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><br/>
<b>The <span id="xdx_903_edei--SecurityExchangeName_c20250625__20250625__us-gaap--StatementClassOfStockAxis__custom--ClassOrdinarySharesParValue0.0001PerShareMember_zEUIthXpu213"><ix:nonNumeric contextRef="From2025-06-252025-06-25_custom_ClassOrdinarySharesParValue0.0001PerShareMember" format="ixt-sec:exchnameen" id="Fact000031" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Stock Market LLC</b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_902_edei--Security12bTitle_c20250625__20250625__us-gaap--StatementClassOfStockAxis__custom--WarrantsEachWholeWarrantExercisableForOneClassOrdinaryShareAtExercisePriceOf11.50PerShareMember_zv7kR5xkzIT1"><ix:nonNumeric contextRef="From2025-06-252025-06-25_custom_WarrantsEachWholeWarrantExercisableForOneClassOrdinaryShareAtExercisePriceOf11.50PerShareMember" id="Fact000032" name="dei:Security12bTitle">Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share</ix:nonNumeric></span></b></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90E_edei--TradingSymbol_c20250625__20250625__us-gaap--StatementClassOfStockAxis__custom--WarrantsEachWholeWarrantExercisableForOneClassOrdinaryShareAtExercisePriceOf11.50PerShareMember_zJC8JL4vswP5"><ix:nonNumeric contextRef="From2025-06-252025-06-25_custom_WarrantsEachWholeWarrantExercisableForOneClassOrdinaryShareAtExercisePriceOf11.50PerShareMember" id="Fact000033" name="dei:TradingSymbol">LPAAW</ix:nonNumeric></span></b></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The <span id="xdx_90E_edei--SecurityExchangeName_c20250625__20250625__us-gaap--StatementClassOfStockAxis__custom--WarrantsEachWholeWarrantExercisableForOneClassOrdinaryShareAtExercisePriceOf11.50PerShareMember_z2X4hV3Qb6a5"><ix:nonNumeric contextRef="From2025-06-252025-06-25_custom_WarrantsEachWholeWarrantExercisableForOneClassOrdinaryShareAtExercisePriceOf11.50PerShareMember" format="ixt-sec:exchnameen" id="Fact000034" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Stock Market LLC</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the
Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Emerging growth company&#160;<span id="xdx_907_edei--EntityEmergingGrowthCompany_c20250625__20250625_zKZ06Ktrplc7"><ix:nonNumeric contextRef="AsOf2025-06-25" format="ixt:booleantrue" id="Fact000035" name="dei:EntityEmergingGrowthCompany">&#9746;</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act.&#160;<span id="xdx_90D_edei--EntityExTransitionPeriod_c20250625__20250625_z57gABh7u3Rl"><ix:nonNumeric contextRef="AsOf2025-06-25" format="ixt:booleanfalse" id="Fact000036" name="dei:EntityExTransitionPeriod">&#9744;</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 1.01 Entry Into A Material Definitive
Agreement.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Business Combination Agreement </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>This section describes the material provisions
of the Business Combination Agreement but does not purport to describe all of the terms thereof. Launch One Acquisition Corp. shareholders,
warrant holders and other interested parties are urged to read such agreement in its entirety. The following summary is qualified in its
entirety by reference to the complete text of the Business Combination Agreement, a copy of which is attached hereto as Exhibit 2.1. Unless
otherwise defined herein, the capitalized terms used below are defined in the Business Combination Agreement</i>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>General Description of the Merger Agreement</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On June 25, 2025, Launch
One Acquisition Corp., a Cayman Islands exempted company (&#8220;<b>Launch One</b>&#8221; or &#8220;<b>SPAC</b>&#8221;), entered
into a Business Combination Agreement (the &#8220;<b>Business Combination Agreement</b>&#8221; or &#8220;<b>BCA</b>&#8221;) with (i)
Launch One Sponsor LLC, a Delaware limited liability company (the &#8220;<b>Sponsor</b>&#8221;), in the capacity as the
representative from and after the effective time of the SPAC Merger (as defined below) for the shareholders of SPAC and Pubco (as
defined below) (other than the shareholders of the Company (as defined below) as of immediately prior to the effective time of the
Company Merger (as defined below) and their successors and assigns) in accordance with the terms and conditions of the BCA (the
&#8220;<b>SPAC Representative</b>&#8221;), (ii) Minovia Therapeutics Ltd., an Israeli company limited by shares (together with its
successors, the &#8220;<b>Company</b>&#8221; or &#8220;<b>Minovia</b>&#8221;), (iii) Natalie Yivgi-Ohana, in the capacity as the
representative from and after the effective time of the Company Merger for the Company shareholders as of immediately prior to the
effective time of the Company Merger (and their successors and assigns) (the &#8220;<b>Seller Representative</b>&#8221;), (iv) Mito
US One Ltd., an Israeli company limited by shares (together with its successors, &#8220;<b>Pubco</b>&#8221;), (v) Mito Sub Israel
Ltd., an Israeli company limited by shares and a wholly-owned subsidiary of Pubco (&#8220;<b>Company Merger Sub</b>&#8221;), and
(vi) upon its execution and delivery of a joinder agreement to the BCA, a to-be-formed Cayman Islands exempted company
(&#8220;<b>SPAC Merger Sub,</b>&#8221; and together with Company Merger Sub, the &#8220;<b>Merger Subs</b>&#8221;). The transactions
contemplated by the Business Combination Agreement are referred to herein as the &#8220;<b>Business Combination</b>.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Subject to its terms and conditions, the Business Combination provides
that at the consummation of the transactions contemplated by the BCA (the &#8220;<b>Closing</b>&#8221;), the Company Merger Sub will merge
with and into the Company, with the Company continuing as the surviving entity (the &#8220;<b>Company Merger</b>&#8221;), and immediately
after the consummation of the Company Merger, SPAC Merger Sub will merge with and into SPAC, with SPAC continuing as the surviving company
(the &#8220;<b>SPAC Merger</b>&#8221; and, together with the Company Merger, the &#8220;<b>Mergers</b>&#8221; and collectively with the
other transactions contemplated by the BCA and the related ancillary documents, the &#8220;<b>Transactions</b>&#8221;). As a result of
such Mergers, SPAC and the Company each will become wholly owned subsidiaries of Pubco, and Pubco will become a publicly traded company
with the Pubco ordinary shares listed on Nasdaq (subject to Nasdaq approval).&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Transaction Consideration</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">According to the Business Combination Agreement, the total consideration
to be paid by Pubco to the Company&#8217;s security holders at the Closing (including holders of in-the-money Company options and holders
of Simple Agreements for Future Equity (&#8220;<b>SAFEs</b>&#8221;) with the Company) will be an amount equal to (the &#8220;<b>Merger
Consideration</b>&#8221;) the sum of (i) $180 million plus (ii) the aggregate net cash proceeds received by the Company or its subsidiaries
from financing activities between the signing of the BCA and the Closing, payable in Pubco ordinary shares, each valued at the price per
share that will be paid to SPAC&#8217;s public shareholders that choose to redeem their shares in connection with the Closing (the &#8220;<b>Redemption
Price</b>&#8221;). Each Company security holder will receive its pro rata share of the Merger Consideration (and any Earnout Shares after
the Closing, as detailed below).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Earnout</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition to the right to receive the Merger Consideration, the Company
securityholders at the Closing (including holders of in-the-money Company options and holders of Company SAFEs) (&#8220;<b>Eligible Earnout
Recipients</b>&#8221;) will have the contingent right after the Closing to receive an additional $57.5 million in Pubco ordinary shares,
each valued at the Redemption Price (the &#8220;<b>Earnout Shares</b>&#8221;), if during the five (5) year period after the Closing (the
&#8220;<b>Earnout Period</b>&#8221;) either: (i) the volume-weighted average price for Pubco&#8217;s ordinary shares for five (5) consecutive
trading days is at least $11.50 per share; or (ii) the Company or its subsidiaries begin a phase 3 clinical trial with the U.S. Food and
Drug Administration (the &#8220;<b>FDA</b>&#8221;) (or the FDA approves a Biologics License Application without a phase 3 clinical trial)
for its Pearson syndrome clinical development program or any other clinical development program for pharmaceutical products developed
by the Company or its subsidiaries. If there is a change-in-control transaction during the Earnout Period, to the extent that the implied
price per Pubco ordinary share in such transaction is above the $11.50 share price target, the vesting of the Earnout Shares will accelerate,
and the Earnout Shares will be issuable upon the closing of such transaction. Each Eligible Earnout Recipient will receive its pro rata
share of the Earnout Shares if they vest and are issued, except that if an Eligible Earnout Recipient transfers the Pubco ordinary shares
received as Merger Consideration prior to the issuance of the Earnout Shares, they will lose a pro rata portion of their Earnout Shares
equal to the number of Pubco ordinary shares transferred, and such lost Earnout Shares will be reallocated to the other Eligible Earnout
Recipient(s).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Representations and Warranties</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The BCA contains
customary representations and warranties of SPAC, Pubco, Merger Subs and the Company as of the date of the BCA or other specified
dates solely for the benefit of certain of the parties to the BCA, which in certain cases are subject to specified exceptions and
materiality, Material Adverse Effect (as defined below), knowledge and other qualifications contained in the BCA or in information
provided pursuant to certain disclosure schedules to the BCA. &#8220;<b>Material Adverse Effect</b>&#8221; as used in the BCA means,
in short, with respect to any specified person or entity, any fact, event, occurrence, change or effect that has had, or would
reasonably be expected to have, individually or in the aggregate, a material adverse effect upon the business, assets, liabilities,
customer relationships, operations, results of operations, prospects or condition (financial or otherwise) of such person and its
subsidiaries, taken as a whole, or the ability of such person or any of its subsidiaries on a timely basis to consummate the <span style="background-color: white">Transactions,
in each case subject to certain customary exceptions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the BCA, the Company made certain customary representations and
warranties to SPAC and Pubco as of the date of the BCA and as of the Closing, including, among other things, with respect to (i) organization
and qualification, (ii) capitalization, (iii) authorization, (iv) subsidiaries, (v) government approvals, (vi) non-contravention, (vii)
financial statements, (viii) permits, (ix) material contracts, (x) absence of certain changes, (xi) litigation, (xii) compliance with
laws, (xiii) employee plans, (xiv) environmental matters, (xv) intellectual property, (xvi) labor matters, (xvii) insurance, (xviii) taxes,
(xix) brokers, (xx) real and personal property, (xxi) transactions with affiliates, (xxii) title to and sufficiency of assets, (xxiii)
suppliers, (xxiv) product regulatory matters, (xxv) anti-corruption laws, (xxvi) investment company act, (xxvii) finders and brokers and
(xxviii) information supplied.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the BCA, the SPAC made
certain customary representations and warranties to the Company and Pubco as of the date of the BCA and as of the Closing, including among
others, related to the following: (i) organization and qualification, (ii) capitalization, (iii) authorization, (iv) government approvals,
(v) non-contravention, (vi) Securities and Exchange Commission (the &#8220;<b>SEC</b>&#8221;) filings and financial statements, (vii)
absence of certain changes, (viii) compliance with laws, (ix) actions, orders and permits, (x) taxes, (xi) employees and employee plans,
(xii) properties, (xiii) material contracts, (xiv) transactions with affiliates, (xv) investment company act, (xvi) finders and brokers,
(xvii) anti-corruption laws, (xviii) insurance, (xix) information supplied and (xx) trust account.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the BCA, Pubco and the Merger Subs made certain customary representations
and warranties to SPAC and the Company with respect to Pubco and Merger Subs as of the date of the BCA (or as of the date of the execution
of the joinder agreement, with respect to SPAC Merger Sub) and as of the Closing, including among others, representations and warranties
related to the following: (i) organization and qualification, (ii) capitalization, (iii) authorization, (iv) government approvals, (v)
non-contravention, (vi) ownership of merger consideration shares, (vii) activities of Pubco and the Merger Subs, (viii) finders and brokers,
(ix) investment company act and (x) information supplied. Each party&#8217;s representations, warranties and pre-Closing covenants contained
in the BCA do not survive the Closing, and no party has any post-Closing indemnification obligations. Only the covenants and agreements
of the parties to be performed after the Closing will survive the Closing, with such covenants and agreements surviving until fully performed.
The BCA does not permit recourse against anyone other than the parties to the BCA.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Covenants</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition to customary covenants
regarding the conduct of their respective businesses, efforts, access, confidentiality and public announcements, notice of breaches, no
insider trading, D&amp;O indemnification, SPAC public filings, Nasdaq listing, U.S. and Israeli tax matters, use of trust account proceeds,
and other customary covenants, the parties agreed to the following covenants:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The Company will use its reasonable best efforts to deliver to SPAC
PCAOB audited annual financial statements for its fiscal year ended December 31, 2024 and December 31, 2023 and its PCAOB reviewed interim
financial statements for the six-month period ended June 30, 2025 (together the &#8220;<b>PCAOB Financials</b>&#8221;), as promptly as
practicable after the date of the BCA. Additionally, during the period from the signing of the BCA through the Closing, the Company will
deliver to SPAC monthly, quarterly and annual unaudited income statements and balance sheets of the Company and its subsidiaries for the
period from December 31, 2024 through each such calendar month, quarterly period of fiscal year, in each case accompanied by a certificate
of the Company&#8217;s chief financial officer.</span></td></tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Each party is subject to a &#8220;no shop&#8221; between signing and
Closing and will not be allowed to solicit or discuss competing transactions with other potential parties.</span></td></tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The parties will promptly prepare and file with the SEC a registration
statement on Form F-4 (the &#8220;<b>Registration Statement</b>&#8221;) to register the Pubco securities to be issued in replacement of
SPAC and Company securities, and the SPAC proxy statement that will be contained therein (the &#8220;<b>Proxy Statement</b>&#8221;) for
the purpose of soliciting proxies from SPAC&#8217;s shareholders for the matters to be acted upon at a shareholders' meeting to be called
for SPAC shareholders to vote on, among other matters, the BCA and the Transactions. As part of the Registration Statement, Pubco will
approve and adopt, subject to SPAC shareholder approval, a new incentive equity plan with total awards equal to 10% of the outstanding
shares of Pubco immediately after the Closing and otherwise in a form to be reasonably agreed upon by the Company and SPAC. The SPAC board
of directors will not be able to change its recommendation that SPAC shareholders approve the BCA and the Transactions and related matters
(the &#8220;<b>Board Recommendation</b>&#8221;), except as required by fiduciary duties (including after giving a chance to the Company
to revise the terms of the BCA so that the change in Board Recommendation is no longer required).</span></td></tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The Company will call a shareholder meeting as promptly as practicable
after the Registration Statement has become effective and use its reasonable best efforts to have its shareholders approve the BCA and
related matters.</span></td></tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The Pubco board of directors after the Closing will consist of eight
(8) directors, to be composed as follows: (a) five (5) directors designated by the Company prior to the Closing, (b) one (1) director
designated by the Sponsor prior to the Closing, and (c) two (2) directors designated by Alex Greystoke and Jon Bakhshi as long as (x)
they pay the expenses of the Company&#8217;s U.S. securities counsel and PCAOB auditor in accordance with their agreement with the Company,
and (y) the Minimum Cash Condition (as described below) is satisfied. A majority of the directors of the Pubco board of directors following
the Closing will qualify as independent directors under applicable Nasdaq rules. The Pubco board will be a classified board with three
(3) classes of directors each serving three (3) year terms after their initial term, with the Class I directors (consisting of two (2)
directors) initially serving a one-year term, Class II directors (consisting of three (3) directors) initially serving a two-year term
and Class III directors (consisting of three (3) directors) initially serving a three-year term. The director designated by the Sponsor
shall serve as a Class III director.</span></td></tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The Company, with the reasonable assistance of SPAC, will use its commercially
reasonable efforts to seek, enter into and consummate, within 30 days after the execution of the BCA, bridge financing agreements with
certain accredited investors (on terms and conditions and in such form as mutually agreed upon, such agreement not to be unreasonably
withheld, delayed or conditioned) for an aggregate investment amount into the Company of at least $5 million at a pre-money equity valuation
of the Company of $120 million (the &#8220;<b>Bridge Financing</b>&#8221;).</span></td></tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Between the signing of the BCA and the Closing, SPAC, the Company and
Pubco will use their commercially reasonable efforts to enter into additional financing agreements for aggregate proceeds of at least
$18 million (excluding any committed capital on demand or equity line facility) in addition to the Bridge Financing on such terms and
structuring as SPAC and the Company shall mutually agree upon (such agreement not to be unreasonably withheld, delayed or conditioned)
(the &#8220;<b>Additional Transaction Financing</b>&#8221; and, together with the Bridge Financing, the &#8220;<b>Transaction Financing</b>&#8221;),
except that the Company&#8217;s prior written consent, in its sole and absolute discretion, is required with respect to any Additional
Transaction Financing that is for debt or debt-like securities (including mandatorily redeemable preferred equity) that is not convertible
into common equity of Pubco.</span></td></tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The Company will use its reasonable best efforts to cause certain specified
individuals, including the Company&#8217;s chief executive officer and chief financial officer to enter into new employment agreements,
effective as of the Closing, with Pubco in form and substance reasonably acceptable to the Company and SPAC (the &#8220;<b>Employment
Agreements</b>&#8221;).</span></td></tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The Company will use its reasonable best efforts to ensure that all
Locked-Up Company Security Holders (as defined below) that did not sign Lock-Up Agreements at the time of the BCA, sign Lock-Up Agreements
as promptly as practicable after the signing of the BCA.</span></td></tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Unless SPAC notifies the Company within 30 days after the date of the
BCA that it elects not to seek an FTO Opinion (as defined below), during a period of up to 30 days after the date of the BCA, SPAC will,
and will cause its U.S. IP counsel to, use commercially reasonable efforts to perform a freedom to operate analysis directed to whether
the products and technology of the Company and its Subsidiaries are reasonably likely to infringe upon any third-party U.S. Patents (the
&#8220;<b>FTO Opinion</b>&#8221;), and the Company will reasonably cooperate with such efforts.</span></td></tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">As promptly as practicable after the signing of the BCA and before
the initial filing of the Registration Statement, the Company shall cause SPAC Merger Sub to be formed in the Cayman Islands, and for
the SPAC Merger Sub to execute a joinder agreement to the BCA.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Conditions to Closing</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The BCA is subject to customary Closing conditions, including (i) receipt
of SPAC shareholder approval, (ii) receipt of Company shareholder approval, (iii) completion of any antitrust expiration periods, as applicable,
(iv) receipt of any specified third party and governmental authority consents, (v) no law or order preventing the Transactions, (vi) no
material uncured breach by the other party of its representations, warranties, covenants and agreements under the BCA, (vii) the Pubco
ordinary shares having been approved for listing on Nasdaq, (viii) no occurrence of a material adverse effect which is continuing and
uncured with respect to SPAC, Company or Pubco, (ix) Pubco&#8217;s qualification as a foreign private issuer under the Securities Exchange
Act of 1934, as amended, (x) that the Registration Statement will have been declared effective by the SEC, (xi) the members of the post-Closing
Pubco board of directors will have been appointed in accordance with the BCA, (xii) Pubco will have amended and restated its organizational
documents in substantially the form attached to the BCA, (xiii) the parties will have entered into an amendment and restatement of SPAC&#8217;s
registration rights agreement from its initial public offering in form and substance reasonably acceptable to the SPAC and the Company
(the &#8220;<b>Amended Registration Rights Agreement</b>&#8221;) to have Pubco assume the registration obligations of SPAC under the original
registration rights agreement and have such rights apply to Pubco&#8217;s securities, and to add thereto certain Company security holders
that are expected to be officers, directors or affiliates of Pubco immediately after the Closing in order to provide them with registration
rights with respect to the Pubco ordinary shares received in the Company Merger and any Earnout Shares, (xiv) receipt of the Employment
Agreements, (xv) SPAC having received Lock-Up Agreements from all Locked-Up Company Security Holders that did not sign a Lock-Up Agreement
at the time of the BCA, (xvi) the receipt of certain Israeli tax rulings and Israeli securities laws rulings; (xvii) the conclusion of
statutory merger waiting periods under Israeli law and (xviii) SPAC Merger Sub having been formed and executed and having delivered a
joinder agreement to become party to the BCA.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company&#8217;s obligation to complete the Closing is also subject
to a minimum cash condition (the &#8220;<b>Minimum Cash Condition</b>&#8221;) requiring that, upon Closing, SPAC shall have an aggregate
amount of cash and cash equivalents, including funds remaining in the trust account, after redemptions, that when added to the aggregate
proceeds of all Transaction Financing, whether received by SPAC, Pubco or the Company or its subsidiaries, and after deducting all SPAC
unpaid transaction expenses (including deferred initial public offering expenses) and administrative expenses, including placement agent
fees, and other cash liabilities (including up to $275,000 of fees payable to the Company&#8217;s Israeli legal counsel), is at least
equal to $23 million.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Termination </i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition to
termination by mutual written consent of SPAC and the Company, the BCA provides for termination, in each case by written notice from
the terminating party to the other party: (i) by either party if the conditions to the Closing have not been satisfied (except as
the result of an uncured breach by the terminating party or its affiliates) or waived and the Closing does not occur by December 24,
2025 (the &#8220;<b>Outside Date</b>&#8221;); (ii) by either party if a governmental authority of competent jurisdiction has issued
an order or taken any other action permanently restraining, enjoining or otherwise prohibiting the Transactions, and such order or
other action has become final and non-appealable (except as the result of an uncured breach by the terminating party or its
affiliates); (iii) by either party for the other party&#8217;s (or its affiliates) uncured material breach of its representations,
warranties, covenants or agreements set forth in the BCA (except where the terminating party or its affiliate is then in uncured
material breach); (iv) by SPAC if there has been an event after the signing of the BCA that has had a Material Adverse Effect on the
Company and its subsidiaries, taken as a whole, or Pubco, which is uncured and continuing; (v) by the Company if there has been an
event after the signing of the BCA that has had a Material Adverse Effect on SPAC and its subsidiaries, taken as a whole, which is
uncured and continuing; (vi) by the Company if SPAC publicly changes its Board Recommendation or fails to include the Board
Recommendation in the Registration Statement; (vii) by either party if the SPAC shareholders do not approve the BCA and related
proposals at the shareholder meeting of SPAC; (viii) by either party if Bridge Financing with aggregate gross proceeds of at least
$5 million is not consummated within 30 days after the date of the BCA (with the termination right falling away once $5 million in
Bridge Financing is consummated); (ix) by SPAC upon written notice to the Company if the SPAC&#8217;s U.S. IP counsel concludes in
connection with the FTO Opinion analysis that the products or technology of the Company and its subsidiaries, as currently
contemplated, are reasonably likely to materially infringe one or more valid and enforceable third-party U.S. Patents, where such
infringement would reasonably be expected to result in a Material Adverse Effect on the Company, and the Company does not propose
within 15 days of receiving such notice a commercially reasonable mitigation plan to address such issues that is reasonably
acceptable to SPAC (with the termination right falling away if SPAC waives the provisions regarding the FTO Opinion or once the FTO
Opinion is actually delivered).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">There is no termination fee,
but each party will continue to be liable after termination of the BCA for any willful breach or fraud claim prior to such termination.
Each party will bear its own expenses if the transaction does not close.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Trust Account Waiver</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Each of the Company, Pubco, the Company Merger Sub, SPAC Merger Sub
(upon its execution and delivery of a joinder to become party to the BCA), and the Seller Representative has agreed that they and their
affiliates will not have any right, title, interest or claim of any kind in or to any monies in SPAC&#8217;s trust account (including
any distributions therefrom) held for its public shareholders. They have further agreed not to assert, and have waived any right to assert,
any claim against the trust account (including any distributions from the trust account to SPAC&#8217;s public shareholders).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Related Agreements</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Voting Agreements</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Simultaneously with the execution of the BCA, certain Company securityholders
constituting approximately 35% of the outstanding voting securities of the Company each entered into a voting agreement with SPAC and
the Company (each, a &#8220;<b>Voting Agreement</b>&#8221;), pursuant to which, among other matters, such Company securityholders have
undertaken to vote their Company shares in favor of the BCA and the Transactions and against competing transactions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>A copy of the form of
Voting Agreement is filed as Exhibit 10.2 to this Current Report on Form 8-K and is incorporated herein by reference, and the foregoing
description of the Voting Agreement is qualified in its entirety by reference thereto.</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Lock-Up Agreements</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Company securityholders that, as of the date of the BCA are or as of
immediately prior to the Closing will be, officers or directors of the Company or own at least 3% of the fully-diluted equity of the Company
(the &#8220;<b>Locked-Up Company Securityholders</b>&#8221;) have entered or will enter into, either simultaneously with the execution
of the BCA or prior to the Closing, a lock-up agreement (each, a &#8220;<b>Lock-Up Agreement</b>&#8221;) with Pubco, SPAC and the SPAC
Representative, pursuant to which such Company securityholder agrees to lock-up the Pubco ordinary shares that it receives in the transaction
(including any Earnout Shares) for a period commencing from the Closing and ending on the one-year anniversary of the Closing (subject
to early release if (x) the closing price of Pubco ordinary shares exceeds $12.00 per share for any 20 trading days within any 30 trading
day period commencing at least 150 days after the Closing or (y) Pubco consummates a liquidation, merger, share exchange or other similar
transaction with an unaffiliated third party that results in at least a majority of Pubco&#8217;s shareholders having the right to exchange
their equity holdings in Pubco for cash, securities or other property), subject to certain customary transfer exceptions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>A copy of the form of
Lock-Up Agreement is filed as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated herein by reference, and the foregoing
description of the Lock-Up Agreement is qualified in its entirety by reference thereto.</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Sponsor Agreement</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Simultaneously with the execution and delivery of the BCA, the Sponsor,
Pubco and the Seller Representative entered into a letter agreement (the &#8220;<b>Sponsor Agreement</b>&#8221;), pursuant to which the
Sponsor agreed to subject 22.5% of its SPAC founder shares (the &#8220;<b>Sponsor Earnout Shares</b>&#8221;) to certain transfer restrictions
and potential forfeiture if a Triggering Event does not occur during the Earnout Period and, therefore, the Eligible Earnout Recipients
no longer have the contingent right to receive any Earnout Shares. Additionally, the Sponsor agreed to subject a portion of such Sponsor
Earnout Shares to additional escrow and transfer restrictions if the Minimum Cash Condition is not satisfied but is waived by the Company
and the Closing occurs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>A copy of the Sponsor
Agreement is filed as Exhibit 10.3 to this Current Report on Form 8-K and is incorporated herein by reference, and the foregoing
description of the Sponsor Agreement is qualified in its entirety by reference thereto</i>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b></b></p>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Additional Information and Where to Find It</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Current Report on Form 8-K (&#8220;<b>Form
8-K</b>&#8221;) is provided for informational purposes only and contains information with respect to a proposed business combination (the
&#8220;<b>Proposed Business Combination</b>&#8221;) among Launch One, Pubco and the Company.</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In
connection with the Proposed Business Combination, Pubco intends to file a registration statement on Form F-4 with the SEC, which will
include a proxy statement to Launch One shareholders and a prospectus for the registration of Pubco securities in connection with the
Proposed Business Combination (as amended from time to time, the &#8220;<b>Registration Statement</b>&#8221;). After the Registration
Statement is declared effective by the SEC, the definitive proxy statement/prospectus and other relevant documents will be mailed to
the shareholders of Launch One as of the record date in the future to be established for voting on the Proposed Business Combination
and will contain important information about the Proposed Business Combination and related matters. Shareholders of Launch One and other
interested persons are advised to read, when available, these materials (including any amendments or supplements thereto) and any other
relevant documents, because they will contain important information about Launch One, Pubco, Minovia, and the Proposed Business Combination.
Shareholders and other interested persons will also be able to obtain copies of the preliminary proxy statement/prospectus, the definitive
proxy statement/prospectus, and other relevant materials in connection with the Proposed Business Combination, without charge, once available,
at the SEC&#8217;s website at www.sec.gov or by directing a request to: Launch One Acquisition Corp., 180 Grand Avenue, Suite 1530, Oakland
CA, 94612, Attn: Jurgen van de Vyver, Chief Financial Officer. The information contained on, or that may be accessed through, the websites
referenced in this Form 8-K in each case is not incorporated by reference into, and is not a part of, this Form 8-K.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">BEFORE MAKING ANY VOTING DECISION, INVESTORS AND
SECURITY HOLDERS OF LAUNCH ONE ARE URGED TO READ THE REGISTRATION STATEMENT, THE PROXY STATEMENT/PROSPECTUS AND ALL OTHER RELEVANT DOCUMENTS
FILED OR THAT WILL BE FILED WITH THE SEC IN CONNECTION WITH THE PROPOSED BUSINESS COMBINATION AS THEY BECOME AVAILABLE BECAUSE THEY WILL
CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED BUSINESS COMBINATION.</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Participants in the Solicitation</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Launch One, Pubco, and the Company and their respective
directors and executive officers may be deemed participants in the solicitation of proxies from Launch One&#8217;s shareholders in connection
with the Proposed Business Combination. Launch One&#8217;s shareholders and other interested persons may obtain, without charge, more
detailed information regarding the directors and officers of Launch One in Launch One&#8217;s Form 10-K, as amended, filed with the SEC
on March 26, 2025, or its Form 10-Q, filed with the SEC on May 15, 2025. Information regarding the persons who may, under SEC rules, be
deemed participants in the solicitation of proxies to Launch One&#8217;s shareholders in connection with the Proposed Business Combination
will be set forth in the proxy statement/prospectus for the Proposed Business Combination, accompanying the Registration Statement that
Launch One intends to file with the SEC. Additional information regarding the interests of participants in the solicitation of proxies
in connection with the Proposed Business Combination will likewise be included in that Registration Statement. You may obtain free copies
of these documents as described above.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>No Offer or Solicitation</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Form 8-K is not a proxy statement or solicitation
of a proxy, consent or authorization with respect to any securities or in respect of the Proposed Business Combination and shall not constitute
an offer to sell or a solicitation of an offer to buy any securities, or a solicitation of any vote or approval, nor shall there be any
sale of securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or
qualification under the securities laws of any such state or jurisdiction. No offer of securities shall be made except by means of a prospectus
meeting the requirements of the Securities Act of 1933, as amended, or an exemption therefrom.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b></b>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Cautionary Note Regarding Forward-Looking Statements</b>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Form 8-K contains
certain statements that may be considered forward-looking statements within the meaning of the federal securities laws.
Forward-looking statements include, without limitation, statements about future events or Launch One&#8217;s or Minovia&#8217;s
future financial or operating performance. For example, statements regarding the Proposed Business Combination, and the anticipated
timing of the completion of the Proposed Business Combination are forward-looking statements. In some but not all cases, you can
identify forward-looking statements by terminology such as &#8220;may,&#8221; &#8220;should,&#8221; &#8220;could,&#8221;
&#8220;might,&#8221; &#8220;plan,&#8221; &#8220;possible,&#8221; &#8220;project,&#8221; &#8220;strive,&#8221; &#8220;budget,&#8221;
&#8220;forecast,&#8221; &#8220;expect,&#8221; &#8220;intend,&#8221; &#8220;will,&#8221; &#8220;estimate,&#8221;
&#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;predict,&#8221; &#8220;potential&#8221; or &#8220;continue,&#8221; or the
negatives of these terms or variations of them or similar terminology.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">These forward-looking
statements regarding future events and the future results of Launch One and Minovia are based on current expectations, estimates,
forecasts, and projections as well as the beliefs and assumptions of Launch One&#8217;s management and Minovia&#8217;s management.
These forward-looking statements are only predictions and are subject to, without limitation, (i) known and unknown risks, including
the risks and uncertainties indicated from time to time in the final prospectus of Launch One relating to its initial public
offering filed with the SEC, including those under &#8220;Risk Factors&#8221; therein, and other documents filed or to be filed with
the SEC by Launch One; (ii) uncertainties; (iii) assumptions; and (iv) other factors beyond Launch One&#8217;s or Minovia&#8217;s
control that are difficult to predict because they relate to events and depend on circumstances that will occur in the future. They
are neither statements of historical fact nor promises or guarantees of future performance. Therefore, Minovia&#8217;s actual
results may differ materially and adversely from those expressed or implied in any forward-looking statements and Launch One and
Minovia therefore caution against relying on any of these forward-looking statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">These forward-looking statements are based upon
estimates and assumptions that, while considered reasonable by Launch One and its management, Minovia and its management, as the case
may be, are inherently uncertain and are inherently subject to risks,&#160;variability and contingencies, many of which are beyond Launch
One&#8217;s or Minovia&#8217;s control. Factors that may cause actual results to differ materially from current expectations include,
but are not limited to: (i)&#160;the occurrence of any event, change or other circumstances that could give rise to the termination of
the Business Combination Agreement and any subsequent definitive agreements with respect to the Proposed Business Combination; (ii)&#160;the
outcome of any legal proceedings that may be instituted against Launch One, Minovia, or others following the announcement of the Proposed
Business Combination and any definitive agreements with respect thereto; (iii)&#160;the inability to complete the Proposed Business Combination
due to the failure to obtain consents and approvals of the shareholders of Launch One, to obtain financing to complete the Proposed Business
Combination or to satisfy other conditions to closing, or delays in obtaining, adverse conditions contained in, or the inability to obtain
necessary regulatory approvals required to complete the transactions contemplated by the Business Combination Agreement; (iv)&#160;changes
to the proposed structure of the Proposed Business Combination that may be required or appropriate as a result of applicable laws or regulations
or as a condition to obtaining regulatory approval of the Proposed Business Combination; (v)&#160;projections, estimates and forecasts
of revenue and other financial and performance metrics, projections of market opportunity and expectations, and the estimated implied
enterprise value of Minovia; (vi)&#160;Minovia&#8217;s ability to scale and grow its business, and the advantages and expected growth
of Minovia; (vii)&#160;Minovia&#8217;s ability to source and retain talent, the cash position of Minovia following closing of the Proposed
Business Combination; (viii)&#160;the ability to meet stock exchange listing standards in connection with, and following, the consummation
of the Proposed Business Combination; (ix)&#160;the risk that the Proposed Business Combination disrupts current plans and operations
of Minovia as a result of the announcement and consummation of the Proposed Business Combination; (x)&#160;the ability to recognize the
anticipated benefits of the Proposed Business Combination, which may be affected by, among other things, competition, the ability of Minovia
to grow and manage growth profitably, maintain key relationships and retain its management and key employees; (xi)&#160;costs related
to the Proposed Business Combination; (xii)&#160;changes in applicable laws, regulations, political and economic developments; (xiii)&#160;the
possibility that Minovia may be adversely affected by other economic, business and/or competitive factors; (xiv)&#160;Minovia&#8217;s
estimates of expenses and profitability; (xv)&#160;the failure to realize estimated shareholder redemptions, purchase price and other
adjustments; and (xvi)&#160;other risks and uncertainties set forth in the filings by Launch One with the SEC. There may be additional
risks that neither Launch One nor Minovia presently know or that Launch One and Minovia currently believe are immaterial that could also
cause actual results to differ from those contained in the forward-looking statements. Any forward-looking statements made by or on behalf
of Launch One or Minovia speak only as of the date they are made. None of Launch One or Minovia undertakes any obligation to update any
forward-looking statements to reflect any changes in their respective expectations with regard thereto or any changes in events, conditions
or circumstances on which any such statement is based.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b></b>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 9.01 Financial Statements and Exhibits.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(d) Exhibits</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr>
    <td style="border-bottom: black 1.5pt solid; vertical-align: bottom; width: 9%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit No.</b></span></td>
    <td style="vertical-align: top; width: 1%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; vertical-align: bottom; width: 90%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1*</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="ea024761201ex2-1_launch.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Business</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Combination
    Agreement, dated as of June 25, 2025, by and among Launch One, the Company, Seller Representative, Pubco, and Company Merger Sub. </span></a></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1 </span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="ea024761201ex10-1_launch.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Lock-Up Agreement, dated as of June 25, 2025, by and among Pubco, Launch One, the Sponsor, and certain Company securityholders therein.</span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="ea024761201ex10-2_launch.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Voting Agreement, dated as of June 25, 2025, by and among Launch One, and the Company, and certain Company securityholders therein. </span></a></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3</span></td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ea024761201ex10-3_launch.htm">Sponsor Agreement, dated as of June 25, 2025, by and among the Company, the Sponsor, Pubco, and the Seller Representative.</a></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover Page Interactive Data File (embedded with the Inline XRBL document).</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">*The exhibits and schedules to this Exhibit have
been omitted in accordance with Item 601(b)(2) of Regulation S-K. The Registrant agrees to furnish supplementally to the SEC a copy of
all omitted exhibits and schedules upon its request.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURE</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b>LAUNCH ONE ACQUISITION CORP.</b></span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="2">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="width: 60%">&#160;</td>
    <td style="width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1.5pt solid; width: 35%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/ Chris Ehrlich</i></span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chris Ehrlich</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: </span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer &#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated: July 1, 2025</span></td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">7</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p>













<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJyFUttum0AQ/QL/wwjl0XUWqqQSby5yoqpOjdw06esEhnjVZRfN4ks+qX/Z2QWSh7opQiBmzsy5sEkyT27djTbE8PPzdg331HYGe4ItNcRkKxJE8eVrDvLe0rP2PaPt4+c0WDiZIZm5XqQo9Yg8aE91Dur68qO6zK5AfcrlWd4ls9AvnG10TbbXaABtDSW7jjX1yC/Dhns8Oeval8j0QOy1szmkCzW0f0Om0gy+uQMeHf/ysF4XyWwer1lyy27fCWp16smGSVgZaoXOD9Nvd1RT7X3v2vwROXjzK6x2jztnaCysTsSV9vhk6MbxxlJh0PsN19qK3O87ZFpOICpZV7Rp0nRxpUri2L2j9olYiFKVZalajh4mvjmQMMIxUMJxKAK9kULjGJwliLywBDdSgw/bAXuJcBog6IICcA1cRBHQyS+KwDOW/3biS+QHNHtSC6VU+h8L5xWJow4ZDmENXAyL3pXxw+ohdjkXXo6Yts+b5nzQtpb6Dk0TAVuqidoQ0hjmP3RGgjHn6pUjhPRernIupf0hsE1QfiWc/tRk5w9fXQ+P -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-2.1
<SEQUENCE>2
<FILENAME>ea024761201ex2-1_launch.htm
<DESCRIPTION>BUSINESS COMBINATION AGREEMENT, DATED AS OF JUNE 25, 2025, BY AND AMONG LAUNCH ONE, THE COMPANY, SELLER REPRESENTATIVE, PUBCO, AND MERGER SUBS
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 2.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B><I>EXECUTION COPY</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>CONFIDENTIAL</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>&nbsp;</B></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B></B></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: auto; margin-right: auto; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>BUSINESS COMBINATION AGREEMENT</B></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">by and among</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>LAUNCH ONE ACQUISITION CORP.</B>,<BR>
as SPAC,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>LAUNCH ONE SPONSOR LLC,<BR>
</B>in the capacity as the SPAC Representative</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>MINOVIA THERAPEUTICS LTD.<BR>
</B>as the Company,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NATALIE YIVGI-OHANA,</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">in the capacity as the Seller Representative,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>MITO US ONE LTD.,</B><BR>
as Pubco,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>MITO SUB ISRAEL LTD.,<BR>
</B> as Company Merger Sub,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">upon execution of the Joinder,<BR>
SPAC Merger Sub</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Dated as of June 25, 2025</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B></B></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: auto; margin-right: auto; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>




<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-transform: uppercase; text-indent: -0.5in">&nbsp;</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase">TABLE OF CONTENTS</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-transform: uppercase; text-indent: -0.5in"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: center"><B>Page</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="width: 90%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>I. MERGERS</B></FONT></TD>
    <TD STYLE="text-align: center; width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>3</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1. Company Merger</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.2. SPAC Merger</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.3. Effective Times</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.4. Effect of the Mergers</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.5. Organizational Documents of Surviving Subsidiaries</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.6. Directors and Officers of the Surviving Subsidiaries</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.7. Amended Pubco Organizational Documents</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.8. Effect of SPAC Merger on Outstanding Securities
    of SPAC and SPAC Merger Sub</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.9. Effect of Company Merger on Outstanding Securities of the Company and Company Merger Sub</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.10. Effect of Mergers on Outstanding Securities of Pubco</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.11. Merger Consideration for Company Security Holders</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.12. Closing Calculations</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.13. Earnout</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.14. Surrender of Company Securities and Disbursement of Merger Consideration</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.15. U.S. Federal Income Tax Consequences</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.16. Israeli Withholding Taxes</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.17. Taking of Necessary Action; Further Action</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>II. CLOSING</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>14</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1. Closing</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>III. representations and warranties of SPAC</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>15</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1. Organization and Standing</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2. Authorization; Binding Agreement</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3. Governmental Approvals</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.4. Non-Contravention</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.5. Capitalization</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.6. SEC Filings and SPAC Financials</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.7. Absence of Certain Changes</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.8. Compliance with Laws</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.9. Actions; Orders; Permits</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.10. Taxes and Returns</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.11. Employees and Employee Benefit Plans</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">19</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.12. Properties</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">19</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.13. Material Contracts</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">19</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.14. Transactions with Affiliates</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">19</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.15. Investment Company Act</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">19</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.16. Finders and Brokers</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">19</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.17. Certain Business Practices</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.18. Insurance</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.19. Information Supplied</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.20. Trust Account</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.21. Independent Investigation</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.22. No Other Representations</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>Article IV. representations and warranties of pubco AND THE MERGER SUBS</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>22</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1.Organization and Standing</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2. Authorization; Binding Agreement</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="width: 90%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3. Governmental Approvals</FONT></TD>
    <TD STYLE="text-align: center; width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4. Non-Contravention</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.5. Capitalization</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.6. Ownership of Merger Consideration Shares</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.7. Pubco and Merger Sub Activities</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.8. Finder and Brokers</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.9.Investment Company Act</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.10. Information Supplied</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.11. Independent Investigation</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.12. No Other Representations</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>Article V. representations and warranties of THE COMPANY</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>24</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1. Organization and Standing</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2. Authorization; Binding Agreement</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.3. Capitalization</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.4. Subsidiaries</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">26</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.5. Governmental Approvals</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">26</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.6. Non-Contravention</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">27</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.7. Financial Statements</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">27</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.8. Absence of Certain Changes</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">28</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.9. Compliance with Laws</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">28</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.10. Company Permits</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">29</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.11. Litigation</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">29</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.12. Material Contracts</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">29</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.13. Intellectual Property</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">31</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.14. Taxes and Returns</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">33</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.15. Real Property</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">34</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.16. Personal Property</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">35</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.17. Title to and Sufficiency of Assets</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">35</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.18. Employee Matters</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">35</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.19. Benefit Plans</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">36</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.20. Environmental Matters</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">37</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.21. Transactions with Related Persons</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">38</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.22. Business Insurance</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">38</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.23. Top Vendors</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">39</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.24. Product Regulatory Matters</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">39</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.25. Certain Business Practices</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">40</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.26. Investment Company Act</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">40</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.27. Finders and Brokers</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">40</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.28. Information Supplied</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">40</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.29. Independent Investigation</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">41</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.30. No Other Representations</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">41</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>VI. COVENANTS</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>41</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.1. Access and Information</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">41</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.2. Conduct of Business of the Company, Pubco and the Merger Subs</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">42</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.3. Conduct of Business of SPAC</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">44</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.4. PCAOB Financials; Annual and Interim Financial Statements</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">46</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.5. SPAC Public Filings</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">46</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.6. No Solicitation</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">47</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.7. No Trading</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">47</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="width: 90%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.8. Notification of Certain Matters</FONT></TD>
    <TD STYLE="text-align: center; width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">48</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.9. Efforts</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">48</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.10. Further Assurances</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">49</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.11. The Registration Statement</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">50</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.12. Tax Matters</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">51</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.13. Required Company Shareholder Approval; Company Merger Proposal</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">52</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.14. Public Announcements</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">53</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.15. Confidential Information</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">53</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.16. Post-Closing Board of Directors and Executive Officers</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">54</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.17. Indemnification of Directors and Officers; Tail Insurance</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">54</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.18. Trust Account and Transaction Financing Proceeds</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">55</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.19. Bridge Financing; Other Transaction Financing</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">55</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.20. Employment Agreements</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">56</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.21. Nasdaq Listing</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">56</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.22. Israeli Securities Law; IAA</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">56</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.23. Israeli Tax Rulings</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">57</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.24. SPAC Merger Sub Formation and Joinder</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">57</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>Article VII. Closing conditions</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>58</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.1. Conditions of Each Party&rsquo;s Obligations</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">58</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.2. Conditions to Obligations of the Company, Pubco and the Merger Subs</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">59</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.3. Conditions to Obligations of SPAC</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">60</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.4. Frustration of Conditions</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">61</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>VIII. TERMINATION AND EXPENSES</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>61</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1. Termination</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">61</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.2. Effect of Termination</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">62</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.3. Fees and Expenses</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">62</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>IX. WAIVERs AND RELEASES</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>63</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.1. Waiver of Claims Against Trust</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">63</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>x. MISCELLANEOUS</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>63</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1. Survival</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">63</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2. Non-Recourse</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">63</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3. Notices</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">64</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.4. Binding Effect; Assignment</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">66</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.5. Third Parties</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">66</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.6. Arbitration</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">66</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.7. Governing Law; Jurisdiction</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">67</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.8. WAIVER OF JURY TRIAL</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">67</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.9. Specific Performance</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">67</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.10. Severability</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">67</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.11. Amendment</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">67</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.12. Waiver</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">67</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.13. Entire Agreement</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">67</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.14. Interpretation</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">68</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.15. Counterparts</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">68</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.16. Legal Representation</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">68</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.17. SPAC Representative</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">69</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.18. Seller Representative</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">70</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>XI DEFINITIONS</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>72</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.1. Certain Definitions</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">72</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.2. Section References</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">81</FONT></TD></TR>
  </TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-transform: uppercase; text-indent: -0.5in">&nbsp;<B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>INDEX OF EXHIBITS</U></B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 9%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 90%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U STYLE="text-decoration: none">Description</U></B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit A</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Voting Agreement</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit B</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Lock-Up Agreement</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit C</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sponsor Letter Agreement</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit D</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Amended Pubco Organizational Documents</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit E</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Joinder</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iii<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>BUSINESS COMBINATION AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Business Combination
Agreement (this &ldquo;<B><I>Agreement</I></B>&rdquo;) is made and entered into as of June 25, 2025, by and among (i) <B>Launch One Acquisition
Corp.</B>, a Cayman Islands exempted company limited by shares (together with its successors, &ldquo;<B><I>SPAC</I></B>&rdquo;), (ii)
<B>Launch One Sponsor LLC</B>, a Delaware limited liability company (the &ldquo;<B><I>Sponsor</I></B>&rdquo;), in the capacity as the
representative from and after the SPAC Merger Effective Time (as defined below) for the shareholders of SPAC and Pubco (other than the
Company Shareholders (as defined below) as of immediately prior to the Company Merger Effective Time and their successors and assigns)
in accordance with the terms and conditions of this Agreement (the &ldquo;<B><I>SPAC Representative</I></B>&rdquo;), (iii) <B>Minovia
Therapeutics Ltd.</B>, an Israeli company limited by shares (together with its successors, the &ldquo;<B><I>Company</I></B>&rdquo;), (iv)
<B>Natalie Yivgi-Ohana</B>, in the capacity as the representative from and after the Company Merger Effective Time for the Company Shareholders
as of immediately prior to the Company Merger Effective Time (and their successors and assigns) in accordance with the terms and conditions
of this Agreement (the &ldquo;<B><I>Seller Representative</I></B>&rdquo; and each of the SPAC Representative and the Seller Representative,
a &ldquo;<B><I>Representative Party</I></B>&rdquo;), (v) <B>Mito US One Ltd.</B>, an Israeli company limited by shares (together with
its successors, &ldquo;<B><I>Pubco</I></B>&rdquo;), (vi) <B>Mito Sub Israel Ltd.</B>, an Israeli company limited by shares and a wholly-owned
subsidiary of Pubco (&ldquo;<B><I>Company Merger Sub</I></B>&rdquo;) and (vii) upon execution and delivery of the Joinder (as defined
below), a to-be-formed Cayman Islands exempted company limited by shares (&ldquo;<B><I>SPAC Merger Sub</I></B>&rdquo;, and together with
Company Merger Sub, the &ldquo;<B><I>Merger Subs</I></B>&rdquo;). As of the date hereof, each of SPAC, Pubco, the Company, Company Merger
Sub and the Representative Parties are sometimes referred to herein individually as a &ldquo;<B><I>Party</I></B>&rdquo; and, collectively,
as the &ldquo;<B><I>Parties</I></B>&rdquo;, and upon its execution and delivery of the Joinder, the term &ldquo;<B><I>Party</I></B>&rdquo;
shall also include SPAC Merger Sub.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>RECITALS:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>WHEREAS,</B> the Company,
directly and indirectly through its subsidiaries, is engaged in the business of researching, developing and advancing mitochondrial therapies
for primary-genetic and age-related mitochondrial diseases;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>WHEREAS,</B> Pubco is a
newly-incorporated Israeli company limited by shares that is owned entirely by one or more directors or executive officers of the Company
who are not U.S. citizens or residents, and Company Merger Sub is a newly-incorporated Israeli company limited by shares that is wholly-owned
by Pubco;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>, promptly after
the date of this Agreement, the Company will cause SPAC Merger Sub to be formed and execute a Joinder;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>WHEREAS,</B> the Parties
desire and intend to effect a business combination transaction whereby (a) Company Merger Sub shall merge with and into the Company, with
the Company continuing as the surviving company (the &ldquo;<B><I>Company Merger</I></B>&rdquo;), and in connection therewith (i) the
shares of the Company issued and outstanding immediately prior to the Company Merger Effective Time (as defined below) shall be cancelled
in exchange for the right of the holders thereof to receive Pubco Ordinary Shares (as defined below), (ii) outstanding In-the-Money Company
Options (as defined below) will automatically vest and be cancelled in exchange for the right of the holders thereof to receive Pubco
Ordinary Shares, (iii) outstanding Company SAFEs (as defined below) will automatically be cancelled in exchange for the right of the holders
thereof to receive Pubco Ordinary Shares, and (iv) all other Company Convertible Securities (as defined below) that have not been cancelled
or converted prior to the Company Merger Effective Time will be terminated; (b) immediately after the consummation of the Company Merger,
SPAC Merger Sub shall merge with and into SPAC, with SPAC continuing as the surviving company (the &ldquo;<B><I>SPAC Merger</I></B>&rdquo;
and, together with the Company Merger, the &ldquo;<B><I>Mergers</I></B>&rdquo; and collectively with the other transactions contemplated
by this Agreement and the Ancillary Documents (as defined below), the &ldquo;<B><I>Transactions</I></B>&rdquo;), and in connection therewith
each issued and outstanding security of SPAC immediately prior to the SPAC Merger Effective Time (as defined below) shall no longer be
outstanding and shall automatically be cancelled, and the holders thereof shall receive a substantially equivalent security of Pubco;
and (c) as a result of such Mergers, SPAC and the Company each shall become wholly owned subsidiaries of Pubco, and Pubco shall become
a publicly traded company, all upon the terms and subject to the conditions set forth in this Agreement and in accordance with the provisions
of the Cayman Islands Companies Act, Israeli Companies Law and other applicable Law;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<!-- Field: Page; Sequence: 5; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>WHEREAS, </B>on the date
hereof, SPAC has received voting agreements in the form attached as <U>Exhibit A</U> hereto (collectively, the &ldquo;<B><I>Voting Agreements</I></B>&rdquo;)
signed by the Company and certain Company Shareholders which, in the aggregate, represent approximately 35% of the voting power of the
issued and outstanding Company Securities as of the date of this Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>WHEREAS,</B> the Company
Security Holders that are now, or as of immediately prior to the Closing will be, officers or directors of the Company or holders of at
least three percent (3%) of the Company&rsquo;s issued and outstanding shares on a fully diluted basis, including the HSC Principals with
respect to any Company Securities that they may receive under the HSC Letter Agreement (collectively, the &ldquo;<B><I>Locked-Up Company
Security Holde</I></B>rs&rdquo;) have either contemporaneously with the execution and delivery of this Agreement entered into lock-up
agreements with SPAC, Pubco and the SPAC Representative, in the form attached hereto as <U>Exhibit B</U> (the &ldquo;<B><I>Lock-Up Agreements</I></B>&rdquo;),
which Lock-Up Agreements shall become effective as of the Closing, or will enter into such Lock-Up Agreements prior to the Closing;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>WHEREAS, </B>prior to the
Closing, Pubco, SPAC, the Sponsor, the IPO Underwriter and Company Security Holders that are expected to be officers, directors or Affiliates
of Pubco immediately after the Closing (the &ldquo;<B><I>RRA Company Security Holders</I></B>&rdquo;) shall enter into an Amended and
Restated Registration Rights Agreement, in form and substance reasonably acceptable to SPAC and the Company (the &ldquo;<B><I>Amended
Registration Rights Agreement</I></B>&rdquo;), which will amend and restate the Registration Rights Agreement, to among other matters,
have Pubco assume the obligations of SPAC under the Registration Rights Agreement and to provide the Company Security Holders party thereto
with registration rights thereunder covering, among other securities, the Pubco Ordinary Shares to be issued to any officers, directors
or other equity holders of the Company deemed &ldquo;affiliates&rdquo; under Rule 144 of the Securities Act immediately after the Closing,
which Amended Registration Rights Agreement will become effective as of the Closing;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>WHEREAS, </B>contemporaneously
with the execution and delivery of this Agreement, Sponsor has entered into a letter agreement with Pubco and the Seller Representative,
a copy of which is attached as <U>Exhibit C</U> hereto (the &ldquo;<B><I>Sponsor Letter Agreement</I></B>&rdquo;), pursuant to which the
Sponsor has agreed to subject 22.5% of the SPAC Class B Ordinary Shares owned by the Sponsor (together with the Pubco Ordinary Shares
issued in exchange therefor in the SPAC Merger, the &ldquo;<B><I>Sponsor Earnout Shares</I></B>&rdquo;) to certain transfer restrictions
and potential forfeiture if the Earnout Milestones (as defined below) set forth in <U>Section 1.13(a)</U>) are not achieved during the
Earnout Period (as defined below), as well as to subject a portion of such Sponsor Earnout Shares to additional escrow and transfer restrictions
if the Minimum Cash Condition is not satisfied, but is waived by the Company and the Closing occurs;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>, prior to the
execution and delivery of this Agreement, the Company has entered into a letter agreement (the &ldquo;<B><I>HSC Letter Agreement</I></B>&rdquo;)
with Alex Greystoke and Jon Bakhshi (together, the &ldquo;<B><I>HSC Principals</I></B>&rdquo;), pursuant to which the HSC Principals have
agreed to pay for the costs and expenses of the Company DeSPAC Advisors incurred by or on behalf of the Company and its Subsidiaries;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>, the Company
intends to consummate the Bridge Financing (as defined below) for an aggregate amount equal to at least Five Million U.S. Dollars ($5,000,000)
within thirty (30) days after the date of this Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>WHEREAS, </B>the boards
of directors of SPAC, the Company, Pubco and the Company Merger Sub each have (and upon the SPAC Merger Sub&rsquo;s execution and delivery
of the Joinder, the board of directors of Company Merger Sub will have) (a) determined that the Transactions are fair, advisable and in
the best interests of their respective companies and shareholders or equity holders (as applicable), (b) approved this Agreement and the
Transactions, upon the terms and subject to the conditions set forth herein, and (c) determined to recommend to their respective shareholders
the approval and adoption of this Agreement and the Transactions; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>WHEREAS,</B> certain capitalized
terms used and not otherwise defined herein are defined in <U>Article XI</U> hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>NOW, THEREFORE,</B> in
consideration of the premises set forth above, and the representations, warranties, covenants and agreements contained in this Agreement,
and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, and intending to be legally
bound hereby, the Parties hereto agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Article
I<U><BR>
MERGERS</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.1 <U>Company
Merger</U>. At the Company Merger Effective Time, and subject to and upon the terms and conditions of this Agreement, and in accordance
with the applicable provisions of the Israeli Companies Law or by any other applicable Law, the Company and the Company Merger Sub (as
the target company (<I>Chevrat Ha&rsquo;Ya&rsquo;ad</I>) in the Company Merger) shall consummate the Company Merger, pursuant to which
Company Merger Sub shall be merged with and into the Company, with the Company being the surviving company, following which the separate
corporate existence of Company Merger Sub shall cease and the Company shall continue as the surviving corporation in the Company Merger.
The Company, as the surviving corporation following the Company Merger, is hereinafter sometimes referred to as the &ldquo;<B><I>Company
Surviving Subsidiary</I></B>&rdquo; (provided, that references to the Company for periods after the Company Merger Effective Time shall
include the Company Surviving Subsidiary). As a result of the Company Merger, the Company Surviving Subsidiary will become a wholly-owned
subsidiary of Pubco. In the event that SPAC Merger Sub is not a wholly-owned subsidiary of Pubco immediately prior to the Company Merger
Effective Time, at the Company Merger Effective Time, the Company, Pubco and SPAC Merger Sub shall cause any owners of the outstanding
shares or other equity interests of SPAC Merger Sub to transfer such equity interests to Pubco free and clear of any Liens without any
consideration therefor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.2 <U>SPAC
Merger</U>. At the SPAC Merger Effective Time, and subject to and upon the terms and conditions of this Agreement, and in accordance with
the applicable provisions of the Cayman Islands Companies Act or by any other applicable Law, SPAC and SPAC Merger Sub shall consummate
the SPAC Merger, pursuant to which SPAC Merger Sub shall be merged with and into SPAC, with SPAC being the surviving company, following
which the separate corporate existence of SPAC Merger Sub shall cease and SPAC shall continue as the surviving company in the SPAC Merger.
SPAC, as the surviving company following the SPAC Merger, is hereinafter sometimes referred to as the &ldquo;<B><I>SPAC Surviving Subsidiary</I></B>&rdquo;
(provided, that references to SPAC for periods after the SPAC Merger Effective Time shall include the SPAC Surviving Subsidiary), and
together with the Company Surviving Subsidiary, the &ldquo;<B><I>Surviving Subsidiaries</I></B>&rdquo;. As a result of the SPAC Merger,
the SPAC Surviving Subsidiary will become a wholly-owned subsidiary of Pubco.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.3 <U>Effective
Times</U>. Subject to the conditions of this Agreement, the Parties shall cause (a) the Company Merger to be consummated by filing with
the Registrar of Companies of the State of Israel (the &ldquo;<B><I>Companies Registrar</I></B>&rdquo;) notice of the contemplated Company
Merger, in form and substance reasonably acceptable to the Company and SPAC, which shall inform the Companies Registrar that all conditions
to the Company Merger under the Israeli Companies Law and this Agreement have been met (other than those conditions that by their nature
are to be satisfied at the Closing, but subject to the satisfaction or waiver of those conditions at such time) (the &ldquo;<B><I>Company
Plan of Merger</I></B>&rdquo;) and (b) the SPAC Merger to be consummated by filing a plan of merger together with such other documents
as may be required in accordance with the applicable provisions of the Cayman Islands Companies Act in form and substance reasonably acceptable
to the Company and SPAC (the &ldquo;<B><I>SPAC Plan of Merger</I></B>&rdquo; and together with the Company Plan of Merger, the &ldquo;<B><I>Merger
Plans</I></B>&rdquo;) with the Cayman Islands Registrar in accordance with the applicable provisions of the Cayman Islands Companies Act.
First, the Company Merger will be consummated and effective on the Closing Date after another notice is served to the Companies Registrar,
which the Parties shall cause to be delivered on or before the Closing Date, for the issuance by the Companies Registrar of the certificate
evidencing the Company Merger in accordance with Section 323(5) of the Israeli Companies Law by the Companies Registrar (the &ldquo;<B><I>Company
Certificate of Merger</I></B>&rdquo;). Immediately after the Company Merger, the SPAC Merger will be consummated and effective on the
Closing Date, as evidenced by the issuance of the certificate of merger by the Cayman Islands Registrar (the &ldquo;<B><I>SPAC Certificate
of Merger</I></B>&rdquo; and, together with the Company Certificate of Merger, the &ldquo;<B><I>Merger Certificates</I></B>&rdquo;). The
effective time of the Company Merger is referred to herein as the &ldquo;<B><I>Company Merger Effective Time</I></B>&rdquo;, the effective
time of the SPAC Merger is referred to herein as the &ldquo;<B><I>SPAC Merger Effective Time</I></B>&rdquo;, and each of the Company Merger
Effective Time and the SPAC Merger Effective Time are referred to herein as an &ldquo;<B><I>Effective Time</I></B>&rdquo;.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.4 <U>Effect
of the Mergers</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a) At
the Company Merger Effective Time, the effect of the Company Merger shall be as provided in this Agreement, the Company Certificate of
Merger and the applicable provisions of the Israeli Companies Law and other applicable Law. Without limiting the generality of the foregoing,
and subject thereto, at the Company Merger Effective Time all the property, rights, agreements, privileges, powers and franchises of Company
Merger Sub shall vest in the Company Surviving Subsidiary, and all debts, liabilities, obligations and duties of Company Merger Sub shall
become the debts, liabilities, obligations and duties of the Company Surviving Subsidiary, including in each case the rights and obligations
of each such Party under this Agreement and the Ancillary Documents from and after the Company Merger Effective Time, and the Company
Surviving Subsidiary shall continue its existence as wholly-owned Subsidiary of Pubco.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b) At
the SPAC Merger Effective Time, the effect of the SPAC Merger shall be as provided in this Agreement, the SPAC Certificate of Merger and
the applicable provisions of the Cayman Islands Companies Act and other applicable Law. Without limiting the generality of the foregoing,
and subject thereto, at the SPAC Merger Effective Time all the rights, property of every description including choses in action, and the
business, undertaking, goodwill, benefits, immunities and privileges of SPAC Merger Sub shall vest in the SPAC Surviving Subsidiary, and
all contracts, obligations, claims, debts and liabilities of SPAC Merger Sub shall become the contracts, obligations, claims, debts and
liabilities of the SPAC Surviving Subsidiary, including in each case the rights and obligations of each such Party under this Agreement
and the Ancillary Documents from and after the SPAC Merger Effective Time, and the SPAC Surviving Subsidiary shall continue its existence
as a wholly-owned Subsidiary of Pubco.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.5 <U>Organizational
Documents of Surviving Subsidiaries</U>. At each applicable Effective Time, (a) the Organizational Documents of Company Merger Sub shall
become the Organizational Documents of Company Surviving Subsidiary, except that the name of Company Surviving Subsidiary in such Organizational
Documents shall be &ldquo;Minovia Therapeutics Ltd.&rdquo;, and (b) the memorandum and articles of association of SPAC Merger Sub shall
become the memorandum and articles of association of SPAC Surviving Subsidiary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.6 <U>Directors
and Officers of the Surviving Subsidiaries</U>. At each Effective Time, each of the board of directors and executive management of the
applicable Surviving Subsidiary shall consist of two individuals, each of whom shall be designated by the board of directors of Pubco,
each to hold office in accordance with the respective Organizational Documents of the Surviving Subsidiaries until their respective successors
are duly elected or appointed and qualified or their earlier death, resignation or removal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.7 <U>Amended
Pubco Organizational Documents</U>. Effective upon the Company Merger Effective Time, Pubco shall amend and restate its Organizational
Documents to be in substantially the form attached as <U>Exhibit D</U> hereto (the &ldquo;<B><I>Amended Pubco Organizational Documents</I></B>&rdquo;);
provided, that in the event that SPAC issues any SPAC Preference Shares during the Interim Period as part of any Transaction Financing,
the Amended Pubco Organizational Documents shall be revised to take into account the rights, preferences, obligations, terms and conditions
of the Pubco Preference Shares to be issued in exchange for such SPAC Preference Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.8 <U>Effect
of SPAC Merger on Outstanding Securities of SPAC and SPAC Merger Sub</U>. At the SPAC Merger Effective Time, by virtue of the SPAC Merger
and without any action on the part of any Party or the holders of securities of any Party:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a) <I>SPAC
Units</I>. Each SPAC Unit issued and outstanding immediately prior to the SPAC Merger Effective Time shall be automatically detached and
the holder thereof shall be deemed to hold one (1) SPAC Class A Ordinary Share and one-half (&frac12;) of a SPAC Public Warrant in accordance
with the terms of the SPAC Unit, which underlying SPAC Securities shall be converted in accordance with the applicable terms of this <U>Section
1.8</U> below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b) <I>SPAC
Ordinary Shares</I>. Each SPAC Class B Ordinary Share issued and outstanding immediately prior to the SPAC Merger Effective Time shall
automatically be converted into one (1) SPAC Class A Ordinary Share, and, after giving effect to such conversion of the SPAC Class B Ordinary
Shares, each SPAC Class A Ordinary Share issued and outstanding immediately prior to the SPAC Merger Effective Time (other than those
described in <U>Section 1.8(d)</U> below) shall automatically be converted into one Pubco Ordinary Share, following which all such SPAC
Ordinary Shares shall cease to be outstanding and shall automatically be canceled and shall cease to exist. The holders of certificates
previously evidencing SPAC Ordinary Shares issued and outstanding immediately prior to the SPAC Merger Effective Time shall cease to have
any rights with respect to such shares except as provided herein or by Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c) <I>SPAC
Preference Shares</I>. Each SPAC Preference Share issued and outstanding immediately prior to the SPAC Merger Effective Time (other than
those described in <U>Section 1.8(d)</U> below), if any, shall be automatically converted into one Pubco Preference Share, following which
all such shares of SPAC Preference Shares shall cease to be outstanding and shall automatically be canceled and shall cease to exist.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d) <I>Treasury
Shares</I>. If there are any shares of SPAC that are owned by SPAC as treasury shares immediately prior to the SPAC Merger Effective Time,
such shares shall be canceled and extinguished without any conversion thereof or payment therefor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e) <I>SPAC
Warrants</I>. Each (i) SPAC Public Warrant outstanding immediately prior to the SPAC Merger Effective Time shall be converted into the
right to receive one Pubco Public Warrant and (ii) each SPAC Private Warrant outstanding immediately prior to the SPAC Merger Effective
Time shall be converted into the right to receive one Pubco Private Warrant, and all SPAC Warrants shall thereupon cease to be outstanding
and shall automatically be canceled and retired and shall cease to exist. Each of the Pubco Public Warrants shall have, and be subject
to, substantially the same terms and conditions set forth in the SPAC Public Warrants, and each of the Pubco Private Warrants shall have,
and be subject to, substantially the same terms and conditions set forth in the SPAC Private Warrants, except that in each case they shall
represent the right to acquire Pubco Ordinary Shares in lieu of SPAC Class A Ordinary Shares. At or prior to the SPAC Merger Effective
Time, Pubco shall take all corporate action necessary to reserve for future issuance, and shall maintain such reservation for so long
as any of the Pubco Warrants remain outstanding, a sufficient number of Pubco Ordinary Shares for delivery upon the exercise of such Pubco
Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f) <I>SPAC
Merger Sub Shares</I>. All of the shares of SPAC Merger Sub issued and outstanding immediately prior to the SPAC Merger Effective Time
shall be converted into an equal number of shares of the SPAC Surviving Subsidiary, with the same rights, powers and privileges as the
shares so converted and shall constitute the only outstanding shares of the SPAC Surviving Subsidiary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(g) <I>Transfers
of Ownership</I>. If any certificate representing securities of SPAC is to be issued in a name other than that in which the certificate
surrendered in exchange therefor is registered, it will be a condition of the issuance thereof that the certificate so surrendered will
be properly endorsed (or accompanied by an appropriate instrument of transfer) and otherwise in proper form for transfer and that the
person requesting such exchange will have paid to SPAC or any agent designated by it any transfer or other Taxes required by reason of
the issuance of a certificate for securities of SPAC in any name other than that of the registered holder of the certificate surrendered,
or established to the satisfaction of Pubco or any agent designated by it that such tax has been paid or is not payable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(h) <I>No
Liability</I>. Notwithstanding anything to the contrary in this <U>Section 1.8</U>, none of the SPAC Surviving Subsidiary, Pubco or any
Party hereto shall be liable to any Person for any amount properly paid to a public official pursuant to any applicable abandoned property,
escheat or similar law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i) <I>Surrender
of SPAC Certificates</I>. Securities issued upon the surrender of SPAC Securities in accordance with the terms hereof shall be deemed
to have been issued in full satisfaction of all rights pertaining to such securities, provided that any restrictions on the sale and transfer
of SPAC Securities shall also apply to the Pubco Securities so issued in exchange.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(j) <I>Lost,
Stolen or Destroyed SPAC Certificates</I>. In the event any certificates shall have been lost, stolen or destroyed, Pubco shall issue
in exchange for such lost, stolen or destroyed certificates or securities, as the case may be, upon the making of an affidavit of that
fact by the holder thereof, such securities, as may be required pursuant to this <U>Section 1.8</U>; provided, however, that Pubco may,
in its discretion and as a condition precedent to the issuance thereof, require the owner of such lost, stolen or destroyed certificates
to agree to indemnify Pubco and the SPAC Surviving Subsidiary, or deliver a bond in such sum as it may reasonably direct as indemnity
against any claim that may be made against the SPAC Surviving Subsidiary or Pubco, with respect to the certificates alleged to have been
lost, stolen or destroyed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.9 <U>Effect
of Company Merger on Outstanding Securities of the Company and Company Merger Sub</U>. At the Company Merger Effective Time, by virtue
of the Company Merger and without any action on the part of any Party or the holders of securities of any Party:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a) <I>Company
Ordinary Shares</I>. Subject to clause (b) below, all Company Ordinary Shares issued and outstanding immediately prior to the Company
Merger Effective Time will automatically be cancelled and cease to exist in exchange for the right to receive a portion of the Merger
Consideration (and any Earnout Shares after the Closing in accordance with <U>Section 1.13</U>), with each Company Shareholder being entitled
to receive its Pro Rata Share of the Merger Consideration (and its Earnout Pro Rata Portion of any Earnout Shares after the Closing in
accordance with <U>Section 1.13</U>), without interest, upon delivery of the Transmittal Documents in accordance with <U>Section 1.14</U>.
As of the Company Merger Effective Time, each Company Shareholder shall cease to have any other rights in and to the Company or the Company
Surviving Subsidiary. Notwithstanding anything to the contrary herein, any consideration paid or issued to a holder of Section 102 Shares
will be delivered to the 102 Trustee (for the benefit of such holder of Section 102 Shares) to be held and released in accordance with
the provisions of Section 102 and the Israeli Tax Rulings.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b) <I>Treasury
Shares</I>. Notwithstanding clause (a) above or any other provision of this Agreement to the contrary, at the Company Merger Effective
Time, if there are any Company Securities that are owned by the Company as treasury shares or any Company Securities owned by any direct
or indirect Subsidiary of the Company immediately prior to the Company Merger Effective Time, such Company Securities, if any, shall be
deemed to have been transferred to Pubco and no consideration shall be delivered or deliverable in exchange therefor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c) <I>In-the-Money
Company Options</I>. At the Company Merger Effective Time, each outstanding In-the-Money Company Option (whether vested or unvested) shall
become fully vested and shall, without any further action on the part of the holder thereof, be cancelled and automatically converted
into the right to receive, as part of the Merger Consideration, (x) a number of Pubco Ordinary Shares equal to (i) the excess, if any,
of (A) the Per Share Price over (B) the exercise price per Company Ordinary Share subject to such In-the-Money Company Option, multiplied
by (ii) the number of Company Ordinary Shares subject to such In-the-Money Company Option immediately prior to the Company Merger Effective
Time, divided by (iii) the Redemption Price (such calculation, the &ldquo;<B><I>Net Share Settlement</I></B>&rdquo;), and (y) the contingent
right to receive any Earnout Shares after the Closing in accordance with <U>Section 1.13</U>. For the avoidance of doubt, no Company Option
shall be assumed by Pubco, and the Company Equity Plan shall automatically terminate upon the Company Merger Effective Time. Following
the Company Merger Effective Time, each former holder of an In-the-Money Company Option shall cease to have any rights with respect to
such In-the-Money Company Option, except the right to receive the Pubco Ordinary Shares as provided in this <U>Section 1.9(c)</U> and
any Earnout Shares to the extent provided in <U>Section 1.13</U>, if applicable; provided that such applicable holder of In-the-Money
Company Options shall execute, as a condition to the release of any Pubco Ordinary Shares by the Exchange Agent, Pubco or the Section
102 Trustee, an option cancellation and waiver acknowledgment in a form satisfactory to the Company and SPAC (the &ldquo;<B><I>Option
Cancellation and Waiver Consents</I></B>&rdquo;). The issuance of Pubco Ordinary Shares pursuant to this <U>Section 1.9(c)</U> shall be
subject to applicable Tax withholding and compliance with applicable Law and in accordance with <U>Sections 1.14(g)</U> and <U>1.16</U>
and the Israeli Tax Rulings. Notwithstanding anything to the contrary herein, any Pubco Ordinary Shares issuable pursuant to this Agreement
with respect to In-the-Money Company Options that are Section 102 Options shall be issued under the capital gains track of Section 102,
in accordance with the terms and conditions of Section 102, and the Israeli Tax Rulings. Notwithstanding anything to the contrary herein,
any consideration paid or issued to a holder of Section 102 Options or Section 3(i) Options will be delivered to the 102 Trustee (for
the benefit of such holder of Section 102 Options or Section 3(i) Options) to be held and released in accordance with the provisions of
Section 102 and the Israeli Tax Rulings.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d) <I>Company
SAFEs</I>. At the Company Merger Effective Time, each outstanding Company SAFE shall, without any further action on the part of the holder
thereof, be cancelled and automatically be converted into the right to receive a portion of the Merger Consideration (and any Earnout
Shares after the Closing in accordance with <U>Section 1.13</U>), with each holder of a Company SAFE being entitled to receive its Pro
Rata Share of the Merger Consideration (and its Earnout Pro Rata Portion of any Earnout Shares after the Closing in accordance with <U>Section
1.13</U>), without interest, based on the number of Company Ordinary Shares into which such Company SAFE would otherwise convert in accordance
with its terms as of the Closing, upon delivery of the documents required in accordance with <U>Section 1.14(h)</U>. As of the Company
Merger Effective Time, each holder of Company SAFEs shall cease to have any other rights in and to the Company or the Company Surviving
Subsidiary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e) <I>Other
Company Convertible Securities</I>. Any Company Convertible Security other than an In-the-Money Company Option or a Company SAFE (including
any Company Option that is not an In-the-Money Company Option), if not exercised or converted prior to the Company Merger Effective Time
into Company Ordinary Shares shall be cancelled, retired and terminated and thereby cease to represent any right to acquire, be exchanged
for or convert into Company Ordinary Shares or any other security or otherwise receive payment of cash or other consideration therefor,
whether upon any contingency or valuation or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f) <I>Company
Merger Sub Shares</I>. All of the shares of Company Merger Sub issued and outstanding immediately prior to the Company Merger Effective
Time shall be converted into an equal number of shares of the Company Surviving Subsidiary, with the same rights, powers and privileges
as the shares so converted and shall constitute the only outstanding shares of the Company Surviving Subsidiary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.10 <U>Effect
of Mergers on Outstanding Securities of Pubco</U>. At the Company Merger Effective Time, by virtue of the Company Merger and without any
action on the part of any Party or the holders of securities of any Party, all of the shares of Pubco issued and outstanding immediately
prior to the Company Merger Effective Time shall be canceled and extinguished without any conversion thereof or payment therefor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.11 <U>Merger
Consideration for Company Security Holders</U>. The aggregate consideration to be paid to Company Security Holders pursuant to the Company
Merger (the &ldquo;<B><I>Merger Consideration</I></B>&rdquo;) shall be an amount equal to (i) One Hundred Eighty Million U.S. Dollars
($180,000,000), plus (ii) the Interim Investment Amount, payable to all Company Security Holders in the form of Pubco Ordinary Shares,
each valued at the Redemption Price. Each Company Shareholder will receive for each Company Ordinary Share held (but excluding any Company
Securities described in <U>Section 1.9(b)</U>) an amount equal to the Per Share Price, which will be paid in the form of Pubco Ordinary
Shares, with each Pubco Ordinary Share valued at the Redemption Price (the &ldquo;<B><I>Share Consideration Per Share</I></B>&rdquo;).
Each holder of In-the-Money Company Options that are outstanding immediately prior to the Company Merger Effective Time shall receive
in full settlement and cancellation of such In-the-Money Company Options, a number of Pubco Ordinary Shares determined on a Net Share
Settlement basis in accordance with <U>Section 1.9(c)</U>. For the avoidance of doubt, no Company Options will be assumed by Pubco or
converted into options to purchase Pubco Ordinary Shares. Each Holder of Company SAFEs that are outstanding immediately prior to the Company
Merger Effective Time shall receive in full settlement for the conversion and cancellation of such Company SAFE, a number of Pubco Ordinary
Shares determined in accordance with <U>Section 1.9(d)</U>. For the avoidance of doubt, other than holders of In-the Money Company Options
who execute and deliver Option Cancellation and Waiver Consents in accordance with <U>Section 1.9(c)</U> and holders of Company SAFEs,
no holder of Company Securities will receive any consideration under or in connection with this Agreement unless they are holders of Company
Ordinary Shares as of the Company Merger Effective Time. Additionally, after the Closing, subject to the terms and conditions set forth
in this Agreement, the Eligible Earnout Recipients shall have the contingent right to receive Earnout Shares from Pubco as additional
consideration if the applicable conditions as set forth in <U>Section 1.13</U> are satisfied.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.12 <U>Closing
Calculations</U>. At least three (3) Business Days prior to the Closing Date, the Company shall deliver to SPAC a statement certified
by the Company&rsquo;s chief executive officer (the &ldquo;<B><I>Closing Statement</I></B>&rdquo;) setting forth a good faith calculation
of the Interim Investment Amount, the Per Share Price and the Share Consideration Per Share, each in reasonable detail. Promptly upon
delivering the Closing Statement to SPAC, if requested by SPAC, the Company will meet with SPAC to review and discuss the Closing Statement
and the Company will consider in good faith SPAC&rsquo;s comments to the Closing Statement and make any appropriate adjustments to the
Closing Statement prior to the Closing, which adjusted Closing Statement, as mutually approved by the Company and SPAC both acting reasonably
and in good faith, shall thereafter become the Closing Statement for all purposes of this Agreement. The Closing Statement and the determinations
contained therein shall be prepared in accordance with the Accounting Principles and otherwise in accordance with this Agreement, and,
as finally agreed upon in accordance with this <U>Section 1.12</U>, shall be the final determinations with respect to the amounts set
forth therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.13 <U>Earnout</U><B>.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a) After
the Closing, subject to the terms and conditions set forth herein, the Eligible Earnout Recipients (as defined below) shall have the contingent
right to receive an additional aggregate number of Pubco Ordinary Shares equal to (i) Fifty-Seven Million Five Hundred Thousand U.S. Dollars
($57,500,000), divided by (ii) the Redemption Price (subject to equitable adjustment for share splits, share dividends, combinations,
recapitalizations and the like after the Closing, including to account for any equity securities into which such shares are exchanged
or converted) (the &ldquo;<B><I>Earnout Shares</I></B>&rdquo;), with each Eligible Earnout Recipient receiving its Earnout Pro Rata Portion
of such Earnout Shares, as additional consideration based on the Trading Price of Pubco Ordinary Shares during the five (5) year period
after the Closing (the &ldquo;<B><I>Earnout Period</I></B>&rdquo;) or the achievement of certain clinical milestones specified below during
the Earnout Period. If an Eligible Earnout Recipient transfers, sells, or otherwise disposes of any Pubco Ordinary Shares received as
Merger Consideration (other than Excluded Transfers) prior to the issuance of the Earnout Shares, such Eligible Earnout Recipient&rsquo;s
participation in the Earnout Shares shall decrease proportionally to the number of such shares no longer held by such Eligible Earnout
Recipient at the time of the Triggering Event. The Eligible Earnout Recipients shall be entitled to receive 100% of the Earnout Shares
(and their right to receive such Earnout Shares shall vest and become due and issuable) upon the first of the following circumstances
to occur to during the Earnout Period (each, a &ldquo;<B><I>Triggering Event</I></B>&rdquo;):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i) the
Trading Price equaling or exceeding $11.50 per share for five (5) consecutive Trading Days (the &ldquo;<B><I>Share Price Milestone</I></B>&rdquo;);
or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ii) the
beginning of a Phase 3 clinical trial with the FDA (or approval by the FDA of a Biologics License Application without the need for a Phase
3 clinical trial) for the Target Companies&rsquo; clinical development program for the Pearson syndrome or any other clinical development
program for Pharmaceutical Products developed by a Target Company (the &ldquo;<B><I>Clinical Milestone</I></B>&rdquo; and together with
the Share Price Milestone, the &ldquo;<B><I>Earnout Milestones</I></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">The share price threshold set
forth above is referred to herein as the &ldquo;<B><I>Share Price Target</I></B>&rdquo;, and such Share Price Target shall be subject
to equitable adjustment for share splits, share dividends, combinations, recapitalizations and the like after the Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b) In
the event that during the Earnout Period Pubco is subject to a Change of Control at an express or implied price per share in the applicable
transaction (taking into account any issuance of Earnout Shares pursuant to this <U>Section 1.13(b)</U> in connection therewith) (the
&ldquo;<B><I>Change of Control Price</I></B>&rdquo;) that is equal to or greater than the Share Price Target, then, subject to the terms
and conditions of this Agreement, a Triggering Event shall be considered to have occurred pursuant to <U>Section 1.13(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c) During
the Earnout Period, Pubco&rsquo;s Chief Financial Officer (the &ldquo;<B><I>CFO</I></B>&rdquo;) shall monitor the Trading Price on each
Trading Day and monitor the potential achievement of the Clinical Milestone, and shall, as promptly as practicable (and in any event within
five (5) Business Days) after becoming aware that an Earnout Milestone has been achieved, prepare and deliver to each Representative Party
a written statement (each, a &ldquo;<B><I>Triggered Earnout Statement</I></B>&rdquo;) that sets forth the CFO&rsquo;s determination that
a Triggering Event has occurred and the basis for such determination, including which Earnout Milestone(s) have been achieved and, if
it is the Share Price Milestone, the relevant Trading Prices for the Trading Days during the applicable period. As soon as practicable
(and in any event within five (5) Business Days) after the end of each calendar month during the Earnout Period, the CFO will also prepare
and deliver to each Representative Party a written statement (each, a &ldquo;<B><I>Monthly Earnout Statement</I></B>&rdquo;) that sets
forth the CFO&rsquo;s determination of (i) the Trading Price on each Trading Day for such month and the preceding month and (ii) whether
an Earnout Milestone has been met and a Triggering Event has occurred during those months. In addition, as soon as practicable, and in
any event within five (5) Business Days, after a Change of Control of Pubco, the CFO will send a written statement (a &ldquo;<B><I>Change
of Control Earnout Statement</I></B>&rdquo; and, together with the Triggered Earnout Statements and the Monthly Earnout Statements, the
&ldquo;<B><I>Earnout Statements</I></B>&rdquo;) to each Representative Party indicating that a Change of Control has occurred, along with
the details of such Change of Control, including the applicable Change of Control Price for the Change of Control, and indicating whether
a Triggering Event has occurred as a result of such Change of Control. Notwithstanding the foregoing, neither any failure by the CFO to
prepare or provide any Earnout Statement referenced in this <U>Section 1.13(c)</U>, nor any error contained within an Earnout Statement,
shall in any way prejudice whether a Triggering Event has occurred or whether any Earnout Shares are issuable by Pubco.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d) Each
Representative Party will have ten (10) Business Days after its receipt of an Earnout Statement to review it. The Representative Parties,
and their respective Representatives on their behalf, may make inquiries of the CFO and related personnel and advisors of Pubco, the Target
Companies and their respective Subsidiaries regarding questions concerning or disagreements with the Earnout Statement arising in the
course of their review thereof, and Pubco, the Target Companies and their respective Subsidiaries shall provide reasonable cooperation
in connection therewith. If either Representative Party has any objections to an Earnout Statement, such Representative Party shall deliver
to Pubco (to the attention of the CFO) and the other Representative Party a statement setting forth its objections thereto (in reasonable
detail). If such written statement is not delivered by a Representative Party within ten (10) Business Days following the date of delivery
of the applicable Earnout Statement, then such Representative Party will have waived its right to contest such Earnout Statement and the
calculation of the Trading Price during the applicable portion of the Earnout Period, the potential achievement of the Share Price Milestone
or the Clinical Milestone during the applicable portion of the Earnout Period, or the Change of Control Price in the event of a Change
of Control (and whether a Change of Control has occurred), as applicable, and the determination of whether a Triggering Event has occurred,
in each case, as set forth therein. If such written statement is delivered by a Representative Party within such ten (10) Business Day
period, then the Representative Parties shall negotiate in good faith to resolve any such objections for a period of twenty (20) days
thereafter. If the Representative Parties do not reach a final resolution within such twenty (20) day period, then, upon the written request
of either Representative Party, the Representative Parties will refer the dispute to the Independent Expert for final resolution of the
dispute in accordance with the procedures set forth in <U>Section 1.13(e)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e) If
a dispute with respect to an Earnout Statement is submitted in accordance with this <U>Section 1.13</U> to the Independent Expert for
final resolution, the Parties will follow the procedures set forth in this <U>Section 1.13(e)</U>. Each Representative Party agrees to
execute, if requested by the Independent Expert, a reasonable engagement letter with respect to the determination to be made by the Independent
Expert. All fees and expenses of the Independent Expert, and all other out-of-pocket costs and expenses incurred by a Representative Party
in connection with resolving any dispute hereunder before the Independent Expert, will be borne by Pubco. The Independent Expert will
determine only those issues still in dispute with respect to such Earnout Statement as of the Independent Expert Notice Date and the Independent
Expert&rsquo;s determination will be based solely upon and consistent with the terms and conditions of this Agreement. The determination
by the Independent Expert will be based solely on presentations with respect to such disputed items by the Representative Parties to the
Independent Expert and not on the Independent Expert&rsquo;s independent review; provided, that such presentations will be deemed to include
any work papers, records, accounts or similar materials delivered to the Independent Expert by a Representative Party in connection with
such presentations and any materials delivered to the Independent Expert in response to requests by the Independent Expert. Each Representative
Party will use their reasonable efforts to make their respective presentations as promptly as practicable following submission to the
Independent Expert of the disputed items, and each Representative Party will be entitled, as part of its presentation, to respond to the
presentation of the other Representative Party and any questions and requests of the Independent Expert. In deciding any matter, the Independent
Expert will be bound by the provisions of this Agreement, including this <U>Section 1.13</U>. It is the intent of the parties hereto that
the activities of the Independent Expert in connection herewith are not (and should not be considered to be or treated as) an arbitration
proceeding or similar arbitral process and that no formal arbitration rules should be followed (including rules with respect to procedures
and discovery). The Representative Parties will request that the Independent Expert&rsquo;s determination be made within forty-five (45)
days after its engagement, or as soon thereafter as possible, will be set forth in a written statement delivered to the Representative
Parties and will be final, conclusive, non-appealable and binding for all purposes hereunder (other than for fraud or manifest error).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f) If
there is a final determination in accordance with this <U>Section 1.13</U> that the Eligible Earnout Recipients are entitled to receive
the Earnout Shares for there being a Triggering Event, the Earnout Shares for such Triggering Event will be due upon such final determination
and Pubco will deliver such shares to the Eligible Earnout Recipients within ten (10) Business Days thereafter, with each Eligible Earnout
Recipient receiving its Earnout Pro Rata Portion of such Earnout Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(g) Following
the Closing (including during the Earnout Period), Pubco and its Subsidiaries, including the Target Companies, will be entitled to operate
their respective businesses based upon their respective business requirements. Each of Pubco and its Subsidiaries, including the Target
Companies, will be permitted, following the Closing (including during the Earnout Period), to make changes at their sole discretion to
their respective operations, organization, personnel, accounting practices and other aspects of their business, including actions that
may have an impact on the Trading Price, the progress or advancement of the clinical development program for the Pearson syndrome (including
a determination by Pubco or its Subsidiaries to abandon the clinical development program for the Peason syndrome), the occurrence of a
Change of Control and any related Change of Control Price and ability of the Eligible Earnout Recipients to earn the Earnout Shares, and
the Eligible Earnout Recipients will not have any right to claim the loss of all or any portion of any Earnout Shares or other damages
as a result of such decisions. Notwithstanding the foregoing, following the Closing, Pubco shall not, and shall cause its Subsidiaries,
including the Target Companies, to not, take or omit to take any action that is in bad faith and has the primary purpose of avoiding,
reducing or preventing the achievement or attainment of the Earnout Milestones.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(h) For
purposes of this Agreement, an &ldquo;<B><I>Eligible Earnout Recipient</I></B>&rdquo; means a Company Security Holder who (i) was a holder
of Company Ordinary Shares, In-the-Money Company Options, or Company SAFEs immediately prior to the Company Merger Effective Time and
(ii) is a holder of Pubco Ordinary Shares received as Merger Consideration in exchange for such Company Securities at the time the applicable
Triggering Event occurs. The right to receive Earnout Shares pursuant to this <U>Section 1.13</U> is personal to Eligible Earnout Recipients
and is not transferable, assignable, or otherwise alienable, whether by operation of Law or otherwise, except by will or the laws of descent
and distribution. Notwithstanding anything to the contrary in this Agreement, only Eligible Earnout Recipients shall be entitled to receive
Earnout Shares upon satisfaction of the applicable Triggering Events, and any subsequent transferee or assignee of any Pubco Ordinary
Shares (including any shares received as Merger Consideration) shall not have any right to receive any Earnout Shares or any portion thereof.
If an Eligible Earnout Recipient transfers, sells, or otherwise disposes of any Pubco Ordinary Shares received as Merger Consideration
following the Company Merger Effective Time, such Eligible Earnout Recipient&rsquo;s participation in the Earnout Shares shall decrease
proportionally to the number of such Pubco Ordinary Shares no longer held by such Eligible Earnout Recipient at the time of the Triggering
Event (and all other Eligible Earnout Recipients shall receive a pro rata increase in the number of Earnout Shares to be received by such
other Eligible Earnout Recipients).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i) Notwithstanding
anything to the contrary herein, any Earnout Shares issued to an Eligible Earnout Recipient shall be issued in compliance with the provisions
of the Israeli Tax Rulings, to the extent applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">1.14 </FONT><U>Surrender
of Company Securities and Disbursement of Merger Consideration<B>.</B></U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a) At
or prior to the Effective Time, the Company shall send to each Company Shareholder a letter of transmittal, in a form to be reasonably
mutually agreed upon by the Company and SPAC (each, a &ldquo;<B><I>Letter of Transmittal</I></B>&rdquo;) (which shall specify that the
delivery of certificates representing Company Ordinary Shares (&ldquo;<B><I>Company Certificates</I></B>&rdquo;) in respect of the Merger
Consideration shall be effected, and risk of loss and title shall pass, only upon proper delivery of the Company Certificates to Pubco
(or a Lost Certificate Affidavit)), and shall also include instructions for Company Shareholders who hold their Company Ordinary Shares
in book-entry form (i.e., not represented by physical certificates) regarding the procedures for exchanging such book-entry shares for
the Merger Consideration. The Letter of Transmittal shall provide that holders of book-entry shares will not be required to deliver a
physical certificate, but must follow the procedures set forth in the Letter of Transmittal to effect the exchange of their Company Ordinary
Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b) Each
Company Shareholder shall be entitled to receive its Pro Rata Share of the Merger Consideration (and its Earnout Pro Rata Portion of any
Earnout Shares after the Closing in accordance with <U>Section 1.13</U>) as set forth in <U>Section 1.11</U> in respect of the Company
Ordinary Shares represented by the Company Certificate(s) (excluding any Company Securities described in <U>Section 1.9(b)</U>) or held
in book-entry form, as soon as reasonably practicable after the Company Merger Effective Time, but subject to the delivery to Pubco and
SPAC of the following items prior thereto (collectively, the &ldquo;<B><I>Transmittal Documents</I></B>&rdquo;): (i) in the case of Company
Certificates, the Company Certificate(s) for its Company Ordinary Shares (or a Lost Certificate Affidavit), together with a properly completed
and duly executed Letter of Transmittal, or, in the case of book-entry shares, a properly completed and duly executed Letter of Transmittal
and compliance with the procedures set forth therein, and (ii) such other documents as may be reasonably requested by Pubco or SPAC. Until
so surrendered or exchanged in accordance with the procedures set forth in the Letter of Transmittal, each Company Certificate or book-entry
share shall represent after the Company Merger Effective Time for all purposes only the right to receive such portion of the Merger Consideration
attributable to such Company Certificate or book-entry share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c) If
any portion of the Merger Consideration is to be delivered or issued to a Person other than the Person in whose name the surrendered Company
Certificate is registered immediately prior to the Company Merger Effective Time, it shall be a condition to such delivery that (i) the
transfer of such Company Ordinary Share shall have been permitted in accordance with the terms of the Company&rsquo;s Organizational Documents,
each as in effect immediately prior to the Company Merger Effective Time, (ii) such Company Certificate shall be properly endorsed or
shall otherwise be in proper form for transfer, (iii) the recipient of such portion of the Merger Consideration, or the Person in whose
name such portion of the Merger Consideration is delivered or issued, shall have already executed and delivered, if the transferring Person
is a party thereto, counterparts to a Lock-Up Agreement, and the Amended Registration Rights Agreement and such other Transmittal Documents
as are reasonably deemed necessary by SPAC or Pubco and (iv) the Person requesting such delivery shall pay to Pubco any transfer or other
similar Taxes required as a result of such delivery to a Person other than the registered holder of such Company Certificate or establish
to the satisfaction of Pubco that such Tax has been paid or is not payable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d) Notwithstanding
anything to the contrary contained herein, in the event that any Company Certificate shall have been lost, stolen or destroyed, in lieu
of delivery of a Company Certificate to Pubco, the applicable Company Shareholder may instead deliver to Pubco an affidavit of lost certificate
and indemnity of loss in form and substance reasonably acceptable to Pubco and SPAC (a &ldquo;<B><I>Lost Certificate Affidavit</I></B>&rdquo;),
which at the reasonable discretion of Pubco or SPAC may include a requirement that the owner of such lost, stolen or destroyed Company
Certificate deliver a bond in such sum as it may reasonably direct as indemnity against any claim that may be made against Pubco or any
Surviving Subsidiary with respect to the Company Ordinary Shares represented by the Company Certificates alleged to have been lost, stolen
or destroyed. Any Lost Certificate Affidavit properly delivered in accordance with this <U>Section 1.14(d)</U> shall be treated as a Company
Certificate for all purposes of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e) After
the Company Merger Effective Time, there shall be no further registration of transfers of Company Ordinary Shares. If, after the Company
Merger Effective Time, Company Certificates or evidence of book-entry shares are presented to Pubco or a Surviving Subsidiary, they shall
be canceled and exchanged for the applicable portion of the Merger Consideration provided for, and in accordance with the procedures set
forth in this <U>Section 1.14</U>. No dividends or other distributions declared or made after the date of this Agreement with respect
to Pubco Ordinary Shares with a record date after the Company Merger Effective Time will be paid to the holders of any Company Certificates
or book-entry shares that have not yet been surrendered with respect to Pubco Ordinary Shares to be issued upon surrender thereof until
the holders of record of such Company Certificates or book-entry shares shall surrender such certificates or evidence of book-entry shares
(or provide a Lost Certificate Affidavit), and, if applicable, deliver the other Transmittal Documents. Subject to applicable Law, following
surrender of any such Company Certificates or evidence of book-entry shares (or delivery of a Lost Certificate Affidavit) and, if applicable,
delivery of the other Transmittal Documents, Pubco shall promptly deliver to the record holders thereof, without interest, the certificates
representing the Pubco Ordinary Shares issued in exchange therefor and the amount of any such dividends or other distributions with a
record date after the Company Merger Effective Time theretofore paid with respect to such Pubco Ordinary Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f) All
securities issued upon the surrender of Company Securities in accordance with the terms hereof shall be deemed to have been issued in
full satisfaction of all rights pertaining to such Company Securities. Any Company Shareholder who has not exchanged its Company Ordinary
Shares for the applicable portion of the Merger Consideration in accordance with this <U>Section 1.14</U> shall look only to Pubco for
payment of the portion of the Merger Consideration in respect of such Company Ordinary Shares without any interest thereon (but with any
dividends paid with respect thereto). Notwithstanding the foregoing, none of Pubco, a Surviving Subsidiary or any other Party hereto shall
be liable to any Person for any amount properly paid to a public official pursuant to any applicable abandoned property, escheat or similar
law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(g) Prior
to the Company Merger Effective Time, the Company shall send to each holder of In-the-Money Company Options a customary letter of transmittal
in form and substance reasonably acceptable to SPAC, which shall specify that the holder&rsquo;s Company Options will be cancelled and
the In-the-Money Company Options settled by the issuance of Pubco Ordinary Shares on a Net Share Settlement basis as Merger Consideration
in accordance with <U>Section 1.9(c)</U> of this Agreement. The Company shall include with each such letter of transmittal an Option Cancellation
and Waiver Consent acknowledging that such holder&rsquo;s Company Options are being cancelled and the In-the-Money Company Options settled
by the issuance of Pubco Ordinary Shares on a Net Share Settlement basis in accordance with the terms and conditions set forth in this
Agreement, without further obligation on the part of the Company, SPAC or Pubco, and that the holder of such Company Options has no further
rights or claims to any further equity in the Company, SPAC or Pubco other than such Pubco Ordinary Shares issued as Merger Consideration
under this Agreement. The Company shall use its commercially reasonable efforts to obtain duly executed copies of all such letters of
transmittal and Option Cancellation and Waiver Consents, and Pubco shall not issue Pubco Ordinary Shares in respect of Company Options
until it shall have received from each holder thereof such letter of transmittal (including the Option Cancellation and Waiver Consent),
completed and duly executed by such holder, with respect to such Company Option. The cancellation and Net Share Settlement of Company
Options as Merger Consideration shall comply with the terms of the Israeli Tax Rulings.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(h) Prior
to the Company Merger Effective Time, the Company shall send to each holder of a Company SAFE a customary letter of transmittal in form
and substance reasonably acceptable to SPAC, which shall specify that the holder&rsquo;s Company SAFE will be cancelled and settled for
a Pro Rata Share of the Merger Consideration (including its Earnout Pro Rata Portion of any Earnout Shares after the Closing in accordance
with <U>Section 1.13</U>) in accordance with <U>Section 1.9(d)</U> of this Agreement. The Company shall use its commercially reasonable
efforts to obtain duly executed copies of all such letter of transmittals, and Pubco shall not issue Pubco Ordinary Shares in respect
of Company SAFEs until it shall have received from each holder thereof such letter of transmittal, completed and duly executed by such
holder, with respect to such Company SAFE.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i) Notwithstanding
anything to the contrary contained in this Agreement, no fraction of a Pubco Ordinary Share will be issued by virtue of the Mergers or
the other Transactions, and each Person who would otherwise be entitled to a fraction of a Pubco Ordinary Share (after aggregating all
fractional Pubco Ordinary Shares that otherwise would be received by such holder) shall instead have the number of Pubco Ordinary Shares
issued to such Person rounded down in the aggregate to the nearest whole Pubco Ordinary Share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.15 <U>U.S.
Federal Income Tax Consequences</U>. The Parties hereby agree and acknowledge that, for U.S. federal income tax purposes, (i) the Mergers,
taken together, are intended to qualify as exchanges described in Section 351 of the Code and (ii) the Company Merger qualifies as a &ldquo;reorganization&rdquo;
within the meaning of Section 368(a)(2)(E) of the Code and that this Agreement be, and hereby is, adopted as a &ldquo;plan of reorganization&rdquo;
for purposes of Section 368 of the Code. Each Party shall, and shall cause its respective Affiliates to, use commercially reasonable efforts
to cause the Transactions to so qualify. The cancellation and Net Share Settlement of Company Options shall be treated as part of the
Merger Consideration for all Tax purposes. The Parties shall file all Tax Returns consistent with, and take no position (whether in audits,
Tax Returns or otherwise) inconsistent with the positions (unless, in each case, required to do so pursuant to a &ldquo;determination&rdquo;
within the meaning of Section 1313(a) of the Code) that: (A) (i) the formation of Pubco and the Mergers, are together treated as exchanges
described in Sections 351 of the Code and (ii) the Company Merger qualifies as a &ldquo;reorganization&rdquo; within the meaning of Section
368(a)(2)(E) of the Code (&ldquo;<B><I>Intended Tax Treatment</I></B>&rdquo;); and (B) that the Mergers should not result in gain being
recognized because of the application of Section 367(a)(1) of the Code (other than for potentially for any shareholder that would be a
&ldquo;five-percent transferee shareholder&rdquo; that does not enter into a five-year GRA in the form provided in Treasury Regulations
Section 1.367(a)-8(c)). Each of the Parties acknowledges and agrees that each (i) has had the opportunity to obtain independent legal
and tax advice with respect to the Transactions, and (ii) is responsible for paying its own Taxes, including any Taxes that may arise
if the Mergers, taken together, do not qualify as exchanges described in Section 351 of the Code or that the Company Merger does not qualify
as a &ldquo;reorganization&rdquo; within the meaning of Section 368(a) of the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.16 <U>Israeli
Withholding Taxes</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a) Notwithstanding
anything in this Agreement to the contrary, the Exchange Agent, Pubco, the Section 102 Trustee, their respective Affiliates, and any other
applicable agent, including withholding agent (each, a &ldquo;<B><I>Payor</I></B>&rdquo;) shall be entitled to deduct and withhold from
any amount payable or other consideration deliverable pursuant to this Agreement to any recipient subject to Israeli Tax (an &ldquo;<B><I>Israeli
Payee</I></B>&rdquo;), any amount required to be deducted or withheld with respect to the making of such payment or delivery of such consideration
under applicable Law, including with respect to the issuance of Pubco Ordinary Shares to holders of In-the-Money Company Options in connection
with the Net Share Settlement of such In-the-Money Company Options as Merger Consideration, unless, no later than three (3) Business Days
prior to the Closing Date, the Payor is provided with the Israeli Tax Rulings or a Valid Tax Certificate, in which case, the Payor shall
act in accordance with such Israeli Tax Rulings or Valid Tax Certificate. To the extent that any amounts are so deducted or withheld and
paid to the appropriate Governmental Authority, such deducted or withheld amounts shall be treated for all purposes of this Agreement
as having been paid to the Israeli Payee in respect of which such deduction or withholding was made; provided that the Payor provides
to such Israeli Payee evidence that such amounts have been paid to the applicable Governmental Authority.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b) Notwithstanding
<U>Section 1.16(a)</U> or anything else to the contrary in this Agreement, if neither the Israeli Tax Rulings nor a Valid Tax Certificate
is provided to the Payor providing for a full exemption from Israeli withholding Tax, at least three (3) Business Days prior to the Closing
Date, Pubco will be entitled to appoint a third party Israeli withholding tax agent (the &ldquo;<B><I>Exchange Agent</I></B>&rdquo;),
and deliver all payments (including payment in-kind) under this Agreement (including any amounts payable after the Closing Date) to the
Exchange Agent, who will be entitled to deduct and withhold therefrom any applicable Taxes applicable to Israeli Payees, as determined
by the Exchange Agent according to applicable Law, and remit any such amounts deducted or withheld to the ITA. The Exchange Agent shall
provide Pubco, prior to the Closing Date, with an undertaking as required under Section 6.2.4.3 of Income Tax Circular 19/2018 (Transaction
for Sale of Rights in a Corporation that includes Consideration that will be transferred to the Seller at Future Dates). Any such amount
required to be withheld shall be funded first through payment by the applicable Israeli Payee of the Tax amount required as determined
by the Exchange Agent according to applicable Law, or as determined in a Valid Tax Certificate that provides for withholding of a certain
amount on account of Taxes, which amount to be transferred to the Exchange Agent within seven (7) days of such request. To the extent
that an Israeli Payee does not comply with the provisions of the preceding sentence, the Exchange Agent shall at any time following the
Company Merger Effective Time be entitled to satisfy any such withholding obligation, through the forfeiture or sale of the portion of
the Pubco Ordinary Shares otherwise transferrable to such Israeli Payee that is required to enable the Exchange Agent to comply with applicable
deduction or withholding requirements. Each Israeli Payee will, pursuant to the Letter of Transmittal, waive, release and absolutely and
forever discharge Pubco or anyone acting on its behalf and the Exchange Agent from and against any and all claims for any losses in connection
with the forfeiture or sale of any portion of the Pubco Ordinary Shares otherwise transferrable to such Israeli Payee in compliance with
the withholding requirements under this <U>Section 1.16(b)</U>. To the extent that the Exchange Agent is unable, for whatever reason,
to effect a forfeiture or to sell the applicable portion of Pubco Ordinary Shares required to finance the applicable deduction or withholding
requirements, then the Exchange Agent shall be entitled to hold all of Pubco Ordinary Shares, otherwise transferrable to the applicable
Israeli Payee until the earlier of: (i) the receipt of a Valid Tax Certificate from such Israeli Payee fully exempting the Exchange Agent
from tax withholding; or (ii) such time when the Exchange Agent is practically able to sell the portion of such Pubco Ordinary Shares
otherwise transferrable to such Israeli Payee that is required to enable the Payor to comply with such applicable deduction or withholding
requirements. Any costs or expenses incurred by the Exchange Agent in connection with such sale shall be borne by, and deducted from the
payment to, the applicable Israeli Payee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c) Notwithstanding
the above, any consideration paid or issued to a holder Company Options, or Section 102 Shares will be subject to deduction or withholding
of Israeli Tax under the Israeli Tax Ordinance on the sixteenth (16<SUP>th</SUP>) day of the calendar month following the month during
which the Closing occurs, unless prior to the sixteenth (16<SUP>th</SUP>) day of the calendar month following the month during which the
Closing occurs, (i) with respect to Section 102 Options, Section 3(i) Options and Section 102 Shares, the applicable Israeli Tax Ruling
shall have been obtained, in which case, Pubco or the Company, or any Person acting on their behalf, will act in accordance with the applicable
Israeli Tax Ruling; (ii) with respect to holders of Company Options that are not residents of Israel for Tax purposes, are engaged by
a non-Israeli resident Affiliate and who were granted such Company Options in consideration for work or services performed solely outside
of Israel, such holder provides Pubco with a validly executed residency declaration in a form mutually agreed to by Pubco, SPAC and the
Company, provided that, if the ITA prescribes such a form, including in connection with any Israeli Tax Ruling given in connection with
the Company Merger, then such form shall be used, and (iii) with respect to any holder of Company Options or Section 102 Shares which
does not fall under sub-sections (i) and (ii) above, a Valid Tax Certificate was provided.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d) Notwithstanding
anything to the contrary in this <U>Section 1.16</U>, if the Israeli Tax Rulings shall be received prior to the applicable withholding
date, then the provisions of the Israeli Tax Rulings shall apply with respect to any consideration covered by such rulings, and all applicable
withholding procedures with respect to any such consideration shall be made in accordance with the provisions of such rulings (including,
for the avoidance of doubt, the engagement of the Exchange Agent or other sub-agent to the extent required by the Israeli Tax Rulings).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.17 <U>Taking
of Necessary Action; Further Action</U>. If, at any time after the Closing, any further action is necessary or desirable to carry out
the purposes of this Agreement and to vest SPAC Surviving Subsidiary and Company Surviving Subsidiary with full right, title and possession
to all assets, property, rights, agreements, privileges, powers and franchises of SPAC Merger Sub and Company Merger Sub, respectively,
the then current officers and directors of SPAC, the Company, Pubco and the Merger Subs are fully authorized in the name of their respective
corporations or otherwise to take, and shall take, all such lawful and necessary action, so long as such action is not inconsistent with
this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Article
II<U><BR>
CLOSING</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.1 <U>Closing</U>.
Subject to the satisfaction or waiver of the conditions set forth in <U>Article VII</U>, the consummation of the transactions contemplated
by this Agreement (the &ldquo;<B><I>Closing</I></B>&rdquo;) shall take place at the offices of Ellenoff Grossman &amp; Schole LLP (&ldquo;<B><I>EGS</I></B>&rdquo;),
1345 Avenue of the Americas, New York, NY 10105, or remotely via the electronic exchange of signatures, on the second (2<SUP>nd</SUP>)
Business Day after all of the Closing conditions set forth in this Agreement have been satisfied or waived, at 10:00 a.m. local time,
or at such other date, time or place as SPAC and the Company may agree (the date and time at which the Closing is actually held being
the &ldquo;<B><I>Closing Date</I></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Article
III<U><BR>
REPRESENTATIONS AND WARRANTIES OF SPAC</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Except as set forth in (i)
the disclosure schedules delivered by SPAC to the Company and Pubco on the date hereof (the &ldquo;<B><I>SPAC Disclosure Schedules</I></B>&rdquo;),
the Section numbers of which are numbered to correspond to the Section numbers of this Agreement to which they refer, or (ii) the SEC
Reports that are available on the SEC&rsquo;s website through EDGAR, SPAC represents and warrants to the Company and Pubco, as of the
date hereof and as of the Closing, as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.1 <U>Organization
and Standing</U>. SPAC is an exempted company limited by shares duly incorporated, validly existing and in good standing under the Laws
of the Cayman Islands, and has all requisite corporate power and authority to own, lease and operate its properties and to carry on its
business as now being conducted. SPAC is duly qualified or licensed and in good standing to do business in each jurisdiction in which
the character of the property owned, leased or operated by it or the nature of the business conducted by it makes such qualification or
licensing necessary. SPAC has heretofore made available to the Company accurate and complete copies of its Organizational Documents, each
as currently in effect. SPAC is not in violation of any provision of its Organizational Documents in any material respect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.2 <U>Authorization;
Binding Agreement</U>. SPAC has all requisite corporate power and authority to execute and deliver this Agreement and each Ancillary Document
to which it is a party, to perform its obligations hereunder and thereunder and to consummate the transactions contemplated hereby and
thereby, subject to obtaining the Required SPAC Shareholder Approval. The execution and delivery of this Agreement and each Ancillary
Document to which it is a party and the consummation of the transactions contemplated hereby and thereby (a)&nbsp;have been duly and validly
authorized by the board of directors of SPAC and (b) other than the Required SPAC Shareholder Approval, no other corporate proceedings,
other than as set forth elsewhere in this Agreement, on the part of SPAC are necessary to authorize the execution and delivery of this
Agreement and each Ancillary Document to which it is a party or to consummate the transactions contemplated hereby and thereby. This Agreement
has been, and each Ancillary Document to which SPAC is a party shall be when delivered, duly and validly executed and delivered by SPAC
and, assuming the due authorization, execution and delivery of this Agreement and such Ancillary Documents by the other parties hereto
and thereto, constitutes, or when delivered shall constitute, the valid and binding obligation of SPAC, enforceable against SPAC in accordance
with its terms, except to the extent that enforceability thereof may be limited by applicable bankruptcy, insolvency, restructuring, reorganization
and moratorium laws and other laws of general application affecting the enforcement of creditors&rsquo; rights generally or by any applicable
statute of limitation or by any valid defense of set-off or counterclaim, and the fact that equitable remedies or relief (including the
remedy of specific performance) are subject to the discretion of the court from which such relief may be sought (collectively, the &ldquo;<B><I>Enforceability
Exceptions</I></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.3 <U>Governmental
Approvals</U>. Except as otherwise described in <U>Schedule 3.3</U>, no Consent of or with any Governmental Authority on the part of SPAC
is required to be obtained or made in connection with the execution, delivery or performance by SPAC of this Agreement and each Ancillary
Document to which it is a party or the consummation by SPAC of the transactions contemplated hereby and thereby, other than (a) pursuant
to Antitrust Laws, (b) such filings as are contemplated by this Agreement, (c) any filings required with Nasdaq or the SEC with respect
to the Transactions, (d) applicable requirements, if any, of the Securities Act, the Exchange Act, and/or any state &ldquo;blue sky&rdquo;
securities Laws, and the rules and regulations thereunder, and (e) where the failure to obtain or make such Consents or to make such filings
or notifications would not reasonably be expected to be, individually or in the aggregate, material to SPAC or the ability of SPAC to
perform its obligations under this Agreement or the Ancillary Documents to which it is or required to be a party or otherwise bound.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.4 <U>Non-Contravention</U>.
Except as otherwise described in <U>Schedule 3.4</U>, the execution and delivery by SPAC of this Agreement and each Ancillary Document
to which it is a party, the consummation by SPAC of the transactions contemplated hereby and thereby, and the compliance by SPAC with
any of the provisions hereof and thereof, will not (a) conflict with or violate any provision of SPAC&rsquo;s Organizational Documents,
(b)&nbsp;subject to obtaining the Consents from Governmental Authorities referred to in <U>Section&nbsp;3.3</U> hereof, and the waiting
periods referred to therein having expired, and any condition precedent to such Consent or waiver having been satisfied, conflict with
or violate any Law, Order or Consent applicable to SPAC or any of its properties or assets, or (c) (i) violate, conflict with or result
in a breach of, (ii) constitute a default (or an event which, with notice or lapse of time or both, would constitute a default) under,
(iii) result in the termination, withdrawal, suspension, cancellation or modification of, (iv) accelerate the performance required by
SPAC under, (v) result in a right of termination or acceleration under, (vi) give rise to any obligation to make payments or provide compensation
under, (vii) result in the creation of any Lien upon any of the properties or assets of SPAC under, (viii) give rise to any obligation
to obtain any third party Consent or provide any notice to any Person under or (ix) give any Person the right to declare a default, exercise
any remedy, claim a rebate, chargeback, penalty or change in delivery schedule, accelerate the maturity or performance, cancel, terminate
or modify any right, benefit, obligation or other term under, any of the terms, conditions or provisions of, any SPAC Material Contract,
except for any deviations from any of the foregoing clauses (a), (b) or (c) that would not reasonably be expected to be, individually
or in the aggregate, material to SPAC or the ability of SPAC to perform its obligations under this Agreement or the Ancillary Documents
to which it is or required to be a party or otherwise bound.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.5 <U>Capitalization</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a) The
authorized share capital of SPAC is $55,500, divided into 500,000,000 SPAC Class A Ordinary Shares, 50,000,000 SPAC Class B Ordinary Shares,
and 5,000,000 SPAC Preference Shares. The issued and outstanding SPAC Securities as of the date of this Agreement are set forth on <U>Schedule
3.5(a)</U>. As of the date of this Agreement, there are no issued or outstanding SPAC Preference Shares. All outstanding SPAC Ordinary
Shares are duly authorized, validly issued, fully paid and non-assessable and are not subject to or issued in violation of any purchase
option, right of first refusal, preemptive right, subscription right or any similar right under any provision of the Cayman Islands Companies
Act, SPAC&rsquo;s Organizational Documents or any Contract to which SPAC is a party. None of the outstanding SPAC Securities have been
issued in violation of any applicable securities Laws. Prior to giving effect to the transactions contemplated by this Agreement, SPAC
does not have any Subsidiaries or own any equity interests in any other Person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b) Except
as set forth in <U>Schedule 3.5(a)</U> or <U>Schedule 3.5(b)</U>, there are no (i) outstanding options, warrants, puts, calls, convertible
securities, preemptive or similar rights, (ii) bonds, debentures, notes or other Indebtedness having general voting rights or that are
convertible or exchangeable into securities having such rights or (iii) subscriptions or other rights, agreements, arrangements, Contracts
or commitments of any character (other than this Agreement and the Ancillary Documents), (A) relating to the issued or unissued securities
of SPAC or (B) obligating SPAC to issue, transfer, deliver or sell or cause to be issued, transferred, delivered, sold or repurchased
any options or shares or securities convertible into or exchangeable for such securities, or (C) obligating SPAC to grant, extend or enter
into any such option, warrant, call, subscription or other right, agreement, arrangement or commitment for such capital shares. Other
than any redemption of Public Shareholders conducted in connection with an Extension (an &ldquo;<B><I>Extension Redemption</I></B>&rdquo;)
or the Closing Redemption (any of an Extension Redemption or a Closing Redemption, a &ldquo;<B><I>Redemption</I></B>&rdquo;), or as expressly
set forth in this Agreement, there are no outstanding obligations of SPAC to repurchase, redeem or otherwise acquire any shares of SPAC
or to provide funds to make any investment (in the form of a loan, capital contribution or otherwise) in any Person. Except as set forth
in <U>Schedule 3.5(b)</U>, there are no shareholders&rsquo; agreements, voting trusts or other agreements or understandings to which SPAC
is a party with respect to the voting of any shares of SPAC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c) All
Indebtedness of SPAC as of the date of this Agreement is disclosed on <U>Schedule 3.5(c)</U>. No Indebtedness of SPAC contains any restriction
upon: (i) the prepayment of any such Indebtedness, (ii) the incurrence of Indebtedness by SPAC, (iii) the ability of SPAC to grant any
Lien on its properties or assets, or (iv) the consummation of the Transactions (other than becoming due and payable upon the Closing).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d) Since
the date of formation of SPAC, and except as contemplated by this Agreement, SPAC has not declared or paid any distribution or dividend
in respect of its shares and has not repurchased, redeemed or otherwise acquired any of its shares, and SPAC&rsquo;s board of directors
has not authorized any of the foregoing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.6 <U>SEC
Filings and SPAC Financials</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a) SPAC,
since the IPO, has filed all forms, reports, schedules, statements, registration statements, prospectuses and other documents required
to be filed or furnished by the SPAC with the SEC under the Securities Act and/or the Exchange Act, together with any amendments, restatements
or supplements thereto, and will file all such forms, reports, schedules, statements and other documents required to be filed subsequent
to the date of this Agreement. Except to the extent available on the SEC&rsquo;s web site through EDGAR, SPAC has delivered to the Company
copies in the form filed with the SEC of all of the following: (i) SPAC&rsquo;s annual reports on Form 10-K for each fiscal year of SPAC
beginning with the first year SPAC was required to file such a form, (ii) SPAC&rsquo;s quarterly reports on Form 10-Q for each fiscal
quarter that SPAC filed such reports to disclose its quarterly financial results in each of the fiscal years of SPAC referred to in clause
(i) above, (iii) all other forms, reports, registration statements, prospectuses and other documents (other than preliminary materials)
filed by SPAC with the SEC since the beginning of the first fiscal year referred to in clause (i) above (the forms, reports, registration
statements, prospectuses and other documents referred to in clauses (i), (ii) and (iii) above, whether or not available through EDGAR,
are referred to herein collectively as the &ldquo;<B><I>SEC Reports</I></B>&rdquo;) and (iv) all certifications and statements required
by (A) Rules 13a-14 or 15d-14 under the Exchange Act, and (B) 18 U.S.C. &sect;1350 (Section 906 of SOX) with respect to any report referred
to in clause (i) above (collectively, the &ldquo;<B><I>Public Certifications</I></B>&rdquo;). The SEC Reports (x) were prepared in all
material respects in accordance with the requirements of the Securities Act and the Exchange Act, as the case may be, and the rules and
regulations thereunder, and (y) did not, as of their respective effective dates (in the case of SEC Reports that are registration statements
filed pursuant to the requirements of the Securities Act) and at the time they were filed with the SEC (in the case of all other SEC Reports)
contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to
make the statements made therein, in the light of the circumstances under which they were made, not misleading. The Public Certifications
are each true as of their respective dates of filing. As used in this <U>Section&nbsp;3.6</U>, the term &ldquo;file&rdquo; shall be broadly
construed to include any manner permitted by SEC rules and regulations in which a document or information is furnished, supplied or otherwise
made available to the SEC. As of the date of this Agreement, (A) the SPAC Units, the SPAC Class A Ordinary Shares and the SPAC Public
Warrants are listed on the Nasdaq Global Market, (B) SPAC has not received any written deficiency notice from Nasdaq relating to the continued
listing requirements of such SPAC Securities, (C) there are no Actions pending or, to the Knowledge of SPAC, threatened, against SPAC
by the Financial Industry Regulatory Authority with respect to any intention by such entity to suspend, prohibit or terminate the quoting
of such SPAC Securities on Nasdaq and (D) such SPAC Securities are in compliance with all of the applicable corporate governance rules
of Nasdaq.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b) The
financial statements and notes of SPAC contained or incorporated by reference in the SEC Reports (the &ldquo;<B><I>SPAC Financials</I></B>&rdquo;),
fairly present in all material respects the financial position and the results of operations, changes in shareholders&rsquo; equity, and
cash flows of SPAC at the respective dates of and for the periods referred to in such financial statements, all in accordance with (i)
GAAP methodologies applied on a consistent basis throughout the periods involved and (ii) Regulation S-X or Regulation S-K, as applicable
(except as may be indicated in the notes thereto and for the omission of notes and audit adjustments in the case of unaudited quarterly
financial statements to the extent permitted by Regulation S-X or Regulation S-K, as applicable).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c) Except
as and to the extent reflected or reserved against in the SPAC Financials, SPAC has not incurred any Liabilities or obligations of the
type required to be reflected on a balance sheet in accordance with GAAP that are not adequately reflected or reserved on or provided
for in the SPAC Financials, other than Liabilities of the type required to be reflected on a balance sheet in accordance with GAAP that
have been incurred since SPAC&rsquo;s last annual report on Form 10-K.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.7 <U>Absence
of Certain Changes</U>. As of the date of this Agreement, except as set forth in <U>Schedule 3.7</U>, SPAC has (a) since its formation,
conducted no business other than its formation, the public offering of its securities (and the related private offerings), public reporting
and its search for an initial Business Combination as described in the IPO Prospectus (including the investigation of the Target Companies
and the negotiation and execution of this Agreement) and related activities and (b) since January 1, 2025, not been subject to a Material
Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.8 <U>Compliance
with Laws</U>. SPAC is, and has since its formation been, in compliance with all Laws applicable to it and the conduct of its business
except for such noncompliance which would not reasonably be expected to be, individually or in the aggregate, material to SPAC or the
ability of SPAC to perform its obligations under this Agreement or the Ancillary Documents to which it is or required to be a party or
otherwise bound, and SPAC has not received written notice alleging any violation of applicable Law in any material respect by SPAC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.9 <U>Actions;
Orders; Permits</U>. There is no pending or, to the Knowledge of SPAC, threatened Action to which SPAC is subject which would reasonably
be expected to be, individually or in the aggregate, material to SPAC or the ability of SPAC to perform its obligations under this Agreement
or the Ancillary Documents to which it is or required to be a party or otherwise bound. There is no material Action that SPAC has pending
against any other Person. SPAC is not subject to any material Orders of any Governmental Authority, nor are any such Orders pending. SPAC
holds all Permits necessary to lawfully conduct its business as presently conducted, and to own, lease and operate its assets and properties,
all of which are in full force and effect, except where the failure to hold such Permit or for such Permit to be in full force and effect
would not reasonably be expected to be, individually or in the aggregate, material to SPAC or the ability of SPAC to perform its obligations
under this Agreement or the Ancillary Documents to which it is or required to be a party or otherwise bound.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.10 <U>Taxes
and Returns</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a) SPAC
has or will have timely filed, or caused to be timely filed, all material Tax Returns required to be filed by it, which Tax Returns are
true, accurate, correct and complete in all material respects, and has paid, collected or withheld, or caused to be paid, collected or
withheld, all material Taxes required to be paid, collected or withheld, other than such Taxes for which adequate reserves in the SPAC
Financials have been established in accordance with GAAP. <U>Schedule 3.10(a) </U>sets forth each jurisdiction where SPAC files or is
required to file a Tax Return. There are no audits, examinations, investigations or other proceedings pending against SPAC in respect
of any Tax, and SPAC has not been notified in writing of any proposed Tax claims or assessments against SPAC (other than, in each case,
claims or assessments for which adequate reserves in the SPAC Financials have been established in accordance with GAAP or are immaterial
in amount). There are no Liens with respect to any Taxes upon any of SPAC&rsquo;s assets, other than Permitted Liens. SPAC has no outstanding
waivers or extensions of any applicable statute of limitations to assess any material amount of Taxes. There are no outstanding requests
by SPAC for any extension of time within which to file any Tax Return or within which to pay any Taxes shown to be due on any Tax Return.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b) Since
the date of its formation, SPAC has not (i) changed any Tax accounting methods, policies or procedures except as required by a change
in Law, (ii) made, revoked, or amended any material Tax election, (iii) filed any amended Tax Returns or claim for refund or (iv) entered
into any closing agreement affecting or otherwise settled or compromised any material Tax Liability or refund.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c) No
claim in relation to Tax has been made in the preceding three (3) years against SPAC by a Governmental Authority in a jurisdiction where
SPAC does not file Tax Returns that it is or may be subject to taxation by that jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d) SPAC
is not and has never been a member of any consolidated, combined, unitary or affiliated group of corporations for any Tax purposes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e) SPAC
has not requested any private letter ruling, technical advice memorandum, closing agreement, settlement agreement or similar ruling, memorandum
or agreement with any Governmental Authority with respect to any Taxes, which such request is currently outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f) SPAC
has not engaged in or entered into a &ldquo;listed transaction&rdquo; within the meaning of Treasury Regulations Section 1.6011-4(b)(2)
or any similar provision of state, local or non-U.S. Tax Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(g) During
the two (2) year period ending on the date of this Agreement, SPAC was not a distributing corporation or a controlled corporation in a
transaction purported or intended to be governed by Section 355 of the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(h) SPAC
has not taken, and has not agreed to take, any action not contemplated by this Agreement and/or any Ancillary Documents that would reasonably
be expected to prevent the Transactions from qualifying for the Intended Tax Treatment. To the Knowledge of SPAC, there are no facts or
circumstances that would reasonably be expected to prevent the Transactions from qualifying for the Intended Tax Treatment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.11 <U>Employees
and Employee Benefit Plans</U>. SPAC does not (a) have any paid employees or (b) maintain, sponsor, contribute to or otherwise have any
Liability under, any Benefit Plans.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.12 <U>Properties</U>.
SPAC does not own, license or otherwise have any right, title or interest in any material Intellectual Property. SPAC does not own or
lease any material real property or Personal Property.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.13 <U>Material
Contracts</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a) Except
as set forth on <U>Schedule 3.13(a)</U>, other than this Agreement and the Ancillary Documents, there are no Contracts to which SPAC is
a party or by which any of its properties or assets may be bound, subject or affected, which (i) creates or imposes a Liability greater
than $200,000, (ii) may not be cancelled by SPAC on less than sixty (60) days&rsquo; prior notice without payment of a material penalty
or termination fee or (iii) prohibits, prevents, restricts or impairs in any material respect any business practice of SPAC as its business
is currently conducted, any acquisition of material property by SPAC, or restricts in any material respect the ability of SPAC to engage
in business as currently conducted by it or to compete with any other Person or to consummate the Transactions (each, a &ldquo;<B><I>SPAC
Material Contract</I></B>&rdquo;). All SPAC Material Contracts have been made available to the Company other than those that are exhibits
to the SEC Reports.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b) With
respect to each SPAC Material Contract: (i) the SPAC Material Contract was entered into at arms&rsquo; length and in the ordinary course
of business; (ii) the SPAC Material Contract is legal, valid, binding and enforceable in all material respects against SPAC and, to the
Knowledge of SPAC, the other parties thereto, and is in full force and effect (except, in each case, as such enforcement may be limited
by the Enforceability Exceptions); (iii) SPAC is not in breach or default in any material respect, and no event has occurred that with
the passage of time or giving of notice or both would constitute such a breach or default in any material respect by SPAC, or permit termination
or acceleration by the other party, under such SPAC Material Contract; and (iv) to the Knowledge of SPAC, no other party to any SPAC Material
Contract is in breach or default in any material respect, and no event has occurred that with the passage of time or giving of notice
or both would constitute such a breach or default by such other party, or permit termination or acceleration by SPAC under any SPAC Material
Contract.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.14 <U>Transactions
with Affiliates</U>. <U>Schedule 3.14</U> sets forth a true, correct and complete list of the Contracts and arrangements that are in existence
as of the date of this Agreement under which there are any existing or future Liabilities or obligations between SPAC and any (a) present
or former director, officer or employee or Affiliate of SPAC, or any immediate family member of any of the foregoing, or (b) record or
beneficial owner of more than five percent (5%) of SPAC&rsquo;s outstanding shares as of the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.15 <U>Investment
Company Act</U>. As of the date of this Agreement, SPAC is not an &ldquo;investment company&rdquo; or a Person directly or indirectly
&ldquo;controlled&rdquo; by or acting on behalf of an &ldquo;investment company&rdquo;, in each case within the meaning of the Investment
Company Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.16 <U>Finders
and Brokers</U>. Except for the IPO Underwriter and the Placement Agent or as otherwise set forth on <U>Schedule 3.16</U>, no broker,
finder or investment banker is entitled to any brokerage, finder&rsquo;s or other fee or commission from SPAC, Pubco, the Target Companies
or any of their respective Affiliates in connection with the transactions contemplated hereby based upon arrangements made by or on behalf
of SPAC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 23; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.17 <U>Certain
Business Practices</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a) Neither
SPAC, nor any of its Representatives acting on its behalf, has (i) used any funds for unlawful contributions, gifts, entertainment or
other unlawful expenses relating to political activity, (ii) made any unlawful payment to foreign or domestic government officials or
employees, to foreign or domestic political parties or campaigns or violated any provision of the U.S. Foreign Corrupt Practices Act of
1977 or any other local or foreign anti-corruption or bribery Law, (iii) made any other unlawful payment or (iv) since the formation of
SPAC, directly or indirectly, given or agreed to give any unlawful gift or similar benefit in any material amount to any customer, supplier,
governmental employee or other Person who is or may be in a position to help or hinder SPAC or assist it in connection with any actual
or proposed transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b) The
operations of SPAC are and have been conducted at all times in material compliance with money laundering statutes in all applicable jurisdictions,
the rules and regulations thereunder and any related or similar rules, regulations or guidelines, issued, administered or enforced by
any Governmental Authority, and no Action involving SPAC with respect to any of the foregoing is pending or, to the Knowledge of SPAC,
threatened.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c) None
of SPAC or any of its directors or officers, or, to the Knowledge of SPAC, any other Representative acting on behalf of SPAC is currently
identified on the specially designated nationals or other blocked person list or otherwise currently subject to any U.S. sanctions administered
by the Office of Foreign Assets Control of the U.S. Treasury Department (&ldquo;<B><I>OFAC</I></B>&rdquo;), and SPAC has not, directly
or indirectly, used any funds, or loaned, contributed or otherwise made available such funds to any Subsidiary, joint venture partner
or other Person, in connection with any sales or operations in any other country sanctioned by OFAC or for the purpose of financing the
activities of any Person currently subject to, or otherwise in violation of, any U.S. sanctions administered by OFAC in the last five
(5) fiscal years.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.18 <U>Insurance</U>.
<U>Schedule 3.18</U> lists all insurance policies (by policy number, insurer, coverage period, coverage amount, annual premium and type
of policy) held by SPAC relating to SPAC or its business, properties, assets, directors, officers and employees, copies of which have
been provided to the Company. All premiums due and payable under all such insurance policies have been timely paid and SPAC is otherwise
in material compliance with the terms of such insurance policies. All such insurance policies are in full force and effect, and to the
Knowledge of SPAC, there is no threatened termination of, or material premium increase with respect to, any of such insurance policies.
There have been no insurance claims made by SPAC. SPAC has each reported to its insurers all claims and pending circumstances that would
reasonably be expected to result in a claim, except where such failure to report such a claim would not be reasonably likely to be, individually
or in the aggregate, material to SPAC or the ability of SPAC to perform its obligations under this Agreement or the Ancillary Documents
to which it is or required to be a party or otherwise bound.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.19 <U>Information
Supplied</U>. None of the information supplied or to be supplied by the SPAC expressly for inclusion or incorporation by reference: (a)
in any current report on Form 8-K, and any exhibits thereto or any other report, form, registration or other filing made with any Governmental
Authority or stock exchange with respect to the transactions contemplated by this Agreement or any Ancillary Documents; (b) in the Registration
Statement; or (c) in the mailings or other distributions to the SPAC&rsquo;s shareholders and/or prospective investors with respect to
the consummation of the transactions contemplated by this Agreement or in any amendment to any of documents identified in (a) through
(c), will, when filed, made available, mailed or distributed, as the case may be, contain any untrue statement of a material fact or omit
to state any material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances
under which they are made, not misleading. None of the information supplied or to be supplied by the SPAC expressly for inclusion or incorporation
by reference in any of the Signing Press Release, the Signing Filing, the Closing Press Release and the Closing Filing will, when filed
or distributed, as applicable, contain any untrue statement of a material fact or omit to state any material fact required to be stated
therein or necessary in order to make the statements therein, in light of the circumstances under which they are made, not misleading.
Notwithstanding the foregoing, the SPAC makes no representation, warranty or covenant with respect to any information supplied by or on
behalf of the Company, Pubco or any of their respective Affiliates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 24; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.20 <U>Trust
Account</U>. As of the date hereof, there is at least $239,725,000 held in the Trust Account. Prior to the Closing, none of the funds
held in the Trust Account may be released except in accordance with the Trust Agreement, the SPAC&rsquo;s Organizational Documents and
the IPO Prospectus. Amounts in the Trust Account are invested in United States Government securities or in money market funds meeting
certain conditions under Rule 2a-7 promulgated under the Investment Company Act. The SPAC has performed all material obligations required
to be performed by it to date under, and is not in material default, breach or delinquent in performance or any other respect (claimed
or actual) in connection with, the Trust Agreement, and no event has occurred which, with due notice or lapse of time or both, would constitute
such a default or breach thereunder. The Trust Agreement is in full force and effect and is a legal, valid and binding obligation of the
SPAC and, to the Knowledge of the SPAC, the Trustee, enforceable in accordance with its terms, subject to the Enforceability Exceptions.
The Trust Agreement has not been terminated, repudiated, rescinded, amended or supplemented or modified, in any respect, and to the Knowledge
of the SPAC, no such termination, repudiation, rescission, amendment, supplement or modification is contemplated. There are no separate
Contracts, side letters or other arrangements (whether written or unwritten, express or implied) that would cause the description of the
Trust Agreement in the SEC Reports filed or furnished by the SPAC to be inaccurate or that would entitle any Person (other than holders
of SPAC Class A Ordinary Shares who shall have elected to redeem their SPAC Class A Ordinary Shares pursuant to the SPAC&rsquo;s Organizational
Documents and the underwriters of the IPO with respect to deferred underwriting commissions) to any portion of the proceeds in the Trust
Account prior to the closing of a Business Combination. As of the date hereof, the SPAC does not have any reason to believe that any of
the conditions to the use of funds in the Trust Account will not be satisfied or funds available in the Trust Account will not be available
to the SPAC (subject to any Redemptions) on the Closing Date. There are no Actions pending with respect to the Trust Account. The SPAC
has not released any money from the Trust Account other than as permitted by the Trust Agreement. As of the SPAC Merger Effective Time,
the obligations of the SPAC to dissolve or liquidate pursuant to the SPAC&rsquo;s Organizational Documents shall terminate and the SPAC
shall have no obligation whatsoever pursuant to the SPAC&rsquo;s Organizational Documents to dissolve and liquidate the assets of the
SPAC by reason of the consummation of the transactions contemplated herein. Following the Closing, no shareholder of the SPAC is or shall
be entitled to receive any amount from the Trust Account except to the extent such shareholder shall have elected to tender its SPAC Class
A Ordinary Shares for redemption pursuant to any Redemption in compliance with the SPAC&rsquo;s Organizational Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.21 <U>Independent
Investigation</U>. SPAC has conducted its own independent investigation, review and analysis of the business, results of operations, condition
(financial or otherwise) and assets of the Target Companies, Pubco and the Merger Subs and acknowledges that it has been provided adequate
access to the personnel, properties, assets, premises, books and records, and other documents and data of the Target Companies, Pubco
and the Merger Subs for such purpose. SPAC acknowledges and agrees that: (a) in making its decision to enter into this Agreement and to
consummate the transactions contemplated hereby, it has relied solely upon its own investigation and the express representations and warranties
of the Company and Pubco set forth in this Agreement (including the related portions of the Company Disclosure Schedules) and in any certificate
delivered to SPAC pursuant hereto, and the information provided by or on behalf of the Company, Pubco or the Merger Subs for the Registration
Statement; and (b) none of the Company, Pubco, the Merger Subs or their respective Representatives have made any representation or warranty
as to the Target Companies, Pubco or the Merger Subs or this Agreement, except as expressly set forth in this Agreement (including the
related portions of the Company Disclosure Schedules) or in any certificate delivered to SPAC pursuant hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.22 <U>No
Other Representations</U>. Except for the representations and warranties expressly made by the SPAC in this <U>Article III</U> (as modified
by the SPAC Disclosure Schedules) or as expressly set forth in an Ancillary Document, neither the SPAC nor any other Person on its behalf
makes any express or implied representation or warranty with respect to the SPAC or its business, operations, assets or Liabilities, or
the transactions contemplated by this Agreement or any of the other Ancillary Documents, and the SPAC hereby expressly disclaims any other
representations or warranties, whether implied or made by the SPAC or any of its Representatives. Except for the representations and warranties
expressly made by the SPAC in this <U>Article III</U> (as modified by the SPAC Disclosure Schedules) or in an Ancillary Document, the
SPAC hereby expressly disclaims all liability and responsibility for any representation, warranty, projection, forecast, statement or
information made, communicated or furnished (orally or in writing) to the Target Companies, Pubco or any of their respective Representatives
(including any opinion, information, projection or advice that may have been or may be provided to the Target Companies, Pubco or any
of their respective Representatives by any Representative of the SPAC), including any representations or warranties regarding the probable
success or profitability of the businesses of the SPAC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B></B></FONT></P>

<!-- Field: Page; Sequence: 25; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Article
IV</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: center"><B><U>REPRESENTATIONS AND WARRANTIES
OF PUBCO AND THE MERGER SUBS</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Each of Pubco and the Merger
Subs represent and warrant to the SPAC and the Company, as of the date hereof (or with respect to SPAC Merger Sub, as of the date of its
execution and delivery of the Joinder) and as of the Closing, as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.1 <U>Organization
and Standing</U>. Pubco is duly formed as an Israeli company limited by shares, duly incorporated and validly existing under the Laws
of the State of Israel and is not categorized as a &ldquo;Company in Breach&rdquo; (&#1495;&#1489;&#1512;&#1492; &#1502;&#1508;&#1512;&#1492;)
by the Companies Registrar. Company Merger Sub is duly formed as an Israeli company, duly incorporated and validly existing under the
Laws of the State of Israel and is not categorized as a &ldquo;Company in Breach&rdquo; (&#1495;&#1489;&#1512;&#1492; &#1502;&#1508;&#1512;&#1492;)
by the Companies Registrar. From and after its formation, SPAC Merger Sub will be an exempted company duly incorporated, validly existing
and in good standing under the Laws of the Cayman Islands. Each of Pubco and the Company Merger Sub has (and from and after its formation,
SPAC Merger Sub shall have) all requisite corporate power and authority to own, lease and operate its properties and to carry on its business
as now being conducted. Each of Pubco and the Company Merger Sub is (and from and after its formation, SPAC Merger Sub shall be) duly
qualified or licensed and in good standing to do business in each jurisdiction in which the character of the property owned, leased or
operated by it or the nature of the business conducted by it makes such qualification or licensing necessary. Pubco has heretofore made
available to SPAC and the Company accurate and complete copies of the Organizational Documents of Pubco and Company Merger Sub, each as
currently in effect, and upon the formation of SPAC Merger Sub, Pubco will make available to SPAC accurate and complete copies of the
Organizational Documents of SPAC Merger Sub. Neither Pubco nor Company Merger Sub is (nor from and after its formation, SPAC Merger Sub
shall be) in violation of any provision of its Organizational Documents in any material respect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.2 <U>Authorization;
Binding Agreement</U>. Each of Pubco and Company Merger Sub has (and from and after its execution and delivery of the Joinder, SPAC Merger
Sub shall have) all requisite corporate power and authority to execute and deliver this Agreement and each Ancillary Document to which
it is a party, and, subject to adoption of the Amended Pubco Organizational Documents, to perform its obligations hereunder and thereunder
and to consummate the transactions contemplated hereby and thereby. The execution and delivery of this Agreement and each Ancillary Document
to which it is a party and the consummation of the transactions contemplated hereby and thereby have been duly and validly authorized
by the board of directors and shareholders of Pubco and Company Merger Sub (and from and after its execution and delivery of the Joinder,
SPAC Merger Sub) and no other corporate proceedings, other than as expressly set forth elsewhere in the Agreement (including the filing
of the Amended Pubco Organizational Documents), on the part of Pubco or Company Merger Sub (or from and after its execution and delivery
of the Joinder, SPAC Merger Sub) and are necessary to authorize the execution and delivery of this Agreement and each Ancillary Document
to which it is a party or to consummate the transactions contemplated hereby and thereby. This Agreement has been, and each Ancillary
Document to which Pubco or Company Merger Sub (or from and after its execution and delivery of the Joinder, SPAC Merger Sub) is a party
has been or shall be when delivered, duly and validly executed and delivered by such Party and, assuming the due authorization, execution
and delivery of this Agreement and such Ancillary Documents by the other parties hereto and thereto, constitutes, or when delivered shall
constitute, the valid and binding obligation of such Party, enforceable against such Party in accordance with its terms, subject to the
Enforceability Exceptions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.3 <U>Governmental
Approvals</U>. No Consent of or with any Governmental Authority, on the part of Pubco or a Merger Sub is required to be obtained or made
in connection with the execution, delivery or performance by such Party of this Agreement and each Ancillary Document to which it is a
party or the consummation by such Party of the transactions contemplated hereby and thereby, other than (a) pursuant to Antitrust Laws,
(b) such filings as contemplated by this Agreement, including those with the Companies Registrar and the Amended Pubco Organizational
Documents, (c) any filings required with Nasdaq or the SEC with respect to the transactions contemplated by this Agreement, (d) applicable
requirements, if any, of the Securities Act, the Exchange Act, and/ or any state &ldquo;blue sky&rdquo; securities Laws, and the rules
and regulations thereunder, and (e) where the failure to obtain or make such Consents or to make such filings or notifications, would
not, individually or in the aggregate, reasonably be expected to have a material impact on the ability of Pubco or either Merger Sub to
consummate on a timely basis the Transactions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 26; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.4 <U>Non-Contravention</U>.
The execution and delivery by Pubco, Company Merger Sub and SPAC Merger Sub (through a Joinder) of this Agreement and each Ancillary Document
to which it is a party, the consummation by such Party of the transactions contemplated hereby and thereby, and compliance by such Party
with any of the provisions hereof and thereof, will not (a) subject to the filing of the Amended Pubco Organizational Documents, conflict
with or violate any provision of such Party&rsquo;s Organizational Documents, (b) subject to obtaining the Consents from Governmental
Authorities referred to in <U>Section 4.3</U> hereof, and the waiting periods referred to therein having expired, and any condition precedent
to such Consent or waiver having been satisfied, conflict with or violate any Law, Order or Consent applicable to such Party or any of
its properties or assets, or (c) (i) violate, conflict with or result in a breach of, (ii) constitute a default (or an event which, with
notice or lapse of time or both, would constitute a default) under, (iii) result in the termination, withdrawal, suspension, cancellation
or modification of, (iv) accelerate the performance required by such Party under, (v) result in a right of termination or acceleration
under, (vi) give rise to any obligation to make payments or provide compensation under, (vii) result in the creation of any Lien upon
any of the properties or assets of such Party under, (viii) give rise to any obligation to obtain any third party Consent or provide any
notice to any Person or (ix) give any Person the right to declare a default, exercise any remedy, claim a rebate, chargeback, penalty
or change in delivery schedule, accelerate the maturity or performance, cancel, terminate or modify any right, benefit, obligation or
other term under, any of the terms, conditions or provisions of, any material Contract of such Party, except for any deviations from any
of the foregoing clauses (a), (b) or (c) that would not reasonably be expected to have a material impact on the ability of Pubco or either
Merger Sub to consummate on a timely basis the Transactions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.5 <U>Capitalization</U>.
As of the date hereof, (i) Pubco is authorized to issue 1,000,000,000 Pubco Ordinary Shares, of which 1 Pubco Ordinary Shares is issued
and outstanding, all of which are owned by Guy &amp; Guya Trusts and Management, Ltd., and (ii) Company Merger Sub is authorized to issue
10,000 ordinary shares, no par value, of which 100 shares are issued and outstanding, and all of which are owned by Pubco. Upon its execution
and delivery of the Joinder, SPAC Merger Sub will be authorized to issue 1,000 ordinary shares, no par value, of which 1,000 shares will
be issued and outstanding, and all of which will be owned by a Permitted SPAC Merger Sub Owner. Prior to giving effect to the Transactions,
other than the Merger Subs, Pubco does not have any Subsidiaries or own any equity interests in any other Person. Pubco qualifies as a
foreign private issuer pursuant to Rule 3b-4 of the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.6 <U>Ownership
of Merger Consideration Shares</U>. All Pubco Ordinary Shares to be issued and delivered to the Company Security Holders as Merger Consideration
in accordance with <U>Article I</U> shall be, upon issuance and delivery of such shares, duly authorized and validly issued and fully
paid and non-assessable, free and clear of all Liens, other than restrictions arising from applicable securities Laws, any applicable
Lock-Up Agreement and any Liens incurred by any Company Shareholder, and the issuance and sale of such Pubco Ordinary Shares pursuant
hereto will not be subject to or give rise to any preemptive rights or rights of first refusal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.7 <U>Pubco
and Merger Sub Activities</U>. Since their formation, Pubco and the Merger Subs have not engaged in any business activities other than
as contemplated by this Agreement, do not own directly or indirectly any ownership, equity, profits or voting interest in any Person (other
than Pubco&rsquo;s 100% ownership of Company Merger Sub and, if applicable, SPAC Merger Sub) and have no assets or Liabilities except
those incurred in connection with this Agreement and the Ancillary Documents to which they are a party and the Transactions, and, other
than this Agreement and the Ancillary Documents to which they are a party, Pubco and the Merger Subs are not party to or bound by any
Contract.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.8 <U>Finders
and Brokers</U>. No broker, finder or investment banker is entitled to any brokerage, finder&rsquo;s or other fee or commission from SPAC,
Pubco, the Target Companies or any of their respective Affiliates in connection with the transactions contemplated hereby based upon arrangements
made by or on behalf of Pubco or a Merger Sub.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase">4.9 </FONT><U>Investment
Company Act</U>. As of the date of this Agreement, Pubco is not an &ldquo;investment company&rdquo; or, a Person directly or indirectly
controlled by or acting on behalf of an &ldquo;investment company&rdquo;, in each case within the meanings of the Investment Company Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.10 <U>Information
Supplied</U>. None of the information supplied or to be supplied by Pubco or a Merger Sub expressly for inclusion or incorporation by
reference: (a) in any Current Report on Form 8-K or 6-K, and any exhibits thereto or any other report, form, registration or other filing
made with any Governmental Authority (including the SEC) with respect to the transactions contemplated by this Agreement or any Ancillary
Documents; (b) in the Registration Statement; or (c) in the mailings or other distributions to SPAC&rsquo;s or Pubco&rsquo;s shareholders
and/or prospective investors with respect to the consummation of the transactions contemplated by this Agreement or in any amendment to
any of documents identified in (a) through (c), will, when filed, made available, mailed or distributed, as the case may be, contain any
untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary in order to make the
statements therein, in light of the circumstances under which they are made, not misleading. None of the information supplied or to be
supplied by Pubco or a Merger Sub expressly for inclusion or incorporation by reference in any of the Signing Press Release, the Signing
Filing, the Closing Filing and the Closing Press Release will, when filed or distributed, as applicable, contain any untrue statement
of a material fact or omit to state any material fact required to be stated therein or necessary in order to make the statements therein,
in light of the circumstances under which they are made, not misleading. Notwithstanding the foregoing, neither Pubco nor either Merger
Sub makes any representation, warranty or covenant with respect to any information supplied by or on behalf of SPAC, the Target Companies
or any of their respective Affiliates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 27; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.11 <U>Independent
Investigation</U>. Each of Pubco and Company Merger Sub has (and upon its execution and delivery of the Joinder, SPAC Merger Sub shall
have) conducted its own independent investigation, review and analysis of the business, results of operations, condition (financial or
otherwise) or assets of the Target Companies and SPAC and acknowledges that it has been provided adequate access to the personnel, properties,
assets, premises, books and records, and other documents and data of the Target Companies and SPAC for such purpose. Each of Pubco and
the Merger Subs (with respect to SPAC Merger Sub, upon its execution and delivery of the Joinder) acknowledges and agrees that: (a) in
making its decision to enter into this Agreement and to consummate the transactions contemplated hereby, it has relied solely upon its
own investigation and the express representations and warranties of the Company and SPAC set forth in this Agreement (including the related
portions of the Company Disclosure Schedules and the SPAC Disclosure Schedules) and in any certificate delivered to Pubco or a Merger
Sub pursuant hereto, and the information provided by or on behalf of the Company or SPAC for the Registration Statement; and (b) none
of the Company, SPAC or their respective Representatives have made any representation or warranty as to the Target Companies, SPAC or
this Agreement, except as expressly set forth in this Agreement (including the related portions of the Company Disclosure Schedules and
the SPAC Disclosure Schedules) or in any certificate delivered to Pubco or a Merger Sub pursuant hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.12 <U>No
Other Representations</U>. Except for the representations and warranties expressly made by Pubco in this <U>Article IV</U> or as expressly
set forth in an Ancillary Document, neither Pubco nor any other Person on its behalf makes any express or implied representation or warranty
with respect to any of Pubco or the Merger Subs or their respective business, operations, assets or Liabilities, or the transactions contemplated
by this Agreement or any of the other Ancillary Documents, and Pubco and the Merger Subs each hereby expressly disclaims any other representations
or warranties, whether implied or made by Pubco, a Merger Sub or any of their respective Representatives. Except for the representations
and warranties expressly made by Pubco in this <U>Article IV</U> or in an Ancillary Document, Pubco hereby expressly disclaims all liability
and responsibility for any representation, warranty, projection, forecast, statement or information made, communicated or furnished (orally
or in writing) to the SPAC, the Target Companies or any of their respective Representatives (including any opinion, information, projection
or advice that may have been or may be provided to the SPAC, the Target Companies or any of their respective Representatives by any Representative
of Pubco or a Merger Sub), including any representations or warranties regarding the probable success or profitability of the businesses
of Pubco or a Merger Sub.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Article
V<U><BR>
REPRESENTATIONS AND WARRANTIES </U></B></FONT><B><U>OF THE COMPANY</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Except as set forth in the
disclosure schedules delivered by the Company to SPAC on the date hereof (the &ldquo;<B><I>Company Disclosure Schedules</I></B>&rdquo;),
the Section numbers of which are numbered to correspond to the Section numbers of this Agreement to which they refer, the Company hereby
represents and warrants to SPAC and Pubco, as of the date hereof and as of the Closing, as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.1 <U>Organization
and Standing</U>. The Company is a corporation duly formed and validly existing under the Israeli Companies Law and is not categorized
as a &ldquo;Company in Breach&rdquo; (<FONT STYLE="font-family: Times New Roman, Times, Serif">&#1495;&#1489;&#1512;&#1492; &#1502;&#1508;&#1512;&#1492;</FONT>)
by the Companies Registrar. The Company has all requisite corporate power and authority to own, lease and operate its properties and to
carry on its business as now being conducted, except as has not been, and would not reasonably expected to be, individually or in the
aggregate, material to the Target Companies or the ability of the Company to perform its obligations under this Agreement or the Ancillary
Documents to which it is or required to be a party or otherwise bound. Each other Target Company is a corporation or other entity duly
formed, validly existing and in good standing (if the concept of good standing is recognized under its jurisdiction of organization) under
the Laws of its jurisdiction of organization and has all requisite corporate power and authority to own, lease and operate its properties
and to carry on its business as now being conducted, except as has not been, and would not reasonably expected to be, individually or
in the aggregate, material to the Target Companies or the ability of the Company to perform its obligations under this Agreement or the
Ancillary Documents to which it is or required to be a party or otherwise bound. Each Target Company is duly qualified or licensed and
in good standing in the jurisdiction in which it is incorporated or registered and in each other jurisdiction where it does business or
operates to the extent that the character of the property owned, or leased or operated by it or the nature of the business conducted by
it makes such qualification or licensing necessary, except as has not been, and would not reasonably expected to be, individually or in
the aggregate, material to the Target Companies or the ability of the Company to perform its obligations under this Agreement or the Ancillary
Documents to which it is or required to be a party or otherwise bound. <U>Schedule 5.1</U> lists all jurisdictions in which any Target
Company is qualified to conduct business and all names other than its legal name under which any Target Company does business. The Company
has provided to SPAC accurate and complete copies of the Organizational Documents of each Target Company, each as amended to date and
as currently in effect. No Target Company is in violation of any provision of its Organizational Documents in any material respect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 28; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.2 <U>Authorization;
Binding Agreement</U>. The Company has all requisite corporate power and authority to execute and deliver this Agreement and each Ancillary
Document to which it is or is required to be a party, to perform the Company&rsquo;s obligations hereunder and thereunder and to consummate
the transactions contemplated hereby and thereby, subject to obtaining the Required Company Shareholder Approval. The execution and delivery
of this Agreement and each Ancillary Document to which the Company is or is required to be a party and the consummation of the transactions
contemplated hereby and thereby, (a) have been duly and validly authorized by the board of directors of the Company in accordance with
the Company&rsquo;s Organizational Documents, the Israeli Companies Law, any other applicable Law and any Contract to which the Company
is party or bound and (b) other than the Required Company Shareholder Approval, no other corporate proceedings on the part of the Company
are necessary to authorize the execution and delivery of this Agreement and each Ancillary Document to which it is a party or to consummate
the transactions contemplated hereby and thereby. This Agreement has been, and each Ancillary Document to which the Company is or is required
to be a party shall be when delivered, duly and validly executed and delivered by the Company Party and assuming the due authorization,
execution and delivery of this Agreement and any such Ancillary Document by the other parties hereto and thereto, constitutes, or when
delivered shall constitute, the legal, valid and binding obligation of the Company, enforceable against the Company in accordance with
its terms, subject to the Enforceability Exceptions. The Company&rsquo;s board of directors, by resolutions duly adopted at a meeting
duly called and held (i) determined that this Agreement and the Transactions contemplated are advisable, fair to, and in the best interests
of, the Company and its shareholders, (ii) approved this Agreement and the Transactions in accordance with the Israeli Companies Law,
(iii) directed that this Agreement and the Transactions be submitted to the Company&rsquo;s shareholders for adoption and (iv) resolved
to recommend that the Company shareholders adopt this Agreement and the Transactions. The Voting Agreements delivered by the Company include
holders of Company Ordinary Shares representing in the aggregate, at least 35% of the voting power of the issued and outstanding Company
Securities as of the date of this Agreement, and such Voting Agreements are in full force and effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.3 <U>Capitalization</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a) As
of the date of this Agreement, the Company is authorized to issue 10,000,000 Company Ordinary Shares. The issued and outstanding share
capital of the Company as of the date hereof consists of 2,877,697 Company Ordinary Shares, and there are no other issued or outstanding
equity interests of the Company. Prior to giving effect to the Transactions, all of the issued and outstanding Company Ordinary Shares
and other equity interests of the Company, including the number and class or series (as applicable) of shares, are set forth on <U>Schedule
5.3(a)</U>, along with the beneficial and record owners thereof, all of which Company Ordinary Shares and other equity interests are owned
free and clear of any Liens other than those imposed under the Company&rsquo;s Organizational Documents and applicable securities Laws.
All of the outstanding Company Ordinary Shares and other equity interests of the Company have been duly authorized, are fully paid and
non-assessable and not in violation of any purchase option, right of first refusal, preemptive right, subscription right or any similar
right under any provision of the Israeli Companies Law, any other applicable Law, the Company&rsquo;s Organizational Documents or any
Contract to which the Company is a party or by which the Company or its securities are bound. The Company does not, directly or indirectly,
hold any of its shares or other equity interests in treasury.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b) The
Company is a party to the outstanding Company SAFEs set forth on <U>Schedule 5.3(b)</U> (which <U>Schedule 5.3(b)</U> includes the investors
party thereto, the valuation cap and the discount rate set forth therein for their investment and the number of Company Ordinary Shares
to be issued pursuant thereto based on the Merger Consideration set forth in <U>Section 1.11</U> (assuming for such purposes that the
Interim Investment Amount is $5,000,000 in Bridge Financing and such SAFEs have not been converted following the Bridge Financing), pursuant
to which the Company is obligated to issue an additional number of Company Ordinary Shares based on the valuation of the Company at the
time of issuance. The investors to the Company SAFEs will be entitled to receive an aggregate of 553,523 Company Ordinary Shares based
on the Merger Consideration set forth in <U>Section 1.11</U> (assuming for such purposes that the Interim Investment Amount is $5,000,000
in Bridge Financing and such SAFEs have not been converted following the Bridge Financing). True, complete and correct copies of the Company
SAFEs have been provided to SPAC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<!-- Field: Page; Sequence: 29; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c) The
Company has reserved 500,000 Company Ordinary Shares for issuance to officers, directors, employees and consultants of the Company pursuant
to the Company Equity Plan, which was duly adopted by the Company&rsquo;s board of directors. Of such Company Ordinary Shares reserved
for issuance under the Company Equity Plan, (x) 297,142 of such shares are reserved for issuance upon exercise of currently outstanding
Company Options, (y) 3,743 of such shares are currently issued and outstanding that were issued upon exercise of Company Options previously
granted under the Company Equity Plan, and (z) 199,115 shares remain available for future awards permitted under the Company Equity Plan.
The Company has furnished to SPAC complete and accurate copies of the Company Equity Plan and forms of agreements used thereunder, which
Company Equity Plan shall be terminated and cancelled upon the Closing. S<U>chedule 5.3(c)</U> sets forth the beneficial and record owners
of all outstanding Company Options (including in each case the grant date, number and type of shares issuable thereunder, the exercise
price, the expiration date and any vesting schedule) prior to the Company Merger.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d) Except
as described in <U>Sections 5.3(b)</U> and <U>5.3(c)</U>, or as set forth on <U>Schedule 5.3(d)</U>, there are no Company Convertible
Securities or preemptive rights or rights of first refusal or first offer, nor are there any Contracts, commitments, arrangements or restrictions
to which the Company or, to the Knowledge of the Company, any of their respective shareholders are a party or bound relating to any equity
securities of the Company, whether or not outstanding. There are no outstanding or authorized equity appreciation, phantom equity or similar
rights with respect to the Company. Except as set forth on <U>Schedule 5.3(d)</U>, there are no voting trusts, proxies, shareholder agreements
or any other agreements or understandings with respect to the voting of the Company&rsquo;s equity interests. Except as set forth in the
Company&rsquo;s Organizational Documents, there are no outstanding contractual obligations of the Company to repurchase, redeem or otherwise
acquire any of its equity interests or securities, nor has the Company granted any registration rights to any Person with respect to its
equity securities. All of the issued and outstanding securities of the Company have been granted, offered, sold and issued in compliance
with all applicable securities Laws. Except as expressly provided pursuant to the terms of this Agreement, as a result of the consummation
of the transactions contemplated by this Agreement, no equity interests of the Company are issuable and no rights in connection with any
interests, warrants, rights, options or other securities of the Company accelerate or otherwise become triggered (whether as to vesting,
exercisability, convertibility or otherwise).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e) Except
as disclosed in the Company Financials or as set forth on <U>Schedule 5.3(e)</U>, since January 1, 2024, the Company has not declared
or paid any distribution or dividend in respect of its equity interests and has not repurchased, redeemed or otherwise acquired any equity
interests of the Company, and the board of directors of the Company has not authorized any of the foregoing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.4 <U>Subsidiaries</U>.
<U>Schedule 5.4</U> sets forth the name of each Subsidiary of the Company, and with respect to each Subsidiary (a) its jurisdiction of
organization, (b) its authorized shares or other equity interests (if applicable), and (c) the number of issued and outstanding shares
or other equity interests and the record holders and beneficial owners thereof. All of the outstanding equity securities of each Subsidiary
of the Company are duly authorized and validly issued, fully paid and non-assessable (if applicable), and were offered, sold and delivered
in compliance with all applicable securities Laws, and owned by one or more of the Target Companies free and clear of all Liens (other
than those, if any, imposed by such Subsidiary&rsquo;s Organizational Documents). There are no Contracts to which the Company or any of
its Affiliates is a party or bound with respect to the voting (including voting trusts or proxies) of the equity interests of any Subsidiary
of the Company other than the Organizational Documents of any such Subsidiary. There are no outstanding or authorized options, warrants,
rights, agreements, subscriptions, convertible securities or commitments to which any Subsidiary of the Company is a party or which are
binding upon any Subsidiary of the Company providing for the issuance or redemption of any equity interests of any Subsidiary of the Company.
There are no outstanding equity appreciation, phantom equity, profit participation or similar rights granted by any Subsidiary of the
Company. No Subsidiary of the Company has any limitation, whether by Contract, Order or applicable Law, on its ability to make any distributions
or dividends to its equity holders or repay any debt owed to another Target Company. Except for the equity interests of the Subsidiaries
listed on <U>Schedule 5.4</U>, the Company does not own or have any rights to acquire, directly or indirectly, any equity interests of,
or otherwise Control, any Person. No Target Company is a participant in any joint venture, partnership or similar arrangement. There are
no outstanding contractual obligations of a Target Company to provide funds to, or make any investment (in the form of a loan, capital
contribution or otherwise) in, any other Person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.5 <U>Governmental
Approvals</U>. Except as otherwise described in <U>Schedule 5.5</U>, no Consent of or with any Governmental Authority on the part of any
Target Company is required to be obtained or made in connection with the execution, delivery or performance by the Company of this Agreement
or any Ancillary Documents or the consummation by the Company of the transactions contemplated hereby or thereby other than (a) such filings
as expressly contemplated by this Agreement, including the filing of the IIA Notice, the receipt of the ISA Exemptions and the issuance
of the Merger Certificates, (b) the filing of any notifications required pursuant to Antitrust Laws and the expiration of the required
waiting periods thereunder and (c) those Consents, the failure of which to obtain prior to the Closing, would not individually or in the
aggregate reasonably be expected to be material to the Target Companies or the ability of the Company to perform its obligations under
this Agreement or the Ancillary Documents to which it is or required to be a party or otherwise bound.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 30; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.6 <U>Non-Contravention</U>.
Except as otherwise described in <U>Schedule 5.6</U>, the execution and delivery by the Company (or any other Target Company, as applicable)
of this Agreement and each Ancillary Document to which any Target Company is or is required to be a party or otherwise bound, and the
consummation by any Target Company of the transactions contemplated hereby and thereby and compliance by any Target Company with any of
the provisions hereof and thereof, will not (a) conflict with or violate any provision of any Target Company&rsquo;s Organizational Documents,
(b) subject to obtaining the Consents from Governmental Authorities referred to in <U>Section 5.5</U> hereof, the waiting periods referred
to therein having expired, and any condition precedent to such Consent or waiver having been satisfied, conflict with or violate any Law,
Order or Consent applicable to any Target Company or any of its properties or assets, or (c) (i) violate, conflict with or result in a
breach of, (ii) constitute a default (or an event which, with notice or lapse of time or both, would constitute a default) under, (iii)
result in the termination, withdrawal, suspension, cancellation or modification of, (iv) accelerate the performance required by any Target
Company under, (v) result in a right of termination or acceleration under, (vi) give rise to any obligation to make payments or provide
compensation under, (vii) result in the creation of any Lien upon any of the properties or assets of any Target Company under, (viii)
give rise to any obligation to obtain any third party Consent or provide any notice to any Person or (ix) give any Person the right to
declare a default, exercise any remedy, claim a rebate, chargeback, penalty or change in delivery schedule, accelerate the maturity or
performance, cancel, terminate or modify any right, benefit, obligation or other term under, any of the terms, conditions or provisions
of any Company Material Contract, except in cases of clauses (b) and (c), as would not individually or in the aggregate reasonably be
expected to be material to the Target Companies or the ability of the Company to perform its obligations under this Agreement or the Ancillary
Documents to which it is or required to be a party or otherwise bound.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.7 <U>Financial
Statements</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a) As
used herein, the term &ldquo;<B><I>Company Financials</I></B>&rdquo; means (i) the consolidated financial statements of the Target Companies
(including, in each case, any related notes thereto), consisting of the consolidated balance sheets of the Target Companies as of December
31, 2023 and December 31, 2022, and the related consolidated audited income statements, changes in shareholder equity and statements of
cash flows for the years then ended, each audited in accordance with PCAOB auditing standards by a PCAOB qualified auditor (the &ldquo;<B><I>2023/2022
Audited Financials</I></B>&rdquo;), and (ii) when delivered in accordance with the requirements of <U>Section 6.4(a)</U>, (A) the consolidated
financial statements of the Target Companies (including, in each case, any related notes thereto), consisting of the consolidated balance
sheets of the Target Companies as of December 31, 2024 and December 31, 2023, and the related consolidated audited income statements,
changes in shareholder equity and statements of cash flows for the years then ended, each audited in accordance with PCAOB auditing standards
by a PCAOB qualified auditor (the &ldquo;<B><I>Audited Financials</I></B>&rdquo;), and (B) the Company prepared and auditor reviewed financial
statements, consisting of the consolidated balance sheet of the Target Companies as of June 30, 2025, and the related consolidated income
statement, changes in shareholder equity and statement of cash flows for the six (6) months then ended (the &ldquo;<B><I>Interim Reviewed
Financials</I></B>&rdquo; and together with the Audited Financials, the &ldquo;<B><I>PCAOB Financials</I></B>&rdquo;). True and correct
copies of the 2023/2022 Audited Financials have been provided to SPAC, and the Audited Financials will be delivered in accordance with
the requirements of <U>Section 6.4(a)</U>. The Company Financials (i) do and will accurately reflect in all material respects the books
and records of the Target Companies as of the times and for the periods referred to therein, (ii) were and will be prepared in accordance
with IFRS, consistently applied throughout and among the periods involved (except that the unaudited statements exclude the footnote disclosures
and other presentation items required for IFRS and exclude year-end adjustments which will not be material in amount), (iii) do and will
comply in all material respects with all applicable accounting requirements under the Securities Act and the rules and regulations of
the SEC thereunder, and (iv) do and will fairly present in all material respects the consolidated financial position of the Target Companies
as of the respective dates thereof and the consolidated results of the operations and cash flows of the Target Companies for the periods
indicated. No Target Company has ever been subject to the reporting requirements of Sections 13(a) and 15(d) of the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<!-- Field: Page; Sequence: 31; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b) Each
Target Company maintains accurate books and records reflecting its assets and Liabilities and maintains proper and adequate internal accounting
controls that provide reasonable assurance that (i) such Target Company does not maintain any off-the-book accounts and that such Target
Company&rsquo;s assets are used only in accordance with such Target Company&rsquo;s management directives, (ii) transactions are executed
with management&rsquo;s authorization, (iii) transactions are recorded as necessary to permit preparation of the financial statements
of such Target Company and to maintain accountability for such Target Company&rsquo;s assets, (iv) access to such Target Company&rsquo;s
assets is permitted only in accordance with management&rsquo;s authorization, (v) the reporting of such Target Company&rsquo;s assets
is compared with existing assets at regular intervals and verified for actual amounts, and (vi) accounts, notes and other receivables
and inventory are recorded accurately, and proper and adequate procedures are implemented to effect the collection of accounts, notes
and other receivables on a current and timely basis. All of the financial books and records of the Target Companies are complete and accurate
in all material respects and have been maintained in the ordinary course consistent with past practice and in accordance with applicable
Laws. No Target Company has been subject to or involved in any material fraud that involves management or other employees who have a significant
role in the internal controls over financial reporting of any Target Company. Since January 1, 2022, no Target Company or, to the Knowledge
of the Company, its Representatives has received any written complaint, allegation, assertion or claim regarding the accounting or auditing
practices, procedures, methodologies or methods of any Target Company or its internal accounting controls, including any material written
complaint, allegation, assertion or claim that any Target Company has engaged in questionable accounting or auditing practices.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c) The
Target Companies do not have any Indebtedness other than the Indebtedness set forth on <U>Schedule 5.7(c)</U>, and in such amounts (including
principal and any accrued but unpaid interest or other obligations with respect to such Indebtedness), as set forth on <U>Schedule 5.7(c)</U>.
Except as disclosed on <U>Schedule 5.7(c)</U>, no Indebtedness of any Target Company contains any restriction upon (i) the prepayment
of any of such Indebtedness, (ii) the incurrence of Indebtedness by any Target Company, or (iii) the ability of the Target Companies to
grant any Lien on their respective properties or assets.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d) Except
as set forth on <U>Schedule 5.7(d)</U>, no Target Company is subject to any Liabilities or obligations (whether or not required to be
reflected on a balance sheet prepared in accordance with IFRS or GAAP), including any off-balance sheet obligations or any &ldquo;variable
interest entities&rdquo; (within the meaning Accounting Standards Codification 810), except for those that are either (i) adequately reflected
or reserved on or provided for in the consolidated balance sheet of the Company and its Subsidiaries as of December 31, 2023 contained
in the 2023/2022 Audited Financials or (ii) not material and that were incurred after December 31, 2024 in the ordinary course of business
consistent with past practice (other than Liabilities for breach of any Contract or violation of any Law).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e) All
financial projections with respect to the Target Companies that were delivered by or on behalf of the Company to SPAC or Pubco or their
respective Representatives were prepared in good faith using assumptions that the Company believes to be reasonable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f) All
accounts, notes and other receivables, whether or not accrued, and whether or not billed, of the Target Companies (the &ldquo;<B><I>Accounts
Receivable</I></B>&rdquo;) arose from sales actually made or services actually performed in the ordinary course of business and represent
valid obligations to a Target Company arising from its business. None of the Accounts Receivable are subject to any right of recourse,
defense, deduction, return of goods, counterclaim, offset, or set off on the part of the obligor in excess of any amounts reserved therefore
on the Company Financials. All of the Accounts Receivable are, to the Knowledge of the Company, fully collectible according to their terms
in amounts not less than the aggregate amounts thereof carried on the books of the Target Companies (net of reserves) within ninety (90)
days.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.8 <U>Absence
of Certain Changes</U>. Except as set forth on <U>Schedule 5.8</U> or for actions expressly contemplated by this Agreement, since January
1, 2025, each Target Company has (a) conducted its business only in the ordinary course of business consistent with past practice, (b)
not been subject to a Material Adverse Effect and (c) has not taken any action or committed or agreed to take any action that would be
prohibited by <U>Section 6.2</U> (without giving effect to <U>Schedule 6.2</U>) if such action were taken on or after the date hereof
without the consent of SPAC, except as has not been, and would not reasonably expected to be, individually or in the aggregate, material
to the Target Companies or the ability of the Company to perform its obligations under this Agreement or the Ancillary Documents to which
it is or required to be a party or otherwise bound.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.9 <U>Compliance
with Laws</U>. Except as set forth on <U>Schedule 5.9</U>, no Target Company is or has been in conflict or non-compliance with, or in
default or violation of, nor has any Target Company received, in the past five (5) years, any written or, to the Knowledge of the Company,
oral notice of any conflict or non-compliance with, or default or violation of, any applicable Laws by which it or any of its properties,
assets, employees, business or operations are or were bound or affected, except as has not been, and would not reasonably expected to
be, individually or in the aggregate, material to the Target Companies or the ability of the Company to perform its obligations under
this Agreement or the Ancillary Documents to which it is or required to be a party or otherwise bound.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 32; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.10 <U>Company
Permits</U>. Each Target Company (and its employees who are legally required to be licensed by a Governmental Authority in order to perform
his or her duties with respect to his or her employment with any Target Company), holds all Permits necessary to lawfully conduct in all
material respects its business as presently conducted and as currently contemplated to be conducted, and to own, lease and operate its
assets and properties (collectively, the &ldquo;<B><I>Company Permits</I></B>&rdquo;), except as has not been, and would not reasonably
expected to be, individually or in the aggregate, material to the Target Companies or the ability of the Company to perform its obligations
under this Agreement or the Ancillary Documents to which it is or required to be a party or otherwise bound. The Company has made available
to SPAC true, correct and complete copies of all material Company Permits, all of which material Company Permits are listed on <U>Schedule
5.10</U>. All of the Company Permits are in full force and effect, and no suspension or cancellation of any of the Company Permits is
pending or, to the Company&rsquo;s Knowledge, threatened, except as has not been, and would not reasonably expected to be, individually
or in the aggregate, material to the Target Companies or the ability of the Company to perform its obligations under this Agreement or
the Ancillary Documents to which it is or required to be a party or otherwise bound. No Target Company is in violation in any material
respect of the terms of any Company Permit, and no Target Company has received any written or, to the Knowledge of the Company, oral notice
of any Actions relating to the revocation or modification of any Company Permit, except as has not been, and would not reasonably expected
to be, individually or in the aggregate, material to the Target Companies or the ability of the Company to perform its obligations under
this Agreement or the Ancillary Documents to which it is or required to be a party or otherwise bound.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.11 <U>Litigation</U>.
Except as described on <U>Schedule 5.11</U>, there is no (a) Action of any nature currently pending or, to the Company&rsquo;s Knowledge,
threatened, nor is there any reasonable basis for any Action to be made (and no such Action has been brought or, to the Company&rsquo;s
Knowledge, threatened in the past five (5) years), except as has not been, and would not reasonably expected to be, individually or in
the aggregate, material to the Target Companies or the ability of the Company to perform its obligations under this Agreement or the Ancillary
Documents to which it is or required to be a party or otherwise bound, or (b) material Order now pending or outstanding or that was rendered
by a Governmental Authority in the past five (5) years, in either case of (a) or (b) by or against any Target Company, its current or
former directors, officers or equity holders (provided, that any litigation involving the directors, officers or equity holders of a Target
Company must be related to the Target Company&rsquo;s business, equity securities or assets), its business, equity securities or assets.
The items listed on <U>Schedule 5.11</U>, if finally determined adverse to the Target Companies, will not have, either individually or
in the aggregate, a Material Adverse Effect upon any Target Company. In the past five (5) years, to the Knowledge of the Company, none
of the current or former officers, senior management or directors of any Target Company have been charged with, indicted for, arrested
for, or convicted of any felony or any crime involving fraud.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.12 <U>Material
Contracts</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a) <U>Schedule
5.12(a)</U> sets forth a true, correct and complete list of, and the Company has made available to SPAC (including written summaries of
oral Contracts), true, correct and complete copies of, each Contract to which any Target Company is a party or by which any Target Company,
or any of its properties or assets are bound or affected (each Contract required to be set forth on <U>Schedule 5.12(a)</U>, a &ldquo;<B><I>Company
Material Contract</I></B>&rdquo;) that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i) contains
covenants that limit the ability of any Target Company (A) to compete in any line of business or with any Person or in any geographic
area or to sell, or provide any service or product or solicit any Person, including any non-competition covenants, employee and customer
non-solicit covenants, exclusivity restrictions, rights of first refusal or most-favored pricing clauses or (B) to purchase or acquire
an interest in any other Person;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ii) involves
any joint venture, profit-sharing, partnership, limited liability company or other similar agreement or arrangement relating to the formation,
creation, operation, management or control of any partnership or joint venture;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iii) involves
any exchange-traded, over-the-counter or other swap, cap, floor, collar, futures contract, forward contract, option or other derivative
financial instrument or Contract, based on any commodity, security, instrument, asset, rate or index of any kind or nature whatsoever,
whether tangible or intangible, including currencies, interest rates, foreign currency and indices;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-size: 10pt">(iv) </FONT>evidences
Indebtedness (whether incurred, assumed, guaranteed or secured by any asset) of any Target Company having an outstanding principal amount
in excess of $100,000;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(v) involves
the acquisition or disposition, directly or indirectly (by merger or otherwise), of assets with an aggregate value in excess of $100,000
(other than in the ordinary course of business consistent with past practice) or shares or other equity interests of any Target Company
or another Person;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(vi) relates
to any merger, consolidation or other business combination with any other Person or the acquisition or disposition of any other entity
or its business or material assets or the sale of any Target Company, its business or material assets;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(vii) by
its terms, individually or with all related Contracts, calls for aggregate payments or receipts by the Target Companies under such Contract
or Contracts of at least $100,000 per year or $250,000 in the aggregate;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 33; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(viii) is
with any Top Vendor;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ix) obligates
the Target Companies to provide continuing indemnification or a guarantee of obligations of a third party after the date hereof in excess
of $100,000, except with respect to any such Contracts with vendors, partners or service providers that were entered into in the ordinary
course of business consistent with past practice;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(x) is
between any Target Company and any directors, officers or employees of a Target Company (other than at-will employment arrangements with
employees entered into in the ordinary course of business consistent with past practice), including all non-competition, severance and
indemnification agreements, or any Related Person;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(xi) obligates
the Target Companies to make any capital commitment or expenditure in excess of $100,000 (including pursuant to any joint venture);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(xii) relates
to a material settlement entered into within three (3) years prior to the date of this Agreement or under which any Target Company has
outstanding obligations (other than customary confidentiality obligations);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(xiii) provides
another Person (other than another Target Company or any manager, director or officer of any Target Company) with a power of attorney;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(xiv) relates
to the development, ownership, licensing or use of any material Intellectual Property by, to or from any Target Company, other than Off-the-Shelf
Software;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(xv) that
will be required to be filed with the Registration Statement under applicable SEC requirements or would otherwise be required to be filed
by the Company as an exhibit for a Form S-1 pursuant to Items 601(b)(1), (2), (4), (9) or (10) of Regulation S-K under the Securities
Act as if the Company was the registrant; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(xvi) is
otherwise material to any Target Company and not described in clauses (i) through (xv) above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b) Except
as disclosed in <U>Schedule 5.12(b)</U>, with respect to each Company Material Contract: (i) such Company Material Contract is valid and
binding and enforceable in all respects against the Target Company party thereto and, to the Knowledge of the Company, each other party
thereto, and is in full force and effect (except, in each case, as such enforcement may be limited by the Enforceability Exceptions);
(ii) the consummation of the transactions contemplated by this Agreement will not affect the validity or enforceability of any Company
Material Contract; (iii) no Target Company is in breach or default in any material respect, and, to the Knowledge of the Company, no event
has occurred that with the passage of time or giving of notice or both would constitute a material breach or default by any Target Company,
or permit termination or acceleration by the other party thereto, under such Company Material Contract; (iv) to the Knowledge of the Company,
no other party to such Company Material Contract is in breach or default in any material respect, and no event has occurred that with
the passage of time or giving of notice or both would constitute such a material breach or default by such other party, or permit termination
or acceleration by any Target Company, under such Company Material Contract; (v) no Target Company has received written or, to the Knowledge
of the Company, oral notice of an intention by any party to any such Company Material Contract to terminate such Company Material Contract
or amend the terms thereof, other than modifications in the ordinary course of business that do not adversely affect any Target Company
in any material respect; and (vi) no Target Company has waived any rights under any such Company Material Contract.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 34; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.13 <U>Intellectual
Property</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a) <U>Schedule
5.13(a)(i)</U> sets forth: (i) all Patents and Patent applications (including any utility models), Trademark and service mark registrations
and applications, design registrations and applications, copyright registrations and applications and registered Internet Assets and applications
owned by or exclusively licensed to a Target Company (&ldquo;<B><I>Company Registered IP</I></B>&rdquo;), specifying as to each item,
as applicable: (A) the nature of the item, including the title, (B) the owner of the item, (C) the jurisdictions in which the item is
issued or registered or in which an application for issuance or registration has been filed and (D) the issuance, registration or application
numbers and dates; and (ii) all material unregistered Intellectual Property owned or purported to be owned by a Target Company. <U>Schedule
5.13(a)(ii)</U> sets forth all Intellectual Property licenses, sublicenses and other agreements or permissions (&ldquo;<B><I>Company IP
Licenses</I></B>&rdquo;) (other than &ldquo;shrink wrap,&rdquo; &ldquo;click wrap,&rdquo; and &ldquo;off the shelf&rdquo; software agreements
and other agreements for Software commercially available on reasonable terms to the public generally with license, maintenance, support
and other fees of less than $20,000 per year (collectively, &ldquo;<B><I>Off-the-Shelf Software</I></B>&rdquo;), which are not required
to be listed, although such licenses are &ldquo;Company IP Licenses&rdquo; as that term is used herein), under which a Target Company
is a licensee or otherwise is authorized to use or practice any Intellectual Property, and describes (A) the applicable Intellectual Property
licensed, sublicensed or used and (B) any royalties, license fees or other compensation due from a Target Company, if any. Each Target
Company owns, free and clear of all Liens (other than Permitted Liens), has valid and enforceable rights in, and has the unrestricted
right to use, sell, license, transfer or assign, all Intellectual Property currently used, licensed or held for use by such Target Company,
and previously used or licensed by such Target Company, except for the Intellectual Property that is the subject of the Company IP Licenses.
Except as set forth on <U>Schedule 5.13(a)(iii)</U>, all Company Registered IP is owned exclusively by the applicable Target Company without
obligation to pay royalties, licensing fees or other fees, or otherwise account to any third party with respect to such Company Registered
IP.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b) Each
Target Company has a valid and enforceable license to use all Intellectual Property that is the subject of the Company IP Licenses applicable
to such Target Company. The Company IP Licenses include all of the licenses, sublicenses and other agreements or permissions necessary
to use the Intellectual Property that is the subject of the Company IP Licenses in the same manner that it is currently being used by
the Target Companies . Each Target Company has performed all obligations imposed on it in the Company IP Licenses, has made all payments
required to date, and such Target Company is not, nor, to the Knowledge of the Company, is any other party thereto, in breach or default
thereunder, nor has any event occurred that with notice or lapse of time or both would constitute a default thereunder. The continued
use by the Target Companies of the Intellectual Property that is the subject of the Company IP Licenses in the same manner that it is
currently being used is not restricted by any applicable license of any Target Company. All registrations for Copyrights, Patents, Trademarks
and Internet Assets that are owned by or exclusively licensed to any Target Company are valid and in force, and all applications to register
any Copyrights, Patents and Trademarks are pending and in good standing, all without any material challenge. No Target Company is party
to any Contract that requires a Target Company to assign or license to any Person any rights in any Intellectual Property developed by
a Target Company, other than Intellectual Property rights that have been assigned or licensed as of the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c) <U>Schedule
5.13(c)</U> sets forth all licenses, sublicenses and other agreements or permissions under which a Target Company is the licensor (each,
an &ldquo;<B><I>Outbound IP License</I></B>&rdquo;), and for each such Outbound IP License, describes (i) the applicable Intellectual
Property licensed, (ii) the licensee under such Outbound IP License, and (iii) any royalties, license fees or other compensation due to
a Target Company, if any. Each Target Company has performed all obligations imposed on it in the Outbound IP Licenses, and such Target
Company is not, nor, to the Knowledge of the Company, is any other party thereto, in breach or default thereunder, nor has any event occurred
that with notice or lapse of time or both would constitute a default thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d) No
Action is pending, settled or, to the Company&rsquo;s Knowledge, threatened against a Target Company that challenges the validity, enforceability,
inventorship, ownership, or right to use, sell, license, sublicense, assert or enforce any material Intellectual Property currently owned,
licensed, used or held for use by the Target Companies. No Target Company has received any written or, to the Knowledge of the Company,
oral notice or claim, including in the form of an offer to obtain a license, asserting or suggesting that any infringement, misappropriation,
violation, dilution or unauthorized use of the Intellectual Property of any other Person is or may be occurring or has or may have occurred,
as a consequence of the business activities of any Target Company, nor to the Knowledge of the Company is there a reasonable basis therefor.
There are no Orders to which any Target Company is a party or its otherwise bound that (i) restrict the rights of a Target Company to
use, transfer, license or enforce any Intellectual Property owned by a Target Company, (ii) restrict the conduct of the business of a
Target Company in order to accommodate a third Person&rsquo;s Intellectual Property, or (iii) grant any third Person any right with respect
to any Intellectual Property owned by a Target Company. No Target Company is currently infringing, or has, in the past, infringed, misappropriated
or violated any Intellectual Property of any other Person in any material respect in connection with the ownership, use or license of
any Intellectual Property owned or purported to be owned by a Target Company or, to the Knowledge of the Company, otherwise in connection
with the conduct of the respective businesses of the Target Companies. To the Company&rsquo;s Knowledge, no third party is infringing
upon, has misappropriated or is otherwise violating any Intellectual Property owned, licensed by, licensed to, or otherwise used or held
for use by any Target Company (&ldquo;<B><I>Company IP</I></B>&rdquo;) in any material respect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<!-- Field: Page; Sequence: 35; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e) Except
as disclosed in <U>Schedule 5.13(e)</U>, all employees and independent contractors of a Target Company have assigned to the Target Companies
all Intellectual Property arising from the services performed for a Target Company by such Persons or arising from use of a Target Company&rsquo;s
assets. All employees and independent contractors that have contributed to any Company IP have waived any rights to claim royalties or
other compensation, including in accordance with Section 134 of the Israeli Patents Law and any similar Laws. No current or former officers,
employees or independent contractors of a Target Company have claimed any ownership interest in any Intellectual Property owned by a Target
Company, including the Company Registered IP. To the Knowledge of the Company, there has been no material violation of a Target Company&rsquo;s
policies or practices related to protection of Company IP or any confidentiality or nondisclosure Contract relating to the Intellectual
Property owned by a Target Company. The Company has made available to SPAC true and complete copies of all written Contracts referenced
in subsections under which employees and independent contractors assigned their Intellectual Property to a Target Company. To the Company&rsquo;s
Knowledge, none of the employees of any Target Company has any obligation under any Contract, or is subject to any Order, that would materially
interfere with the use of such employee&rsquo;s best efforts to promote the interests of the Target Companies, or that would materially
conflict with the business of any Target Company as presently conducted or contemplated to be conducted. Each Target Company has taken
reasonable security measures in order to protect the secrecy, confidentiality and value of the material Company IP.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f) Except
as disclosed in <U>Schedule 5.13(f)</U>, no employee, consultant or independent contractor of any Target Company who was involved in,
or who contributed to, the creation or development of any Owned Intellectual Property owed or owes any duty or rights to any Governmental
Authority, or any military, university, college or other educational institution or a research center, in each case, which may affect
such Target Company&rsquo;s ownership or its right to use any Owned Intellectual Property or may impose any restrictions or obligations
on the Target Company in respect thereof. No facilities, funding or property of any military, university, college, other educational institution
or research center or other Governmental Authority were received by or for any Target Company or used in the development of any Owned
Intellectual Property. Neither any Governmental Authority, nor any military university, college, other academic institution or research
center, owns, purport to owns, has any other rights in or to (including through any Outbound IP License) or has any option to obtain any
rights in or to, any Owned Intellectual Property. None of the Target Companies is required to pay any royalty or make any other form of
payment to any Governmental Authority to allow the use, licensing or transfer of any Owned Intellectual Property.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(g) Except
as disclosed in <U>Schedule 5.13(g)</U>, to the Knowledge of the Company, in the past three (3) years, no Person has obtained unauthorized
access to Company Confidential Information or third party confidential, proprietary or protected information and data in the possession
of a Target Company, nor has there been any other material compromise of the security, confidentiality or integrity of such information
or data. In the past three (3) years, each Target Company has complied in all material respects with all applicable Laws relating to privacy,
personal data protection, and the collection, processing and use of personal information and/or protected health information and its own
privacy policies and guidelines. The operation of the business of the Target Companies has not and does not violate any right to privacy
or publicity of any third person, or constitute unfair competition or trade practices under applicable Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(h) The
consummation of any of the transactions contemplated by this Agreement will not result in the material breach, material modification,
cancellation, termination, suspension of, or acceleration of any payments with respect to, or release of source code because of (i) any
Contract providing for the license or other use of Intellectual Property owned by a Target Company, or (ii) any Company IP License. Following
the Closing, the Company shall be permitted to exercise, directly or indirectly through its Subsidiaries, all of the Target Companies&rsquo;
rights under such Contracts or Company IP Licenses to the same extent that the Target Companies would have been able to exercise had the
transactions contemplated by this Agreement not occurred, without the payment of any additional amounts or consideration other than ongoing
fees, royalties or payments which the Target Companies would otherwise be required to pay in the absence of such transactions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 36; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.14 <U>Taxes
and Returns</U>. Except as set forth on <U>Schedule 5.14</U>:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a) Each
Target Company has or will have timely filed, or caused to be timely filed, all material Tax Returns required to be filed by it (taking
into account all available extensions), which Tax Returns are true, accurate, correct and complete in all material respects, and has paid,
collected or withheld, or caused to be paid, collected or withheld, all material Taxes required to be paid, collected or withheld, other
than such Taxes for which adequate reserves in the Company Financials have been established. Each Target Company has complied in all material
respects with all applicable Laws relating to Tax.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b) There
is no current pending or, to the Knowledge of the Company, threatened Action, and there has been no prior Action within the past five
(5) years, against a Target Company by a Governmental Authority in a jurisdiction where the Target Company does not file Tax Returns that
it is or may be subject to taxation by that jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c) No
Target Company has undergone a Tax audit by a Tax authority in the past five (5) years. No Target Company is being audited by any Tax
authority or has been notified in writing or, to the Knowledge of the Company, orally by any Tax authority that any such audit is contemplated
or pending. There are no claims, assessments, audits, examinations, investigations or other Actions pending against a Target Company in
respect of any Tax, and no Target Company has been notified in writing of any proposed Tax claims or assessments against it (other than,
in each case, claims or assessments for which adequate reserves in the Company Financials have been established).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d) There
are no Liens with respect to any Taxes upon any Target Company&rsquo;s assets, other than Permitted Liens.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e) Each
Target Company has collected or withheld all Taxes currently required to be collected or withheld by it, and all such Taxes have been
paid to the appropriate Governmental Authorities or set aside in appropriate accounts for future payment when due.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f) No
Target Company has any outstanding waivers or extensions of any applicable statute of limitations to assess any material amount of Taxes.
There are no outstanding requests by a Target Company for any extension of time within which to file any Tax Return or within which to
pay any Taxes shown to be due on any Tax Return.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(g) No
Target Company has made any change in accounting method (except as required by a change in Law) or received a ruling from, or signed an
agreement with, any taxing authority that would reasonably be expected to have a material impact on its Taxes following the Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(h) No
Target Company has any Liability for the Taxes of another Person (other than another Target Company) (i) under any applicable Tax Law,
(ii) as a transferee or successor, or (iii) by contract, indemnity or otherwise (excluding commercial agreements entered into in the ordinary
course of business the primary purpose of which was not the sharing of Taxes). No Target Company is a party to or bound by any Tax indemnity
agreement, Tax sharing agreement or Tax allocation agreement or similar agreement, arrangement or practice (excluding commercial agreements
entered into in the ordinary course of business the primary purpose of which was not the sharing of Taxes) with respect to Taxes (including
advance pricing agreement, closing agreement or other agreement relating to Taxes with any Governmental Authority) that will be binding
on such Target Company with respect to any period following the Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i) No
Target Company has requested, or is it the subject of or bound by any private letter ruling, technical advice memorandum, closing agreement
or similar ruling, memorandum or agreement with any Governmental Authority with respect to any Taxes, nor is any such request outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(j) No
Target Company is treated as a domestic corporation (as such term is defined in Section 7701 of the Code) for U.S. federal income tax
purposes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<!-- Field: Page; Sequence: 37; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(k) Any
Company Equity Plan maintained by any Target Company that is intended to qualify as a capital gains route plan under Section 102, has
received a favorable determination or approval letter from, or is otherwise approved by, or deemed approved by passage of time without
objection by, the ITA. All Section 102 Shares and Section 102 Options have been granted and/or issued, as applicable, and are currently
in compliance with the applicable requirements of Section 102 (including the relevant sub-section of Section 102) and the written requirements
and guidance of the ITA, including the adoption of the applicable board and shareholders resolutions, the timely filing of the necessary
documents with the ITA, the appointment of an authorized trustee to hold the Section 102 Shares and Section 102 Options, the receipt of
all tax rulings from the ITA if required, the execution by each holder of Section 102 Shares and Section 102 Options of an undertaking
to comply with the provisions of Section 102, and the due deposit of such Section 102 Shares and Section 102 Options with the 102 Trustee
pursuant to the terms of Section 102 and the guidance published by the ITA on July 24, 2012 and on November 6, 2012.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(l) No
Target Company has ever effected or has ever been part of any action or transaction that is classified as a &ldquo;reportable transaction&rdquo;
under Section 131(g) of the Israeli Tax Ordinance and the Israeli Income Tax Regulations (Reportable Tax Planning), 5767-2006, regarding
aggressive tax planning or any similar or comparable provision under applicable Law. No Target Company has ever received any &ldquo;<I>reportable
opinion</I>&rdquo; or taken any &ldquo;<I>reportable position</I>&rdquo; under Sections 131D and 131E of the Israeli Tax Ordinance, Sections
67C and 67D of the Israeli VAT Law, Sections 231D and 231E of the Customs Ordinance [New Version], 1957, Section 21(c) of Fuel Excise
Law, 1958, and the regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(m) No
Target Company has, or has ever had, any permanent establishment (within the meaning of an applicable Tax treaty) outside of the country
of its formation and is not, and has never been, resident for Tax purposes in any jurisdiction outside of the country of its formation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(n) Each
Target Company is duly registered for the purposes of Israeli value added Tax, to the extent required by the Israeli Value Added Tax Law,
5735-1975 (the &ldquo;<B><I>VAT Law</I></B>&rdquo;), and has complied in all material respects with all requirements concerning value
added Taxes (&ldquo;<B><I>VAT</I></B>&rdquo;). No Target Company has effected any exempt transactions (as defined in the VAT Law) and
there are no circumstances by reason of which there might not be an entitlement to full credit of all VAT chargeable or paid on inputs,
supplies, and other transactions and imports made by the Target Company. Each Target Company has collected and timely remitted to the
relevant Tax authority all output VAT which it is required to collect and remit under any applicable Law, and no Target Company has received
a refund or credit for input VAT for which it is not entitled under any applicable Law. Each Target Company which is not an Israeli Tax
resident is not required (and has never been required) to effect Israeli VAT registration.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(o) No
Target Company is benefiting (or has never benefited) from any grants, Tax incentives, tax holidays, reduced tax rates or accelerated
depreciation, nor has any Target Company ever made any election to be treated or claimed any benefits as an &ldquo;Approved Enterprise&rdquo;
(<I>mifal meushar</I>), &ldquo;Benefited Enterprise&rdquo; (<I>mifal mutav</I>), &ldquo;Preferred Enterprise&rdquo; (<I>mifal mu&rsquo;adaf</I>)
or &ldquo;Preferred Technological Enterprise&rdquo; (<I>mifal technology mu&rsquo;adaf</I>), under the Israeli Capital Investment Encouragement
Law, 5719-1959.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(p) Each
Target Company is in material compliance with all applicable transfer pricing laws and regulations. The prices for any property or services
(or for the use of any property) provided by or to each Target Company are arms&rsquo; length prices for purposes of all applicable transfer
pricing laws, including Section 85A of the Israeli Tax Ordinance and the regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(q) No
Target Company is subject to any restrictions or limitations pursuant to Part E2 of the Israeli Tax Ordinance or pursuant to any Tax ruling
made with reference to the provisions of Part E2 of the Israeli Tax Ordinance, except for any such restrictions or limitations that may
be imposed as a result of the Company Merger or pursuant to the terms of the Israeli Tax Rulings.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(r) No
Target Company is or has ever been a real property corporation (<I>igud mekarke&rsquo;in</I>) within the meaning of such term under Section
1 of the Israeli Land Taxation Law (Appreciation and Acquisition), 5723-1963.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.15 <U>Real
Property</U>. <U>Schedule 5.15</U> contains a complete and accurate list in all material respects of all premises currently leased or
subleased or otherwise used or occupied by a Target Company for the operation of the business of a Target Company, and of all current
leases, lease guarantees, agreements and documents related thereto, including all amendments, terminations and modifications thereof or
waivers thereto (collectively, the &ldquo;<B><I>Company Real Property Leases</I></B>&rdquo;), as well as the current annual rent and term
under each Company Real Property Lease. The Company has provided to SPAC a true and complete copy of each of the Company Real Property
Leases, and in the case of any oral Company Real Property Lease, a written summary of the material terms of such Company Real Property
Lease. The Company Real Property Leases are valid, binding and enforceable in accordance with their terms and are in full force and effect.
To the Knowledge of the Company, no event has occurred which (whether with or without notice, lapse of time or both or the happening or
occurrence of any other event) would constitute a material default on the part of a Target Company or any other party under any of the
Company Real Property Leases, and no Target Company has received notice of any such condition. No Target Company owns or has ever owned
any real property or any interest in real property (other than the leasehold interests in the Company Real Property Leases).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 38; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.16 <U>Personal
Property</U>. Each item of Personal Property which is currently owned, used or leased by a Target Company with a book value or fair market
value of greater than Fifty Thousand Dollars ($50,000) is set forth on <U>Schedule 5.16</U>, along with, to the extent applicable, a list
of lease agreements, lease guarantees, security agreements and other agreements related thereto, including all amendments, terminations
and modifications thereof or waivers thereto (&ldquo;<B><I>Company Personal Property Leases</I></B>&rdquo;). Except as set forth in <U>Schedule
5.16</U>, all such items of Personal Property are in good operating condition and repair (reasonable wear and tear excepted consistent
with the age of such items), and are suitable for their intended use in the business of the Target Companies. The operation of each Target
Company&rsquo;s business as it is now conducted or presently proposed to be conducted is not dependent upon the right to use the Personal
Property of Persons other than a Target Company, except for such Personal Property that is owned, leased or licensed by, or otherwise
contracted to, a Target Company The Company has provided to the SPAC a true and complete copy of each of the Company Personal Property
Leases, and in the case of any oral Company Personal Property Lease, a written summary of the material terms of such Company Personal
Property Lease. The Company Personal Property Leases are valid, binding and enforceable in accordance with their terms and are in full
force and effect. To the Knowledge of the Company, no event has occurred which (whether with or without notice, lapse of time or both
or the happening or occurrence of any other event) would constitute a default on the part of a Target Company or any other party under
any of the Company Personal Property Leases, and no Target Company has received notice of any such condition.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.17 <U>Title
to and Sufficiency of Assets</U>. Each Target Company has good and marketable title to, or a valid leasehold interest in or right to use,
all of its assets, free and clear of all Liens other than (a) Permitted Liens, (b) the rights of lessors under leasehold interests, (c)
Liens specifically identified on the December 31, 2023 balance sheet included in the 2023/2022 Audited Financials and (d) Liens set forth
on <U>Schedule 5.17</U>. The assets (including Intellectual Property rights and contractual rights) of the Target Companies constitute
all of the assets, rights and properties that are used in the operation of the businesses of the Target Companies as it is now conducted
and presently proposed to be conducted or that are used or held by the Target Companies for use in the operation of the businesses of
the Target Companies, and taken together, are adequate and sufficient for the operation of the businesses of the Target Companies as currently
conducted and as presently proposed to be conducted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.18 <U>Employee
Matters</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a) Except
as set forth in <U>Schedule 5.18(a)</U>, no Target Company is a party to any collective bargaining agreement or other Contract covering
any group of employees, labor organization or other representative of any of the employees of any Target Company, and no Target Company
is bound by and no employee benefits from any extension orders (&lsquo;<I>tzavei harchava</I>&rsquo;) except for extension orders which
generally apply to all employees in Israel. The Company has no Knowledge of any material activities or proceedings of any labor union
or other party to organize or represent such employees. There has not occurred or, to the Knowledge of the Company, been threatened any
material strike, slow-down, picketing, work-stoppage, or other similar labor activity with respect to any such employees. <U>Schedule
5.18(a)</U> sets forth all unresolved labor controversies (including unresolved grievances and age or other discrimination claims), if
any, that are pending or, to the Knowledge of the Company, threatened between any Target Company and Persons employed by or providing
services as independent contractors to a Target Company. No current officer or employee of a Target Company has provided any Target Company
written or, to the Knowledge of the Company, oral notice of his or her plan to terminate his or her employment with any Target Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b) Except
as set forth in <U>Schedule 5.18(b)</U>, each Target Company (i) is and has been in compliance in all material respects with all applicable
Laws respecting employment and employment practices, terms and conditions of employment, health and safety and wages and hours, and other
Laws relating to discrimination, disability, labor relations, hours of work, payment of wages and overtime wages, pay equity, immigration,
workers compensation, working conditions, family and medical leave, and employee terminations, and has not received written or, to the
Knowledge of the Company, oral notice that there is any pending Action involving unfair labor practices against a Target Company, (ii)&nbsp;is
not liable for any material past due arrears of wages or any material penalty for failure to comply with any of the foregoing, and (iii)&nbsp;is
not liable for any material payment to any Governmental Authority with respect to unemployment compensation benefits, social security
or other benefits or obligations for employees, independent contractors or consultants (other than routine payments to be made in the
ordinary course of business and consistent with past practice). There are no Actions pending or, to the Knowledge of the Company, threatened
against a Target Company brought by or on behalf of any applicant for employment, any current or former employee, any Person alleging
to be a current or former employee, or any Governmental Authority, relating to any such Law or regulation, or alleging breach of any express
or implied contract of employment, wrongful termination of employment, or alleging any other discriminatory, wrongful or tortious conduct
in connection with the employment relationship.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<!-- Field: Page; Sequence: 39; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c) <U>Schedule
5.18(c)</U> hereto sets forth a complete and accurate list as of the date hereof of all employees of the Target Companies showing for
each as of such date (i) the employee&rsquo;s name, job title, employer, location, salary level (including any bonus, commission, deferred
compensation or other remuneration payable (other than any such arrangements under which payments are at the discretion of the Target
Companies)), (ii) any bonus, commission or other remuneration other than salary paid during the calendar year ended December 31, 2024,
and (iii) any wages, salary, bonus, commission or other compensation due and owing to each employee during or for the calendar year ending
December 31, 2025. Except as set forth on <U>Schedule 5.18(c)</U>, (A) no employee is a party to a written employment Contract with a
Target Company and each is employed &ldquo;at will&rdquo;, and (B) the Target Companies have paid in full to all their employees all wages,
salaries, commission, bonuses and other compensation due to their employees, including overtime compensation, and no Target Company has
any obligation or Liability (whether or not contingent) with respect to severance payments to any such employees under the terms of any
written or, to the Company&rsquo;s Knowledge, oral agreement, or commitment or any applicable Law, custom, trade or practice. Except as
set forth in <U>Schedule 5.18(c)</U>, each Target Company employee has entered into the Company&rsquo;s standard form of employee non-disclosure,
inventions and restrictive covenants agreement with a Target Company (whether pursuant to a separate agreement or incorporated as part
of such employee&rsquo;s overall employment agreement), a copy of which has been made available to SPAC by the Company. Without derogating
from the above representations, the Target Companies&rsquo; liabilities towards present or former employees regarding severance pay, accrued
vacation, recreation pay and contributions to all pension plans and Company Benefit Plans (as defined below) are either fully funded or
are accrued for on the Target Companies consolidated financial statements as of the date of such financial statements. Section 14 of the
Israel Severance Pay Law, 5723-1963 (a &ldquo;<B><I>Section 14 Arrangement</I></B>&rdquo;) was properly applied in accordance with the
terms of the general permit issued by the Israeli Minister of Labor regarding mandatory pension arrangement regarding all employees based
on their full salaries and from the date of the commencement of their employment and, upon the termination of employment of any of the
employees, no Target Company will have to make any payment under the Severance Pay Law, 5723-1963, except for release of the funds accumulated
in accordance with the applicable Section 14 Arrangement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d) <U>Schedule
5.18(d)</U> contains a list of all independent contractors whose annual compensation exceeds $5,000 during the calendar year ended December
31, 2024 (each a &ldquo;<B><I>Material Contractor</I></B>&rdquo;) that are currently engaged by any Target Company, along with the position,
the entity engaging such Person, date of retention and rate of remuneration for each such Person. Except as set forth on <U>Schedule 5.18(d)</U>,
all of such Material Contractors are a party to a written Contract with a Target Company that includes customary provisions regarding
confidentiality, non-competition (where applicable) and assignment of inventions and copyrights in such Person&rsquo;s agreement with
a Target Company, a copy of which has been provided to SPAC by the Company. For the purposes of applicable Law, including the Code, all
independent contractors who are currently, or within the last six (6) years have been, engaged by a Target Company are bona fide independent
contractors and not employees of a Target Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.19 <U>Benefit
Plans</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a) Set
forth on <U>Schedule 5.19(a)</U> is a true and complete list of each Foreign Plan of a Target Company and any other agreement, practice,
custom, arrangement, plan, policy or program (including any employment, consulting, bonus, commission, incentive or deferred compensation,
employee loan, note or pledge agreement, equity or equity-based compensation, severance, termination, retention, retirement, supplemental
retirement, profit sharing, change in control, fringe benefits vacation, sick, insurance, pension (including pension funds, managers&rsquo;
insurance or similar funds, education fund (&lsquo;<I>keren hishtalmut</I>&rsquo;), medical, welfare, fringe or similar plan, policy,
program, agreement or other arrangement) providing compensation or other benefits or remuneration to any current or former director, officer,
employee or other service provider, which is maintained, sponsored or contributed to by a Target Company or under which a Target Company
has or may have any obligation or liability, direct or indirect, contingent or otherwise, whether or not in writing and whether or not
funded (each, a &ldquo;<B><I>Company Benefit Plan</I></B>&rdquo;). No Target Company has ever maintained or contributed to (or had an
obligation to contribute to) or has any Liability under any Benefit Plan, whether or not subject to ERISA, which is not a Foreign Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b) With
respect to each Company Benefit Plan, the Company has made available to SPAC accurate and complete copies, if applicable, of: (i) all
plan documents and related trust agreements or annuity Contracts (including any amendments, modifications or supplements thereto), and
written descriptions of any Company Benefit Plans which are not in writing; (ii) the most recent annual and periodic accounting of plan
assets; (iii) the most recent actuarial valuation; and (iv) all communications with any Governmental Authority concerning any matter that
is still pending or for which a Target Company has any outstanding Liability or obligation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<!-- Field: Page; Sequence: 40; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c) With
respect to each Company Benefit Plan: (i) such Company Benefit Plan has been administered and enforced in all material respects in accordance
with its terms and the requirements of all applicable Laws, and has been maintained, where required, in good standing with applicable
regulatory authorities and Governmental Authorities; (ii) no breach of fiduciary duty has occurred; (iii) no Action is pending, or to
the Company&rsquo;s Knowledge, threatened (other than routine claims for benefits arising in the ordinary course of administration); (iv)
all contributions, premiums and other payments (including any special contribution, interest or penalty) required to be made with respect
to a Company Benefit have been timely made; (v) all benefits accrued under any unfunded Company Benefit Plan has been paid, accrued, or
otherwise adequately reserved in accordance with IFRS and are reflected on the Company Financials; and (vi) no Company Benefit Plan provides
for retroactive increases in contributions, premiums or other payments in relation thereto. No Target Company has incurred any Liability
in connection with the termination of, or withdrawal from, any Company Benefit Plan, other than severance obligations owed to Israeli
employees of the Company pursuant to the Israeli Severance Pay Law, 5723-1963, if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d) No
Target Company has ever sponsored, maintained, contributed to or been required to maintain or contribute to, and does not otherwise have
any Liability (including as a result of its relationship with any other Person that would be or, at any relevant time, would have been
considered a single employer with any Target Company under Section 414(b), (c), (m) or (o) of the Code or ERISA), with respect to a plan
subject to Title IV of ERISA or Code Section 412, including any &ldquo;single employer&rdquo; defined benefit plan or any &ldquo;multiemployer
plan,&rdquo; each within the meaning of Section 4001 of ERISA. No Target Company maintains, contributes to, or participates in any &ldquo;multiple
employer plan&rdquo; within the meaning of Section 413(c) of the Code, or any &ldquo;multiple employer welfare arrangement&rdquo; within
the meaning of Section 3(40) of ERISA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e) Each
Company Benefit Plan intended to qualify for special Tax treatment meets (and at all times has met) all the requirements for such treatment
and no facts or circumstances exist that could adversely affect such qualified treatment. To the extent applicable, the present value
of the accrued benefit liabilities (whether or not vested) under each Company Benefit Plan, determined as of the end of the Company&rsquo;s
most recently ended fiscal year on the basis of reasonable actuarial assumptions, each of which is reasonable, did not exceed the current
value of the assets of such Company Benefit Plan allocable to such benefit liabilities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f) The
consummation of the transactions contemplated by this Agreement and the Ancillary Documents will not: (i) entitle any individual to severance
pay, unemployment compensation or other benefits or compensation under any Company Benefit Plan or under any applicable Law; or (ii) accelerate
the time of payment or vesting, funding or increase the amount of any compensation due, or in respect of, any director, employee or independent
contractor of a Target Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(g) Except
to the extent required by applicable Law, no Target Company provides or has any obligation or Liability to provide health or welfare benefits
to any former or retired employee or is obligated or has any Liability to provide such benefits to any active employee following such
employee&rsquo;s retirement or other termination of employment or service.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(h) No
material Tax penalties or material additional Taxes have been imposed or would reasonably be expected to be imposed on any current or
former officer, director, consultant or employee (or beneficiary thereof) of a Target Company (each a &ldquo;<B><I>Target Company Service
Provider</I></B>&rdquo;), and no acceleration of Taxes has occurred or would be reasonably expected to occur. No current or former officer,
director, consultant or employee (or beneficiary thereof) of a Target Company is entitled to receive any gross-up or additional payment
or benefit in connection with any applicable Tax.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i) All
Company Benefit Plans can be terminated at any time as of or after the Closing Date without resulting in any Liability to any Target Company,
Pubco, SPAC or their respective Affiliates for any additional contributions, penalties, premiums, fees, fines, Taxes or any other charges
or liabilities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.20 <U>Environmental
Matters</U>. Except as set forth in <U>Schedule 5.20</U>:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a) Each
Target Company is and has been in compliance in all material respects with all applicable Environmental Laws, including obtaining, maintaining
in good standing, and complying in all material respects with all Permits required for its business and operations by Environmental Laws
(&ldquo;<B><I>Environmental Permits</I></B>&rdquo;), no Action is pending or, to the Company&rsquo;s Knowledge, threatened to revoke,
modify, or terminate any such Environmental Permit, and, to the Company&rsquo;s Knowledge, no facts, circumstances, or conditions currently
exist that could adversely affect such continued compliance with Environmental Laws and Environmental Permits or require capital expenditures
to achieve or maintain such continued compliance with Environmental Laws and Environmental Permits.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b) No
Target Company is the subject of any outstanding Order or Contract with any Governmental Authority or other Person in respect of any (i)
Environmental Laws, (ii) Remedial Action, or (iii) Release or threatened Release of a Hazardous Material. No Target Company has assumed,
contractually or by operation of Law, any Liabilities or obligations under any Environmental Laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<!-- Field: Page; Sequence: 41; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c) No
Action has been made or is pending, or to the Company&rsquo;s Knowledge, threatened against any Target Company or any assets of a Target
Company alleging either or both that a Target Company may be in material violation of any Environmental Law or Environmental Permit or
may have any material Liability under any Environmental Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d) No
Target Company has manufactured, treated, stored, disposed of, arranged for or permitted the disposal of, generated, handled or Released
any Hazardous Material, or owned or operated any property or facility, in a manner that has given or would reasonably be expected to give
rise to any material Liability or obligation under applicable Environmental Laws. To the Knowledge of the Company, no fact, circumstance,
or condition exists in respect of any Target Company or any property currently or formerly owned, operated, or leased by any Target Company
or any property to which a Target Company arranged for the disposal or treatment of Hazardous Materials that could reasonably be expected
to result in a Target Company incurring any material Environmental Liabilities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e) There
is no investigation of the business, operations, or currently owned, operated, or leased property of a Target Company or, to the Company&rsquo;s
Knowledge, previously owned, operated, or leased property of a Target Company pending or, to the Company&rsquo;s Knowledge, threatened
that could lead to the imposition of any Liens under any Environmental Law or material Environmental Liabilities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f) To
the Knowledge of the Company, there is not located at any of the properties of a Target Company any (i) underground storage tanks, (ii)
asbestos-containing material, or (iii) equipment containing polychlorinated biphenyls.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(g) The
Company has provided to SPAC all environmentally related site assessments, audits, studies, reports, analysis and results of investigations
that have been performed in respect of the currently or previously owned, leased, or operated properties of any Target Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.21 <U>Transactions
with Related Persons</U>. Except as set forth on <U>Schedule 5.21</U>, no Target Company nor any of its Affiliates, nor any officer, director,
manager, employee, trustee or beneficiary of a Target Company or any of its Affiliates, nor any immediate family member of any of the
foregoing (whether directly or indirectly through an Affiliate of such Person) (each of the foregoing, a &ldquo;<B><I>Related Person</I></B>&rdquo;)
is presently, or in the past three (3) years, has been, a party to any transaction with a Target Company, including any Contract or other
arrangement (a) providing for the furnishing of services by (other than as officers, directors or employees of the Target Company), (b)
providing for the rental of real property or Personal Property from, or (c) otherwise requiring payments to (other than for services or
expenses as directors, officers or employees of the Target Company in the ordinary course of business consistent with past practice),
any Related Person or, to the Knowledge of the Company, any Person in which any Related Person has an interest as an owner, officer, manager,
director, trustee or partner or in which any Related Person has any direct or indirect interest (other than the ownership of securities
representing no more than five percent (5%) of the outstanding voting power or economic interest of a publicly traded company). Except
as set forth on <U>Schedule 5.21</U>, no Target Company has outstanding any Contract or other arrangement or commitment with any Related
Person, and no Related Person owns any real property or Personal Property, or right, tangible or intangible (including Intellectual Property)
which is used in the business of any Target Company. The assets of the Target Companies do not include any receivable or other obligation
from a Related Person, and the liabilities of the Target Companies do not include any payable or other obligation or commitment to any
Related Person. Except as set forth on <U>Schedule 5.21</U>, all material transactions between a Target Company and interested parties
that require approvals pursuant to Sections 268 to 284 of the Israeli Companies Law or pursuant to the Organizational Documents of the
Target Companies have been duly approved .</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.22 <U>Business
Insurance</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a) <U>Schedule
5.22(a)</U> lists all insurance policies (by policy number, insurer, coverage period, coverage amount, annual premium and type of policy)
held by a Target Company relating to a Target Company or its business, properties, assets, directors, officers and employees, copies of
which have been provided to the SPAC. All premiums due and payable under all such insurance policies have been timely paid and the Target
Companies are otherwise in compliance with the terms of such insurance policies, except as has not been, and would not reasonably expected
to be, individually or in the aggregate, material to the Target Companies or the ability of the Company to perform its obligations under
this Agreement or the Ancillary Documents to which it is or required to be a party or otherwise bound. Each such insurance policy (i)
is legal, valid, binding, enforceable and in full force and effect and (ii) will continue to be legal, valid, binding, enforceable, and
in full force and effect on identical terms following the Closing, except as has not been, and would not reasonably expected to be, individually
or in the aggregate, material to the Target Companies or the ability of the Company to perform its obligations under this Agreement or
the Ancillary Documents to which it is or required to be a party or otherwise bound. No Target Company has any self-insurance or co-insurance
programs. Since January 1, 2023, no Target Company has received any notice from, or on behalf of, any insurance carrier relating to or
involving any adverse change or any change other than in the ordinary course of business, in the conditions of insurance, any refusal
to issue an insurance policy or non-renewal of a policy, except as has not been, and would not reasonably expected to be, individually
or in the aggregate, material to the Target Companies or the ability of the Company to perform its obligations under this Agreement or
the Ancillary Documents to which it is or required to be a party or otherwise bound.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<!-- Field: Page; Sequence: 42; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b) <U>Schedule
5.22(b)</U> identifies each individual insurance claim in excess of $50,000 made by a Target Company since January 1, 2023. Each Target
Company has reported to its insurers all claims and pending circumstances that would reasonably be expected to result in a claim, except
where such failure to report such a claim would not be reasonably likely to be material to the Target Companies. To the Knowledge of the
Company, no event has occurred, and no condition or circumstance exists, that would reasonably be expected to (with or without notice
or lapse of time) give rise to or serve as a basis for the denial of any such insurance claim. No Target Company has made any claim against
an insurance policy as to which the insurer is denying coverage.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.23 <U>Top
Vendors</U>. <U>Schedule 5.23</U> lists, by dollar volume paid for each of (a) the twelve (12) months ended on December 31, 2024 and (b)
the period from January 1, 2025 through March 31, 2025, the ten (10) largest suppliers of goods or services to the Target Companies (the
&ldquo;<B><I>Top Vendors</I></B>&rdquo;), along with the amounts of such dollar volumes. The relationships of each Target Company with
the Top Vendors are good commercial working relationships and (i) no Top Vendor within the last twelve (12) months has cancelled or otherwise
terminated, or, to the Company&rsquo;s Knowledge, intends to cancel or otherwise terminate, any material relationships of such Person
with a Target Company, (ii) no Top Vendor has during the last twelve (12) months decreased materially or, to the Company&rsquo;s Knowledge,
threatened to stop, decrease or limit materially, or intends to modify materially its material relationships with a Target Company or
intends to stop, decrease or limit materially its products or services to any Target Company, (iii) no Target Company has within the past
two (2) years been engaged in any material dispute with any Top Vendor, and (iv) to the Company&rsquo;s Knowledge, the consummation of
the transactions contemplated in this Agreement and the Ancillary Documents will not adversely affect the relationship of any Target Company
with any Top Vendor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.24 <U>Product
Regulatory Matters</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a) As
to each therapy or product, or therapy or product candidate, subject to the jurisdiction of the FDA under the Federal Food, Drug and Cosmetic
Act, as amended, and the regulations thereunder (&ldquo;<B><I>FDCA</I></B>&rdquo;), or subject to the jurisdiction of the IMOH or any
other Governmental Authority, that is manufactured, packaged, labeled, tested, distributed, sold, and/or marketed by any Target Company
(each such product, a &ldquo;<B><I>Pharmaceutical Product</I></B>&rdquo;), to the Company&rsquo;s Knowledge such Pharmaceutical Product
is being manufactured, packaged, labeled, tested, distributed, sold and/or marketed by the Company in compliance in all material respects
with all applicable phase-appropriate requirements under FDCA and similar Laws relating to registration, investigational use, premarket
clearance, licensure, or application approval, good manufacturing practices, good laboratory practices, good clinical practices, product
listing, quotas, labeling, advertising, record keeping and filing of reports.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b) There
is no pending, completed or, to the Company&rsquo;s Knowledge, threatened, Action against any Target Company or any third parties with
whom a Target Company is under contract for services, and none of the Target Companies or such third parties has received any notice,
warning letter or other communication from the FDA, the IMOH or any other Governmental Authority, which (i) contests the premarket clearance,
licensure, registration, or approval of, the uses of, the distribution of, the manufacturing or packaging of, the testing of, the sale
of, or the labeling and promotion of any Pharmaceutical Product, (ii) withdraws its approval of, requests the recall, suspension, or seizure
of, or withdraws or orders the withdrawal of advertising or sales promotional materials relating to, any Pharmaceutical Product, (iii)
imposes a clinical hold on any clinical investigation by a Target Company, (iv) enjoins production at any facility of a Target Company
or with whom a Target Company is under contract, (v) enters or proposes to enter into a consent decree of permanent injunction with a
Target Company, or (vi) otherwise alleges any violation of any Laws in any material respect by a Target Company. No Target Company has
been informed by the FDA, the IMOH or any other Governmental Authority that any of them will prohibit the marketing, sale, license or
use in the United States, Israel or any other jurisdiction of any Pharmaceutical Product to be developed, produced or marketed by a Target
Company, nor has the FDA, IMOH nor any other Governmental Authority expressed any concern as to approving or clearing for marketing any
such Pharmaceutical Product.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c) All
required pre-clinical toxicology studies conducted by or on behalf of a Target Company and clinical trials sponsored by a Target Company
conducted or being conducted with respect thereto, have been and are being conducted in compliance in all material respects with experimental
protocols, procedures and controls pursuant to accepted professional scientific standards and applicable Permits and Laws. The results
of any such studies, tests and trials, and all other material information related to such studies, tests and trials, have been made available
to the SPAC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 43; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.25 <U>Certain
Business Practices</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(a) No
Target Company, nor any of their respective Representatives acting on their behalf has (i) used any funds for unlawful contributions,
gifts, entertainment or other unlawful expenses relating to political activity, (ii) made any unlawful payment to foreign or domestic
government officials or employees, to foreign or domestic political parties or campaigns or violated any provision of the U.S. Foreign
Corrupt Practices Act of 1977</FONT> or <FONT STYLE="font-size: 10pt">Sub-chapter 5 of Chapter 9 of Part B of the Israeli Penal Law, 5737-1977
or (iii) made any other unlawful payment. No Target Company, nor any of their respective directors or officers acting on their behalf,
nor, to the Knowledge of the Company, any other Representatives acting on their behalf, has directly or indirectly, given or agreed to
give any unlawful gift or similar benefit in any material amount to any customer, supplier, governmental employee or other Person who
is or may be in a position to help or hinder any Target Company or assist any Target Company in connection with any actual or proposed
transaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b) The
operations of each Target Company are and have been conducted at all times in compliance with money laundering statutes in all applicable
jurisdictions, the rules and regulations thereunder and any related or similar rules, regulations or guidelines, issued, administered
or enforced by any Governmental Authority, and no Action involving a Target Company with respect to the any of the foregoing is pending
or, to the Knowledge of the Company, threatened.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c) No
Target Company or any of their respective directors or officers, or, to the Knowledge of the Company, any other Representative acting
on behalf of a Target Company is currently identified on the specially designated nationals or other blocked person list or otherwise
currently subject to any sanctions administered by OFAC, the State of Israel, the United Nations Security Council, Her Majesty&rsquo;s
Treasury of the United Kingdom or the European Union, and in the last five (5) fiscal years no Target Company has, directly or indirectly,
used any funds, or loaned, contributed or otherwise made available such funds (i) to any Subsidiary, joint venture partner or other Person,
in connection with any sales or operations in Cuba, Iran, Syria, Sudan, Myanmar or any other country sanctioned by OFAC, the State of
Israel, the United Nations Security Council, Her Majesty&rsquo;s Treasury of the United Kingdom or the European Union, or (ii) for the
purpose of financing the activities of any Person currently subject to, or otherwise in violation of, any sanctions administered by OFAC,
the State of Israel, the United Nations Security Council, Her Majesty&rsquo;s Treasury of the United Kingdom or the European Union.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.26 <U>Investment
Company Act</U>. No Target Company is an &ldquo;investment company&rdquo; or a Person directly or indirectly &ldquo;controlled&rdquo;
by or acting on behalf of an &ldquo;investment company&rdquo;, in each case within the meaning of the Investment Company Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.27 <U>Finders
and Brokers</U>. Except as set forth on <U>Schedule 5.27</U>, no broker, finder or investment banker is entitled to any brokerage, finder&rsquo;s
or other fee or commission from SPAC, Pubco, the Target Companies or any of their respective Affiliates in connection with the transactions
contemplated hereby based upon arrangements made by or on behalf of any Target Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.28 <U>Information
Supplied</U>. None of the information supplied or to be supplied by the Company expressly for inclusion or incorporation by reference:
(a) in any current report on Form 8-K, and any exhibits thereto or any other report, form, registration or other filing made with any
Governmental Authority (including the SEC) with respect to the transactions contemplated by this Agreement or any Ancillary Documents;
(b) in the Registration Statement; or (c) in the mailings or other distributions to SPAC&rsquo;s or Pubco&rsquo;s shareholders and/or
prospective investors with respect to the consummation of the transactions contemplated by this Agreement or in any amendment to any of
documents identified in (a) through (c), will, when filed, made available, mailed or distributed, as the case may be, contain any untrue
statement of a material fact or omit to state any material fact required to be stated therein or necessary in order to make the statements
therein, in light of the circumstances under which they are made, not misleading. None of the information supplied or to be supplied by
the Company expressly for inclusion or incorporation by reference in any of the Signing Press Release, the Signing Filing, the Closing
Press Release and the Closing Filing will, when filed or distributed, as applicable, contain any untrue statement of a material fact or
omit to state any material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances
under which they are made, not misleading. Notwithstanding the foregoing, the Company makes no representation, warranty or covenant with
respect to any information supplied by or on behalf of SPAC or its Affiliates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 44; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.29 <U>Independent
Investigation</U>. The Company has conducted its own independent investigation, review and analysis of the business, results of operations,
condition (financial or otherwise) or assets of SPAC, Pubco and the Merger Subs and acknowledges that it has been provided adequate access
to the personnel, properties, assets, premises, books and records, and other documents and data of SPAC, Pubco and the Merger Subs for
such purpose. The Company acknowledges and agrees that: (a) in making its decision to enter into this Agreement and to consummate the
transactions contemplated hereby, it has relied solely upon its own investigation and the express representations and warranties of SPAC
and Pubco set forth in this Agreement (including the related portions of the SPAC Disclosure Schedules) and in any certificate delivered
to the Company pursuant hereto, and the information provided by or on behalf of SPAC, Pubco or a Merger Sub for the Registration Statement;
and (b) none of SPAC, Pubco, the Merger Subs or their respective Representatives have made any representation or warranty as to SPAC,
Pubco or either Merger Sub or this Agreement, except as expressly set forth in this Agreement (including the related portions of the SPAC
Disclosure Schedules) or in any certificate delivered to Company pursuant hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.30 <U>No
Other Representations</U>. Except for the representations and warranties expressly made by the Company in this <U>Article V</U> (as modified
by the Company Disclosure Schedules) or as expressly set forth in an Ancillary Document, neither the Company nor any other Person on its
behalf makes any express or implied representation or warranty with respect to the Target Companies or their respective businesses, operations,
assets or Liabilities, or the transactions contemplated by this Agreement or any of the other Ancillary Documents, and the Company hereby
expressly disclaims any other representations or warranties, whether implied or made by the Company or any of its Representatives. Except
for the representations and warranties expressly made by the Company in this <U>Article V</U> (as modified by the Company Disclosure Schedules)
or in an Ancillary Document, the Company hereby expressly disclaims all liability and responsibility for any representation, warranty,
projection, forecast, statement or information made, communicated or furnished (orally or in writing) to the SPAC, Pubco or any of their
respective Representatives (including any opinion, information, projection or advice that may have been or may be provided to the SPAC,
Pubco or any of their respective Representatives by any Representative of the Company), including any representations or warranties regarding
the probable success or profitability of the businesses of the Target Companies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Article
VI<U><BR>
COVENANTS</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6.1 <U>Access
and Information</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a) During
the period from the date of this Agreement and continuing until the earlier of the termination of this Agreement in accordance with <U>Section
8.1</U> or the Closing (the &ldquo;<B><I>Interim Period</I></B>&rdquo;), subject to <U>Section 6.15</U>, each of the Company, Pubco and
the Merger Subs shall give, and shall cause its Representatives to give, SPAC and its Representatives, at reasonable times during normal
business hours and upon reasonable intervals and notice, reasonable access to all offices and other facilities and to all employees, properties,
Contracts, agreements, commitments, books and records, financial and operating data and other information (including Tax Returns, internal
working papers, client files, client Contracts and director service agreements), of or pertaining to the Target Companies, Pubco or Merger
Subs as SPAC or its Representatives may reasonably request regarding the Target Companies, Pubco or the Merger Subs and their respective
businesses, assets, Liabilities, financial condition, prospects, operations, management, employees and other aspects (including unaudited
quarterly financial statements, including a consolidated quarterly balance sheet and income statement, a copy of each material report,
schedule and other document filed with or received by a Governmental Authority pursuant to the requirements of applicable securities Laws,
and independent public accountants&rsquo; work papers (subject to the consent or any other conditions required by such accountants, if
any)) and cause each of the Representatives of the Company, Pubco and the Merger Subs to reasonably cooperate with SPAC and its Representatives
in their investigation; provided, however, that SPAC and its Representatives shall conduct any such activities in such a manner as not
to unreasonably interfere with the business or operations of the Target Companies, Pubco or the Merger Subs. Without limiting the foregoing,
unless SPAC notifies the Company in writing within thirty (30) days after the date of this Agreement that it will not seek the FTO Opinion,
during a period of up to thirty (30) days after the date of this Agreement, SPAC will, and will cause its U.S. intellectual property counsel
to, use commercially reasonable efforts to perform a freedom to operate analysis directed to whether the products and technology of the
Target Companies, as currently contemplated, are reasonably likely to infringe upon one or more valid and enforceable third-party U.S.
Patents (the &ldquo;<B><I>FTO Opinion</I></B>&rdquo;) (for purposes of the preceding sentence and <U>Section 8.1(k)</U> of this Agreement,
the commercially reasonable efforts of the SPAC&rsquo;s U.S. intellectual property counsel will require such counsel to expend such efforts
that a reasonable person in the position of such counsel would use under similar circumstances to accomplish the object as promptly as
practicable, but not requiring the expenditure of unreasonable or extraordinary resources). The Company hereby agrees to, and to cause
its Representatives to, reasonably cooperate with such analysis by SPAC and its U.S. intellectual property counsel and the preparation
of the FTO Opinion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<!-- Field: Page; Sequence: 45; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b) During
the Interim Period, subject to <U>Section 6.15</U>, SPAC shall give, and shall cause its Representatives to give, the Company, Pubco,
the Merger Subs and their respective Representatives, at reasonable times during normal business hours and upon reasonable intervals and
notice, reasonable access to all offices and other facilities and to all employees, properties, Contracts, agreements, commitments, books
and records, financial and operating data and other information (including Tax Returns, internal working papers, client files, client
Contracts and director service agreements), of or pertaining to SPAC or its Subsidiaries, as the Company, Pubco, the Merger Subs or their
respective Representatives may reasonably request regarding SPAC, its Subsidiaries and their respective businesses, assets, Liabilities,
financial condition, prospects, operations, management, employees and other aspects (including unaudited quarterly financial statements,
including a consolidated quarterly balance sheet and income statement, a copy of each material report, schedule and other document filed
with or received by a Governmental Authority pursuant to the requirements of applicable securities Laws, and independent public accountants&rsquo;
work papers (subject to the consent or any other conditions required by such accountants, if any)) and cause each of SPAC&rsquo;s Representatives
to reasonably cooperate with the Company, Pubco and the Merger Subs and their respective Representatives in their investigation; provided,
however, that the Company, Pubco, the Merger Subs and their respective Representatives shall conduct any such activities in such a manner
as not to unreasonably interfere with the business or operations of SPAC or any of its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6.2 <U>Conduct
of Business of the Company, Pubco and the Merger Subs</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a) Unless
SPAC shall otherwise consent in writing (such consent not to be unreasonably withheld, conditioned or delayed), during the Interim Period,
except as expressly contemplated by this Agreement or as set forth on <U>Schedule 6.2</U>, the Company, Pubco and the Merger Subs shall,
and shall cause their respective Subsidiaries to, (i) conduct their respective businesses, in all material respects, in the ordinary course
of business consistent with past practice, (ii) comply with all Laws applicable to the Target Companies, Pubco and the Merger Subs and
their respective businesses, assets and employees, and (iii) take all commercially reasonable measures necessary or appropriate to preserve
intact, in all material respects, their respective business organizations, to keep available the services of their respective managers,
directors, officers, employees and consultants, and to preserve the possession, control and condition of their respective material assets,
all as consistent with past practice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b) Without
limiting the generality of <U>Section 6.2(a)</U> and except as contemplated by the terms of this Agreement or as set forth on <U>Schedule
6.2</U>, during the Interim Period, without the prior written consent of SPAC (such consent not to be unreasonably withheld, conditioned
or delayed), the Company, Pubco and the Merger Subs each shall not, and each shall cause its Subsidiaries not to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i) amend,
waive or otherwise change, in any respect, its Organizational Documents, except as required by applicable Law;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ii) other
than securities issued in connection with, or as a result of, any Transaction Financing in accordance with the terms of this Agreement,
the issuance of Company Ordinary Shares upon the exercise of Company Options outstanding as of the date of this Agreement, or the issuance
of Company Securities upon the exercise or conversion of Company Convertible Securities outstanding as of the date of this Agreement,
authorize for issuance, issue, grant, sell, pledge, dispose of or propose to issue, grant, sell, pledge or dispose of any of its equity
securities or any options, warrants, commitments, subscriptions or rights of any kind to acquire or sell any of its equity securities,
or other securities, including any securities convertible into or exchangeable for any of its shares or other equity securities or securities
of any class and any other equity-based awards, or engage in any hedging transaction with a third Person with respect to such securities;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iii) split,
combine, recapitalize or reclassify any of its shares or other equity interests or issue any other securities in respect thereof or pay
or set aside any dividend or other distribution (whether in cash, equity or property or any combination thereof) in respect of its equity
interests, or directly or indirectly redeem, purchase or otherwise acquire or offer to acquire any of its securities;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iv) incur,
create, assume, prepay or otherwise become liable for any Indebtedness (directly, contingently or otherwise) in excess of $100,000 individually
or $250,000 in the aggregate, make a loan or advance to or investment in any third party (other than advancement of expenses to employees
in the ordinary course of business), or guarantee or endorse any Indebtedness, Liability or obligation of any Person in excess of $100,000
individually or $250,000 in the aggregate;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 46; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(v) (A)
increase the wages, salaries or compensation of any Target Company Service Provider other than in the ordinary course of business, consistent
with past practice, and in any event not in the aggregate by more than ten percent (10%), (B) make or commit to make any bonus payment
(whether in cash, property or securities) to any Target Company Service Provider other than in the ordinary course of business, consistent
with past practice, (C) materially increase other benefits of Target Company Service Providers generally, (D) accelerate the vesting,
lapsing of restrictions or payment, or in any way amend, modify or supplement the terms of any equity or equity based compensation or
phantom equity, (E) accelerate the vesting, lapsing of restrictions or payment, or to fund or in any other way secure any material rights
or benefits under any Company Benefit Plan, (F) forgive any loans or issue any loans to any Target Company Service Providers, or (G) enter
into, establish, materially amend or terminate any Company Benefit Plan with, for or in respect of any Target Company Service Provider,
in each case other than as required by applicable Law, pursuant to the terms of any Company Benefit Plan or in the ordinary course of
business consistent with past practice;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(vi) make
or rescind any material election relating to Taxes, settle any claim, action, suit, litigation, proceeding, arbitration, investigation,
audit or controversy relating to Taxes, file any amended Tax Return or claim for refund, or make any material change in its accounting
or Tax policies or procedures, in each case except as required by applicable Law or in compliance with IFRS;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(vii) transfer
or license to any Person or otherwise extend, materially amend or modify, permit to lapse or fail to preserve any Company Registered IP,
Company Licensed IP or other Company IP, or disclose to any Person who has not entered into a confidentiality agreement any Trade Secrets;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(viii) terminate,
or waive or assign any material right under any Company Material Contract or enter into any Contract that would be a Company Material
Contract, in any case outside of the ordinary course of business consistent with past practice;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ix) fail
to maintain its books, accounts and records in all material respects in the ordinary course of business consistent with past practice;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(x) establish
any Subsidiary or enter into any new line of business;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(xi) fail
to use commercially reasonable efforts to keep in force insurance policies or replacement or revised policies providing insurance coverage
with respect to its assets, operations and activities in such amount and scope of coverage as are currently in effect;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(xii) revalue
any of its material assets or make any change in accounting methods, principles or practices, except to the extent required to comply
with IFRS and after consulting with such Party&rsquo;s outside auditors;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(xiii) waive,
release, assign, settle or compromise any claim, action or proceeding (including any suit, action, claim, proceeding or investigation
relating to this Agreement or the transactions contemplated hereby), other than waivers, releases, assignments, settlements or compromises
that involve only the payment of monetary damages (and not the imposition of equitable relief on, or the admission of wrongdoing by, such
Party or its Affiliates) not in excess of $100,000 (individually or in the aggregate), or otherwise pay, discharge or satisfy any Actions,
Liabilities or obligations, unless such amount has been reserved in the Company Financials or the consolidated financial statements of
Pubco, as applicable;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(xiv) close
or materially reduce its activities, or effect any layoff or other personnel reduction or change, at any of its facilities;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(xv) acquire,
including by merger, consolidation, acquisition of equity interests or assets, or any other form of business combination, any corporation,
partnership, limited liability company, other business organization or any division thereof, or any material amount of assets outside
the ordinary course of business consistent with past practice;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 47; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(xvi) make
capital expenditures in excess of $100,000 (individually for any project (or set of related projects) or $250,000 in the aggregate) (excluding,
for the avoidance of doubt, incurring any Expenses);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(xvii) adopt
a plan of complete or partial liquidation, dissolution, merger, consolidation, restructuring, recapitalization or other reorganization;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(xviii) voluntarily
incur any Liability or obligation (whether absolute, accrued, contingent or otherwise) in excess of $100,000 individually or $250,000
in the aggregate other than pursuant to the terms of a Company Material Contract or Company Benefit Plan;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(xix) sell,
lease, license, transfer, exchange or swap, mortgage or otherwise pledge or encumber (including securitizations), or otherwise dispose
of any material portion of its properties, assets or rights;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(xx) enter
into any agreement, understanding or arrangement with respect to the voting of equity securities of the Company, Pubco or a Merger Sub;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(xxi) take
any action that would reasonably be expected to significantly delay or impair the obtaining of any Consents of any Governmental Authority
to be obtained in connection with this Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(xxii) accelerate
the collection of any trade receivables or delay the payment of trade payables or any other liabilities other than in the ordinary course
of business consistent with past practice;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(xxiii) enter
into, amend, waive or terminate (other than terminations in accordance with their terms or as contemplated by this Agreement) any transaction
with any Related Person (other than compensation and benefits and advancement of expenses, in each case, provided in the ordinary course
of business consistent with past practice); or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(xxiv) authorize
or agree to do any of the foregoing actions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6.3 <U>Conduct
of Business of SPAC.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a) Unless
the Company and Pubco shall otherwise consent in writing (such consent not to be unreasonably withheld, conditioned or delayed), during
the Interim Period, except as expressly contemplated by this Agreement or as set forth on <U>Schedule 6.3</U>, SPAC shall, and shall cause
its Subsidiaries to, (i) conduct their respective businesses, in all material respects, in the ordinary course of business consistent
with past practice, (ii) comply with all Laws applicable to SPAC and its Subsidiaries and their respective businesses, assets and employees,
and (iii) take all commercially reasonable measures necessary or appropriate to preserve intact, in all material respects, their respective
business organizations, to keep available the services of their respective managers, directors, officers, employees and consultants, and
to preserve the possession, control and condition of their respective material assets, all as consistent with past practice. Notwithstanding
anything to the contrary in this <U>Section 6.3</U>, nothing in this Agreement shall prohibit or restrict SPAC from extending, in accordance
with the SPAC Charter and IPO Prospectus, the deadline by which it must complete its Business Combination (an &ldquo;<B><I>Extension</I></B>&rdquo;),
whether pursuant to exercise of automatic extension rights in accordance with SPAC&rsquo;s current Organizational Documents or by amendment
of SPAC&rsquo;s Organizational Documents to extend such deadline, and no consent of any other Party shall be required in connection therewith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b) Without
limiting the generality of <U>Section 6.3(a)</U> and except as contemplated by the terms of this Agreement or the Ancillary Documents
(including as contemplated by the Transaction Financing) or as set forth on <U>Schedule 6.3</U>, during the Interim Period, without the
prior written consent of the Company and Pubco (such consent not to be unreasonably withheld, conditioned or delayed), SPAC shall not,
and shall cause its Subsidiaries not to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i) amend,
waive or otherwise change, in any respect, its Organizational Documents;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ii) authorize
for issuance, issue, grant, sell, pledge, dispose of or propose to issue, grant, sell, pledge or dispose of any of its equity securities
or any options, warrants, commitments, subscriptions or rights of any kind to acquire or sell any of its equity securities, or other securities,
including any securities convertible into or exchangeable for any of its equity securities or other security interests of any class and
any other equity-based awards, or engage in any hedging transaction with a third Person with respect to such securities;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iii) split,
combine, recapitalize or reclassify any of its shares or other equity interests or issue any other securities in respect thereof or pay
or set aside any dividend or other distribution (whether in cash, equity or property or any combination thereof) in respect of its shares
or other equity interests, or directly or indirectly redeem, purchase or otherwise acquire or offer to acquire any of its securities;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 48; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iv) incur,
create, assume, prepay or otherwise become liable for any Indebtedness (directly, contingently or otherwise) in excess of $100,000 (individually
or in the aggregate), make a loan or advance to or investment in any third party, or guarantee or endorse any Indebtedness, Liability
or obligation of any Person (provided, that this <U>Section 6.3(b)(iv)</U> shall not prevent SPAC from borrowing funds necessary to finance
(A) its ordinary course administrative costs and expenses and Expenses incurred in connection with the consummation of the Transactions,
including any Transaction Financing, up to aggregate additional Indebtedness during the Interim Period of $1,000,000 and (B) the costs
and expenses necessary for an Extension (including to fund payments by SPAC to the Trust Account for (x) an automatic extension right
in accordance with SPAC&rsquo;s Organizational Documents or (y) to incentivize Public Shareholders not to redeem their SPAC Class A Ordinary
Shares in an Extension Redemption in connection with an amendment of SPAC&rsquo;s Organizational Documents to extend its deadline to consummate
a Business Combination) (such expenses, &ldquo;<B><I>Extension Expenses</I></B>&rdquo;);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(v) make
or rescind any material election relating to Taxes, settle any claim, action, suit, litigation, proceeding, arbitration, investigation,
audit or controversy relating to Taxes, file any amended Tax Return or claim for refund, or make any material change in its accounting
or Tax policies or procedures, in each case except as required by applicable Law or in compliance with GAAP or IFRS, as applicable;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(vi) amend,
waive or otherwise change the Trust Agreement in any manner adverse to SPAC;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(vii) terminate,
waive or assign any material right under any SPAC Material Contract;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(viii) fail
to maintain its books, accounts and records in all material respects in the ordinary course of business consistent with past practice;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ix) establish
any Subsidiary or enter into any new line of business;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(x) fail
to use commercially reasonable efforts to keep in force insurance policies or replacement or revised policies providing insurance coverage
with respect to its assets, operations and activities in such amount and scope of coverage as are currently in effect;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(xi) revalue
any of its material assets or make any change in accounting methods, principles or practices, except to the extent required to comply
with GAAP or IFRS, as applicable, and after consulting the SPAC&rsquo;s outside auditors;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(xii) waive,
release, assign, settle or compromise any claim, action or proceeding (including any suit, action, claim, proceeding or investigation
relating to this Agreement or the transactions contemplated hereby), other than waivers, releases, assignments, settlements or compromises
that involve only the payment of monetary damages (and not the imposition of equitable relief on, or the admission of wrongdoing by, SPAC
or its Subsidiary) not in excess of $100,000 (individually or in the aggregate), or otherwise pay, discharge or satisfy any Actions, Liabilities
or obligations, unless such amount has been reserved in the SPAC Financials;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(xiii) acquire,
including by merger, consolidation, acquisition of equity interests or assets, or any other form of business combination, any corporation,
partnership, limited liability company, other business organization or any division thereof, or any material amount of assets outside
the ordinary course of business;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(xiv) make
capital expenditures in excess of $100,000 individually for any project (or set of related projects) or $250,000 in the aggregate (excluding,
for the avoidance of doubt, incurring any Expenses);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 49; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(xv) adopt
a plan of complete or partial liquidation, dissolution, merger, consolidation, restructuring, recapitalization or other reorganization
(other than with respect to the Merger);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(xvi) voluntarily
incur any Liability or obligation (whether absolute, accrued, contingent or otherwise) in excess of $100,000 individually or $250,000
in the aggregate (excluding the incurrence of any Expenses) other than pursuant to the terms of a Contract in existence as of the date
of this Agreement or entered into in the ordinary course of business or in accordance with the terms of this <U>Section 6.3</U> during
the Interim Period;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(xvii) sell,
lease, license, transfer, exchange or swap, mortgage or otherwise pledge or encumber (including securitizations), or otherwise dispose
of any material portion of its properties, assets or rights;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(xviii) enter
into any agreement, understanding or arrangement with respect to the voting of its equity securities;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(xix) take
any action that would reasonably be expected to significantly delay or impair the obtaining of any Consents of any Governmental Authority
to be obtained in connection with this Agreement; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(xx) authorize
or agree to do any of the foregoing actions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6.4 <U>PCAOB
Financials; Annual and Interim Financial Statements</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a) The
Company shall use its reasonable best efforts to deliver the PCAOB Financials to SPAC as promptly as practicable after the date of this
Agreement. The Company shall cause the Audited Financials to be audited in accordance with the standards of the PCAOB and to contain a
report of the Company&rsquo;s auditor. The Company shall cause the PCAOB Financials to be prepared in accordance with IFRS applied on
a consistent basis throughout the periods indicated (except as may be specifically indicated in the notes thereto), and to comply in all
material respects with the applicable accounting requirements and with the rules and regulations of the SEC, the Exchange Act and the
Securities Act in effect as of date of delivery (including Regulation S-X or Regulation S-K, as applicable).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b) During
the Interim Period, within forty (40) calendar days following the end of each calendar month, each three-month quarterly period and each
fiscal year, the Company shall deliver to SPAC an unaudited consolidated income statement and an unaudited consolidated balance sheet
of the Target Companies for the period from December 31, 2024 through the end of such calendar month, quarterly period or fiscal year
and the applicable comparative period in the preceding fiscal year, in each case accompanied by a certificate of the Chief Financial Officer
of the Company to the effect that all such financial statements fairly present the consolidated financial position and results of operations
of the Target Companies as of the date or for the periods indicated, in accordance with IFRS, subject to year-end audit adjustments and
excluding footnotes. From the date hereof through the Closing Date, the Company will also promptly deliver to SPAC copies of any audited
consolidated financial statements of the Target Companies that the Target Companies&rsquo; certified public accountants may issue.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6.5 <U>SPAC
Public Filings</U>. During the Interim Period, SPAC shall keep current and timely file all of its public filings with the SEC and otherwise
comply in all material respects with applicable securities Laws and shall use its commercially reasonable efforts prior to the Merger
to maintain the listing of the SPAC Units, the SPAC Class A Ordinary Shares and the SPAC Public Warrants on Nasdaq; provided, that the
Parties acknowledge and agree that from and after the Closing, the Parties intend to list on Nasdaq only the Pubco Ordinary Shares and
the Pubco Public Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 50; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6.6 <U>No
Solicitation</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a) For
purposes of this Agreement, (i) an &ldquo;<B><I>Acquisition Proposal</I></B>&rdquo; means any inquiry, proposal or offer, or any indication
of interest in making an offer or proposal, from any Person or group at any time relating to an Alternative Transaction, and (ii) an &ldquo;<B><I>Alternative
Transaction</I></B>&rdquo; means (A) with respect to the Company, Pubco, the Merger Subs, the Seller Representative and their respective
Affiliates, a transaction (other than the transactions contemplated by this Agreement) concerning the sale of (x) all or any material
part of the business or assets of the Target Companies (other than in the ordinary course of business consistent with past practice) or
(y) any of the shares or other equity interests or profits of the Target Companies, in any case, whether such transaction takes the form
of a sale of shares or other equity interests, assets, merger, amalgamation, consolidation, issuance of debt securities, management Contract,
joint venture or partnership, or otherwise, and (B) with respect to SPAC and its Affiliates, a transaction (other than the transactions
contemplated by this Agreement) concerning a Business Combination involving SPAC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b) During
the Interim Period, in order to induce the other Parties to continue to commit to expend management time and financial resources in furtherance
of the transactions contemplated hereby, each Party shall not, and shall cause its Representatives to not, without the prior written consent
of the Company and SPAC, directly or indirectly, (i) solicit, assist, initiate or facilitate the making, submission or announcement of,
or intentionally encourage, any Acquisition Proposal, (ii) furnish any non-public information regarding such Party or its Affiliates or
their respective businesses, operations, assets, Liabilities, financial condition, prospects or employees to any Person or group (other
than a Party to this Agreement or their respective Representatives) in connection with or in response to an Acquisition Proposal, (iii)
engage or participate in discussions or negotiations with any Person or group with respect to, or that could be expected to lead to, an
Acquisition Proposal, (iv) approve, endorse or recommend, or publicly propose to approve, endorse or recommend, any Acquisition Proposal,
(v) negotiate or enter into any letter of intent, agreement in principle, acquisition agreement or other similar agreement related to
any Acquisition Proposal, or (vi) release any third Person from, or waive any provision of, any confidentiality agreement to which such
Party is a party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c) Each
Party shall notify the others as promptly as practicable (and in any event within 48 hours) orally and in writing of the receipt by such
Party or any of its Representatives of (i) any bona fide inquiries, proposals or offers, requests for information or requests for discussions
or negotiations regarding or constituting any Acquisition Proposal or any bona fide inquiries, proposals or offers, requests for information
or requests for discussions or negotiations that could be expected to result in an Acquisition Proposal, and (ii) any request for non-public
information relating to such Party or its Affiliates, specifying in each case, the material terms and conditions thereof (including a
copy thereof if in writing or a written summary thereof if oral) and the identity of the party making such inquiry, proposal, offer or
request for information. Each Party shall keep the others promptly informed of the status of any such inquiries, proposals, offers or
requests for information. During the Interim Period, each Party shall, and shall cause its Representatives to, immediately cease and cause
to be terminated any solicitations, discussions or negotiations with any Person with respect to any Acquisition Proposal and shall, and
shall direct its Representatives to, cease and terminate any such solicitations, discussions or negotiations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6.7 <U>No
Trading</U>. The Company, Pubco, the Seller Representative and the Merger Subs (with respect to SPAC Merger Sub, upon its execution and
delivery of the Joinder) each acknowledge and agree that it is aware, and that their respective Affiliates are aware (and each of their
respective Representatives is aware or, upon receipt of any material nonpublic information of SPAC, will be advised) of the restrictions
imposed by U.S. federal securities laws and the rules and regulations of the SEC and Nasdaq promulgated thereunder or otherwise (the &ldquo;<B><I>Federal
Securities Laws</I></B>&rdquo;) and other applicable foreign and domestic Laws on a Person possessing material nonpublic information about
a publicly traded company. The Company, Pubco, the Seller Representative and the Merger Subs each hereby agree that, while it is in possession
of such material nonpublic information, it shall not purchase or sell any securities of SPAC, communicate such information to any third
party, take any other action with respect to SPAC in violation of such Laws, or cause or encourage any third party to do any of the foregoing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 51; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6.8 <U>Notification
of Certain Matters</U>. During the Interim Period, each Party shall give prompt notice to the other Parties if such Party or its Affiliates:
(a) fails to comply with or satisfy any covenant, condition or agreement to be complied with or satisfied by it or its Affiliates hereunder
in any material respect; (b) receives any notice or other communication in writing from any third party (including any Governmental Authority)
alleging (i) that the Consent of such third party is or may be required in connection with the Transactions or (ii) any non-compliance
with any Law by such Party or its Affiliates; (c) receives any notice or other communication from any Governmental Authority in connection
with the Transactions; (d) discovers any fact or circumstance that, or becomes aware of the occurrence or non-occurrence of any event
the occurrence or non-occurrence of which, would reasonably be expected to cause or result in any of the conditions to set forth in <U>Article
VII</U> not being satisfied or the satisfaction of those conditions being materially delayed; or (e) becomes aware of the commencement
or threat, in writing, of any Action against such Party or any of its Affiliates, or any of their respective properties or assets, or,
to the Knowledge of such Party, any officer, director, partner, member or manager, in his, her or its capacity as such, of such Party
or of its Affiliates with respect to the consummation of the transactions contemplated by this Agreement. No such notice shall constitute
an acknowledgement or admission by the Party providing the notice regarding whether or not any of the conditions to the Closing have been
satisfied or in determining whether or not any of the representations, warranties or covenants contained in this Agreement have been breached.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6.9 <U>Efforts</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a) Subject
to the terms and conditions of this Agreement, each Party shall use its commercially reasonable efforts, and shall cooperate fully with
the other Parties, to take, or cause to be taken, all actions and to do, or cause to be done, all things reasonably necessary, proper
or advisable under applicable Laws and regulations to consummate the transactions contemplated by this Agreement (including the receipt
of all applicable Consents of Governmental Authorities) and to comply as promptly as practicable with all requirements of Governmental
Authorities applicable to the transactions contemplated by this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b) In
furtherance and not in limitation of <U>Section 6.9(a)</U>, to the extent required under any Laws that are designed to prohibit, restrict
or regulate actions having the purpose or effect of monopolization or restraint of trade (&ldquo;<B><I>Antitrust Laws</I></B>&rdquo;),
each Party hereto agrees to make any required filing or application under Antitrust Laws, as applicable, with each of the SPAC and the
Company bearing fifty percent (50%) of the costs and expenses thereof, with respect to the transactions contemplated hereby as promptly
as practicable, to supply as promptly as reasonably practicable any additional information and documentary material that may be reasonably
requested pursuant to Antitrust Laws and to take all other actions reasonably necessary, proper or advisable to cause the expiration or
termination of the applicable waiting periods under Antitrust Laws as soon as practicable, including by requesting early termination of
the waiting period provided for under the Antitrust Laws. Each Party shall, in connection with its efforts to obtain all requisite approvals
and authorizations for the transactions contemplated by this Agreement under any Antitrust Law, use its commercially reasonable efforts
to: (i) cooperate in all respects with each other Party or its Affiliates in connection with any filing or submission and in connection
with any investigation or other inquiry, including any proceeding initiated by a private Person; (ii) keep the other Parties reasonably
informed of any communication received by such Party or its Representatives from, or given by such Party or its Representatives to, any
Governmental Authority and of any communication received or given in connection with any proceeding by a private Person, in each case
regarding any of the transactions contemplated by this Agreement; (iii) permit a Representative of the other Parties and their respective
outside counsel to review any communication given by it to, and consult with each other in advance of any meeting or conference with,
any Governmental Authority or, in connection with any proceeding by a private Person, with any other Person, and to the extent permitted
by such Governmental Authority or other Person, give a Representative or Representatives of the other Parties the opportunity to attend
and participate in such meetings and conferences; (iv) in the event a Party&rsquo;s Representative is prohibited from participating in
or attending any meetings or conferences, the other Parties shall keep such Party promptly and reasonably apprised with respect thereto;
and (v) use commercially reasonable efforts to cooperate in the filing of any memoranda, white papers, filings, correspondence or other
written communications explaining or defending the transactions contemplated hereby, articulating any regulatory or competitive argument,
and/or responding to requests or objections made by any Governmental Authority.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<!-- Field: Page; Sequence: 52; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c) As
soon as reasonably practicable following the date of this Agreement, the Parties shall reasonably cooperate with each other and use (and
shall cause their respective Affiliates to use) their respective commercially reasonable efforts to prepare and file with Governmental
Authorities requests for approval of the transactions contemplated by this Agreement and shall use all commercially reasonable efforts
to have such Governmental Authorities approve the transactions contemplated by this Agreement. Each Party shall give prompt written notice
to the other Parties if such Party or any of its Representatives receives any notice from such Governmental Authorities in connection
with the transactions contemplated by this Agreement, and shall promptly furnish the other Parties with a copy of such Governmental Authority
notice. If any Governmental Authority requires that a hearing or meeting be held in connection with its approval of the transactions contemplated
hereby, whether prior to the Closing or after the Closing, each Party shall arrange for Representatives of such Party to be present for
such hearing or meeting to the extent permitted by the Governmental Authority. If any objections are asserted with respect to the transactions
contemplated by this Agreement under any applicable Law or if any Action is instituted (or threatened to be instituted) by any applicable
Governmental Authority or any private Person challenging any of the transactions contemplated by this Agreement or any Ancillary Document
as violative of any applicable Law or which would otherwise prevent, materially impede or materially delay the consummation of the transactions
contemplated hereby or thereby, the Parties shall use their commercially reasonable efforts to resolve any such objections or Actions
so as to timely permit consummation of the transactions contemplated by this Agreement and the Ancillary Documents, including in order
to resolve such objections or Actions which, in any case if not resolved, could reasonably be expected to prevent, materially impede or
materially delay the consummation of the transactions contemplated hereby or thereby. In the event any Action is instituted (or threatened
to be instituted) by a Governmental Authority or private Person challenging the transactions contemplated by this Agreement, or any Ancillary
Document, the Parties shall, and shall cause their respective Representatives to, reasonably cooperate with each other and use their respective
commercially reasonable efforts to contest and resist any such Action and to have vacated, lifted, reversed or overturned any Order, whether
temporary, preliminary or permanent, that is in effect and that prohibits, prevents or restricts consummation of the transactions contemplated
by this Agreement or the Ancillary Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d) Prior
to the Closing, each Party shall use its commercially reasonable efforts to obtain any Consents of Governmental Authorities or other third
Persons as may be necessary for the consummation by such Party or its Affiliates of the transactions contemplated by this Agreement or
required as a result of the execution or performance of, or consummation of the transactions contemplated by, this Agreement by such Party
or its Affiliates, and the other Parties shall provide reasonable cooperation in connection with such efforts. With respect to Pubco,
during the Interim Period, the Company, Pubco and the Merger Subs shall take all reasonable actions necessary to cause Pubco to qualify
as &ldquo;foreign private issuer&rdquo; as such term is defined Rule 3b-4 under the Exchange Act and to maintain such status through the
Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6.10 <U>Further
Assurances</U>. The Parties hereto shall further cooperate with each other and use their respective commercially reasonable efforts to
take or cause to be taken all actions, and do or cause to be done all things, necessary, proper or advisable on their part under this
Agreement and applicable Laws to consummate the transactions contemplated by this Agreement as soon as reasonably practicable, including
preparing and filing as soon as practicable all documentation to effect all necessary notices, reports and other filings. For the avoidance
of doubt, if, prior to the Effective Time, the applicable parties hereto are unable to obtain the ISA Exemptions, the Israeli Tax Rulings,
or any other Consent from a Governmental Authority necessary to effectuate the Transaction, each of SPAC, the Company, Pubco and each
of the Merger Subs shall use (and the Company shall cause each of its Subsidiaries to use) its commercially reasonable efforts to (a)&#8239;take
all such actions that are necessary to consummate the Transactions, negotiating in good faith to modify the structure of the Transactions
(provided that such modifications do not materially and adversely affect the other Parties hereto or holders of SPAC Securities) and the
execution and delivery of any documents, certificates, instruments or other papers that are reasonably required for the consummation of
the Transactions; and (b)&#8239;cause the fulfillment at the earliest practicable date of all of the conditions to their respective obligations
to consummate and make effective the Transactions. Without limiting the foregoing, the Company will use its reasonable best efforts to
cause any Locked-Up Company Security Holders that did not execute and delivery Lock-Up Agreements at or prior to the execution and delivery
of this Agreement to execute and deliver Lock-Up Agreements to SPAC, Pubco and the SPAC Representative as promptly as practicable after
the date of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 53; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6.11 <U>The
Registration Statement</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a) As
promptly as practicable after the date hereof, SPAC, Pubco and the Company shall prepare and file with the SEC a registration statement
on Form F-4 (as amended or supplemented from time to time, and including the Proxy Statement contained therein, the &ldquo;<B><I>Registration
Statement</I></B>&rdquo;) in connection with the registration under the Securities Act of the Pubco Securities to be issued under this
Agreement pursuant to the Mergers to the holders of SPAC Securities and Companies Securities as of immediately prior to the applicable
Effective Times, which Registration Statement will also contain a proxy statement of SPAC (as amended, the &ldquo;<B><I>Proxy Statement</I></B>&rdquo;)
for the purpose of soliciting proxies from SPAC shareholders for the matters to be acted upon at the SPAC Shareholder Meeting and providing
the Public Shareholders an opportunity in accordance with SPAC&rsquo;s Organizational Documents and the IPO Prospectus to have their SPAC
Class A Ordinary Shares redeemed (the &ldquo;<B><I>Closing Redemption</I></B>&rdquo;) in conjunction with the shareholder vote on the
Shareholder Approval Matters in the event that the Closing occurs. The Proxy Statement shall include proxy materials for the purpose of
soliciting proxies from SPAC shareholders to vote, at a general meeting of SPAC shareholders to be called and held for such purpose (the
&ldquo;<B><I>SPAC Shareholder Meeting</I></B>&rdquo;), in favor of resolutions approving (i) the adoption and approval of this Agreement
and the Transactions by the holders of SPAC Ordinary Shares in accordance with SPAC&rsquo;s Organizational Documents, the Cayman Islands
Companies Act and the rules and regulations of the SEC and Nasdaq, (ii) to the extent required by Nasdaq, SPAC&rsquo;s Organizational
Documents or the Cayman Islands Companies Act, the issuance of any SPAC Securities in connection with the Transaction Financing, including
adoption and approval of the issuance of more than twenty percent (20%) of the outstanding SPAC Class A Ordinary Shares, (iii) to the
extent required to be approved by holders of SPAC Ordinary Shares, the adoption and approval of the Amended Pubco Organizational Documents,
(iv) the adoption and approval of a new Equity Plan for Pubco in a form to be reasonably agreed to by the Company and SPAC (the &ldquo;<B><I>Pubco
Equity Plan</I></B>&rdquo;), which will provide that the total awards under such Pubco Equity Plan will be a number of Pubco Ordinary
Shares equal to ten percent (10%) of the aggregate number of Pubco Ordinary Shares issued and outstanding immediately after the Closing,
(v) the appointment of the members of the Post-Closing Pubco Board in accordance with <U>Section 6.16</U> hereof, (vi) such other matters
as the Company, Pubco and SPAC shall hereafter mutually determine to be necessary or appropriate in order to effect the Transactions (the
approvals described in foregoing clauses (i) through (vi), collectively, the &ldquo;<B><I>Shareholder Approval Matters</I></B>&rdquo;),
and (vii) the adjournment of the SPAC Shareholder Meeting, if necessary or desirable in the reasonable determination of SPAC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b) The
board of directors of SPAC shall not (and no committee or subgroup thereof shall) withdraw, withhold, amend, qualify or modify, or publicly
propose to withdraw, withhold, amend, qualify or modify, its recommendation to the SPAC&rsquo;s shareholders that they vote in favor of
Shareholder Approval Matters (a &ldquo;<B><I>Change in Recommendation</I></B>&rdquo;), except to the extent that SPAC&rsquo;s board of
directors determines in good faith, after consultation with its outside legal counsel, that such Change in Recommendation is required
by the board&rsquo;s fiduciary duties under applicable Law&#894; provided that the board of directors of the SPAC may not make such Change
in Recommendation unless (A) the board of directors of the SPAC has provided written notice to the Company (the &ldquo;<B><I>Recommendation
Change Notice</I></B>&rdquo;) that it is prepared to make a Change in Recommendation at least ten (10) days prior to taking such action,
which notice shall specify the basis for why a failure to make an Change in Recommendation would constitute a breach of its fiduciary
duties to SPAC and its shareholders under applicable Law, (B) during the ten (10) day period after delivery of the Recommendation Change
Notice, SPAC shall negotiate in good faith with the Company regarding any revisions or adjustments to this Agreement that the Company
proposes to make as would enable the board of directors of the SPAC to reaffirm its recommendation to the SPAC&rsquo;s shareholders that
they vote in favor of the Shareholder Approval Matters and not make such Change in Recommendation and (C) at the end of such ten (10)
day period and taking into account any changes to the terms of this Agreement committed to in a binding written offer by the Company,
the board of directors of the SPAC determines in good faith (after consultation with its outside legal counsel) that the failure to make
such a Change in Recommendation would constitute a breach of its fiduciary duties to SPAC and SPAC&rsquo;s shareholders under applicable
Law. SPAC&rsquo;s obligations to establish a record date for, duly call, give notice of, convene and hold the SPAC Shareholder Meeting
shall not be affected by any Change in Recommendation (provided, that SPAC may, without the consent of the Company, postpone the SPAC
Shareholder Meeting, subject to the SPAC Charter and the Cayman Islands Companies Act, after delivering a Recommendation Change Notice
until such time after which the ten (10) day period required for a Change in Recommendation in connection therewith has elapsed and SPAC
can disclose to its shareholders in accordance with applicable securities Laws, including pursuant to a supplement or amendment to the
Registration Statement, either a Change in Recommendation or the changes to this Agreement that were agreed to by the Company to avoid
a Change in Recommendation). If, on the date for which the SPAC Shareholder Meeting is scheduled, SPAC has not received proxies representing
a sufficient number of shares to obtain the Required SPAC Shareholder Approval, whether or not a quorum is present, SPAC may, subject
to the SPAC Charter and the Cayman Islands Companies Act, make one or more successive postponements or, with the consent of the SPAC Shareholder
Meeting, adjournments of the SPAC Shareholder Meeting. In connection with the Registration Statement, SPAC and Pubco shall file with the
SEC financial and other information about the transactions contemplated by this Agreement in accordance with applicable Law and applicable
proxy solicitation and registration statement rules set forth in the SPAC Charter, the Cayman Islands Companies Act and the rules and
regulations of the SEC and Nasdaq. SPAC and Pubco shall cooperate and provide the Company (and its counsel) with a reasonable opportunity
to review and comment on the Registration Statement and any amendment or supplement thereto prior to filing the same with the SEC. The
Company shall provide SPAC and Pubco with such information concerning the Target Companies and their equity holders, officers, directors,
employees, assets, Liabilities, condition (financial or otherwise), business and operations that may be required or appropriate for inclusion
in the Registration Statement, or in any amendments or supplements thereto, which information provided by the Company shall be true and
correct and not contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements
made, in light of the circumstances under which they were made, not materially misleading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<!-- Field: Page; Sequence: 54; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c) SPAC
and Pubco shall take any and all reasonable and necessary actions required to satisfy the requirements of the Securities Act, the Exchange
Act and other applicable Laws in connection with the Registration Statement, the SPAC Shareholder Meeting and the Closing Redemption.
Each of SPAC, Pubco and the Company shall, and shall cause each of its Subsidiaries to, make their respective directors, officers and
employees, upon reasonable advance notice, available to the Company, Pubco and SPAC and their respective Representatives in connection
with the drafting of the public filings with respect to the transactions contemplated by this Agreement, including the Registration Statement,
and responding in a timely manner to comments from the SEC. Each Party shall promptly correct any information provided by it for use in
the Registration Statement (and other related materials) if and to the extent that such information is determined to have become false
or misleading in any material respect or as otherwise required by applicable Laws. SPAC and Pubco shall amend or supplement the Registration
Statement and cause the Registration Statement, as so amended or supplemented, to be filed with the SEC and to be disseminated to SPAC&rsquo;s
shareholders and the holders of SPAC Warrants, in each case as and to the extent required by applicable Laws and subject to the terms
and conditions of this Agreement and the SPAC Charter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d) SPAC
and Pubco, with the assistance of the other Parties, shall promptly respond to any SEC comments on the Registration Statement and shall
otherwise use their commercially reasonable efforts to cause the Registration Statement to &ldquo;clear&rdquo; comments from the SEC and
become effective. SPAC and Pubco shall provide the Company with copies of any written comments, and shall inform the Company of any material
oral comments, that SPAC, Pubco or their respective Representatives receive from the SEC or its staff with respect to the Registration
Statement, the SPAC Shareholder Meeting and the Closing Redemption promptly after the receipt of such comments and shall give the Company
a reasonable opportunity under the circumstances to review and comment on any proposed written or material oral responses to such comments.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e) As
soon as practicable following the Registration Statement &ldquo;clearing&rdquo; comments from the SEC and becoming effective, SPAC and
Pubco shall distribute the Registration Statement to SPAC&rsquo;s shareholders and, pursuant thereto, shall call the SPAC Shareholder
Meeting in accordance with the Cayman Islands Companies Act for a date no later than thirty (30) days following the effectiveness of the
Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f) SPAC
and Pubco shall comply with all applicable Laws, any applicable rules and regulations of Nasdaq, SPAC&rsquo;s Organizational Documents
and this Agreement in the preparation, filing and distribution of the Registration Statement, any solicitation of proxies thereunder,
the calling and holding of the SPAC Shareholder Meeting and the Closing Redemption.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6.12 <U>Tax
Matters</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a) If,
in connection with the Transactions, the SEC requests or requires that Tax opinions be prepared and submitted with respect to the Tax
treatment of the Transactions, each of the Company, SPAC and Pubco agree to deliver to Tax counsel to each of the SPAC and the Company
customary Tax representation letters satisfactory to such counsel, dated and executed as of such date(s) as determined reasonably necessary
by such counsel in connection with the preparation of such Tax opinions. If a Tax opinion with respect to the treatment of the SPAC Merger
for holders of SPAC Securities is being requested or required, Tax counsel to SPAC (or its Tax advisors) shall provide a Tax opinion on
the application of Section 351 of the Code (and for the avoidance of doubt, neither this provision nor any other provision in this Agreement
shall require Tax counsel to the Company (or its Tax advisors) to provide any opinion regarding the treatment of the SPAC Merger to holders
of SPAC Securities for U.S. federal income tax purposes. If a Tax opinion with respect to the treatment of the Company Merger for holders
of Company Securities is being requested or required, Tax counsel to the Company (or its Tax advisors) shall provide a Tax opinion on
the application of Sections 351 and 368(a) of the Code regarding the treatment of the Company Merger for U.S. federal income Tax purposes
or, to the extent required, Israeli Tax purposes (and for the avoidance of doubt, neither this provision nor any other provision in this
Agreement shall require Tax counsel to the SPAC (or its Tax advisors) to provide any opinion regarding the treatment of the Company Merger
to holders of Company Securities for U.S. federal income Tax purposes or Israeli Tax purposes).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b) Each
of the Parties shall, and shall cause their respective Affiliates to, reasonably cooperate, as and to the extent reasonably requested
by another Party, in connection with the filing of relevant Tax Returns and any audit or Tax proceeding. Such cooperation shall include
the retention and (upon the other Party&rsquo;s request) the provision (with the right to make copies) of records and information reasonably
relevant to any GRA, Tax proceeding or audit, making employees reasonably available on a mutually convenient basis to provide additional
information and explanation of any material provided hereunder (to the extent such information or explanation is not publicly or otherwise
reasonably available).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<!-- Field: Page; Sequence: 55; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c) Pubco
acknowledges that any direct or indirect holder of Pubco Securities who owns five percent (5%) or more of the Pubco Ordinary Shares immediately
after the Closing (a &ldquo;<B><I>Pubco 5% Shareholder</I></B>&rdquo;), as determined under Section 367 of the Code and the Treasury Regulations
promulgated thereunder, may enter into (and cause to be filed with the Internal Revenue Service) a GRA. Upon the written request of any
Pubco 5% Shareholder made following the Closing Date, Pubco shall (i) use commercially reasonable efforts to furnish to such Pubco 5%
Shareholder such information as such Pubco 5% Shareholder reasonably requests in connection with such Pubco 5% Shareholder&rsquo;s preparation
of a GRA, and (ii) use commercially reasonably efforts to provide such Pubco 5% Shareholder with the information reasonably requested
by such Pubco 5% Shareholder for purposes of determining whether there has been a gain &ldquo;triggering event&rdquo; under the terms
of such Pubco 5% Shareholder&rsquo;s GRA, in each case, at the sole cost and expense of such Pubco 5% Shareholder, provided that each
of the Parties shall use commercially reasonable efforts to operate in a manner that avoids or mitigates the likelihood of a triggering
event.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6.13 <U>Required
Company Shareholder Approval; Company Merger Proposal</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a) As
promptly as practicable after the Registration Statement has become effective, the Company will either (i) call a meeting of its shareholders
in order to obtain the Required Company Shareholder Approval (the &ldquo;<B><I>Company Shareholder Meeting</I></B>&rdquo;), and the Company
shall use its reasonable best efforts to solicit from the Company Shareholders proxies in favor of the Required Company Shareholder Approval
prior to such Company Shareholder Meeting, or (ii) use its reasonable best efforts to obtain a signed written consent in lieu of a meeting
of its shareholders for the Required Company Shareholder Approval, and the Company shall take all other actions necessary or advisable
to secure the Requisite Majority, including enforcing the Voting Agreements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b) Without
limiting <U>Section 6.13(a)</U>, in accordance with the Israeli Companies Law, as soon as reasonably practicable following the date of
this Agreement, the Company and Company Merger Sub shall, as applicable, take the following actions within the timeframes set forth in
this <U>Section 6.13(b)</U>; provided, however, that any such actions or the time frame for taking such action shall be subject to any
amendment in the applicable provisions of the Israeli Companies Law (and in case of an amendment thereto, such amendment shall automatically
apply so as to amend this <U>Section 6.13(b)</U> accordingly): (i) as promptly as practicable following the date hereof, cause a merger
proposal (in the Hebrew language) with respect to the Company Merger in a form reasonably acceptable to the Parties hereto (the &ldquo;<B><I>Merger
Proposal</I></B>&rdquo;) to be executed in accordance with Section 316 of the Israeli Companies Law, (ii) deliver the Merger Proposal
to the Companies Registrar within three (3) days from the calling of the Company Shareholder Meeting, (iii) cause a copy of the Merger
Proposal to be delivered to its secured creditors, if any, no later than three (3) business days after the date on which the Merger Proposal
are delivered to the Companies Registrar, (iv) (A) publish a notice to its creditors, stating that the Merger Proposal was submitted to
the Companies Registrar and that the creditors may review the Merger Proposal at the office of the Companies Registrar, the Company&rsquo;s
registered office or Company Merger Sub&rsquo;s registered office, as applicable, and at such other locations as the Company or Company
Merger Sub, as applicable, may determine, in (x) two (2) daily Hebrew newspapers, on the day that the Merger Proposal is submitted to
the Companies Registrar and (y) in a popular newspaper outside of Israel as may be required by applicable Law, within three (3) business
days after the Merger Proposal was submitted to the Companies Registrar; (B) within four (4) business days from the date of submitting
the Merger Proposal to the Companies Registrar, send a notice by registered mail to all of the &ldquo;Substantial Creditors&rdquo; (as
such term is defined in the Israeli Companies Law) that the Company or Company Merger Sub, as applicable, is aware of, in which it shall
state that the Merger Proposal was submitted to the Companies Registrar and that the creditors may review the Merger Proposal at such
additional locations, if such locations were determined in the notice referred to in the immediately preceding clause (A) and at the times
set in such notice; and (C) send to the Company&rsquo;s &ldquo;employees committee&rdquo;, if any, or display in a prominent place at
the Company&rsquo;s premises a copy of the notice published in a daily Hebrew newspaper (as referred to in clause (A) of this <U>Section
6.13(b)</U>), no later than three (3) business days following the day on which the Merger Proposal was submitted to the Companies Registrar;
(v) promptly after the Company and Company Merger Sub, as applicable, shall have complied with the preceding clauses (iii) and (iv) of
this this <U>Section 6.13(b)</U>, but in any event no more than three (3) days following the date on which such notice was sent to the
creditors, inform the Companies Registrar, in accordance with Section 317(b) of the Israeli Companies Law, that notice was given to their
respective creditors, if any, under Section 318 of the Israeli Companies Law (and regulations promulgated thereunder), (vi) not later
than three (3) days after the date on which the Company Shareholder Approval is received, inform (in accordance with Section 317(b) of
Israeli Companies Law) the Companies Registrar of such approval, and (vii) subject to the satisfaction or waiver of the conditions set
forth in <U>Article VII</U> to be satisfied or (to the extent permitted) waived (other than any such conditions that by their nature are
to be satisfied at the Closing, but subject to the satisfaction or (to the extent permitted) waiver of such conditions at the Closing),
in accordance with the customary practice of the Companies Registrar, request that the Companies Registrar declare the Company Merger
effective and issue the Company Certificate of Merger upon such date, that in no event shall be prior to the lapse of fifty (50) days
from the filing of the Merger Proposal with the Companies Registrar and thirty (30) days from the date the Company Shareholder Approval
is received. For the avoidance of doubt, and notwithstanding any provision of this Agreement to the contrary, it is the intention of the
parties that the Company Merger shall be declared effective and the Company Certificate of Merger shall be issued on the Closing Date.
For purposes of this <U>Section 6.13(b)</U>, &ldquo;business day&rdquo; shall have the meaning set forth in the Merger Regulations 5760-2000
promulgated under the Israeli Companies Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 56; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6.14 <U>Public
Announcements</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a) The
Parties agree that, during the Interim Period, no public release, filing or announcement concerning this Agreement or the Ancillary Documents
or the transactions contemplated hereby or thereby shall be issued by any Party or any of their Affiliates without the prior written consent
(not be unreasonably withheld, conditioned or delayed) of SPAC and the Company, except as such release or announcement may be required
by applicable Law or the rules or regulations of any securities exchange, in which case the applicable Party shall use commercially reasonable
efforts to allow the other Parties reasonable time to comment on, and arrange for any required filing with respect to, such release or
announcement in advance of such issuance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b) The
Parties shall mutually agree upon and, as promptly as practicable after the execution of this Agreement (but in any event within four
(4) Business Days thereafter), issue a press release announcing the execution of this Agreement (the &ldquo;<B><I>Signing Press Release</I></B>&rdquo;).
Promptly after the issuance of the Signing Press Release, SPAC shall file a current report on Form 8-K (the &ldquo;<B><I>Signing Filing</I></B>&rdquo;)
with the Signing Press Release and a description of this Agreement as required by Federal Securities Laws, which the Company shall review,
comment upon and approve (which approval shall not be unreasonably withheld, conditioned or delayed) prior to filing (with the Company
reviewing, commenting upon and approving such Signing Filing in any event no later than the third (3<SUP>rd</SUP>) Business Day after
the execution of this Agreement). The Parties shall mutually agree upon and, as promptly as practicable after the Closing (but in any
event within four (4) Business Days thereafter), issue a press release announcing the consummation of the transactions contemplated by
this Agreement (the &ldquo;<B><I>Closing Press Release</I></B>&rdquo;). Promptly after the issuance of the Closing Press Release, Pubco
and SPAC shall file a current report on Form 8-K (the &ldquo;<B><I>Closing Filing</I></B>&rdquo;) with the Closing Press Release and a
description of the Closing as required by Federal Securities Laws, which the Representative Parties shall review, comment upon and approve
(such approval not to be unreasonably withheld, delayed or conditioned) prior to the filing. In connection with the preparation of the
Signing Press Release, the Signing Filing, the Closing Filing, the Closing Press Release, or any other report, statement, filing notice
or application made by or on behalf of a Party to any Governmental Authority or other third party in connection with the transactions
contemplated hereby, each Party shall, upon request by any other Party, furnish the Parties with all information concerning themselves,
their respective directors, officers and equity holders, and such other matters as may be reasonably necessary or advisable in connection
with the transactions contemplated hereby, or any other report, statement, filing, notice or application made by or on behalf of a Party
to any third party and/ or any Governmental Authority in connection with the transactions contemplated hereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6.15 <U>Confidential
Information</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a) The
Company, Pubco, the Seller Representative and the Merger Subs agree that during the Interim Period and, in the event this Agreement is
terminated in accordance with <U>Article VIII</U>, for a period of two (2) years after such termination, they shall, and shall cause their
respective Representatives to: (i) treat and hold in strict confidence any SPAC Confidential Information, and will not use for any purpose
(except in connection with the consummation of the transactions contemplated by this Agreement or the Ancillary Documents, performing
their obligations hereunder or thereunder or enforcing their rights hereunder or thereunder), nor directly or indirectly disclose, distribute,
publish, disseminate or otherwise make available to any third party any of the SPAC Confidential Information without SPAC&rsquo;s prior
written consent; and (ii) in the event that the Company, Pubco, the Seller Representative, the Merger Subs or any of their respective
Representatives, during the Interim Period or, in the event that this Agreement is terminated in accordance with <U>Article VIII</U>,
for a period of two (2) years after such termination, becomes legally compelled to disclose any SPAC Confidential Information, (A) provide
SPAC to the extent legally permitted with prompt written notice of such requirement so that SPAC or an Affiliate thereof may seek, at
SPAC&rsquo;s cost, a protective Order or other remedy or waive compliance with this <U>Section 6.15(a)</U>, and (B) in the event that
such protective Order or other remedy is not obtained, or SPAC waives compliance with this <U>Section 6.15(a)</U>, furnish only that portion
of such SPAC Confidential Information which is legally required to be provided as advised by outside counsel and to exercise its commercially
reasonable efforts to obtain assurances that confidential treatment will be accorded such SPAC Confidential Information. In the event
that this Agreement is terminated and the transactions contemplated hereby are not consummated, the Company, Pubco, the Seller Representative
and the Merger Subs shall, and shall cause their respective Representatives to, promptly deliver to SPAC or destroy (at SPAC&rsquo;s election)
any and all copies (in whatever form or medium) of SPAC Confidential Information and destroy all notes, memoranda, summaries, analyses,
compilations and other writings related thereto or based thereon.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b) Each
of SPAC and the SPAC Representative hereby agrees that during the Interim Period and, in the event that this Agreement is terminated in
accordance with <U>Article VIII</U>, for a period of two (2) years after such termination (or in the case of Trade Secrets, so long as
such Company Confidential Information remains a Trade Secret under applicable Law), it shall, and shall cause its Representatives to:
(i) treat and hold in strict confidence any Company Confidential Information, and will not use for any purpose (except in connection with
the consummation of the transactions contemplated by this Agreement or the Ancillary Documents, performing its obligations hereunder or
thereunder or enforcing its rights hereunder or thereunder), nor directly or indirectly disclose, distribute, publish, disseminate or
otherwise make available to any third party any of the Company Confidential Information without the Company&rsquo;s prior written consent;
and (ii) in the event that SPAC or the SPAC Representative or any of their respective Representatives, during the Interim Period or, in
the event that this Agreement is terminated in accordance with <U>Article VIII</U>, for a period of two (2) years after such termination
(or in the case of Trade Secrets, so long as such Company Confidential Information remains a Trade Secret under applicable Law), becomes
legally compelled to disclose any Company Confidential Information, (A) provide the Company to the extent legally permitted with prompt
written notice of such requirement so that the Company may seek, at the Company&rsquo;s sole expense, a protective Order or other remedy
or waive compliance with this <U>Section 6.15(b)</U> and (B) in the event that such protective Order or other remedy is not obtained,
or the Company waives compliance with this <U>Section 6.15(b)</U>, furnish only that portion of such Company Confidential Information
which is legally required to be provided as advised by outside counsel and to exercise its commercially reasonable efforts to obtain assurances
that confidential treatment will be accorded such Company Confidential Information. In the event that this Agreement is terminated and
the transactions contemplated hereby are not consummated, SPAC and the SPAC Representative shall, and each shall cause its Representatives
to, promptly deliver to the Company or destroy (at the election of the SPAC or the SPAC Representative, as applicable) any and all copies
(in whatever form or medium) of Company Confidential Information and destroy all notes, memoranda, summaries, analyses, compilations and
other writings related thereto or based thereon. Notwithstanding the foregoing, SPAC, the SPAC Representative and their respective Representatives
shall be permitted to disclose any and all Company Confidential Information to the extent required by the Federal Securities Laws; provided,
that, to the extent legally permissible, SPAC and its Representatives shall give the Company prompt written notice of such disclosure
and SPAC and its Representatives shall use commercially reasonable efforts to obtain confidential treatment for any such Company Confidential
Information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 57; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6.16 <U>Post-Closing
Board of Directors and Executive Officers</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a) The
Parties shall take all necessary action, including causing the directors of Pubco to resign, so that effective as of the Closing, Pubco&rsquo;s
board of directors (the &ldquo;<B><I>Post-Closing Pubco Board</I></B>&rdquo;) will consist of eight (8) individuals (not including any
External Directors (as such term is defined in the Israeli Companies Law), to the extent required under the Israeli Companies Law). Immediately
after the Closing, the Parties shall take all necessary action to designate and appoint to the Post-Closing Pubco Board (i) five (5) persons
that are designated by the Company prior to the Closing, (ii) one (1) person who is designated by the Sponsor prior to the Closing (the
&ldquo;<B><I>Sponsor Director</I></B>&rdquo;); and (iii) so long as (A) the HSC Principals pay the Expenses of the Company DeSPAC Advisors
incurred by the Company and its Subsidiaries in accordance the HSC Letter Agreement, and (B) the Minimum Cash Condition is satisfied as
of the Closing, two (2) persons that are designated by the HSC Principals prior to the Closing. A majority of the directors on the Post-Closing
Pubco Board will qualify as an independent directors under Nasdaq rules. Pursuant to the Amended Pubco Organizational Documents, the Post-Closing
Pubco Board will be a classified board with three (3) classes of directors, with (I) the Class I Directors (consisting of two (2) directors)
initially serving a one (1) year term, such initial term effective from the Closing until the first annual meeting of the Pubco shareholders
after the Closing (but any subsequent Class I Directors serving a three (3) year term), (II) the Class II Directors (consisting of three
(3) directors), initially serving a two (2) year term, such initial term effective from the Closing until the second annual meeting of
the Pubco shareholders after the Closing (but any subsequent Class II Directors serving a three (3) year term), and (III) the Class III
Directors (consisting of three (3) directors, including the Sponsor Director) serving a three (3) year term. In accordance with the Amended
Pubco Organizational Documents, no director on the Post-Closing Pubco Board may be removed without cause. At or prior to the Closing,
Pubco will provide each director on the Post-Closing Pubco Board with a customary director indemnification agreement, in form and substance
reasonably acceptable to such director.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b) The
Parties shall take all action necessary, including causing the executive officers of Pubco to resign, so that the individuals serving
as the chief executive officer and chief financial officer, respectively, of Pubco immediately after the Closing will be the same individuals
(in the same office) as that of the Company immediately prior to the Closing (unless, with the consent of SPAC, the Company desires to
appoint another qualified person to either such role, in which case, such other person identified by the Company shall serve in such role).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6.17 <U>Indemnification
of Directors and Officers; Tail Insurance</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a) The
Parties agree that all rights to exculpation, indemnification and advancement of expenses existing in favor of the current or former directors
and officers of SPAC, the Company, Pubco or either Merger Sub and each Person who served as a director, officer, member, trustee or fiduciary
of another corporation, partnership, joint venture, trust, pension or other employee benefit plan or enterprise at the request of SPAC,
the Company, Pubco or a Merger Sub (the &ldquo;<B><I>D&amp;O Indemnified Persons</I></B>&rdquo;) as provided in their respective Organizational
Documents or under any indemnification, employment or other similar agreements between any D&amp;O Indemnified Person and SPAC, the Company,
Pubco or a Merger Sub, in each case as in effect on the date of this Agreement, shall survive the Closing and continue in full force and
effect in accordance with their respective terms to the extent permitted by applicable Law. For a period of seven (7) years after the
Closing, Pubco shall cause the Organizational Documents of Pubco and the Surviving Subsidiaries to contain provisions no less favorable
with respect to exculpation and indemnification of and advancement of expenses to D&amp;O Indemnified Persons than are set forth as of
the date of this Agreement in the Organizational Documents of, as applicable, SPAC, the Company, Pubco or a Merger Sub to the extent permitted
by applicable Law. The provisions of this <U>Section 6.17</U> shall survive the Closing and are intended to be for the benefit of, and
shall be enforceable by, each of the D&amp;O Indemnified Persons and their respective heirs and representatives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b) For
the benefit of the directors and officers of SPAC, the Company, Pubco or either Merger Sub, SPAC or Pubco shall be permitted prior to
the Closing to obtain and fully pay (including from funds in the Trust Account released at the Closing) the premium for a &ldquo;tail&rdquo;
insurance policy that provides coverage for up to a seven-year period (or such period is not reasonably available, such lesser number
of years as is reasonably available) from and after the Closing for events occurring prior to the Closing (the &ldquo;<B><I>D&amp;O Tail
Insurance</I></B>&rdquo;) that is substantially equivalent to and in any event not less favorable in the aggregate than, as applicable,
SPAC&rsquo;s or the Company&rsquo;s existing policy or, if substantially equivalent insurance coverage is unavailable, the best available
coverage. If obtained, Pubco and the Surviving Subsidiaries shall maintain the D&amp;O Tail Insurance in full force and effect, and continue
to honor the obligations thereunder, and Pubco and the Surviving Subsidiaries shall timely pay or cause to be paid all premiums with respect
to the D&amp;O Tail Insurance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c) Prior
to the Closing, Pubco shall obtain directors&rsquo; and officers&rsquo; liability insurance that shall be effective as of Closing and
will cover those Persons who will be directors and officers of Pubco and its Subsidiaries (including the directors and officers of the
Target Companies) from and after the Closing on terms and conditions (including scope and amount of coverage) customary and reasonably
appropriate for a company with its equity listed on Nasdaq and that has similar characteristics (including the line of business, jurisdiction
of operations and revenues) as Pubco and its Subsidiaries (including the Target Companies).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 58; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6.18 <U>Trust
Account and Transaction Financing Proceeds</U>. The Parties agree that after the Closing, the funds in the Trust Account, after taking
into account payments for the Closing Redemption, and any proceeds received by Pubco or SPAC from any Transaction Financing, shall first
be used to pay (i) SPAC&rsquo;s accrued Expenses, including SPAC&rsquo;s deferred Expenses of the IPO and deferred advisor fees, (ii)
any loans owed by SPAC to Sponsor for any Expenses (including deferred Expenses), other administrative costs and expenses incurred by
or on behalf of SPAC or Extension Expenses, (iii) any other cash liabilities of SPAC and (iv) the Company&rsquo;s accrued Expenses. Such
amounts, as well as any Expenses that are required or permitted to be paid by delivery of Pubco securities, shall be paid at the Closing.
Any remaining cash shall be used by Pubco and the Target Companies for working capital and general corporate purposes. During the Interim
Period, if reasonably requested in writing by the Company, the SPAC shall, solely for informational purposes, provide the Company with
a good faith estimate of the SPAC&rsquo;s projected unpaid Expenses and liabilities as of the Closing, including its calculations thereof
in reasonable detail; provided, that the SPAC shall not be deemed to make, and hereby disclaims, any representations, warranties or covenants
in connection with such projections provided pursuant to this <U>Section 6.18</U>. During the Interim Period, if reasonably requested
in writing by SPAC, the Company shall, solely for informational purposes, provide the SPAC with a good faith estimate of the Company&rsquo;s
projected unpaid Expenses as of the Closing, including its calculations thereof in reasonable detail; provided, that the Company shall
not be deemed to make, and hereby disclaims, any representations, warranties or covenants in connection with such projections provided
pursuant to this <U>Section 6.18</U>. As used in this Agreement, &ldquo;<B><I>Expenses</I></B>&rdquo; shall include all out-of-pocket
expenses (including all fees and expenses of counsel, accountants, investment bankers, financial advisors, financing sources, experts
and consultants to a Party hereto or any of its Affiliates) incurred by a Party or on its behalf in connection with or related to the
authorization, preparation, negotiation, execution or performance of this Agreement or any Ancillary Document related hereto and all other
matters related to the consummation of this Agreement. With respect to SPAC, Expenses shall include any and all deferred expenses (including
fees or commissions payable to the underwriters and any legal fees) of the IPO upon consummation of a Business Combination and any Extension
Expenses.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6.19 <U>Bridge
Financing; Other Transaction Financing</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a) The
Company, with the reasonable assistance of SPAC, will use its commercially reasonable efforts to seek and, within thirty (30) days after
the date of this Agreement, enter into and consummate securities purchase agreements(s), subscription agreements or other financing agreement(s)
on such terms and conditions and in such form(s) that are agreed to the Company and SPAC (such agreement not to be unreasonably withheld,
delayed or conditioned) (the &ldquo;<B><I>Bridge Financing Agreements</I></B>&rdquo;) with certain accredited investors reasonably acceptable
to the Company and SPAC (the &ldquo;<B><I>Bridge Financing Investors</I></B>&rdquo;) for an aggregate investment amount into the Company
equal to at least Five Million U.S. Dollars ($5,000,000) at a pre-money equity valuation of the Company of $120,000,000 (such financing,
the &ldquo;<B><I>Bridge Financing</I></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b) Without
limiting anything to the contrary contained herein, during the Interim Period, SPAC, the Company and Pubco shall use their commercially
reasonable efforts to enter into financing agreements (any such agreements, the &ldquo;<B><I>Additional Financing Agreements</I></B>&rdquo;
and, together with the Bridge Financing Agreements, the &ldquo;<B><I>Financing Agreements</I></B>&rdquo;) for aggregate proceeds of at
least Eighteen Million U.S. Dollars ($18,000,000) (excluding the CCOD commitments) in addition to the Bridge Financing on such terms and
structuring (whether structured as a private placement of common equity, convertible preferred equity, convertible debt or other securities
convertible into or that have the right to acquire common equity, as Trust Account non-redemption or backstop arrangements or as a committed
equity line facility (excluding the CCOD) or otherwise), and using such strategy, placement agents and approach, as SPAC and the Company
shall mutually agree (such agreement not to be unreasonably withheld, conditioned or delayed) (collectively, the &ldquo;<B><I>Additional
Transaction Financing</I></B>&rdquo; and, together with the Bridge Financing, the &ldquo;<B><I>Transaction Financing</I></B>&rdquo;),
and also use their commercially reasonable efforts to enter into a committed capital on demand or equity line facility for Pubco (the
&ldquo;<B><I>CCOD</I></B>&rdquo;) for periods from and after the Closing. Notwithstanding the foregoing, any Additional Transaction Financing
that is structured as debt or debt-like securities, including mandatorily redeemable preferred equity, that is not, upon or after the
Closing, convertible into common equity of Pubco shall require the prior written consent of the Company, in its sole and absolute discretion.
The Parties acknowledge that SPAC has engaged Locust Walk Partners, LLC (the &ldquo;<B><I>Placement Agent</I></B>&rdquo;) to serve as
lead placement agent for the Transaction Financing (excluding Transaction Financing involving certain investors that were securityholders
of the Company or the SPAC or that were sourced by SPAC, the Sponsor or the HSC Principals).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c) SPAC,
the Company and Pubco shall, and shall cause their respective Representatives, including the HSC Principals, to, reasonably cooperate
with the others in connection with such Additional Financing Agreements (including having the Company&rsquo;s senior management participate
in any investor meetings and roadshows as reasonably requested by SPAC). Except to the extent permitted pursuant to the terms of the Financing
Agreements or otherwise approved in writing by the Company and SPAC (each of which approval shall not be unreasonably withheld, conditioned
or delayed), and except for any of the following actions that would not materially increase conditionality or impose any new material
obligation on the Company, Pubco or SPAC, during the Interim Period SPAC, the Company and Pubco shall not (i) reduce the committed investment
amount to be received by SPAC, Pubco or the Company under any Financing Agreement or reduce or impair the rights of SPAC, the Company
or Pubco under any Financing Agreement or (ii) permit any amendment or modification to be made to, any waiver (in whole or in part) of,
or provide consent to modify (including consent to terminate), any provision or remedy under, or any replacements of, any of the Financing
Agreements, in each case, other than any assignment or transfer contemplated therein or expressly permitted thereby (without any further
amendment, modification or waiver to such assignment or transfer provision). SPAC, Pubco and the Company shall use their commercially
reasonable efforts to consummate the Transaction Financing in accordance with the Financing Agreements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 59; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">6.20 <U>Employment
Agreements</U>. Prior to the Closing, the Company shall use its reasonable best efforts to cause the persons set forth on <U>Schedule
6.20</U>, including the Company&rsquo;s chief executive officer and chief financial officer, to enter into employment agreements (the
&ldquo;<B><I>Employment Agreements</I></B>&rdquo;), in each case effective as of the Closing, in form and substance reasonably acceptable
to the Company and SPAC, between each such individual and Pubco.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">6.21 <U>Nasdaq
Listing</U>. Pubco, SPAC and the Company shall each use its commercially reasonable efforts to cause, as promptly as practicable after
the date of this Agreement: (a) Pubco&rsquo;s initial listing application with Nasdaq (the &ldquo;<B><I>Listing Application</I></B>&rdquo;)
in connection with the Transactions to have been approved; (b) Pubco to satisfy all applicable initial and continuing listing requirements
of Nasdaq; and (c) the Pubco Ordinary Shares and Pubco Public Warrants to have been approved for listing on Nasdaq (provided, that the
Parties acknowledge that the listing of the Pubco Public Warrants will not be a condition to the Closing). Each of Pubco, the Company
and SPAC shall promptly furnish all information concerning itself and its Affiliates as may be reasonably requested by the other such
parties and shall otherwise reasonably assist and cooperate with the other such parties in connection with the preparation and filing
of the Listing Application. Each of Pubco, SPAC and the Company will use commercially reasonable efforts to (i) cause the Listing Application,
when filed, to comply in all material respects with all requirements applicable thereto, (ii) respond as promptly as reasonably practicable
to and resolve all comments received from Nasdaq or its staff concerning the Listing Application and (iii) have the Listing Application
approved by Nasdaq, as promptly as practicable after such filing. None of SPAC, Pubco or the Company shall submit the Listing Application
or any supplement or amendment thereto or respond to comments received from Nasdaq with respect thereto, without the other such parties&rsquo;
prior consent (which shall not be unreasonably withheld, conditioned or delayed) and without providing the other such parties a reasonable
opportunity to review and comment thereon. Each of SPAC, Pubco and the Company shall promptly notify the other such parties upon the receipt
of any comments from Nasdaq, or any request from Nasdaq for amendments or supplements to the Listing Application and shall provide the
other such parties with copies of all material correspondence between such party or any of its Representatives, on the one hand, and Nasdaq,
on the other hand, and all written comments with respect to the Listing Application received from Nasdaq, and advise the other sch parties
of any oral comments with respect to the Listing Application received from Nasdaq. Promptly after receiving notice thereof, each of SPAC,
Pubco and the Company shall advise the other such parties of the time of the approval of the Listing Application and the approval for
listing on Nasdaq of the Pubco Ordinary Shares to be issued in connection with the transactions contemplated hereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6.22 <U>Israeli
Securities Law; IAA</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a) Without
limiting the generality of <U>Section 6.9</U>, (i) the Company and Pubco shall, in coordination with SPAC, as promptly as practicable
after the date of this Agreement, prepare and file with the ISA an application for an exemption under Section 15D of the Israeli Securities
Law, concerning the publication of an Israeli prospectus, or alternatively an application requesting that the ISA confirms that the issuance
is exempt from prospectus requirements or does not trigger prospectus requirements (the &ldquo;<B><I>15D Exemption</I></B>&rdquo;) and
(ii) as promptly as practicable after the date of this Agreement and in any event within thirty (30) days thereof, the Company, Pubco
and SPAC shall reasonably cooperate and the Company and Pubco shall file with the ISA any required exemption or &ldquo;no action&rdquo;
requests in connection with the issuance of the Merger Consideration, requesting the ISA to exempt or agree not to take any action against
the parties in connection with any such issuance without a publication of a prospectus in accordance with the Israeli Securities Law (an
&ldquo;<B><I>Israeli Prospectus</I></B>&rdquo; and any such exemption, the &ldquo;<B><I>ISA Offering Exemption</I></B>&rdquo; and, together
with the 15D Exemption, the &ldquo;<B><I>ISA Exemptions</I></B>&rdquo;). The Company, Pubco and SPAC shall use their reasonable best efforts
to respond promptly to comments from the ISA and to obtain the ISA Exemptions. The Company and Pubco, as applicable, shall provide to
SPAC a copy of its application to obtain the 15D Exemption for SPAC&rsquo;s prior review and comments and shall update SPAC and its counsel
on any developments with respect to the application and any communications with the ISA in connection with the application and the review
thereof and facilitate SPAC&rsquo;s counsels&rsquo; involvement in such communications to the extent reasonably practicable. Each of Pubco,
the Company and SPAC shall, and shall cause their respective counsels to, reasonably cooperate to obtain the ISA Offering Exemption and
to facilitate each other such Party&rsquo;s and its counsels&rsquo; involvement in all communications with and submission of documents
and information to the ISA in connection with the application and receipt of the ISA Offering Exemption.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b) The
Company shall, immediately after the Closing, deliver the IIA Notice to the IIA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 60; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6.23 <U>Israeli
Tax Rulings</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a) As
soon as reasonably practicable after the date of this Agreement, the Company shall instruct its Israeli counsel, advisors or accountants
to prepare and file with the ITA, in full coordination with SPAC and SPAC&rsquo;s Israeli counsel and tax advisors: (i) an application
or applications for a ruling or rulings (or interim ruling or rulings) confirming that the Company Merger qualifies as a transaction governed
by Section 104B of the Israeli Tax Ordinance and permitting deferral of any applicable Israeli Tax with respect to the Merger Consideration
included in and covered by such ruling and pursuant to this Agreement, in accordance with the provisions of Section 104B of the Israeli
Tax Ordinance until the sale, transfer or other conveyance for cash or such other date set forth in such ruling, which ruling may be subject
to customary conditions regularly associated with such a ruling (the &ldquo;<B><I>Tax Ruling</I></B>&rdquo;); and, (ii) to the extent
not otherwise included in the Tax Ruling, an application or applications for a ruling or rulings (A) confirming that the exchange of In-the-Money
Company Options that are Section 102 Options or Section 3(i) Options for Pubco Ordinary Shares and the exchange of Section 102 Shares
for Pubco Ordinary Shares deposited with the Section 102 Trustee shall not, in either case, constitute a violation of the requirements
of Section 102, shall not be treated as a taxable event and that tax continuity shall apply with respect to such Pubco Ordinary Shares,
provided, in each case, that Pubco Ordinary Shares are deposited with the Section 102 Trustee (which ruling may be subject to customary
conditions regularly associated with such a ruling) (the &ldquo;<B><I>Israeli Option Tax Ruling</I></B>&rdquo;), and/or (B) exempting
Pubco, the Exchange Agent, and their respective agents from any obligation to withhold Israeli Tax from the Merger Consideration payable
or otherwise deliverable pursuant to the SPAC Merger or clarifying that no such obligation exists, or instructing Pubco, Exchange Agent
and their respective agents on how such withholding is to be executed (the &ldquo;<B><I>SPAC Withholding Tax Ruling</I></B>&rdquo;). The
Tax Ruling, the Israeli Option Tax Ruling and the SPAC Withholding Tax Ruling shall be referred to as the &ldquo;<B><I>Israeli Tax Rulings</I></B>&rdquo;.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b) The
Company and SPAC shall cause their respective Israeli counsel, advisors and accountants to coordinate all material activities, and to
cooperate with each other, with respect to the preparation and filing of the applications for the Israeli Tax Rulings and in the preparation
of any written or oral submissions that may be necessary, proper or advisable to obtain the Israeli Tax Rulings. Subject to the terms
and conditions hereof, the Company and Pubco shall use reasonable best efforts to promptly take, or cause to be taken, all actions and
to do, or cause to be done, all things necessary, proper or advisable under applicable laws to obtain the Israeli Tax Rulings, as promptly
as practicable, and shall inform SPAC and its Israeli advisors of the content of any discussions and meetings with the ITA relating thereto.
For the avoidance of doubt, the Company and its legal and accounting Representatives shall not make any application to the ITA with respect
to any matter relating to the Israeli Tax Rulings without first granting the SPAC and SPAC&rsquo;s Israeli counsel and tax advisors reasonable
opportunity to review, comment on and approve the draft application (which approval shall not be unreasonably withheld, delayed or conditioned),
and the Company and its legal and accounting representatives shall enable the SPAC and SPAC&rsquo;s Israeli counsel and tax advisors to
participate in all discussions and meetings with the ITA relating thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">6.24 <U>SPAC
Merger Sub Formation and Joinder</U>. As promptly as practicable following the date hereof (and in any event prior to the initial filing
of the Registration Statement with the SEC), the Company shall cause the SPAC Merger Sub to be formed in the Cayman Islands solely for
the purpose of engaging in the SPAC Merger and the other Transactions. When it is formed, SPAC Merger Sub shall be one-hundred percent
(100%) owned solely by Pubco, a Target Company or a shareholder, officer or director of the Company (any of the foregoing, a &ldquo;<B><I>Permitted
SPAC Merger Sub Owner</I></B>&rdquo;), and from its formation and through the Closing SPAC Merger Sub shall qualify as a foreign private
issuer pursuant to Rule 3b-4 of the Exchange Act. Promptly after the Company receives the memorandum and articles of association following
the formation of the SPAC Merger Sub from the Cayman Islands Registrar (and in any event within two (2) Business Days thereafter), the
Company shall (i) cause SPAC Merger Sub to execute and deliver to the Parties a joinder agreement in the form attached hereto as <U>Exhibit
E</U> (the &ldquo;<B><I>Joinder</I></B>&rdquo;), pursuant to which, among other things, SPAC Merger Sub shall (A) become a party to this
Agreement as of the date thereof and (B) agree to be bound by the terms, covenants and other provisions of this Agreement applicable to
SPAC Merger Sub under this Agreement and shall assume all rights and obligations applicable to SPAC Merger Sub hereunder, with the same
force and effect as if originally named herein, and (ii) deliver to SPAC and the Company evidence of SPAC Merger Sub&rsquo;s adoption
and approval of this Agreement and the Transactions in form and substance reasonably acceptable to SPAC. Notwithstanding anything to the
contrary contained in this Agreement, any reference in this Agreement to SPAC Merger Sub&rsquo;s execution and delivery of this Agreement
will mean SPAC Merger Sub&rsquo;s execution and delivery of the Joinder, and any reference in this Agreement to any representation or
warranty made by SPAC Merger Sub as of the date of this Agreement will mean any representation or warranty made by SPAC Merger Sub as
of the date of its execution and delivery of the Joinder. The rights and obligations of SPAC Merger Sub under this Agreement shall not
be effective until its execution and delivery of the Joinder. Without limiting the foregoing, notwithstanding anything to the contrary
contained in this Agreement, in the event that prior to SPAC Merger Sub&rsquo;s execution and delivery of the Joinder, a Party seeks to
take an action, omission, waiver or amendment that requires the consent, approval or agreement of SPAC Merger Sub under this Agreement,
the consent, approval or agreement of SPAC Merger Sub shall not be required for purposes of this Agreement to take such action, omission,
waiver or amendment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<!-- Field: Page; Sequence: 61; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Article
VII<U><BR>
CLOSING CONDITIONS</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">7.1 <U>Conditions
to Each Party&rsquo;s Obligations</U>. The obligations of each Party to consummate the Transactions shall be subject to the satisfaction
or written waiver (where permissible) by the Company and SPAC of the following conditions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a) <I>Required
SPAC Shareholder Approval</I>. The Shareholder Approval Matters that are submitted to the vote of the shareholders of SPAC at the SPAC
Shareholder Meeting in accordance with the Proxy Statement shall have been approved by the requisite vote of the shareholders of SPAC
at the SPAC Shareholder Meeting in accordance with the SPAC Charter, applicable Law and the Proxy Statement (the &ldquo;<B><I>Required
SPAC Shareholder Approval</I></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b) <I>Required
Company Shareholder Approval</I>. Either (i) the Company Shareholder Meeting shall have been held in accordance with the Israeli Companies
Law and the Company&rsquo;s Organizational Documents, or (ii) the Company shall have obtained a signed unanimous written consent of its
shareholders in lieu of a meeting, where in either case, the requisite vote, consent or approval of the Company Shareholders (including
any separate class or series vote, consent or approval that is required, whether pursuant to the Company&rsquo;s Organizational Documents
or otherwise) shall have authorized, approved and consented to, the execution, delivery and performance of this Agreement and each of
the Ancillary Documents to which the Company is or is required to be a party or bound, and the consummation of the Transactions (the &ldquo;<B><I>Required
Company Shareholder Approval</I></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c) <I>Antitrust
Laws.</I> Any waiting period (and any extension thereof) applicable to the consummation of this Agreement under any Antitrust Laws shall
have expired or been terminated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d) <I>Requisite
Regulatory Approvals</I>. All Consents required to be obtained from or made with any Governmental Authority in order to consummate the
Transactions that are set forth on <U>Schedule 7.1(d)</U> shall have been obtained.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e) <I>Requisite
Consents</I>. The Consents required to be obtained from or made with any third Person (other than a Governmental Authority) in order to
consummate the Transactions that are set forth in <U>Schedule 7.1(e)</U> shall have each been obtained or made.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f) <I>No
Law or Order</I>. No Governmental Authority shall have enacted, issued, promulgated, enforced or entered any Law (whether temporary, preliminary
or permanent) or Order that is then in effect and which has the effect of making the transactions or agreements contemplated by this Agreement
illegal or which otherwise prevents or prohibits consummation of the transactions contemplated by this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(g) <I>Appointment
to the Board</I>. The members of the Post-Closing Pubco Board shall have been elected or appointed as of the Closing consistent with the
requirements of <U>Section 6.16</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(h) <I>Amended
Pubco Organizational Documents</I>. Prior to the Closing, Pubco shall have amended and restated its Organizational Documents to be in
substantially the form of the Amended Pubco Organizational Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i) <I>Foreign
Private Issuer Status. </I>Each of the Company and SPAC shall have received evidence reasonably satisfactory to such Party that Pubco
qualifies as a foreign private issuer pursuant to Rule 3b-4 of the Exchange Act as of the Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(j) <I>Registration
Statement</I>. The Registration Statement shall have been declared effective by the SEC and shall remain effective as of the Closing,
and no stop Order or similar Order shall be in effect with respect to the Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(k) <I>Nasdaq
Listing</I>. The Pubco Ordinary Shares to be issued in connection with the Transactions shall have been approved for listing on Nasdaq,
subject to official notice of issuance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(l) <I>Israeli
Tax Rulings</I>. The Israeli Tax Rulings shall have been obtained.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(m) <I>ISA
Exemptions</I>. The ISA Exemptions shall have been obtained.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(n) <I>Company
Merger Proposal</I>. At least fifty (50) days shall have elapsed after the filing of the Merger Proposal with the Companies Registrar
and at least thirty (30) days shall have elapsed after the Company Shareholder Approval has been received.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 62; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">7.2 <U>Conditions
to Obligations of the Company, Pubco and the Merger Subs</U>. In addition to the conditions specified in <U>Section 7.1</U>, the obligations
of the Company, Pubco and the Merger Subs to consummate the Transactions are subject to the satisfaction or written waiver (by the Company
and Pubco) of the following conditions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a) <I>Representations
and Warranties</I>. All of the representations and warranties of SPAC set forth in this Agreement and in any certificate delivered by
or on behalf of SPAC pursuant hereto shall be true and correct on and as of the date of this Agreement and on and as of the Closing Date
as if made on the Closing Date, except for (i) those representations and warranties that address matters only as of a particular date
(which representations and warranties shall have been accurate as of such date), and (ii) any failures to be true and correct that (without
giving effect to any qualifications or limitations as to materiality or Material Adverse Effect), individually or in the aggregate, have
not had and would not reasonably be expected to have a Material Adverse Effect on, or with respect to, SPAC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b) <I>Agreements
and Covenants</I>. Each of SPAC and the SPAC Representative shall have performed in all material respects all of its obligations and complied
in all material respects with all of its agreements and covenants under this Agreement to be performed or complied with by it on or prior
to the Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c) <I>No
Material Adverse Effect</I>. No Material Adverse Effect shall have occurred with respect to SPAC since the date of this Agreement which
is continuing and uncured.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d) <I>Minimum
Cash Condition</I>. Upon the Closing, SPAC shall have an aggregate amount of (i) cash and cash equivalents, including funds remaining
in the Trust Account (after giving effect to the completion and payment of the Closing Redemption), that (ii) when added to the aggregate
proceeds of all Transaction Financing (including the Bridge Financing), whether received by SPAC, Pubco or a Target Company, and (iii)
after deducing all SPAC Expenses (including SPAC&rsquo;s deferred Expenses of the IPO and deferred advisor fees and the fees owed to the
Placement Agent and SPAC&rsquo;s other expenses incurred in connection with the Transaction Financing) and SPAC&rsquo;s cash liabilities
(whether due as of or after the Closing) (such net amount of clauses (i), (ii) and (iii), the &ldquo;<B><I>Net Cash</I></B>&rdquo;) is
at least equal to Twenty-Three Million U.S. Dollars ($23,000,000) (the condition set forth in this <U>Section 7.2(d)</U>, the &ldquo;<B><I>Minimum
Cash Condition</I></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e) <I>Certain
Ancillary Documents</I>. The Sponsor Letter Agreement shall be in full force and effect in accordance with the terms thereof as of the
Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f) <I>Closing
Deliveries.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i) <I>Officer
Certificate</I>. SPAC shall have delivered to the Company and Pubco a certificate, dated the Closing Date, <I>signed</I> by an executive
officer of SPAC in such capacity, certifying as to the satisfaction of the conditions specified in <U>Sections 7.2(a)</U>, <U>7.2(b)</U>
and <U>7.2(c)</U> with respect to SPAC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ii) <I>Secretary
Certificate</I>. SPAC shall have delivered to the Company and Pubco a certificate from its secretary or other executive officer certifying
as to, and attaching, (A) copies of SPAC&rsquo;s Organizational Documents as in effect as of the Closing Date (immediately prior to the
SPAC Merger Effective Time), (B) the resolutions of SPAC&rsquo;s board of directors authorizing and approving the execution, delivery
and performance of this Agreement and each of the Ancillary Documents to which it is a party or by which it is bound, and the consummation
of the transactions contemplated hereby and thereby, (C) evidence that the Required SPAC Shareholder Approval has been obtained and (D)
the incumbency of directors or officers authorized to execute this Agreement or any Ancillary Document to which SPAC is or is required
to be a party or otherwise bound.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iii) <I>Good
Standing</I>. SPAC shall have delivered to the Company and Pubco a good standing certificate (or similar documents applicable for such
jurisdictions) for SPAC certified as of a date no earlier than thirty (30) days prior to the Closing Date from the proper Governmental
Authority of SPAC&rsquo;s jurisdiction of organization and from each other jurisdiction in which SPAC is qualified to do business as a
foreign entity as of the Closing, in each case to the extent that good standing certificates or similar documents are generally available
in such jurisdictions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iv) <I>Employment
Agreements</I>. The Company shall have received the Employment Agreements, in form and substance reasonably acceptable to SPAC and the
Company, between each of the persons set forth on <U>Schedule 6.20</U> and Pubco (or a Subsidiary thereof), each such Employment Agreement
duly executed by such person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(v) <I>Amended
Registration Rights Agreement</I>. The Company shall have received a copy of the Amended Registration Rights Agreement, in form and substance
reasonably acceptable to SPAC and the Company, duly executed by SPAC, the Sponsor and the IPO Underwriter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 63; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">7.3 <U>Conditions
to Obligations of SPAC</U>. In addition to the conditions specified in <U>Section 7.1</U>, the obligations of SPAC to consummate the Transactions
are subject to the satisfaction or written waiver (by SPAC) of the following conditions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a) <I>Representations
and Warranties</I>. All of the representations and warranties of the Company, Pubco and the Merger Subs set forth in this Agreement and
in any certificate delivered by or on behalf of the Company, Pubco or a Merger Sub pursuant hereto shall be true and correct on and as
of the date of this Agreement (or with respect to SPAC Merger Sub, as of the date of its execution and delivery of the Joinder) and on
and as of the Closing Date as if made on the Closing Date, except for (i) those representations and warranties that address matters only
as of a particular date (which representations and warranties shall have been accurate as of such date), and (ii) any failures to be true
and correct that (without giving effect to any qualifications or limitations as to materiality or Material Adverse Effect), individually
or in the aggregate, have not had and would not reasonably be expected to have a Material Adverse Effect on, or with respect to the Company,
Pubco or a Merger Sub.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b) <I>Agreements
and Covenants</I>. The Company, Pubco, the Merger Subs and the Seller Representative shall have performed in all material respects all
of their respective obligations and complied in all material respects with all of their respective agreements and covenants under this
Agreement to be performed or complied with by them on or prior to the Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c) <I>No
Material Adverse Effect</I>. No Material Adverse Effect shall have occurred with respect to the Company or Pubco since the date of this
Agreement which is continuing and uncured.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d) <I>Certain
Ancillary Documents.</I> SPAC shall have received a Lock-Up Agreement from each Locked-Up Company Security Holder that did not execute
and deliver a Lock-Up Agreement at or prior to the execution of this Agreement, each such Lock-Up Agreement duly executed by Pubco and
such Locked-Up Company Security Holder. Each of the Lock-Up Agreements and the Sponsor Letter Agreement shall be in full force and effect
in accordance with the terms thereof as of the Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e) <I>SPAC
Merger Sub Joinder</I>. SPAC Merger Sub shall have been formed and shall have duly executed and delivered a Joinder to the Parties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f) <I>Closing
Deliveries.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i) <I>Officer
Certificates</I>. SPAC shall have received a certificate from the Company, dated as the Closing Date, signed by an executive officer of
the Company in such capacity, certifying as to the satisfaction of the conditions specified in <U>Sections 7.3(a)</U>, <U>7.3(b)</U> and
<U>7.3(c)</U>. Pubco and each of the Merger Subs shall have delivered to SPAC a certificate, dated the Closing Date, signed by an executive
officer of such Party in such capacity, certifying as to the satisfaction of the conditions specified in <U>Sections 7.3(a)</U>, <U>7.3(b)</U>
and <U>7.3(c)</U> with respect to such Party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ii) <I>Secretary
Certificates</I>. The Company, Pubco and the Merger Subs shall each have delivered to SPAC a certificate from its secretary or other executive
officer certifying as to the validity and effectiveness of, and attaching, (A) copies of its Organizational Documents as in effect as
of the Closing Date (immediately prior to the Company Merger Effective Time), (B) the resolutions of its board of directors and shareholders
authorizing and approving the execution, delivery and performance of this Agreement and each Ancillary Document to which it is a party
or bound, and the consummation of the Transactions, and (C) the incumbency of its officers authorized to execute this Agreement or any
Ancillary Document to which it is or is required to be a party or otherwise bound.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iii) <I>Good
Standing</I>. The Company shall have delivered to SPAC good standing certificates (or similar documents applicable for such jurisdictions)
for each Target Company, certified as of a date no earlier than thirty (30) days prior to the Closing Date from the proper Governmental
Authority of the Target Company&rsquo;s jurisdiction of organization and from each other jurisdiction in which the Target Company is qualified
to do business as a foreign corporation or other entity as of the Closing, in each case to the extent that good standing certificates
or similar documents are generally available in such jurisdictions. Pubco shall have delivered to SPAC good standing certificates (or
similar documents applicable for such jurisdictions) for each of Pubco and the Merger Subs certified as of a date no earlier than thirty
(30) days prior to the Closing Date from the proper Governmental Authority of Pubco&rsquo;s and the Merger Subs&rsquo; jurisdiction of
organization and from each other jurisdiction in which Pubco or a Merger Sub is qualified to do business as a foreign corporation or other
entity as of the Closing, in each case to the extent that good standing certificates or similar documents are generally available in such
jurisdictions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iv) <I>Termination
of Company Convertible Securities</I>. SPAC shall have received evidence reasonably acceptable to SPAC that any issued and outstanding
Company Convertible Securities have been either converted into Company Ordinary Shares prior to the Company Merger Effective Time or terminated,
without any consideration, payment or Liability therefor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 64; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(v) <I>Employment
Agreements</I>. SPAC shall have received the Employment Agreements, in form and substance reasonably acceptable to SPAC and the Company,
between each of the persons set forth on <U>Schedule 6.20</U> and Pubco (or a Subsidiary thereof), each such Employment Agreement duly
executed by such person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(vi) <I>Amended
Registration Rights Agreement</I>. SPAC shall have received a copy of the Amended Registration Rights Agreement, in form and substance
reasonably acceptable to SPAC and the Company, duly executed by Pubco, the IPO Underwriter and the RRA Company Security Holders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(vii) <I>Termination
of Certain Contracts</I>. SPAC shall have received evidence reasonably acceptable to SPAC that the Contracts set forth on <U>Schedule
7.3(f)(vii)</U> involving any of the Target Companies and/or Company Security Holders or other Related Persons shall have been terminated
with no further obligation or Liability of the Target Companies thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">7.4 <U>Frustration
of Conditions</U>. Notwithstanding anything contained herein to the contrary, no Party may rely on the failure of any condition set forth
in this <U>Article VII</U> to be satisfied if such failure was caused by the failure of such Party or its Affiliates (or with respect
to the Company, Pubco, a Merger Sub or the Seller Representative) to comply with or perform any of its covenants or obligations set forth
in this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Article
VIII<U><BR>
TERMINATION AND EXPENSES</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">8.1 <U>Termination</U>.
This Agreement may be terminated and the transactions contemplated hereby may be abandoned at any time prior to the Closing as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a) by
mutual written consent of SPAC and the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b) by
written notice by SPAC or the Company if any of the conditions to the Closing set forth in <U>Article VII</U> have not been satisfied
or waived by December 24, 2025 (the &ldquo;<B><I>Outside Date</I></B>&rdquo;); provided, however, that the right to terminate this Agreement
under this <U>Section 8.1(b)</U> shall not be available to a Party if the breach or violation by such Party or its Affiliates (or with
respect to the Company, Pubco, a Merger Sub or the Seller Representative) of any representation, warranty, covenant or obligation under
this Agreement was the cause of, or resulted in, the failure of the Closing to occur on or before the Outside Date;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c) by
written notice by either SPAC or the Company if a Governmental Authority of competent jurisdiction shall have issued an Order or taken
any other action permanently restraining, enjoining or otherwise prohibiting the transactions contemplated by this Agreement, and such
Order or other action has become final and non-appealable; provided, however, that the right to terminate this Agreement pursuant to this
<U>Section 8.1(c)</U> shall not be available to a Party if the failure by such Party or its Affiliates (or with respect to the Company,
Pubco, a Merger Sub or the Seller Representative) to comply with any provision of this Agreement has been a substantial cause of, or substantially
resulted in, such action by such Governmental Authority;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d) by
written notice by the Company to SPAC, if (i) there has been a breach by SPAC or the SPAC Representative of any of their respective representations,
warranties, covenants or agreements contained in this Agreement, or if any representation or warranty of SPAC shall have become untrue
or inaccurate, in any case, which would result in a failure of a condition set forth in <U>Section 7.2(a)</U> or <U>Section 7.2(b)</U>
to be satisfied (treating the Closing Date for such purposes as the date of this Agreement or, if later, the date of such breach), and
(ii) the breach or inaccuracy is incapable of being cured or is not cured within the earlier of (A) twenty (20) days after written notice
of such breach or inaccuracy is provided to SPAC by the Company or (B) the Outside Date; provided, that the Company shall not have the
right to terminate this Agreement pursuant to this <U>Section 8.1(d)</U> if at such time the Company, Pubco, a Merger Sub or the Seller
Representative is in material uncured breach of this Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e) by
written notice by SPAC to the Company, if (i) there has been a breach by the Company, Pubco, a Merger Sub or the Seller Representative
of any of their respective representations, warranties, covenants or agreements contained in this Agreement, or if any representation
or warranty of such Parties shall have become untrue or inaccurate, in any case, which would result in a failure of a condition set forth
in <U>Section 7.3(a)</U> or <U>Section 7.3(b)</U> to be satisfied (treating the Closing Date for such purposes as the date of this Agreement
or, if later, the date of such breach), and (ii) the breach or inaccuracy is incapable of being cured or is not cured within the earlier
of (A) twenty (20) days after written notice of such breach or inaccuracy is provided to the Company by SPAC or (B) the Outside Date;
provided, that SPAC shall not have the right to terminate this Agreement pursuant to this <U>Section 8.1(e)</U> if at such time SPAC or
the SPAC Representative is in material uncured breach of this Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<!-- Field: Page; Sequence: 65; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f) by
written notice by SPAC to the Company, if there shall have been a Material Adverse Effect on the Company or Pubco following the date of
this Agreement which is uncured and continuing;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(g) by
written notice by the Company to SPAC, if there shall have been a Material Adverse Effect on SPAC following the date of this Agreement
which is uncured and continuing;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(h) by
written notice from the Company to SPAC prior to obtaining the SPAC Shareholder Approval if the board of directors of SPAC shall have
(i) made a Change in Recommendation or (ii) failed to include in the Proxy Statement the recommendation of the SPAC board of directors
in favor of the Shareholder Approval Matters;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i) by
written notice by either SPAC or the Company to the other if the SPAC Shareholder Meeting is held (including any adjournment or postponement
thereof) and has concluded, SPAC&rsquo;s shareholders have duly voted, and the Required SPAC Shareholder Approval was not obtained;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(j) by
written notice by either SPAC or the Company to the other if the Bridge Financing for at least $5,000,000 in gross proceeds to the Company
has not been consummated on or before the thirtieth (30<SUP>th</SUP>) day following the date of this Agreement; provided, that if the
Bridge Financing for at least $5,000,000 in gross proceeds to the Company is consummated after such thirty (30) day period, from and after
the consummation of such Bridge Financing, each of SPAC and the Company shall no longer be entitled to terminate this Agreement pursuant
to this <U>Section 8.1(j)</U>; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(k) by
written notice by SPAC to the Company if SPAC's U.S. intellectual property counsel affirmatively concludes in connection with the FTO
Opinion analysis that the products or technology of the Target Companies, as currently contemplated, are reasonably likely to materially
infringe one or more valid and enforceable third-party U.S. Patents, where such infringement would reasonably be expected to result in
a Material Adverse Effect on the Company, and the Company, after receiving written notice from SPAC of the preceding condition, fails
to propose, within fifteen (15) days after receipt of such notice, a commercially reasonable mitigation plan to address such issues, which
plan is reasonably acceptable to SPAC. For the avoidance of doubt, SPAC shall not be entitled to terminate this Agreement pursuant to
this <U>Section 8.1(k)</U> (A) if SPAC notifies the Company in writing within thirty (30) days after the date of this Agreement in accordance
with <U>Section 6.1(a)</U> that it will not seek the FTO Opinion, or (B) from and after the date that the FTO Opinion is delivered to
SPAC, if such delivery occurs after such thirty (30) day period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">8.2 <U>Effect
of Termination</U>. This Agreement may only be terminated in the circumstances described in <U>Section 8.1</U> and pursuant to a written
notice delivered by the applicable Party to the other applicable Parties, which sets forth the basis for such termination, including the
provision of <U>Section 8.1</U> under which such termination is made. In the event of the valid termination of this Agreement pursuant
to <U>Section 8.1</U>, this Agreement shall forthwith become void, and there shall be no Liability on the part of any Party or any of
their respective Representatives, and all rights and obligations of each Party shall cease, except: (i) <U>Sections 6.14</U>, <U>6.15</U>,
<U>8.3</U>, <U>9.1</U>, <U>Article X</U> and this <U>Section 8.2</U> shall survive the termination of this Agreement, and (ii) nothing
herein shall relieve any Party from Liability for any willful breach of any representation, warranty, covenant or obligation under this
Agreement or any Fraud Claim against such Party, in either case, prior to termination of this Agreement (in each case of clauses (i) and
(ii) above, subject to <U>Section 9.1</U>). Without limiting the foregoing, and except as provided in <U>Sections 8.3</U> and this <U>Section
8.2</U> (but subject to <U>Section 9.1</U>, and subject to the right to seek injunctions, specific performance or other equitable relief
in accordance with <U>Section 10.9</U>), the Parties&rsquo; sole right prior to the Closing with respect to any breach of any representation,
warranty, covenant or other agreement contained in this Agreement by another Party or with respect to the transactions contemplated by
this Agreement shall be the right, if applicable, to terminate this Agreement pursuant to <U>Section 8.1</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">8.3 <U>Fees
and Expenses</U>. Subject to <U>Sections 6.18</U>, and <U>9.1</U>, all Expenses incurred in connection with this Agreement and the transactions
contemplated hereby shall be paid by the Party incurring such expenses; provided that SPAC and the Company shall each be responsible to
pay for fifty percent (50%) of any registration fees and expenses (not including expenses of counsel or auditors to any party) related
to the filing of the Registration Statement. Notwithstanding the foregoing, the Parties acknowledge that pursuant to the HSC Letter Agreement,
the HSC Principals have agreed to pay for all fees and expenses incurred by or on behalf of the Target Companies for the Company&rsquo;s
United States securities counsel and PCAOB qualified auditor (collectively, the &ldquo;<B><I>Company DeSPAC Advisors</I></B>&rdquo;),
and that such fees and expenses will not be borne by the Company, Pubco or SPAC or their respective Subsidiaries. Additionally, if the
Closing occurs, SPAC shall be responsible for paying the fees of the Company&rsquo;s Israeli counsel, up to a maximum amount of $275,000.
This amount shall be included as SPAC Expenses and will be netted out of the Minimum Cash Condition</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<!-- Field: Page; Sequence: 66; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Article
IX<U><BR>
WAIVERS AND Releases</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">9.1 <U>Waiver
of Claims Against Trust</U>. Reference is made to the IPO Prospectus. Each of the Company, Pubco, the Merger Subs (with respect to SPAC
Merger Sub, upon its execution and delivery of the Joinder) and the Seller Representative hereby represents and warrants that it has read
the IPO Prospectus and understands that SPAC has established the Trust Account containing the proceeds of the IPO and the overallotment
securities acquired by SPAC&rsquo;s underwriters and from certain private placements occurring simultaneously with the IPO (including
interest accrued from time to time thereon) for the benefit of SPAC&rsquo;s public shareholders (including overallotment securities acquired
by SPAC&rsquo;s underwriters) (the &ldquo;<B><I>Public Shareholders</I></B>&rdquo;) and that, except as otherwise described in the IPO
Prospectus, SPAC may disburse monies from the Trust Account only: (a) to the Public Shareholders in the event they elect to redeem their
SPAC Class A Ordinary Shares (or Pubco Ordinary Shares upon the SPAC Merger) in connection with the consummation of SPAC&rsquo;s initial
business combination (as such term is used in the IPO Prospectus) (&ldquo;<B><I>Business Combination</I></B>&rdquo;) or in connection
with an amendment to SPAC&rsquo;s Organizational documents to extend SPAC&rsquo;s deadline to consummate a Business Combination, (b) to
the Public Shareholders if SPAC fails to consummate a Business Combination within twenty-four (24) months after the closing of the IPO,
subject to extension by amendment to the SPAC&rsquo;s Organizational Documents, (c) with respect to any interest earned on the amounts
held in the Trust Account, amounts necessary to pay for any taxes and up to $100,000 in dissolution expenses, or (d) to SPAC after or
concurrently with the consummation of a Business Combination. For and in consideration of SPAC entering into this Agreement and for other
good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, each of the Company, Pubco, the Merger Subs
(with respect to SPAC Merger Sub, upon its execution and delivery of the Joinder) and the Seller Representative hereby agrees on behalf
of itself and its Affiliates that, notwithstanding anything to the contrary in this Agreement, none of the Company, Pubco, the Merger
Subs or the Seller Representative nor any of their respective Affiliates do now or shall at any time hereafter have any right, title,
interest or claim of any kind in or to any monies in the Trust Account or distributions therefrom, or make any claim against the Trust
Account (including any distributions therefrom), regardless of whether such claim arises as a result of, in connection with or relating
in any way to, this Agreement or any other matter, and regardless of whether such claim arises based on contract, tort, equity or any
other theory of legal liability (collectively, the &ldquo;<B><I>Released Claims</I></B>&rdquo;). Each of the Company, Pubco, the Merger
Subs (with respect to SPAC Merger Sub, upon its execution and delivery of the Joinder) and the Seller Representative on behalf of itself
and its Affiliates hereby irrevocably waives any Released Claims that any such Party or any of its Affiliates may have against the Trust
Account (including any distributions therefrom) now or in the future and will not seek recourse against the Trust Account (including any
distributions therefrom) for any reason whatsoever (including for an alleged breach of this Agreement or any other agreement with SPAC
or its Affiliates). Each of the Company, Pubco, the Merger Subs (with respect to SPAC Merger Sub, upon its execution and delivery of the
Joinder) and the Seller Representative agrees and acknowledges that such irrevocable waiver is material to this Agreement and specifically
relied upon by SPAC and its Affiliates to induce SPAC to enter in this Agreement, and each of the Company, Pubco, the Merger Subs (with
respect to SPAC Merger Sub, upon its execution and delivery of the Joinder) and the Sellers Representative further intends and understands
such waiver to be valid, binding and enforceable against such Party and each of its Affiliates under applicable Law. To the extent that
the Company, Pubco, the Merger Subs or the Seller Representative or any of their respective Affiliates commences any action or proceeding
based upon, in connection with, relating to or arising out of any matter relating to SPAC or its Representatives, which proceeding seeks,
in whole or in part, monetary relief against SPAC or its Representatives, each of the Company, Pubco, the Merger Subs (with respect to
SPAC Merger Sub, upon its execution and delivery of the Joinder) and the Seller Representative hereby acknowledges and agrees that its
and its Affiliates&rsquo; sole remedy shall be against funds held outside of the Trust Account and that such claim shall not permit such
Party or any of its Affiliates (or any Person claiming on any of their behalves or in lieu of them) to have any claim against the Trust
Account (including any distributions therefrom) or any amounts contained therein. In the event that the Company, Pubco, the Merger Subs
or the Seller Representative or any of their respective Affiliates commences Action based upon, in connection with, relating to or arising
out of any matter relating to SPAC or its Representatives which proceeding seeks, in whole or in part, relief against the Trust Account
(including any distributions therefrom) or the Public Shareholders, whether in the form of money damages or injunctive relief, SPAC and
its Representatives, as applicable, shall be entitled to recover from the Company, Pubco, the Merger Subs and the Seller Representative
and their respective Affiliates, as applicable, the associated legal fees and costs in connection with any such Action, in the event SPAC
or its Representatives, as applicable, prevails in such Action. This <U>Section 9.1</U> shall survive termination of this Agreement for
any reason and continue indefinitely.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Article
X<U><BR>
MISCELLANEOUS</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">10.1 <U>Survival</U>.
The representations and warranties of the Parties contained in this Agreement or in any certificate or instrument delivered by or on behalf
of the Parties pursuant to this Agreement shall not survive the Closing, and from and after the Closing, the Parties and their respective
Representatives shall not have any further obligations, nor shall any claim be asserted or action be brought against any of the Parties
or their respective Representatives with respect thereto. The covenants and agreements made by the Parties in this Agreement or in any
certificate or instrument delivered pursuant to this Agreement, including any rights arising out of any breach of such covenants or agreements,
shall not survive the Closing, except for those covenants and agreements contained herein and therein that by their terms apply or are
to be performed in whole or in part after the Closing (which such covenants shall survive the Closing and continue until fully performed
in accordance with their terms).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">10.2 <U>Non-Recourse</U>.
This Agreement may only be enforced against, and any claim or cause of action based upon, arising out of, or related to this Agreement
or the transactions contemplated hereby may only be brought against, the entities that are expressly named as Parties and then only with
respect to the specific obligations set forth herein with respect to such Party. Except to the extent a Party (and then only to the extent
of the specific obligations undertaken by such Party in this Agreement), (a) no past, present or future director, officer, employee, sponsor,
incorporator, member, partner, shareholder, Affiliate, agent, attorney, advisor or representative or Affiliate of any Party and (b) no
past, present or future director, officer, employee, sponsor, incorporator, member, partner, shareholder, Affiliate, agent, attorney,
advisor or representative or Affiliate of any of the foregoing shall have any liability (whether in contract, tort, equity or otherwise)
for any one or more of the representations, warranties, covenants, agreements or other obligations or liabilities of any one or more of
the Parties under this Agreement of or for any claim based on, arising out of, or related to this Agreement or the Transactions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 67; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">10.3 <U>Notices</U>.
All notices, consents, waivers and other communications hereunder shall be in writing and shall be deemed to have been duly given when
delivered (i) in person, (ii) by email, with affirmative confirmation of receipt, (iii) one Business Day after being sent, if sent by
reputable, nationally recognized overnight courier service or (iv) three (3) Business Days after being mailed, if sent by registered or
certified mail, pre-paid and return receipt requested, in each case to the applicable Party at the following addresses (or at such other
address for a Party as shall be specified by like notice):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 5.4pt; border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 52%; padding-bottom: 5.4pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I></I>If to SPAC at or prior to the Closing, to:</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Launch One Acquisition Corp<BR>
    180 Grand Avenue, Suite 1530<BR>
    Oakland, CA 94612, U.S.A.<BR>
    Attn: Chris Ehrlich, Chief Executive Officer<BR>
    Telephone No.: (415) 994-0582<BR>
    E-mail: chris@launchpad.vc</P></TD>
    <TD STYLE="padding-top: 5.4pt; border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 48%; padding-bottom: 5.4pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I></I>with copies (which will not constitute notice) to:</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ellenoff Grossman &amp; Schole LLP<BR>
    1345 Avenue of the Americas, 11th Floor<BR>
    New York, New York 10105, U.S.A.<BR>
    Attn: Matthew A. Gray, Esq. and<BR>
    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Stuart Neuhauser, Esq.<BR>
    Telephone No.: (212) 370-1300<BR>
    E-mail: mgray@egsllp.com;<BR>
    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;sneuhauser@egsllp.com</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>and</I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Goldfarb Gross Seligman &amp; Co.<BR>
One Azrieli Center, Round Tower<BR>
Tel Aviv, Israel 6701101<BR>
Attn: Aaron M. Lampert and Daniel Kahn<BR>
Telephone No.: 03-607-4444<BR>
E-mail: aaron.lampert@goldfarb.com;<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;daniel.kahn@goldfarb.com</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 5.4pt; border-bottom: Black 1pt solid; padding-bottom: 5.4pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I></I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>If to the SPAC Representative, to:</I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Launch One Sponsor LLC<BR>
    c/o Launchpad Capital Management<BR>
    180 Grand Avenue, Suite 1530<BR>
    Oakland, CA 94612<BR>
    Attn: Jurgen Van de Vyver<BR>
    Telephone No.: (510) 200-8878<BR>
    Email: jurgen@launchpad.vc</P></TD>
    <TD STYLE="padding-top: 5.4pt; border-bottom: Black 1pt solid; padding-bottom: 5.4pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I></I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>with copies (which will not constitute notice) to:</I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ellenoff Grossman &amp; Schole LLP<BR>
    1345 Avenue of the Americas, 11th Floor<BR>
    New York, New York 10105, U.S.A.<BR>
    Attn: Matthew A. Gray, Esq. and<BR>
    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Stuart Neuhauser, Esq.<BR>
    Telephone No.: (212) 370-1300<BR>
    E-mail:mgray@egsllp.com;<BR>
    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;sneuhauser@egsllp.com</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>and</I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Goldfarb Gross Seligman &amp; Co.<BR>
    One Azrieli Center, Round Tower<BR>
    Tel Aviv, Israel 6701101<BR>
    Attn: Aaron M. Lampert and Daniel Kahn<BR>
    Telephone No.: 03-607-4444<BR>
    E-mail: aaron.lampert@goldfarb.com;<BR>
    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;daniel.kahn@goldfarb.com</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 5.4pt; border-bottom: Black 1pt solid; padding-bottom: 5.4pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I></I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>If to the Company at or prior to the Closing, to:</I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Minovia Therapeutics Ltd.<BR>
    3 HaSadna St.<BR>
    Tirat Carmel, 3902603, Israel<BR>
    Attn: Natalie Yivgi Ohana, Chief Executive Officer<BR>
    Telephone No.: +972-545833727<BR>
    E-mail: natalie@minoviatx.com</P></TD>
    <TD STYLE="padding-top: 5.4pt; border-bottom: Black 1pt solid; padding-bottom: 5.4pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>with copies (which will not constitute notice) to:</I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Bevilacqua PLLC<BR>
    1050 Connecticut Avenue, NW, Suite 500<BR>
    Washington, DC 20036<BR>
    Attn: Louis A. Bevilacqua, Esq.<BR>
    Telephone No.: (202) 869-0888 (ext. 100)<BR>
    E-mail: lou@bevilacquapllc.com</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>and</I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Gornitzky &amp; Co.<BR>
Vitania Tel-Aviv Tower<BR>
20 HaHarash Street,<BR>
Tel Aviv, Israel 6761310<BR>
Attn: Chaim Friedland and Timor Belan<BR>
Telephone No.: 03-710-9191<BR>
E-mail: friedland@gornitzky.com;<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;timorb@gornitzky.com</P></TD></TR>
</TABLE>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 68 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->64<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="border-top: Black 1pt solid; font-size: 10pt; border-bottom: Black 1pt solid; padding-top: 5.4pt; padding-bottom: 5.4pt; width: 52%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>If to the Seller Representative, to:</I></P>
    <P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Natalie Yivgi Ohana<BR>
    Minovia Therapeutics Ltd.<BR>
    3 HaSadna St.<BR>
    Tirat Carmel, 3902603, Israel<BR>
    Telephone No.: +972-545833727<BR>
    E-mail: natalie@minoviatx.com</P></TD>
    <TD STYLE="border-top: Black 1pt solid; font-size: 10pt; border-bottom: Black 1pt solid; padding-top: 5.4pt; padding-bottom: 5.4pt; width: 48%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>with copies (which will not constitute notice) to:</I></P>
    <P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Bevilacqua PLLC<BR>
    1050 Connecticut Avenue, NW, Suite 500<BR>
    Washington, DC 20036<BR>
    Attn: Louis A. Bevilacqua, Esq.<BR>
    Telephone No.: (202) 869-0888 (ext. 100)<BR>
    E-mail: lou@bevilacquapllc.com</P>
    <P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>and</I></P>
    <P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Gornitzky &amp; Co.<BR>
    Vitania Tel-Aviv Tower<BR>
    20 HaHarash Street,<BR>
    Tel Aviv, Israel 6761310<BR>
    Attn: Chaim Friedland and Timor Belan<BR>
    Telephone No.: 03-710-9191<BR>
    E-mail: friedland@gornitzky.com;<BR>
    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;timorb@gornitzky.com</P></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; padding-top: 5.4pt; padding-bottom: 5.4pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>If to Pubco or Company Merger Sub at or prior to the Closing, to:</I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">c/o Minovia Therapeutics Ltd.<BR>
    3 HaSadna St.<BR>
    Tirat Carmel, 3902603, Israel<BR>
    Attn: Natalie Yivgi Ohana, Chief Executive Officer<BR>
    Telephone No.: +972-545833727<BR>
    E-mail: natalie@minoviatx.com</P></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; padding-top: 5.4pt; padding-bottom: 5.4pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I></I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>with copies (which will not constitute notice) to:</I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Bevilacqua PLLC<BR>
    1050 Connecticut Avenue, NW, Suite 500<BR>
    Washington, DC 20036<BR>
    Attn: Louis A. Bevilacqua, Esq.<BR>
    Telephone No.: (202) 869-0888 (ext. 100)<BR>
    E-mail: lou@bevilacquapllc.com</P>
    <P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>and</I></P>
    <P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Gornitzky &amp; Co.<BR>
    Vitania Tel-Aviv Tower<BR>
    20 HaHarash Street,<BR>
    Tel Aviv, Israel 6761310<BR>
    Attn: Chaim Friedland and Timor Belan<BR>
    Telephone No.: 03-710-9191<BR>
    E-mail: friedland@gornitzky.com;<BR>
    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;timorb@gornitzky.com</P></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; padding-top: 5.4pt; font-size: 10pt; padding-bottom: 5.4pt"><FONT STYLE="font-size: 10pt"><I>If to SPAC Merger Sub at or prior to the Closing, to:</I>&nbsp;&nbsp;such address as set forth in the Joinder.</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt; padding-top: 5.4pt; padding-bottom: 5.4pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>If to Pubco or any Surviving Subsidiary after the Closing, to:</I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Mito US One Ltd.<BR>
    3 HaSadna St.<BR>
    Tirat Carmel, 3902603, Israel<BR>
    Attn: Natalie Yivgi Ohana, Chief Executive Officer<BR>
    Telephone No.: +972-545833727<BR>
    E-mail: natalie@minoviatx.com</P></TD>
    <TD STYLE="font-size: 10pt; padding-top: 5.4pt; padding-bottom: 5.4pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>with copies (which will not constitute notice) to:</I></P>
    <P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Bevilacqua PLLC<BR>
    1050 Connecticut Avenue, NW, Suite 500<BR>
    Washington, DC 20036<BR>
    Attn: Louis A. Bevilacqua, Esq.<BR>
    Telephone No.: (202) 869-0888 (ext. 100)<BR>
    E-mail: lou@bevilacquapllc.com</P>
    <P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>and</I></P>
    <P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Gornitzky &amp; Co.<BR>
    Vitania Tel-Aviv Tower<BR>
    20 HaHarash Street,<BR>
    Tel Aviv, Israel 6761310<BR>
    Attn: Chaim Friedland and Timor Belan<BR>
    Telephone No.: 03-710-9191<BR>
    E-mail: friedland@gornitzky.com;<BR>
    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;timorb@gornitzky.com</P>
    <P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0"></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 69 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->65<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>


<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; width: 52%">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; padding-bottom: 5.4pt; width: 48%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>and</I></P>
    <P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ellenoff Grossman &amp; Schole LLP<BR>
    1345 Avenue of the Americas, 11th Floor<BR>
    New York, New York 10105, U.S.A.<BR>
    Attn: Matthew A. Gray, Esq. and<BR>
    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Stuart Neuhauser, Esq.<BR>
    Telephone No.: (212) 370-1300<BR>
    E-mail: mgray@egsllp.com;<BR>
    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;sneuhauser@egsllp.com</P>
    <P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>and</I></P>
    <P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Goldfarb Gross Seligman &amp; Co.<BR>
    One Azrieli Center, Round Tower<BR>
    Tel Aviv, Israel 6701101<BR>
    Attn: Aaron M. Lampert and Daniel Kahn<BR>
    Telephone No.: 03-607-4444<BR>
    E-mail: aaron.lampert@goldfarb.com;<BR>
    daniel.kahn@goldfarb.com</P></TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">10.4 <U>Binding
Effect; Assignment</U>. This Agreement and all of the provisions hereof shall be binding upon and inure to the benefit of the Parties
hereto and their respective successors and permitted assigns. This Agreement shall not be assigned by operation of Law or otherwise without
the prior written consent of SPAC, Pubco, the Company and the Representative Parties, and any assignment without such consent shall be
null and void; <U>provided</U> that no such assignment shall relieve the assigning Party of its obligations hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">10.5 <U>Third
Parties</U>. Except for the rights of the HSC Principals to designate two directors to the Post-Closing Pubco Board under <U>Section 6.16(a)</U>,
of the D&amp;O Indemnified Persons set forth in <U>Section 6.17</U> and of each of EGS, the Seller Law Firms and the Sponsor under <U>Section
10.16</U>, which the Parties acknowledge and agree are express third party beneficiaries of this Agreement, nothing contained in this
Agreement or in any instrument or document executed by any party in connection with the transactions contemplated hereby shall create
any rights in, or be deemed to have been executed for the benefit of, any Person that is not a Party hereto or thereto or a successor
or permitted assign of such a Party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">10.6 <U>Arbitration</U>.
Any and all disputes, controversies and claims (other than applications for a temporary restraining order, preliminary injunction, permanent
injunction or other equitable relief or application for enforcement of a resolution under this <U>Section 10.6</U>) arising out of, related
to, or in connection with this Agreement or the transactions contemplated hereby (a &ldquo;<B><I>Dispute</I></B>&rdquo;) shall be governed
by this <U>Section 10.6</U>. A party must, in the first instance, provide written notice of any Disputes to the other parties subject
to such Dispute, which notice must provide a reasonably detailed description of the matters subject to the Dispute. The parties involved
in such Dispute shall seek to resolve the Dispute on an amicable basis within ten (10) Business Days of the notice of such Dispute being
received by such other parties subject to such Dispute (the &ldquo;<B><I>Resolution Period</I></B>&rdquo;); <U>provided</U>, that if any
Dispute would reasonably be expected to have become moot or otherwise irrelevant if not decided within sixty (60) days after the occurrence
of such Dispute, then there shall be no Resolution Period with respect to such Dispute. Any Dispute that is not resolved during the Resolution
Period may immediately be referred to and finally resolved by arbitration pursuant to the then-existing Expedited Procedures (as defined
in the AAA Procedures) of the Commercial Arbitration Rules (the &ldquo;<B><I>AAA Procedures</I></B>&rdquo;) of the AAA. Any party involved
in such Dispute may submit the Dispute to the AAA to commence the proceedings after the Resolution Period. To the extent that the AAA
Procedures and this Agreement are in conflict, the terms of this Agreement shall control. The arbitration shall be conducted by one arbitrator
nominated by the AAA promptly (but in any event within five (5) Business Days) after the submission of the Dispute to the AAA and reasonably
acceptable to each party subject to the Dispute, which arbitrator shall be a commercial lawyer with substantial experience arbitrating
disputes under acquisition agreements. The arbitrator shall accept his or her appointment and begin the arbitration process promptly (but
in any event within five (5) Business Days) after his or her nomination and acceptance by the parties subject to the Dispute. The proceedings
shall be streamlined and efficient. The arbitrator shall decide the Dispute in accordance with the substantive law of the State of Delaware.
Time is of the essence. Each party subject to the Dispute shall submit a proposal for resolution of the Dispute to the arbitrator within
twenty (20) days after confirmation of the appointment of the arbitrator. The arbitrator shall have the power to order any party to do,
or to refrain from doing, anything consistent with this Agreement, the Ancillary Documents and applicable Law, including to perform its
contractual obligation(s); provided, that the arbitrator shall be limited to ordering pursuant to the foregoing power (and, for the avoidance
of doubt, shall order) the relevant party (or parties, as applicable) to comply with only one or the other of the proposals. The arbitrator&rsquo;s
award shall be in writing and shall include a reasonable explanation of the arbitrator&rsquo;s reason(s) for selecting one or the other
proposal. The seat of arbitration shall be in the State of Delaware. The language of the arbitration shall be English.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 70; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->66<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">10.7 <U>Governing
Law; Jurisdiction</U>. This Agreement shall be governed by, construed and enforced in accordance with the Laws of the State of Delaware,
without regard to the conflict of laws principles thereof. Subject to <U>Sections 1.13</U> and <U>10.6</U>, all Actions arising out of
or relating to this Agreement shall be heard and determined exclusively in the Chancery Court of the State of Delaware (or, if such court
lacks subject matter jurisdiction, in any appropriate Delaware State or federal court) (or in any appellate court thereof) (the &ldquo;<B><I>Specified
Courts</I></B>&rdquo;). Subject to <U>Sections 1.13</U> and <U>10.6</U>, each Party hereto hereby (a) submits to the exclusive jurisdiction
of any Specified Court for the purpose of any Action arising out of or relating to this Agreement brought by any Party hereto and (b)
irrevocably waives, and agrees not to assert by way of motion, defense or otherwise, in any such Action, any claim that it is not subject
personally to the jurisdiction of the above-named courts, that its property is exempt or immune from attachment or execution, that the
Action is brought in an inconvenient forum, that the venue of the Action is improper, or that this Agreement or the transactions contemplated
hereby may not be enforced in or by any Specified Court. Each Party agrees that a final judgment in any Action shall be conclusive and
may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by Law. Each Party irrevocably consents
to the service of the summons and complaint and any other process in any other Action relating to the transactions contemplated by this
Agreement, on behalf of itself, or its property, by personal delivery of copies of such process to such Party at the applicable address
set forth in <U>Section 10.3</U>. Nothing in this <U>Section 10.7</U> shall affect the right of any Party to serve legal process in any
other manner permitted by Law. Notwithstanding the foregoing, (i) the provisions related to the matters set forth in <U>Article I</U>
that relate to the effectuation of the Company Merger, and all other provisions of this Agreement that are expressly or otherwise required
to be governed by the Laws of the State of Israel shall be exclusively governed by the Laws of the State of Israel, and (ii) the provisions
related to the matters set forth in <U>Article I</U> that relate to the effectuation of the SPAC Merger, and all other provisions of this
Agreement that are expressly or otherwise required to be governed by the Laws of the Cayman Islands shall be exclusively governed by the
Laws of the Cayman Islands.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">10.8 <FONT STYLE="font-variant: small-caps"><U>WAIVER
OF JURY TRIAL</U>. EACH OF THE PARTIES HERETO HEREBY WAIVES TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW ANY RIGHT IT MAY HAVE TO
A TRIAL BY JURY WITH RESPECT TO ANY ACTION DIRECTLY OR INDIRECTLY ARISING OUT OF, UNDER OR IN CONNECTION WITH THIS AGREEMENT OR THE TRANSACTIONS
CONTEMPLATED HEREBY. EACH PARTY HERETO (A) CERTIFIES THAT NO REPRESENTATIVE OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE,
THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF ANY ACTION, SEEK TO ENFORCE THAT FOREGOING WAIVER AND (B) ACKNOWLEDGES THAT IT AND THE
OTHER PARTIES HERETO HAVE BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS
<U>SECTION 10.8</U></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">10.9 <U>Specific
Performance</U>. Each Party acknowledges that the rights of each Party to consummate the transactions contemplated hereby are unique,
recognizes and affirms that in the event of a breach of this Agreement by any Party, money damages may be inadequate and the non-breaching
Parties may have not adequate remedy at law, and agree that irreparable damage would occur in the event that any of the provisions of
this Agreement were not performed by an applicable Party in accordance with their specific terms or were otherwise breached. Accordingly,
each Party shall be entitled to seek an injunction or restraining order to prevent breaches of this Agreement and to seek to enforce specifically
the terms and provisions hereof, without the requirement to post any bond or other security or to prove that money damages would be inadequate,
this being in addition to any other right or remedy to which such Party may be entitled under this Agreement, at law or in equity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">10.10 <U>Severability</U>.
In case any provision in this Agreement shall be held invalid, illegal or unenforceable in a jurisdiction, such provision shall be modified
or deleted, as to the jurisdiction involved, only to the extent necessary to render the same valid, legal and enforceable, and the validity,
legality and enforceability of the remaining provisions hereof shall not in any way be affected or impaired thereby nor shall the validity,
legality or enforceability of such provision be affected thereby in any other jurisdiction. Upon such determination that any term or other
provision is invalid, illegal or incapable of being enforced, the Parties will substitute for any invalid, illegal or unenforceable provision
a suitable and equitable provision that carries out, so far as may be valid, legal and enforceable, the intent and purpose of such invalid,
illegal or unenforceable provision.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">10.11 <U>Amendment</U>.
This Agreement may be amended, supplemented or modified only by execution of a written instrument signed by SPAC, Pubco and the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">10.12 <U>Waiver</U>.
Each of SPAC, the Company and Pubco on behalf of itself and its Affiliates, the SPAC Representative on behalf of itself and Pubco to the
extent provided in this Agreement, and the Seller Representative on behalf of itself and the Company Shareholders to the extent provided
in this Agreement, may in its sole discretion (i) extend the time for the performance of any obligation or other act of any other non-Affiliated
Party hereto, (ii) waive any inaccuracy in the representations and warranties by such other non-Affiliated Party contained herein or in
any document delivered pursuant hereto and (iii) waive compliance by such other non-Affiliated Party with any covenant or condition contained
herein. Any such extension or waiver shall be valid only if set forth in an instrument in writing signed by the Party or Parties to be
bound thereby. Notwithstanding the foregoing, no failure or delay by a Party in exercising any right hereunder shall operate as a waiver
thereof nor shall any single or partial exercise thereof preclude any other or further exercise of any other right hereunder. Notwithstanding
the foregoing, any waiver of any provision of this Agreement after the Closing by Pubco or SPAC shall also require the prior written consent
of the SPAC Representative.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">10.13 <U>Entire
Agreement</U>. This Agreement and the documents or instruments referred to herein, including any exhibits and schedules attached hereto,
which exhibits and schedules are incorporated herein by reference, together with the Ancillary Documents, embody the entire agreement
and understanding of the Parties hereto in respect of the subject matter contained herein. There are no restrictions, promises, representations,
warranties, covenants or undertakings, other than those expressly set forth or referred to herein or the documents or instruments referred
to herein, which collectively supersede all prior agreements and the understandings among the Parties with respect to the subject matter
contained herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 71; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->67<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">10.14 <U>Interpretation</U>.
The table of contents and the Article and Section headings contained in this Agreement are solely for the purpose of reference, are not
part of the agreement of the Parties and shall not in any way affect the meaning or interpretation of this Agreement. In this Agreement,
unless the context otherwise requires: (a) any pronoun used in this Agreement shall include the corresponding masculine, feminine or neuter
forms, and words in the singular, including any defined terms, include the plural and vice versa; (b) reference to any Person includes
such Person&rsquo;s successors and assigns but, if applicable, only if such successors and assigns are permitted by this Agreement, and
reference to a Person in a particular capacity excludes such Person in any other capacity; (c) any accounting term used and not otherwise
defined in this Agreement or any Ancillary Document has the meaning assigned to such term in accordance with GAAP or IFRS, as applicable,
based on the accounting principles used by the applicable Person; (d) &ldquo;including&rdquo; (and with correlative meaning &ldquo;include&rdquo;)
means including without limiting the generality of any description preceding or succeeding such term and shall be deemed in each case
to be followed by the words &ldquo;without limitation&rdquo;; (e) the words &ldquo;herein,&rdquo; &ldquo;hereto,&rdquo; and &ldquo;hereby&rdquo;
and other words of similar import in this Agreement shall be deemed in each case to refer to this Agreement as a whole and not to any
particular Section or other subdivision of this Agreement; (f) the word &ldquo;if&rdquo; and other words of similar import when used herein
shall be deemed in each case to be followed by the phrase &ldquo;and only if&rdquo;; (g) the term &ldquo;or&rdquo; means &ldquo;and/or&rdquo;;
(h) any reference to the term &ldquo;ordinary course&rdquo; or &ldquo;ordinary course of business&rdquo; shall be deemed in each case
to be followed by the words &ldquo;consistent with past practice&rdquo;; (i) any agreement, instrument, insurance policy, Law or Order
defined or referred to herein or in any agreement or instrument that is referred to herein means such agreement, instrument, insurance
policy, Law or Order as from time to time amended, modified or supplemented, including (in the case of agreements or instruments) by waiver
or consent and (in the case of statutes, regulations, rules or orders) by succession of comparable successor statutes, regulations, rules
or orders and references to all attachments thereto and instruments incorporated therein; (j) except as otherwise indicated, all references
in this Agreement to the words &ldquo;Section,&rdquo; &ldquo;Article&rdquo;, &ldquo;Schedule&rdquo; and &ldquo;Exhibit&rdquo; are intended
to refer to Sections, Articles, Schedules and Exhibits to this Agreement; (k) the term &ldquo;Dollars&rdquo; or &ldquo;$&rdquo; means
United States dollars; and (l) all references to numbers of shares or other securities in this Agreement shall be interpreted to refer
to such numbers on a post-stock split, combination, recapitalization, or similar transaction basis, as applicable. Any reference in this
Agreement to a Person&rsquo;s directors shall include any member of such Person&rsquo;s governing body and any reference in this Agreement
to a Person&rsquo;s officers shall include any Person filling a substantially similar position for such Person. Any reference in this
Agreement or any Ancillary Document to a Person&rsquo;s shareholders or stockholders shall include any applicable owners of the equity
interests of such Person, in whatever form. The Parties have participated jointly in the negotiation and drafting of this Agreement. Consequently,
in the event an ambiguity or question of intent or interpretation arises, this Agreement shall be construed as if drafted jointly by the
Parties hereto, and no presumption or burden of proof shall arise favoring or disfavoring any Party by virtue of the authorship of any
provision of this Agreement. To the extent that any Contract, document, certificate or instrument is represented and warranted to by the
Company to be given, delivered, provided or made available by the Company, in order for such Contract, document, certificate or instrument
to have been deemed to have been given, delivered, provided and made available to SPAC or its Representatives, such Contract, document,
certificate or instrument shall have been posted to the electronic data site maintained on behalf of the Company for the benefit of SPAC
and its Representatives and SPAC and its Representatives have been given access to the electronic folders containing such information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">10.15 <U>Counterparts</U>.
This Agreement may be executed and delivered (including by facsimile or other electronic transmission) in one or more counterparts, and
by the different Parties hereto in separate counterparts, each of which when executed shall be deemed to be an original but all of which
taken together shall constitute one and the same agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">10.16 <U>Legal
Representation</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a) The
Parties agree that, notwithstanding the fact that EGS, Goldfarb Gross Seligman and Ogier (Cayman) LLP (together, the &ldquo;<B><I>SPAC
Law Firms</I></B>&rdquo;) may have, prior to Closing, jointly represented SPAC, the SPAC Representative and/or the Sponsor in connection
with this Agreement, the Ancillary Documents and the Transactions, and has also represented SPAC, the SPAC Representative, the Sponsor
and/or their respective Affiliates in connection with matters other than the Transactions, the SPAC Law Firms will be permitted in the
future, after the Closing, to represent the SPAC Representative, the Sponsor or their respective Affiliates in connection with matters
in which such Persons are adverse to Pubco, SPAC or any of their respective Affiliates, including any disputes arising out of, or related
to, this Agreement. The Company, Pubco, the Merger Subs and the Seller Representative, who are or have the right to be represented by
independent counsel in connection with the Transactions, hereby agree, in advance, to waive (and to cause their Affiliates to waive) any
actual or potential conflict of interest that may hereafter arise in connection with a SPAC Law Firm&rsquo;s future representation after
the Closing of one or more of the SPAC Representative, the Sponsor or its Affiliates in which the interests of such Person are adverse
to the interests of Pubco, the Surviving Subsidiaries and/or the Seller Representative or any of their respective Affiliates, including
any matters that arise out of this Agreement or that are substantially related to this Agreement or to any prior representation by such
SPAC Law Firm of SPAC, the SPAC Representative, the Sponsor or any of their respective Affiliates. The Parties acknowledge and agree that,
for the purposes of the attorney-client privilege, the SPAC Representative and the Sponsor shall be deemed the clients of the SPAC Law
Firms with respect to the negotiation, execution and performance of this Agreement and the Ancillary Documents. All such communications
shall remain privileged after the Closing and the privilege and the expectation of client confidence relating thereto shall belong solely
to, and shall be controlled by, the SPAC Representative and the Sponsor and shall not pass to or be claimed by Pubco or the Surviving
Subsidiaries or their respective Affiliates; provided, further, that nothing contained herein shall be deemed to be a waiver by SPAC or
any of its Affiliates (including, after the SPAC Merger Effective Time, Pubco, the Surviving Subsidiaries and their respective Affiliates)
of any applicable privileges or protections that can or may be asserted to prevent disclosure of any such communications to any third
party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<!-- Field: Page; Sequence: 72; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->68<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b) The
Parties agree that, notwithstanding the fact that Bevilacqua PLLC, Gornitzky &amp; Co. and Ogier (Cayman) LLP in its capacity as Cayman
Islands deal counsel (together, the &ldquo;<B><I>Seller Law Firms</I></B>&rdquo;) may have, prior to the Closing, jointly represented
the Company, Pubco, the Merger Subs, the Seller Representative and the Company Shareholders in connection with this Agreement, the Ancillary
Documents and the Transactions, and has also represented the Company and/or its Affiliates in connection with matters other than the Transactions,
the Seller Law Firms will be permitted in the future, after the Closing, to represent the Seller Representative, the Company Shareholders
or their respective Affiliates in connection with matters in which such Persons are adverse to the Pubco or the Surviving Subsidiaries
or any of their respective Affiliates, including any disputes arising out of, or related to, this Agreement. Each of SPAC and the SPAC
Representative, who is or has the right to be represented by independent counsel in connection with the transactions contemplated by this
Agreement, hereby agrees, in advance, to waive (and to cause its Affiliates to waive) any actual or potential conflict of interest that
may hereafter arise in connection with a Seller Law Firm&rsquo;s future representation after the Closing of one or more of the Seller
Representative, the Company Shareholders or their respective Affiliates in which the interests of such Person are adverse to the interests
of Pubco, the Surviving Subsidiaries or any of their respective Affiliates, including any matters that arise out of this Agreement or
that are substantially related to this Agreement or to any prior representation by such Seller Law Firm of the Company, Pubco, the Merger
Subs, the Seller Representative, the Company Shareholders or any of their respective Affiliates. The Parties acknowledge and agree that,
for the purposes of the attorney-client privilege, the Seller Representative and the Company Shareholders shall be deemed the clients
of the Seller Law Firms with respect to the negotiation, execution and performance of this Agreement and the Ancillary Documents. All
such communications shall remain privileged after the Closing and the privilege and the expectation of client confidence relating thereto
shall belong solely to, and be controlled by, the Seller Representative and the Company Shareholders, and shall not pass to or be claimed
by Pubco or a Surviving Subsidiary; provided, further, that nothing contained herein shall be deemed to be a waiver by the Company or
any of its Affiliates (including, after the Company Merger Effective Time, Pubco, the Surviving Subsidiaries and their respective Affiliates)
of any applicable privileges or protections that can or may be asserted to prevent disclosure of any such communications to any third
party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">10.17 <U>SPAC
Representative</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a) Each
of SPAC and Pubco, on behalf of itself and its Subsidiaries, successors and assigns, by execution and delivery of this Agreement, hereby
irrevocably appoints the Sponsor, in the capacity as the SPAC Representative, as each such Person&rsquo;s agent, attorney-in-fact and
representative, with full power of substitution to act in the name, place and stead of such Person, to act on behalf of such Person from
and after the Closing in connection with: (i) controlling and making any determinations with respect to whether any Triggering Events
have occurred and Earnout Shares are to be issued under <U>Section 1.13</U>; (ii) terminating, amending or waiving on behalf of such Person
any provision of this Agreement or any Ancillary Documents to which the SPAC Representative is a party or otherwise has rights in such
capacity (together with this Agreement, the &ldquo;<B><I>SPAC Representative Documents</I></B>&rdquo;); (iii) signing on behalf of such
Person any releases or other documents with respect to any dispute or remedy arising under any SPAC Representative Documents; (iv) employing
and obtaining the advice of legal counsel, accountants and other professional advisors as the SPAC Representative, in its reasonable discretion,
deems necessary or advisable in the performance of its duties as the SPAC Representative and to rely on their advice and counsel; (v)
incurring and paying reasonable out-of-pocket costs and expenses, including fees of brokers, attorneys and accountants incurred pursuant
to the transactions contemplated hereby, and any other out-of-pocket fees and expenses allocable or in any way relating to such transaction;
and (vi) otherwise enforcing the rights and obligations of any such Persons under any SPAC Representative Documents, including giving
and receiving all notices and communications hereunder or thereunder on behalf of such Person; provided, that the Parties acknowledge
that the SPAC Representative is specifically authorized and directed to act on behalf of, and for the benefit of, the holders of SPAC
Securities and Pubco Securities (other than the Company Security Holders immediately prior to the Company Merger Effective Time and their
respective successors and assigns). All decisions and actions by the SPAC Representative, including any agreement between the SPAC Representative
and the Seller Representative, shall be binding upon the SPAC, Pubco, and their respective Subsidiaries, successors and assigns, and neither
they nor any other Party shall have the right to object, dissent, protest or otherwise contest the same. The provisions of this <U>Section
10.17</U> are irrevocable and coupled with an interest. The SPAC Representative hereby accepts its appointment and authorization as the
SPAC Representative under this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<!-- Field: Page; Sequence: 73; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->69<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b) The
SPAC Representative shall not be liable for any act done or omitted under any SPAC Representative Document as the SPAC Representative
while acting in good faith and without willful misconduct or gross negligence in accordance with the express terms of this Agreement,
and any act done or omitted pursuant to the advice of counsel shall be conclusive evidence of such good faith. Pubco and the SPAC shall
jointly and severally indemnify, defend and hold harmless the SPAC Representative from and against any and all Losses incurred without
gross negligence, bad faith or willful misconduct on the part of the SPAC Representative (in its capacity as such) and arising out of
or in connection with the acceptance or administration of the SPAC Representative&rsquo;s duties under any SPAC Representative Document,
including the reasonable fees and expenses of any legal counsel retained by the SPAC Representative. In no event shall the SPAC Representative
in such capacity be liable under or in connection with any SPAC Representative Document for any indirect, punitive, special or consequential
damages. The SPAC Representative shall be fully protected in relying upon any written notice, demand, certificate or document that it
in good faith believes to be genuine, including facsimiles or copies thereof, and no Person shall have any Liability for relying on the
SPAC Representative in the foregoing manner. In connection with the performance of its rights and obligations hereunder, the SPAC Representative
shall have the right at any time and from time to time to select and engage, at the cost and expense of the Pubco and SPAC, attorneys,
accountants, investment bankers, advisors, consultants and clerical personnel and obtain such other professional and expert assistance,
maintain such records and incur other out-of-pocket expenses, as the SPAC Representative may deem necessary or appropriate from time to
time. All of the indemnities, immunities, releases and powers granted to the SPAC Representative under this <U>Section 10.17</U> shall
survive the Closing and continue indefinitely.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c) The
Person serving as the SPAC Representative may resign upon ten (10) days&rsquo; prior written notice to Pubco, SPAC, the Company and the
Seller Representative, provided, that the SPAC Representative appoints in writing a replacement SPAC Representative, subject to the prior
written approval of Pubco (not to be unreasonably withheld, delayed or conditioned). Each successor SPAC Representative shall have all
of the power, authority, rights and privileges conferred by this Agreement upon the original SPAC Representative, and the term &ldquo;SPAC
Representative&rdquo; as used herein shall be deemed to include any such successor SPAC Representatives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">10.18 <U>Seller
Representative</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a) Each
Company Shareholder, by delivery of a Letter of Transmittal, on behalf of itself and its successors and assigns, hereby irrevocably constitutes
and appoints Natalie Yivgi-Ohana, in the capacity as the Seller Representative, as the true and lawful agent and attorney-in-fact of such
Persons with full powers of substitution to act in the name, place and stead of thereof with respect to the performance on behalf of such
Person under the terms and provisions of this Agreement and the Ancillary Documents to which the Seller Representative is a party or otherwise
has rights in such capacity (together with this Agreement, the &ldquo;<B><I>Seller Representative Documents</I></B>&rdquo;), as the same
may be from time to time amended, and to do or refrain from doing all such further acts and things, and to execute all such documents
on behalf of such Person, if any, as the Seller Representative will deem necessary or appropriate in connection with any of the transactions
contemplated under the Seller Representative Documents, including: (i) controlling and making any determinations with respect to whether
any Triggering Events have occurred and Earnout Shares are to be issued under <U>Section 1.13</U>; (ii) terminating, amending or waiving
on behalf of such Person any provision of any Seller Representative Document (provided, that any such action, if material to the rights
and obligations of the Company Shareholders in the reasonable judgment of the Seller Representative, will be taken in the same manner
with respect to all Company Shareholders unless otherwise agreed by each Company Shareholder who is subject to any disparate treatment
of a potentially material and adverse nature); (iii) signing on behalf of such Person any releases or other documents with respect to
any dispute or remedy arising under any Seller Representative Document; (iv) employing and obtaining the advice of legal counsel, accountants
and other professional advisors as the Seller Representative, in its reasonable discretion, deems necessary or advisable in the performance
of its duties as the Seller Representative and to rely on their advice and counsel; (v) incurring and paying reasonable costs and expenses,
including fees of brokers, attorneys and accountants incurred pursuant to the transactions contemplated hereby, and any other reasonable
fees and expenses allocable or in any way relating to such transaction, whether incurred prior or subsequent to Closing; (vi) receiving
all or any portion of the consideration provided to the Company Shareholders under this Agreement and to distribute the same to the Company
Shareholders in accordance with their Pro Rata Share or Earnout Pro Rata Portion, as applicable; and (vii) otherwise enforcing the rights
and obligations of any such Persons under any Seller Representative Document, including giving and receiving all notices and communications
hereunder or thereunder on behalf of such Person. All decisions and actions by the Seller Representative, including any agreement between
the Seller Representative and the SPAC Representative, shall be binding upon each Company Shareholder and their respective successors
and assigns, and neither they nor any other Party shall have the right to object, dissent, protest or otherwise contest the same. The
provisions of this <U>Section 10.18</U> are irrevocable and coupled with an interest. The Seller Representative hereby accepts its appointment
and authorization as the Seller Representative under this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<!-- Field: Page; Sequence: 74; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->70<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b) Any
other Person, including the SPAC Representative, Pubco, SPAC and the Company may conclusively and absolutely rely, without inquiry, upon
any actions of the Seller Representative as the acts of the Company Shareholders under any Seller Representative Documents. The SPAC Representative,
Pubco, SPAC and the Company shall be entitled to rely conclusively on the instructions and decisions of the Seller Representative as to
(i) the settlement of any disputes with respect to whether the Triggering Events have occurred pursuant to <U>Section 1.13</U>; (ii) any
payment instructions provided by the Seller Representative or (iii) any other actions required or permitted to be taken by the Seller
Representative hereunder, and no Company Shareholder shall have any cause of action against the SPAC Representative, SPAC, the Company
for any action taken by any of them in reliance upon the instructions or decisions of the Seller Representative. The SPAC Representative,
Pubco, SPAC, the Company shall not have any Liability to any Company Shareholder for any allocation or distribution among the Company
Shareholders by the Seller Representative of payments made to or at the direction of the Seller Representative. All notices or other communications
required to be made or delivered to a Company Shareholder under any Seller Representative Document shall be made to the Seller Representative
for the benefit of such Company Shareholder, and any notices so made shall discharge in full all notice requirements of the other parties
hereto or thereto to such Company Shareholder with respect thereto. All notices or other communications required to be made or delivered
by a Company Shareholder shall be made by the Seller Representative (except for a notice under <U>Section 10.18(d)</U> of the replacement
of the Seller Representative).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c) The
Seller Representative will act for the Company Shareholders on all of the matters set forth in this Agreement in the manner the Seller
Representative believes to be in the best interest of the Company Shareholders, but the Seller Representative will not be responsible
to the Company Shareholders for any Losses that any Company Shareholder may suffer by reason of the performance by the Seller Representative
of the Seller Representative&rsquo;s duties under this Agreement, other than Losses arising from the bad faith, gross negligence or willful
misconduct by the Seller Representative in the performance of its duties under this Agreement. From and after the Closing, Pubco shall
jointly and severally with the Company Shareholders indemnify, defend and hold the Seller Representative harmless from and against any
and all Losses reasonably incurred without gross negligence, bad faith or willful misconduct on the part of the Seller Representative
(in its capacity as such) and arising out of or in connection with the acceptance or administration of the Seller Representative&rsquo;s
duties under any Seller Representative Document, including the reasonable fees and expenses of any legal counsel retained by the Seller
Representative. In no event shall the Seller Representative in such capacity be liable hereunder or in connection herewith for any indirect,
punitive, special or consequential damages. The Seller Representative shall not be liable for any act done or omitted under any Seller
Representative Document as the Seller Representative while acting in good faith and without willful misconduct or gross negligence, and
any act done or omitted pursuant to the advice of counsel shall be conclusive evidence of such good faith. The Seller Representative shall
be fully protected in relying upon any written notice, demand, certificate or document that it in good faith believes to be genuine, including
facsimiles or copies thereof, and no Person shall have any Liability for relying on the Seller Representative in the foregoing manner.
In connection with the performance of its rights and obligations hereunder, the Seller Representative shall have the right at any time
and from time to time to select and engage, at the reasonable cost and expense of the Company prior to the Closing, and the Company and
Pubco following the Closing, attorneys, accountants, investment bankers, advisors, consultants and clerical personnel and obtain such
other professional and expert assistance, maintain such records and incur other reasonable out-of-pocket expenses, as the Seller Representative
may reasonably deem necessary or appropriate from time to time. All of the indemnities, immunities, releases and powers granted to the
Seller Representative under this <U>Section 10.18</U> shall survive the Closing and continue indefinitely.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d) If
the Seller Representative shall die, become disabled, dissolve, resign or otherwise be unable or unwilling to fulfill its responsibilities
as representative and agent of Company Shareholders, then the Company Shareholders shall, within ten (10) days after such death, disability,
dissolution, resignation or other event, appoint a successor Seller Representative (by vote or written consent of the Company Shareholders
holding in the aggregate a Pro Rata Share in excess of fifty percent (50%)), and promptly thereafter (but in any event within two (2)
Business Days after such appointment) notify the SPAC Representative, Pubco and the SPAC in writing of the identity of such successor.
Any such successor so appointed shall become the &ldquo;Seller Representative&rdquo; for purposes of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<!-- Field: Page; Sequence: 75; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->71<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Article
XI<U><BR>
DEFINITIONS </U>.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">11.1 <U>Certain
Definitions</U>. For purpose of this Agreement, the following capitalized terms have the following meanings:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>AAA</I></B>&rdquo;
means the American Arbitration Association or any successor entity conducting arbitrations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Accounting Principles</I></B>&rdquo;
means in accordance with IFRS as in effect at the date of the financial statement to which it refers or if there is no such financial
statement, then as of the Closing Date, using and applying the same accounting principles, practices, procedures, policies and methods
(with consistent classifications, judgments, elections, inclusions, exclusions and valuation and estimation methodologies) used and applied
by the Target Companies in the preparation of the latest audited Company Financials.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Action</I></B>&rdquo;
means any notice of noncompliance or violation, or any claim, demand, charge, action, suit, litigation, audit, settlement, complaint,
stipulation, assessment or arbitration, or any request (including any request for information), inquiry, hearing, proceeding or investigation,
by or before any Governmental Authority.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Affiliate</I></B>&rdquo;
means, with respect to any Person, any other Person directly or indirectly Controlling, Controlled by, or under common Control with such
Person. For the avoidance of doubt, Sponsor shall be deemed to be an Affiliate of SPAC prior to the Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Ancillary Documents</I></B>&rdquo;
means each agreement, instrument or document attached hereto as an Exhibit, including the Voting Agreements, the Lock-Up Agreements, the
Sponsor Letter Agreement, the Pubco Amended Organizational Documents, the Joinder and the other agreements, certificates and instruments
to be executed or delivered by any of the Parties hereto in connection with or pursuant to this Agreement, including the Employment Agreements,
the Amended Registration Rights Agreement and any Financing Agreements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Benefit Plans</I></B>&rdquo;
of any Person means any and all deferred compensation, executive compensation, incentive compensation, equity purchase, phantom equity,
stock option, stock purchase, restricted stock, restricted stock unit or other equity-based compensation plan, employment, independent
contractor, director or consulting, severance, transaction, retention or termination pay, holiday, vacation, sick or other bonus plan
or practice, hospitalization or other medical, dental, vision, welfare, fringe benefit or life or other insurance, supplemental unemployment
benefits, profit sharing, pension, or retirement plan, program, agreement, commitment or arrangement, and each other employee benefit
plan, program, agreement or arrangement, including each &ldquo;employee benefit plan&rdquo; as such term is defined under Section 3(3)
of ERISA, maintained or contributed to or required to be contributed to by a Person for the benefit of any employee, independent contractor,
consultant, director or other service provider or terminated employee, independent contractor, consultant, director or other service provider
of such Person, or with respect to which such Person has any Liability, whether direct or indirect, actual or contingent, whether formal
or informal, and whether legally binding or not.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Biologics License
Application</I></B>&rdquo; means a comprehensive submission to the FDA requesting approval to introduce, or deliver for introduction,
a biologic product into interstate commerce in the United States.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Business Day</I></B>&rdquo;
means any day other than a Friday, Saturday, Sunday or a legal holiday on which commercial banking institutions in New York, New York,
the Cayman Islands or Tel Aviv, Israel are authorized to close for business; <U>provided</U> that banks shall not be deemed to be authorized
or obligated to be closed due to a &ldquo;shelter in place&rdquo; or similar closure of physical branch locations at the direction of
any Governmental Authority if such banks&rsquo; electronic funds transfer systems (including for wire transfers) are open for use by customers
on such day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Cayman Islands
Companies Act</I></B>&rdquo; means the Companies Act (Revised) of the Cayman Islands.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Cayman Islands
Registrar</I></B>&rdquo; means the Registrar of Companies of the Cayman Islands.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<!-- Field: Page; Sequence: 76; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->72<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Change of Control</I></B>&rdquo;
means: (a) any acquisition after the Closing Date by any Person or group of Persons (that is not an Affiliate of Pubco) of beneficial
ownership (as defined in Section 13(d) of the Exchange Act) of Pubco equity interests that, with Pubco equity interests already held by
such Person or group of Persons, constitutes more than 50% of the total voting power of Pubco&rsquo;s equity interests; provided, that
for the avoidance of doubt, for purposes of this subsection, the acquisition of additional equity securities of Pubco (other than with
respect to an acquisition that results in a Person or group of Persons (that is not an Affiliate of Pubco) owning 100% of the outstanding
capital stock of Pubco) (i) by any Person or group of Persons who, prior to such acquisition, beneficially owns more than 50% of the total
voting power of the equity interests of Pubco, (ii) as a result of the issuance of any Earnout Shares or (iii) pursuant to a distribution
by Sponsor or Original Sponsor or their respective Affiliates to their respective equityholders will not be considered a Change of Control;
or (b) any acquisition after the Closing Date of Pubco by another Person by means of (i) any transaction or series of related transactions
(including any reorganization, merger, or consolidation but excluding any merger effected exclusively for the purpose of changing the
domicile of Pubco), or (ii) a sale of all or substantially all of the assets of Pubco and its Subsidiaries, taken as a whole, if, in case
of either clause (i) or clause (ii), the equity interests of Pubco outstanding immediately before such transaction, series of related
transactions or sale will immediately after such transaction, series of related transactions or sale, represent less than 50% of the total
voting power of the surviving or acquiring entity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Code</I></B>&rdquo;
means the Internal Revenue Code of 1986, as amended, and any successor statute thereto, as amended. Reference to a specific section of
the Code shall include such section and any valid treasury regulation promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Company Confidential
Information</I></B>&rdquo; means all confidential or proprietary documents and information concerning the Target Companies or any of their
respective Representatives furnished in connection with this Agreement or the Transactions; <U>provided</U>, <U>however</U>, that Company
Confidential Information shall not include any information which, (i) at the time of disclosure by SPAC, the SPAC Representative or their
respective Representatives, is generally available publicly and was not disclosed in breach of this Agreement or (ii) at the time of the
disclosure by or on behalf of the Company or its Representatives to SPAC, the SPAC Representative or their respective Representatives
was previously known by such receiving party without violation of Law or any confidentiality obligation by the Person receiving such Company
Confidential Information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Company Convertible
Securities</I></B>&rdquo; means, collectively, the Company Options, the Company SAFEs and any other options, warrants or rights to subscribe
for or purchase any capital shares of the Company or securities convertible into or exchangeable for, or that otherwise confer on the
holder any right to acquire any capital shares of the Company. For the avoidance of doubt, Company Convertible Securities shall include
any securities, rights and/or profits interests, issued by any Affiliate, plan, holding company, or other entity which, directly or indirectly,
holds Company Securities, and which can cause the revaluation, valuation, issuance, profits or payment compensation in connection with,
or conversion, exercise or exchange of, any Company Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Company Equity
Plan</I></B>&rdquo; means the Company&rsquo;s 2021 Equity Based Incentive Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Company Option</I></B>&rdquo;
means each outstanding and unexercised option to purchase Company Ordinary Shares, whether or not then vested or fully exercisable, granted
prior to the Company Merger Effective Time to any current or former, consultant, employee, officer, director or other service provider
of the Company and/or its Affiliate, pursuant to the Company Equity Plan</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Company Ordinary
Shares</I></B>&rdquo; means the ordinary shares, of nominal value NIS 0.1 (ten Israeli Agorot) per share, of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Company SAFE</I></B>&rdquo;
means a Simple Agreement for Future Equity of the Company, pursuant to which an investor has provided capital to the Company in exchange
for the right to receive equity in the Company upon the occurrence of certain events, such as a financing round or a liquidity event,
as more fully described in the applicable Company SAFE.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Company Securities</I></B>&rdquo;
means, collectively, the Company Ordinary Shares, the Company Options, the Company SAFEs and the other Company Convertible Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Company Security
Holders</I></B>&rdquo; means, collectively, the holders of Company Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 77; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->73<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Company Shareholders</I></B>&rdquo;
means, collectively, the holders of Company Ordinary Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Consent</I></B>&rdquo;
means any consent, approval, waiver, authorization or Permit of, or notice to or declaration or filing with any Governmental Authority
or any other Person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Contracts</I></B>&rdquo;
means all contracts, agreements, binding arrangements, bonds, notes, indentures, mortgages, debt instruments, purchase order, licenses
(and all other contracts, agreements or binding arrangements concerning Intellectual Property), franchises, leases and other instruments
or obligations of any kind, written or oral (including any amendments and other modifications thereto).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Control</I></B>&rdquo;
of a Person means the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies
of such Person, whether through the ownership of voting securities, by contract, or otherwise. &ldquo;Controlled&rdquo;, &ldquo;Controlling&rdquo;
and &ldquo;under common Control with&rdquo; have correlative meanings. Without limiting the foregoing a Person (the &ldquo;<B><I>Controlled
Person</I></B>&rdquo;) shall be deemed Controlled by (a) any other Person (i) owning beneficially, as meant in Rule 13d-3 under the Exchange
Act, securities entitling such Person to cast ten percent (10%) or more of the votes for election of directors or equivalent governing
authority of the Controlled Person or (ii) entitled to be allocated or receive ten percent (10%) or more of the profits, losses, or distributions
of the Controlled Person; (b) an officer, director, general partner, partner (other than a limited partner), manager, or member (other
than a member having no management authority that is not a Person described in clause (a) above) of the Controlled Person; or (c) a spouse,
parent, lineal descendant, sibling, aunt, uncle, niece, nephew, mother-in-law, father-in-law, sister-in-law, or brother-in-law of an Affiliate
of the Controlled Person or a trust for the benefit of an Affiliate of the Controlled Person or of which an Affiliate of the Controlled
Person is a trustee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Copyrights</I></B>&rdquo;
means any works of authorship, mask works and all copyrights therein, including all renewals and extensions, copyright registrations and
applications for registration and renewal, and non-registered copyrights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Earnout Pro Rata
Portion</I></B>&rdquo; means, with respect to each Eligible Earnout Recipient, the portion of the Earnout Shares allocated to such Eligible
Earnout Recipient, which shall be equal to (i) the number of Pubco Ordinary Shares then held by such Eligible Earnout Recipient that were
received as Merger Consideration in exchange for Company Ordinary Shares, In-the-Money Company Options and Company SAFEs (or that were
Excluded Transfers where the transferee has not transferred any of the foregoing other than pursuant to another Excluded Transfer, ),
divided by (ii) the total number of Pubco Ordinary Shares received as Merger Consideration in exchange for Company Ordinary Shares, In-the-Money
Company Options and Company SAFEs that are then held by all Eligible Earnout Recipients at the time the applicable Triggering Event occurs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Environmental Law</I></B>&rdquo;
means any Law in any way relating to (a) the protection of human health and safety, (b) the protection, preservation or restoration of
the environment and natural resources (including air, water vapor, surface water, groundwater, drinking water supply, surface land, subsurface
land, plant and animal life or any other natural resource), or (c) the exposure to, or the use, storage, recycling, treatment, generation,
transportation, processing, handling, labeling, production, release or disposal of Hazardous Materials.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Environmental Liabilities</I></B>&rdquo;
means, in respect of any Person, all Liabilities, obligations, responsibilities, Remedial Actions, Actions, Orders, losses, damages, costs,
and expenses (including all reasonable fees, disbursements, and expenses of counsel, experts, and consultants and costs of investigation
and feasibility studies), fines, penalties, sanctions, and interest incurred as a result of any claim or demand by any other Person or
in response to any violation of Environmental Law, whether known or unknown, accrued or contingent, whether based in contract, tort, implied
or express warranty, strict liability, criminal or civil statute, to the extent based upon, related to, or arising under or pursuant to
any Environmental Law, Environmental Permit, Order, or Contract with any Governmental Authority or other Person, that relates to any environmental,
health or safety condition, violation of Environmental Law, or a Release or threatened Release of Hazardous Materials.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>ERISA</I></B>&rdquo;
means the U.S. Employee Retirement Income Security Act of 1974, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Exchange Act</I></B>&rdquo;
means the U.S. Securities Exchange Act of 1934, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Excluded Transfer</I></B>&rdquo;
means any transfer by an Eligible Earnout Recipient to an Affiliate or a Permitted Transferee (as such term is defined in the Lock-Up
Agreement in the form attached as <U>Exhibit B</U> hereto) of such Eligible Earnout Recipient.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<!-- Field: Page; Sequence: 78; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->74<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>FDA</I></B>&rdquo;
means the U.S. Food and Drug Administration.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Foreign Plan</I></B>&rdquo;
means any plan, fund (including any superannuation fund) or other similar program or arrangement established or maintained outside the
United States by the Company or any one or more of its Subsidiaries primarily for the benefit of employees of the Company or such Subsidiaries
residing outside the United States, which plan, fund or other similar program or arrangement provides, or results in, retirement income,
a deferral of income in contemplation of retirement or payments to be made upon termination of employment, and which plan is not subject
to ERISA or the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Fraud Claim</I></B>&rdquo;
means any claim based in whole or in part upon fraud, willful misconduct or intentional misrepresentation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Fully-Diluted Company
Shares</I></B>&rdquo; means the sum of (i) total number of issued and outstanding Company Ordinary Shares, plus (ii) the total number
of Company Ordinary Shares underlying all outstanding In-the-Money Company Options (treating such In-the-Money Company Options) as fully
vested and as if the In-the-Money Company Options had been exercised in accordance with their terms (and assuming no cashless exercise)
as of the Closing), plus (iii) the total number of Company Ordinary Shares underlying all outstanding Company SAFEs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>GAAP</I></B>&rdquo;
means generally accepted accounting principles as in effect in the United States of America.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Governmental Authority</I></B>&rdquo;
means any federal, state, local, foreign (including Israeli) or other governmental, quasi-governmental or administrative body, instrumentality,
department or agency or any court, tribunal, administrative hearing body, arbitration panel, commission, or other similar dispute-resolving
panel or body.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>GRA</I></B>&rdquo;
means a gain recognition agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Hazardous Material</I></B>&rdquo;
means any waste, gas, liquid or other substance or material that is defined, listed or designated as a &ldquo;hazardous substance&rdquo;,
&ldquo;pollutant&rdquo;, &ldquo;contaminant&rdquo;, &ldquo;hazardous waste&rdquo;, &ldquo;regulated substance&rdquo;, &ldquo;hazardous
chemical&rdquo;, or &ldquo;toxic chemical&rdquo; (or by any similar term) under any Environmental Law, or any other material regulated,
or that could result in the imposition of Liability or responsibility, under any Environmental Law, including petroleum and its by-products,
asbestos, polychlorinated biphenyls, radon, mold, and urea formaldehyde insulation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Health Care Law</I></B>&rdquo;
means any and all applicable criminal or civil health care Laws, including the U.S. federal Anti-Kickback Statute (42 U.S.C. &sect; 1320a-7b(b)),
Stark Law (42 U.S.C. &sect; 1320a-7b(f)), the Israeli Public Health Ordinance &ndash; 1940, the Israeli National Insurance Law &ndash;
1995, the Israeli National Health Insurance Law &ndash; 1994; the Israeli Patients&rsquo; Rights Law &ndash; 1996, and any other state
or federal or foreign Laws that govern activities in the healthcare industry.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>IFRS</I></B>&rdquo;
means international financial reporting standards as adopted by the International Accounting Standards Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>IIA</I></B>&rdquo;
shall mean the Israel Innovation Authority.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>IIA Notice</I></B>&rdquo;
shall mean a written notice of the Company to the IIA regarding the change in ownership of the Company effected as a result of the Company
Merger, required to be submitted to the IIA in connection with the Company Merger in accordance with the Israeli Encouragement of Research,
Development and Technological Innovation in the Industry Law, 5744-1984, and the IIA&rsquo;s regulations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>IMOH</I></B>&rdquo;
means the Israeli Ministry of Health and any other Government Authority with jurisdiction over pharmaceuticals or health in Israel.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>In-the-Money Company
Option</I></B>&rdquo; means a Company Option with an exercise price less than the Per Share Price.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Indebtedness</I></B>&rdquo;
of any Person means, without duplication, (a) all indebtedness of such Person for borrowed money (including the outstanding principal
and accrued but unpaid interest), (b) all obligations for the deferred purchase price of property or services (other than trade payables
incurred in the ordinary course of business), (c) any other indebtedness of such Person that is evidenced by a note, bond, debenture,
credit agreement or similar instrument, (d) all obligations of such Person under leases that should be classified as capital leases in
accordance with GAAP or IFRS (a applicable to such Person), (e) all obligations of such Person for the reimbursement of any obligor on
any line or letter of credit, banker&rsquo;s acceptance, guarantee or similar credit transaction, in each case, that has been drawn or
claimed against, (f) all obligations of such Person in respect of acceptances issued or created, (g) all interest rate and currency swaps,
caps, collars and similar agreements or hedging devices under which payments are obligated to be made by such Person, whether periodically
or upon the happening of a contingency, (h) all obligations secured by an Lien on any property of such Person, (i) any premiums, prepayment
fees or other penalties, fees, costs or expenses associated with payment of any Indebtedness of such Person and (j) all obligation described
in clauses (a) through (i) above of any other Person which is directly or indirectly guaranteed by such Person or which such Person has
agreed (contingently or otherwise) to purchase or otherwise acquire or in respect of which it has otherwise assured a creditor against
loss.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<!-- Field: Page; Sequence: 79; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->75<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Independent Expert</I></B>&rdquo;
shall mean a mutually acceptable independent (i.e., no prior material business relationship with any Party for the prior two (2) years)
expert accounting firm appointed by the SPAC Representative and the Seller Representative, which appointment will be made no later than
ten (10) Business Days after the Independent Expert Notice Date; provided, that if the Independent Expert does not accept its appointment
or if the Representative Parties cannot agree on the Independent Expert, in either case within twenty (20) Business Days after the Independent
Expert Notice Date, either Representative Party may require, by written notice to the other Representative Party, that the Independent
Expert be selected by the regional office of the AAA covering the State of Delaware in accordance with the AAA&rsquo;s procedures. The
parties agree that the Independent Expert will be deemed to be independent even though a Party or its Affiliates may, in the future, designate
the Independent Expert to resolve disputes of the types described in <U>Section 1.13(e)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Independent Expert
Notice Date</I></B>&rdquo; means the date that a Representative Party receives written notice under <U>Section 1.13(d)</U> from the other
Representative Party referring such dispute to the Independent Expert.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Intellectual Property</I></B>&rdquo;
means all of the following as they exist in any jurisdiction throughout the world: Patents, Trademarks, Copyrights, Trade Secrets, Internet
Assets, Software and other intellectual property, and all licenses, sublicenses and other agreements or permissions related to the preceding
property.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Interim Investment
Amount</I></B>&rdquo; means an amount equal to the aggregate net cash proceeds actually received by the Target Companies after the date
of this Agreement and prior to the Closing Date from the Bridge Financing or any Additional Transaction Financing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Internet Assets</I></B>&rdquo;
means any and all domain name registrations, web sites, web addresses, business media and social media accounts and all related rights,
items and documentation related thereto, and applications for registration therefor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Investment Company
Act</I></B>&rdquo; means the U.S. Investment Company Act of 1940, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>IPO</I></B>&rdquo;
means the initial public offering of SPAC Units pursuant to the IPO Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>IPO Prospectus</I></B>&rdquo;
means the final prospectus of SPAC, dated as of July 11, 2024, and filed with the SEC on July 12, 2024 (File No. 333-280188).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>IPO Underwriter</I></B>&rdquo;
means Cantor Fitzgerald &amp; Co., a New York general partnership.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>ISA</I></B>&rdquo;
means the Israel Securities Authority.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Israeli Companies
Law</I></B>&rdquo; means the Israeli Companies Law, 5759-1999, and all the regulations, rules&#8239;and orders promulgated thereunder,
as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Israeli Securities
Law</I></B>&rdquo; means the Israeli Securities Law, 5728-1968, and all the regulations, rules&#8239;and orders promulgated thereunder,
as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Israeli Tax Ordinance</I></B>&rdquo;
means the Israeli Income Tax Ordinance (New Version), 5721-1961, as may be amended from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>ITA</I></B>&rdquo;
shall mean the Israel Tax Authority.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Knowledge</I></B>&rdquo;
means, with respect to (i) the Company, the actual knowledge of the executive officers or directors of any Target Company, after reasonable
inquiry, or (ii) any other Party, (A) if an entity, the actual knowledge of its directors and executive officers, after reasonable inquiry,
or (B) if a natural person, the actual knowledge of such Party after reasonable inquiry.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Law</I></B>&rdquo;
means any federal, state, local, municipal, foreign (including Israeli) or other law, statute, legislation, principle of common law, ordinance,
code, edict, decree, proclamation, treaty, convention, rule, regulation, directive, requirement, writ, injunction, settlement, Order or
Consent that is or has been issued, enacted, adopted, passed, approved, promulgated, made, implemented or otherwise put into effect by
or under the authority of any Governmental Authority, including all Health Care Laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<!-- Field: Page; Sequence: 80; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->76<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Liabilities</I></B>&rdquo;
means any and all liabilities, Indebtedness, Actions or obligations of any nature (whether absolute, accrued, contingent or otherwise,
whether known or unknown, whether direct or indirect, whether matured or unmatured, whether due or to become due and whether or not required
to be recorded or reflected on a balance sheet under GAAP, IFRS or other applicable accounting standards), including Tax liabilities due
or to become due.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Lien</I></B>&rdquo;
means any mortgage, pledge, security interest, attachment, right of first refusal, option, proxy, voting trust, encumbrance, lien or charge
of any kind (including any conditional sale or other title retention agreement or lease in the nature thereof), restriction (whether on
voting, sale, transfer, disposition or otherwise), any subordination arrangement in favor of another Person, or any filing or agreement
to file a financing statement as debtor under the Uniform Commercial Code or any similar Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Losses</I></B>&rdquo;
means any and all losses, Actions, Orders, Liabilities, damages, Taxes, interest, penalties, Liens, amounts paid in settlement, costs
and expenses (including reasonable expenses of investigation and court costs and reasonable attorneys&rsquo; fees and expenses).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Material Adverse
Effect</I></B>&rdquo; means, with respect to any specified Person, any fact, event, occurrence, change or effect that has had, or would
reasonably be expected to have, individually or in the aggregate, a material adverse effect upon (a) the business, assets, Liabilities,
customer relationships, operations, results of operations, prospects or condition (financial or otherwise) of such Person and its Subsidiaries,
taken as a whole, or (b) the ability of such Person or any of its Subsidiaries on a timely basis to consummate the transactions contemplated
by this Agreement or the Ancillary Documents to which it is a party or bound or to perform its obligations hereunder or thereunder; <U>provided</U>,
<U>however</U>, that for purposes of clause (a) above, any changes or effects directly or indirectly attributable to, resulting from,
relating to or arising out of the following (by themselves or when aggregated with any other, changes or effects) shall not be deemed
to be, constitute, or be taken into account when determining whether there has or may, would or could have occurred a Material Adverse
Effect: (i) general changes in the financial or securities markets or general economic or political conditions in the country or region
in which such Person or any of its Subsidiaries do business; (ii) changes, conditions or effects that generally affect the industries
in which such Person or any of its Subsidiaries principally operate; (iii) changes in applicable Laws or in IFRS, GAAP or other applicable
accounting principles or mandatory changes in the regulatory accounting requirements applicable to any industry in which such Person and
its Subsidiaries principally operate; (iv) conditions caused by acts of God, terrorism, war (whether or not declared) (including the Russian
invasion of the Ukraine or any surrounding countries), natural disaster or any outbreak or continuation of an epidemic or pandemic, including
the effects of any Governmental Authority or other third-party responses thereto; (v) any failure in and of itself by such Person and
its Subsidiaries to meet any internal or published budgets, projections, forecasts or predictions of financial performance for any period
(provided that the underlying cause of any such failure may be considered in determining whether a Material Adverse Effect has occurred
or would reasonably be expected to occur to the extent not excluded by another exception herein) and (vi), with respect to SPAC, the consummation
and effects of any Redemption; <U>provided further</U>, <U>however</U>, that any event, occurrence, fact, condition, or change referred
to in clauses (i) - (iv) immediately above shall be taken into account in determining whether a Material Adverse Effect has occurred or
could reasonably be expected to occur to the extent that such event, occurrence, fact, condition, or change has a disproportionate effect
on such Person or any of its Subsidiaries compared to other participants worldwide in the industries (but for the avoidance of doubt,
not the geographies) in which such Person or any of its Subsidiaries primarily conducts its businesses. Notwithstanding the foregoing,
with respect to SPAC, the amount of any Redemption or the failure to obtain the Required SPAC Shareholder Approval shall not be deemed
to be a Material Adverse Effect on or with respect to SPAC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Nasdaq</I></B>&rdquo;
means the Nasdaq Stock Market LLC, and includes either the Nasdaq Global Market or the Nasdaq Capital Market, as applicable to the relevant
listing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>NIS</I></B>&rdquo;
means New Israeli Shekel.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Order</I></B>&rdquo;
means any order, decree, ruling, judgment, injunction, writ, determination, binding decision, verdict, judicial award or other action
that is or has been made, entered, rendered, or otherwise put into effect by or under the authority of any Governmental Authority.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<!-- Field: Page; Sequence: 81; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->77<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Organizational
Documents</I></B>&rdquo; means, with respect to any Person, its certificate of incorporation and bylaws, memorandum and articles of association
or similar organizational documents, in each case, as amended, together with any related shareholders&rsquo; agreements or similar agreements
relating to the governance or ownership of such Person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Patents</I></B>&rdquo;
means any patents, patent applications and the inventions, designs and improvements described and claimed therein, patentable inventions,
and other patent rights (including any divisionals, provisionals, continuations, continuations-in-part, substitutions, or reissues thereof,
whether or not patents are issued on any such applications and whether or not any such applications are amended, modified, withdrawn,
or refiled).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>PCAOB</I></B>&rdquo;
means the U.S. Public Company Accounting Oversight Board (or any successor thereto).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Per Share Price</I></B>&rdquo;
means an amount equal to (i) the sum of (A) the Merger Consideration, plus (B) the aggregate amount of the exercise prices for all Company
Ordinary Shares under In-the-Money Company Options in accordance with their terms (and assuming no cashless exercise) that are outstanding
as of the Closing, divided by (ii) the Fully-Diluted Company Shares as of the Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Permits</I></B>&rdquo;
means all federal, state, local or foreign or other third-party permits, grants, easements, consents, approvals, authorizations, exemptions,
licenses, franchises, concessions, ratifications, permissions, clearances, confirmations, endorsements, waivers, certifications, designations,
ratings, registrations, qualifications or orders of any Governmental Authority or any other Person, including Permits issuable by the
FDA and the IMOH.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Permitted Liens</I></B>&rdquo;
means (a) Liens for Taxes or assessments and similar governmental charges or levies, which either are (i) not delinquent or (ii) being
contested in good faith and by appropriate proceedings, and adequate reserves have been established with respect thereto, (b) other Liens
imposed by operation of Law arising in the ordinary course of business for amounts which are not due and payable and as would not in the
aggregate materially adversely affect the value of, or materially adversely interfere with the use of, the property subject thereto, (c)
Liens incurred or deposits made in the ordinary course of business in connection with social security, (d) Liens on goods in transit incurred
pursuant to documentary letters of credit, in each case arising in the ordinary course of business, or (e) Liens arising under this Agreement
or any Ancillary Document.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Person</I></B>&rdquo;
means an individual, corporation, partnership (including a general partnership, limited partnership or limited liability partnership),
limited liability company, association, trust or other entity or organization, including a government, domestic or foreign, or political
subdivision thereof, or an agency or instrumentality thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Personal Property</I></B>&rdquo;
means any machinery, equipment, tools, vehicles, furniture, leasehold improvements, office equipment, plant, parts and other tangible
personal property.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Pro Rata Share</I></B>&rdquo;
means with respect to each Company Security Holder, a fraction expressed as a percentage, equal to (i) as of the Closing, (A) the number
of Company Ordinary Shares held by such Company Security Holder, plus (B) the number of Company Ordinary Shares underlying In-the-Money
Company Options held by such Company Security Holder, plus (C) the number of Company Ordinary Shares underlying Company SAFEs held by
such Company Security Holder, divided by (ii) the Fully-Diluted Company Shares as of the Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Pubco Ordinary
Shares</I></B>&rdquo; means the ordinary shares, no par value, of Pubco, along with any equity securities paid as dividends or distributions
after the Closing with respect to such shares or into which such shares are exchanged or converted after the Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Pubco Preference
Shares</I></B>&rdquo; means the preference shares, no par value, of Pubco.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Pubco Private Warrant</I></B>&rdquo;
means one whole non-redeemable warrant entitling the holder thereof to purchase one (1) Pubco Ordinary Share at a purchase price of $11.50
per share, which warrants will be issued by Pubco in the SPAC Merger in exchange for the SPAC Private Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Pubco Public Warrant</I></B>&rdquo;
means one whole redeemable warrant entitling the holder thereof to purchase one (1) Pubco Ordinary Share at a purchase price of $11.50
per share, which warrants will be issued by Pubco in the SPAC Merger in exchange for the SPAC Public Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Pubco Securities</I></B>&rdquo;
means the Pubco Ordinary Shares, the Pubco Preference Shares and the Pubco Warrants, collectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<!-- Field: Page; Sequence: 82; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->78<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Pubco Warrants</I></B>&rdquo;
means Pubco Private Warrants and Pubco Public Warrants, collectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Redemption Price</I></B>&rdquo;
means an amount equal to the price at which each SPAC Class A Ordinary Share (or after the SPAC Merger, each Pubco Ordinary Share) is
redeemed or converted pursuant to the Closing Redemption.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Registration Rights
Agreement</I></B>&rdquo; means the Registration Rights Agreement, dated as of July 11, 2024, by and among SPAC, the Sponsor and the IPO
Underwriter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Release</I></B>&rdquo;
means any release, spill, emission, leaking, pumping, injection, deposit, disposal, discharge, dispersal, or leaching into the indoor
or outdoor environment, or into or out of any property.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Remedial Action</I></B>&rdquo;
means all actions to (i) clean up, remove, treat, or in any other way address any Hazardous Material, (ii) prevent the Release of any
Hazardous Material so it does not endanger or threaten to endanger public health or welfare or the indoor or outdoor environment, (iii)
perform pre-remedial studies and investigations or post-remedial monitoring and care, or (iv) correct a condition of noncompliance with
Environmental Laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Representatives</I></B>&rdquo;
means, as to any Person, such Person&rsquo;s Affiliates and the respective managers, directors, officers, employees, independent contractors,
consultants, advisors (including financial advisors, counsel and accountants), agents and other legal representatives of such Person or
its Affiliates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Requisite Majority</I></B>&rdquo;
means the votes required to obtain the Required Company Shareholder Approval.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>SEC</I></B>&rdquo;
means the U.S. Securities and Exchange Commission (or any successor Governmental Authority).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Section 102</I></B>&rdquo;
shall mean section 102 of the Israeli Tax Ordinance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Section 102 Options</I></B>&rdquo;
shall mean Options granted and subject to tax under Sections 102(b)(2) or (3) of the Israeli Tax Ordinance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Section 102 Shares</I></B>&rdquo;
shall mean Company Ordinary Shares issued upon the exercise of Section 102 Options or granted subject to tax under Sections 102(b)(2)
or 102(b)(3) (if applicable) of the Israeli Tax Ordinance and held by the Section 102 Trustee pursuant to the Israeli Tax Ordinance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Section 102 Trustee</I></B>&rdquo;
shall means IBI Trust Management, Israeli company number 515020428, which serves as the trustee of the Company&rsquo;s equity incentive
plan and the awards granted thereunder pursuant to Sections 102(b)(2) or (3) of the Israeli Tax Ordinance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Section 3(i) Options</I></B>&rdquo;
shall mean Company Options granted and subject to tax under Section 3(i) of the Israeli Tax Ordinance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Securities Act</I></B>&rdquo;
means the U.S. Securities Act of 1933, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Software</I></B>&rdquo;
means any computer software programs, including all source code, object code, and documentation related thereto and all software modules,
tools and databases.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>SOX</I></B>&rdquo;
means the U.S. Sarbanes-Oxley Act of 2002, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>SPAC Charter</I></B>&rdquo;
means the amended and restated memorandum and articles of association of SPAC, as amended and in effect under the Cayman Islands Companies
Act; provided, that references herein to the SPAC Charter for periods after the SPAC Merger Effective Time includes the memorandum and
articles of association of the SPAC Surviving Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>SPAC Class A Ordinary
Shares</I></B>&rdquo; means the Class A ordinary shares, par value $0.0001 per share, of SPAC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>SPAC Class B Ordinary
Shares</I></B>&rdquo; means the Class B ordinary shares, par value $0.0001 per share, of SPAC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>SPAC Confidential
Information</I></B>&rdquo; means all confidential or proprietary documents and information concerning SPAC or any of its Representatives;
<U>provided</U>, <U>however</U>, that SPAC Confidential Information shall not include any information which, (i) at the time of disclosure
by the Company, Pubco, a Merger Sub, the Seller Representative or any of their respective Representatives, is generally available publicly
and was not disclosed in breach of this Agreement or (ii) at the time of the disclosure by or on behalf of SPAC or its Representatives
to the Company, Pubco, a Merger Sub, the Seller Representative or any of their respective Representatives, was previously known by such
receiving party without violation of Law or any confidentiality obligation by the Person receiving such SPAC Confidential Information.
For the avoidance of doubt, from and after the Closing, SPAC Confidential Information will include the confidential or proprietary information
of the Target Companies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<!-- Field: Page; Sequence: 83; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->79<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>SPAC Ordinary Shares</I></B>&rdquo;
means the SPAC Class A Ordinary Shares and SPAC Class B Ordinary Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>SPAC Preference
Shares</I></B>&rdquo; means the preference shares, par value $0.0001 par value per share, of SPAC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>SPAC Private Warrants</I></B>&rdquo;
means the warrants issued in a private placement to the Sponsor and the IPO Underwriter by SPAC at the time of the consummation of the
IPO, entitling the holder thereof to purchase one (1) SPAC Class A Ordinary Share per warrant at a purchase price of $11.50 per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>SPAC Public Warrants</I></B>&rdquo;
means one whole redeemable warrant of which one-half (1/2) was included as part of each SPAC Unit, entitling the holder thereof to purchase
one (1) SPAC Class A Ordinary Share at a purchase price of $11.50 per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>SPAC Securities</I></B>&rdquo;
means the SPAC Units, the SPAC Ordinary Shares, the SPAC Preference Shares and the SPAC Warrants, collectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>SPAC Units</I></B>&rdquo;
means the units issued in the IPO (including overallotment units acquired by SPAC&rsquo;s underwriter) consisting of one (1) SPAC Class
A Ordinary Share and one-half (1/2) of one redeemable SPAC Public Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>SPAC Warrants</I></B>&rdquo;
means SPAC Private Warrants and SPAC Public Warrants, collectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Subsidiary</I></B>&rdquo;
means, with respect to any Person, any corporation, partnership, association or other business entity of which (i) if a corporation, a
majority of the total voting power of capital shares entitled (without regard to the occurrence of any contingency) to vote in the election
of directors, managers or trustees thereof is at the time owned or controlled, directly or indirectly, by that Person or one or more of
the other Subsidiaries of that Person or a combination thereof, or (ii) if a partnership, association or other business entity, a majority
of the partnership or other similar ownership interests thereof is at the time owned or controlled, directly or indirectly, by any Person
or one or more Subsidiaries of that Person or a combination thereof. For purposes hereof, a Person or Persons will be deemed to have a
majority ownership interest in a partnership, association or other business entity if such Person or Persons will be allocated a majority
of partnership, association or other business entity gains or losses or will be or control the managing director, managing member, general
partner or other managing Person of such partnership, association or other business entity. A Subsidiary of a Person will also include
any variable interest entity which is consolidated with such Person under applicable accounting rules.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Target Company</I></B>&rdquo;
means each of the Company and its direct and indirect Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Tax Return</I></B>&rdquo;
means any return, declaration, report, claim for refund, information return or other documents (including any related or supporting schedules,
statements or information) filed or required to be filed in connection with the determination, assessment or collection of any Taxes or
the administration of any Laws or administrative requirements relating to any Taxes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Taxes</I></B>&rdquo;
(or &ldquo;<B><I>Tax</I></B>&rdquo;) means (a) all direct or indirect federal, state, local, foreign and other net income, gross income,
gross receipts, sales, use, value-added, ad valorem, transfer, franchise, profits, license, lease, service, service use, withholding,
payroll, employment, Medicare, social security and related contributions due in relation to the payment of compensation to employees (including
Bituach Leumi and Bituach Briyut), excise, severance, stamp, occupation, premium, property, windfall profits, alternative minimum, estimated,
customs, duties or other taxes, fees, assessments or charges of any kind whatsoever, together with any interest, linkage differentials
and any penalties, additions to tax or additional amounts with respect thereto, (b) any Liability for payment of amounts described in
clause (a) whether as a result of being a member of an affiliated, consolidated, combined or unitary group for any period or otherwise
through operation of law and (c) any Liability for the payment of amounts described in clauses (a) or (b) as a result of any tax sharing,
tax group, tax indemnity or tax allocation agreement with, or any other express or implied agreement to indemnify, any other Person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Trade Secrets</I></B>&rdquo;
means any trade secrets, confidential business information, concepts, ideas, designs, research or development information, processes,
procedures, techniques, technical information, specifications, operating and maintenance manuals, engineering drawings, methods, know-how,
data, mask works, discoveries, inventions, modifications, extensions, improvements, and other proprietary rights (whether or not patentable
or subject to copyright, trademark, or trade secret protection).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Trademarks</I></B>&rdquo;
means any trademarks, service marks, trade dress, trade names, brand names, internet domain names, designs, logos, or corporate names
(including, in each case, the goodwill associated therewith), whether registered or unregistered, and all registrations and applications
for registration and renewal thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<!-- Field: Page; Sequence: 84; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->80<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Trading Day</I></B>&rdquo;
means any day on which Pubco Ordinary Shares are actually traded on the principal securities exchange or securities market on which Pubco
Ordinary Shares are then traded.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Trading Price</I></B>&rdquo;
means, on any Trading Day after the Closing, the VWAP for Pubco Ordinary Shares for such Trading Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Treasury Regulations</I></B>&rdquo;
means the regulations promulgated under the Code by the United States Department of the Treasury, as such regulations may be amended from
time to time (including any successor regulations).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Trust Account</I></B>&rdquo;
means the trust account established by SPAC with the proceeds from the IPO pursuant to the Trust Agreement in accordance with the IPO
Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Trust Agreement</I></B>&rdquo;
means that certain Investment Management Trust Agreement, dated as of July 11, 2024, as it may be amended (including to accommodate the
SPAC Merger), by and between SPAC and the Trustee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Trustee</I></B>&rdquo;
means Continental Stock Transfer &amp; Trust Company, in its capacity as trustee under the Trust Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>Valid Tax Certificate</I></B>&rdquo;
shall mean a valid certificate, ruling or any other written instructions regarding Tax withholding, issued by the ITA in customary form
and substance reasonably satisfactory to the Pubco or Exchange Agent, that is applicable to the payments to be made to any Israeli Payee
pursuant to this Agreement stating that no withholding, or reduced withholding, of Israeli Tax is required with respect to such payment
or providing any other instructions regarding Tax withholding. A general certificate issued by the ITA pursuant to the Israeli Income
Tax Regulations (Withholding from Payments for Services or Assets), 5737-1977, will not constitute a Valid Tax Certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><I>VWAP</I></B>&rdquo;
means, for any security as of any date(s), the dollar volume-weighted average price for such security on the principal securities exchange
or securities market on which such security is then traded each day as reported by Bloomberg through its &ldquo;HP&rdquo; function (set
to weighted average) or, if the foregoing does not apply, the dollar volume-weighted average price of such security in the over-the-counter
market on the electronic bulletin board for such security during the day, or, if no dollar volume-weighted average price is reported for
such security by Bloomberg for such day, then the closing price for such day. If the VWAP (or closing price) cannot be calculated for
such security on such date(s) on any of the foregoing bases, the VWAP of such security on such date(s) shall be the fair market value
as determined reasonably and in good faith by a majority of the disinterested independent directors on the board of directors (or equivalent
governing body) of the applicable issuer. All such determinations shall be appropriately adjusted for any share dividend, share split,
share combination, recapitalization or other similar transaction during such period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">11.2 <U>Section
References</U>. The following capitalized terms, as used in this Agreement, have the respective meanings given to them in the Section
as set forth below adjacent to such terms:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 39%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U STYLE="text-decoration: none">Term</U></B></FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 9%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U STYLE="text-decoration: none">Section</U></B></FONT></TD>
    <TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 39%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U STYLE="text-decoration: none">Term</U></B></FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 9%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U STYLE="text-decoration: none">Section</U></B></FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; padding-left: 0.15in; text-indent: -0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15D Exemption</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.22(a)</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company Benefit Plan</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.19(a)</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; padding-left: 0.15in; text-indent: -0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023/2022 Audited Financials</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.7(a)</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company Certificate of Merger</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.3</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; padding-left: 0.15in; text-indent: -0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AAA Procedures</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.6</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company Certificates</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.14(a)</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; padding-left: 0.15in; text-indent: -0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts Receivable</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.7(f)</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company DeSPAC Advisors</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.3</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; padding-left: 0.15in; text-indent: -0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Acquisition Proposal</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.6(a)</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company Disclosure Schedules</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Article V</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; padding-left: 0.15in; text-indent: -0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additional Financing Agreements</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.19(b)</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company Financials</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.7(a)</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; padding-left: 0.15in; text-indent: -0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additional Transaction Financing</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.19(b)</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company IP</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.13(d)</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; padding-left: 0.15in; text-indent: -0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Agreement</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preamble</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company IP Licenses</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.13(a)</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; padding-left: 0.15in; text-indent: -0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alternative Transaction</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.6(a)</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company Material Contract</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.12(a)</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; padding-left: 0.15in; text-indent: -0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amended Pubco Organizational </FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company Merger</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recitals</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; padding-left: 0.25in; text-indent: -0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Documents</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.7</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company Merger Effective Time</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.3</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; padding-left: 0.15in; text-indent: -0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amended Registration Rights </FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company Merger Sub</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preamble</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; padding-left: 0.25in; text-indent: -0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Agreement</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recitals</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company Permits</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.10</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; padding-left: 0.15in; text-indent: -0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Antitrust Laws</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.9(b)</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company Personal Property Leases</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.16</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; padding-left: 0.15in; text-indent: -0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Audited Financials</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.7(a)</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company Plan of Merger</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.3</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; padding-left: 0.15in; text-indent: -0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bridge Financing</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.19(a)</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company Real Property Leases</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.15</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; padding-left: 0.15in; text-indent: -0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bridge Financing Agreements</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.19(a)</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company Registered IP</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.13(a)</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; padding-left: 0.15in; text-indent: -0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bridge Financing Investors</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.19(a)</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company Shareholder Meeting</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.13(a)</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; padding-left: 0.15in; text-indent: -0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Business Combination</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.1</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company Surviving Subsidiary</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; padding-left: 0.15in; text-indent: -0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CCOD</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.19(a)</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">D&amp;O Indemnified Persons</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.17(a)</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; padding-left: 0.15in; text-indent: -0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CFO</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.13(c)</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">D&amp;O Tail Insurance</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.17(b)</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; padding-left: 0.15in; text-indent: -0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change of Control Earnout Statement</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.13(c)</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dispute</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.6</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; padding-left: 0.15in; text-indent: -0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change of Control Price</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.13(b)</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Earnout Milestones</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.13(a)(ii)</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; padding-left: 0.15in; text-indent: -0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change in Recommendation</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.11(b)</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Earnout Period</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.13(a)</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; padding-left: 0.15in; text-indent: -0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Clinical Milestone</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.13(a)(ii)</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Earnout Shares</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.13(a)</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; padding-left: 0.15in; text-indent: -0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Closing</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Earnout Statements</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.13(c)</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; padding-left: 0.15in; text-indent: -0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Closing Date</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective Time</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1 3</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; padding-left: 0.15in; text-indent: -0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Closing Filing</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.14(b)</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EGS </FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2 1</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; padding-left: 0.15in; text-indent: -0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Closing Press Release</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.14(b)</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Eligible Earnout Recipient</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.13(h)</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; padding-left: 0.15in; text-indent: -0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Closing Redemption</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.11(a)</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employment Agreements</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.20</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; padding-left: 0.15in; text-indent: -0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Closing Statement</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.12</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Enforceability Exceptions</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; padding-left: 0.15in; text-indent: -0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Companies Registrar</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.3</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Environmental Permits</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.20(a)</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; padding-left: 0.15in; text-indent: -0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preamble</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exchange Agent</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.16(b)</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 85; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->81<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 39%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U STYLE="text-decoration: none">Term</U></B></FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 9%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U STYLE="text-decoration: none">Section</U></B></FONT></TD>
    <TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 39%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U STYLE="text-decoration: none">Term</U></B></FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 9%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U STYLE="text-decoration: none">Section</U></B></FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; padding-left: 0.15in; text-indent: -0.15in">Expenses</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">6 .18</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top">Pharmaceutical Product</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">5 .24(a)</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; padding-left: 0.15in; text-indent: -0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Extension </FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.3(b)(iv)</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Post-Closing Pubco Board</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.16(a)</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; padding-left: 0.15in; text-indent: -0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Extension Redemption</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.5(b)</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proxy Statement</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.11(a)</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; padding-left: 0.15in; text-indent: -0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FDCA</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.24(a)</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pubco</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preamble</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; padding-left: 0.15in; text-indent: -0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Federal Securities Laws</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.7</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pubco 5% Shareholder</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.12(c)</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; padding-left: 0.15in; text-indent: -0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financing Agreements</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.19(b)</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pubco Equity Plan</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.11(a)</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; padding-left: 0.15in; text-indent: -0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FTO Opinion</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.1(a)</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Public Certifications</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.6(a)</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; padding-left: 0.15in; text-indent: -0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">HSC Letter Agreement</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recitals</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Public Shareholders</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.1</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; padding-left: 0.15in; text-indent: -0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">HSC Principals</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recitals</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recommendation Change Notice</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.11(b)</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; padding-left: 0.15in; text-indent: -0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intended Tax Treatment</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.15</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Redemption</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.5(b)</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; padding-left: 0.15in; text-indent: -0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interim Reviewed Financials</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.7(a)</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registration Statement</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.11(a)</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; padding-left: 0.15in; text-indent: -0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interim Period</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.1(a)</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Related Person</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.21</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; padding-left: 0.15in; text-indent: -0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ISA Exemptions</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.22(a)</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Released Claims</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.1</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; padding-left: 0.15in; text-indent: -0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ISA Offering Exemption</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.22(a)</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Representative Party</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preamble</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; padding-left: 0.15in; text-indent: -0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Israeli Option Tax Ruling</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.23(a)</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Required Company Shareholder </FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; padding-left: 0.15in; text-indent: -0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Israeli Payee</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.16(a)</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Approval</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.1(b)</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; padding-left: 0.15in; text-indent: -0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Israeli Prospectus</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.22(a)</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Required SPAC Shareholder </FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; padding-left: 0.15in; text-indent: -0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Israeli Tax Rulings</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.23(a)</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Approval</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.1(a)</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; padding-left: 0.15in; text-indent: -0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Joinder</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.24</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Resolution Period</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.6</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; padding-left: 0.15in; text-indent: -0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Letter of Transmittal</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.14(a)</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">RRA Company Security Holders</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recitals</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; padding-left: 0.15in; text-indent: -0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Listing Application</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.21</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SEC Reports</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.6(a)</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; padding-left: 0.15in; text-indent: -0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lock-Up Agreements</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recitals</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section 14 Arrangement</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.18(c)</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; padding-left: 0.15in; text-indent: -0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Locked-Up Company Securityholders</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recitals</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Seller Law Firms</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.16(b)</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; padding-left: 0.15in; text-indent: -0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lost Certificate Affidavit</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.14(d)</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Seller Representative</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preamble</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; padding-left: 0.15in; text-indent: -0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Material Contractor</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.18(d)</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Seller Representative Documents</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.18(a)</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; padding-left: 0.15in; text-indent: -0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Merger Certificates</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.3</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share Consideration Per Share</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.11</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; padding-left: 0.15in; text-indent: -0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Merger Consideration</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.11</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share Price Milestone</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.13(a)(i)</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; padding-left: 0.15in; text-indent: -0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Merger Plans</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.3</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share Price Target</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.13(a)</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; padding-left: 0.15in; text-indent: -0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Merger Proposal</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.13(b)</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shareholder Approval Matters</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.11(a)</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; padding-left: 0.15in; text-indent: -0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Merger Subs</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preamble</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signing Filing</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.14(b)</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; padding-left: 0.15in; text-indent: -0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mergers</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recitals</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signing Press Release</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.14(b)</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; padding-left: 0.15in; text-indent: -0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Minimum Cash Condition</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.2(d)</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SPAC</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preamble</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; padding-left: 0.15in; text-indent: -0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Monthly Earnout Statement</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.13(c)</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SPAC Certificate of Merger</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.3</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; padding-left: 0.15in; text-indent: -0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net Cash</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.2(d)</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SPAC Disclosure Schedules</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Article III</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; padding-left: 0.15in; text-indent: -0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net Share Settlement</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.9(c)</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SPAC Financials</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.6(b)</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; padding-left: 0.15in; text-indent: -0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">OFAC</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.17(c)</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SPAC Law Firms</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.16(a)</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; padding-left: 0.15in; text-indent: -0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Off-the-Shelf Software</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.13(a)</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SPAC Material Contract</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.13(a)</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; padding-left: 0.15in; text-indent: -0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Option Cancellation and Waiver </FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SPAC Merger</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recitals</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; padding-left: 0.25in; text-indent: -0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consents</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.9(c)</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SPAC Merger Effective Time</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.3</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; padding-left: 0.15in; text-indent: -0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outbound IP License</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.13(c)</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SPAC Merger Sub</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preamble</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; padding-left: 0.15in; text-indent: -0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outside Date</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1(b)</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SPAC Plan of Merger</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.3</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; padding-left: 0.15in; text-indent: -0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Party(ies)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preamble</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SPAC Representative</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preamble</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; padding-left: 0.15in; text-indent: -0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payor</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.16(a)</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SPAC Representative Documents</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.17(a)</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; padding-left: 0.15in; text-indent: -0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PCAOB Financials</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.7(a)</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SPAC Shareholder Meeting</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.11(a)</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; padding-left: 0.15in; text-indent: -0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Permitted SPAC Merger Sub Owner</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.24</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SPAC Surviving Subsidiary</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.2</FONT></TD></TR>

<TR>
    <TD STYLE="vertical-align: bottom; padding-left: 0.15in; text-indent: -0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SPAC Withholding Tax Ruling</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.23(a)</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Top Vendors</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.23</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; padding-left: 0.15in; text-indent: -0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Specified Courts</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.7</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transaction Financing</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.19(b)</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; padding-left: 0.15in; text-indent: -0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sponsor</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preamble</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transactions</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recitals</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; padding-left: 0.15in; text-indent: -0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sponsor Director</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.16(a)</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transmittal Documents</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.14(b)</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; padding-left: 0.15in; text-indent: -0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sponsor Earnout Shares</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recitals</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Triggered Earnout Statement</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.13(c)</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; padding-left: 0.15in; text-indent: -0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sponsor Letter Agreement</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recitals</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Triggering Event</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.13(a)</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; padding-left: 0.15in; text-indent: -0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Surviving Subsidiaries</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">VAT</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.14(n)</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; padding-left: 0.15in; text-indent: -0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Target Company Service Provider</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.19(h)</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">VAT Law</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.14(n)</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; padding-left: 0.15in; text-indent: -0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tax Ruling</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.23(a)</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Voting Agreements</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recitals</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B></P>


<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><I>{REMAINDER OF PAGE INTENTIONALLY LEFT BLANK;
SIGNATURE PAGE FOLLOWS}</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><I>&nbsp;</I></B></P>


<!-- Field: Page; Sequence: 86; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->82<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, each Party
hereto has caused this Agreement to be signed and delivered by its respective duly authorized officer as of the date first written above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I><U>SPAC:</U></I></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>LAUNCH ONE ACQUISITION CORP.</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U STYLE="text-decoration: none">/s/ <I>Chris Ehrlich</I></U></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="width: 32%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chris Ehrlich</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I><U>SPAC Representative:</U></I></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>LAUNCH ONE SPONSOR LLC</B>, solely in the capacity as the SPAC Representative hereunder</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U STYLE="text-decoration: none">/s/ <I>Chris Ehrlich</I></U></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: </FONT></TD>
    <TD STYLE="width: 32%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chris Ehrlich</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I><U>The Company:</U></I></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>MINOVIA THERAPEUTICS LTD.</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U STYLE="text-decoration: none">/s/ <I>Natalie Yivgi Ohana</I></U></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="width: 32%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Natalie Yivgi Ohana</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I><U>Seller Representative:</U></I></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U STYLE="text-decoration: none">/s/ <I>Natalie Yivgi Ohana</I></U></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Natalie Yivgi-Ohana</B>, solely in the capacity as the Seller Representative hereunder</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B><I>{Signature Page to
Business Combination Agreement}</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 87 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt"><I>&nbsp;</I></FONT></TD>
    <TD COLSPAN="3"><FONT STYLE="font-size: 10pt"><I><U>Pubco:</U></I></FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3"><FONT STYLE="font-size: 10pt"><B>MITO US ONE LTD.</B></FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">By: </FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 10pt"><U STYLE="text-decoration: none">/s/ Natalie Yivgi Ohana</U></FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-size: 10pt">Name:&nbsp;</FONT></TD>
    <TD STYLE="width: 32%"><FONT STYLE="font-size: 10pt">&nbsp;Natalie Yivgi Ohana</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Director </FONT></TD>
    </TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt"><I>&nbsp;</I></FONT></TD>
    <TD COLSPAN="3"><FONT STYLE="font-size: 10pt"><I><U>Company Merger Sub</U></I>: </FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3"><FONT STYLE="font-size: 10pt"><B>MITO SUB ISRAEL LTD.</B></FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 10pt"><U STYLE="text-decoration: none">/s/ Natalie Yivgi Ohana</U></FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="width: 32%"> <FONT STYLE="font-size: 10pt">Natalie Yivgi Ohana</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Title: </FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Director</FONT></TD>
    </TR>
  </TABLE>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><B>&nbsp;</B></P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><B><I>{Signature Page to Business Combination Agreement}</I></B></P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><B>&nbsp;</B></P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><B></B></P>

<!-- Field: Page; Sequence: 88; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><B>&nbsp;</B></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>3
<FILENAME>ea024761201ex10-1_launch.htm
<DESCRIPTION>FORM OF LOCK-UP AGREEMENT, DATED AS OF JUNE 25, 2025, BY AND AMONG PUBCO, LAUNCH ONE, THE SPONSOR, AND CERTAIN COMPANY SECURITYHOLDERS THEREIN
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 10.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B><I>EXECUTION COPY</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>CONFIDENTIAL</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>FORM OF LOCK-UP AGREEMENT</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Lock-Up Agreement (this
&ldquo;<B><I>Agreement</I></B>&rdquo;) is made and entered into as of June 25, 2025, by and among (i) <B>Mito US One Ltd.</B>, an Israeli
company limited by shares (together with its successors, &ldquo;<B><I>Pubco</I></B>&rdquo;), (ii) <B>Launch One Acquisition Corp.</B>,
a Cayman Islands exempted company limited by shares (&ldquo;<B><I>SPAC</I></B>&rdquo;), (iii) <B>Launch One Sponsor LLC</B>, a Delaware
limited liability company, in the capacity under the BCA (as defined below) as the SPAC Representative (including any successor SPAC Representative
appointed in accordance with the BCA, the &ldquo;<B><I>SPAC Representative</I></B>&rdquo;), and (iv) the undersigned holder (&ldquo;<B><I>Holder</I></B>&rdquo;).
Any capitalized term used but not defined in this Agreement will have the meaning ascribed to such term in the BCA (as defined below).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>, on or about
the date hereof, (i) SPAC, (ii) the SPAC Representative, (iii) Minovia Therapeutics Ltd., an Israeli company limited by shares (the &ldquo;<B><I>Company</I></B>&rdquo;),
(iv) Natalie Yivgi-Ohana, in the capacity as the Seller Representative thereunder, (v) Pubco and (vi) Mito Sub Israel Ltd., an Israeli
company limited by shares and a wholly-owned subsidiary of Pubco (&ldquo;<B><I>Company Merger Sub</I></B>&rdquo;), entered into that certain
Business Combination Agreement (as amended from time to time in accordance with the terms thereof, the &ldquo;<B><I>BCA</I></B>&rdquo;),
pursuant to which, among other matters, (a) the Company will cause a Cayman Islands exempted company limited by shares (&ldquo;<B><I>SPAC
Merger Sub</I></B>&rdquo;) (i) to be formed by a Permitted SPAC Merger Sub Owner and (ii) to execute and deliver a joinder to become party
to the BCA, (b) Company Merger Sub shall merge with and into the Company, with the Company continuing as the surviving entity (the &ldquo;<B><I>Company
Merger</I></B>&rdquo;), and in connection therewith (i) the shares of the Company issued and outstanding immediately prior to the effective
time of the Company Merger shall be cancelled in exchange for the right of the holders thereof to receive Pubco Ordinary Shares (along
with the contingent right to receive Earnout Shares after the consummation of the transactions contemplated by the BCA (the &ldquo;<B><I>Closing</I></B>&rdquo;)),
(ii) outstanding In-the-Money Company Options will automatically vest and be cancelled in exchange for the right of the holders thereof
to receive Pubco Ordinary Shares, (iii) outstanding Company SAFEs will automatically be cancelled in exchange for the right of the holders
thereof to receive Pubco Ordinary Shares, and (iv) all other Company Convertible Securities that have not been cancelled or converted
prior to the effective time of the Company Merger will be terminated, (c) immediately after the consummation of the Company Merger, SPAC
Merger Sub shall merge with and into SPAC, with SPAC continuing as the surviving company (the &ldquo;<B><I>SPAC Merger</I></B>&rdquo;
and, together with the Company Merger, the &ldquo;Mergers&rdquo; and collectively with the other transactions contemplated by the BCA
and the Ancillary Documents, the &ldquo;<B><I>Transactions</I></B>&rdquo;), and in connection therewith each issued and outstanding security
of SPAC immediately prior to the effective time of the SPAC Merger shall no longer be outstanding and shall automatically be cancelled,
in exchange for the right of the holders thereof to receive a substantially equivalent security of Pubco, and (d) as a result of such
Mergers, SPAC and the Company each shall become wholly owned subsidiaries of Pubco, and Pubco shall become a publicly traded company,
all upon the terms and subject to the conditions set forth in the BCA and in accordance with the provisions of the Cayman Islands Companies
Act, Israeli Companies Law and other applicable Law;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>, Holder beneficially
owns certain issued and outstanding equity securities of the Company; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>, in view of
the valuable consideration to be received by Holder under the BCA, the parties desire to enter into this Agreement, pursuant to which
the portion of the Merger Consideration received by Holder pursuant to the BCA, along with any Earnout Shares issued to Holder thereunder
(and if Holder is an HSC Principal, any other Pubco Ordinary Shares issued to Holder at or after the Closing pursuant to or in connection
with the HSC Letter Agreement) (all such securities, together with any securities paid as dividends or distributions with respect to such
securities or into which such securities are exchanged or converted, the <I>&ldquo;<B>Restricted Securities</B>&rdquo;</I>), shall become
subject to limitations on disposition as set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B></B></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>NOW, THEREFORE</B>, in
consideration of the premises set forth above, which are incorporated in this Agreement as if fully set forth below, and intending to
be legally bound hereby, the parties hereby agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.   <U>Lock-Up
Provisions</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)   Holder
hereby agrees not to, during the period (the &ldquo;<B><I>Lock-Up Period</I></B>&rdquo;) commencing from the Closing and ending on the
earliest of (x) the one (1) year anniversary of the Closing, (y) the first date after the Closing on which the closing price of Pubco
Ordinary Shares on the principal securities exchange or securities market on which such security is then traded equals or exceeds $12.00
per share (as adjusted for share splits, share capitalizations, share consolidations, rights issuances, subdivisions, reorganizations,
recapitalizations and the like) for any twenty (20) trading days within any thirty (30) trading day period commencing at least one hundred
fifty (150) days after the Closing, and (z) the date after the Closing on which Pubco or its shareholders consummate a third-party tender
offer, stock, sale, liquidation, merger, share exchange, reorganization or other similar transaction with an unaffiliated third party
that results in holders of at least a majority of Pubco Ordinary Shares having the right to exchange their equity holdings in Pubco for
cash, securities or other property; (i) lend, offer, assign, sell, contract to sell, sell any option or contract to purchase, purchase
any option or contract to sell, grant any option, right or warrant to purchase, or otherwise transfer or dispose of, directly or indirectly,
any Restricted Securities, (ii)&nbsp;enter into any swap or other arrangement that transfers to another, in whole or in part, any of the
economic consequences of ownership of the Restricted Securities, or (iii)&nbsp;publicly announce the intention to do any of the foregoing,
whether any such transaction described in clauses (i), (ii) or (iii) above is to be settled by delivery of Restricted Securities or other
securities, in cash or otherwise (any of the foregoing described in clauses (i), (ii) or (iii), a &ldquo;<B><I>Prohibited Transfer</I></B>&rdquo;).
The foregoing sentence shall not apply to the transfer of any or all of the Restricted Securities owned by Holder (I) by gift, will or
intestate succession upon the death of Holder, (II) to any Permitted Transferee (as defined below), (III) pursuant to a court order or
settlement agreement related to the distribution of assets in connection with the dissolution of marriage or civil union or pursuant to
a domestic relations order, (IV) to Pubco in accordance with the requirements of the BCA, or (V) required by virtue of the laws of the
State of Israel; provided, however, that in the of cases of clauses (I), (II) or (III) it shall be a condition to such transfer that the
transferee executes and delivers to Pubco an agreement stating that the transferee is receiving and holding the Restricted Securities
subject to the provisions of this Agreement applicable to Holder, and there shall be no further transfer of such Restricted Securities
except in accordance with this Agreement. As used in this Agreement, the term &ldquo;<B><I>Permitted Transferee</I></B>&rdquo; shall mean:
(A) the members of Holder&rsquo;s immediate family (for purposes of this Agreement, &ldquo;immediate family&rdquo; shall mean with respect
to any natural person, any of the following: such person&rsquo;s spouse, the siblings of such person and his or her spouse, and the direct
descendants and ascendants (including adopted and step children and parents) of such person and his or her spouses and siblings), (B)
any trust or charitable organization for the direct or indirect benefit of Holder or the immediate family of Holder, (C) if Holder is
a trust, the trustor or beneficiary of such trust or to the estate of a beneficiary of such trust, (D) if Holder is an entity, as a distribution
to limited partners, shareholders, members of, or owners of similar equity interests in Holder. Holder further agrees to execute such
agreements as may be reasonably requested by Pubco that are consistent with the foregoing or that are necessary to give further effect
thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)   If
any Prohibited Transfer is made or attempted contrary to the provisions of this Agreement, such purported Prohibited Transfer shall be
null and void <I>ab initio</I>, and Pubco shall refuse to recognize any such purported transferee of the Restricted Securities as one
of its equity holders for any purpose. In order to enforce this&nbsp;<U>Section 1</U>, Pubco may impose stop-transfer instructions with
respect to the Restricted Securities of Holder (and Permitted Transferees and assigns thereof) until the end of the Lock-Up Period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)   During
the Lock-Up Period, each certificate or book entry evidencing any Restricted Securities shall be stamped or otherwise imprinted with a
legend in substantially the following form, in addition to any other applicable legends:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&ldquo;THE SECURITIES REPRESENTED BY
THIS CERTIFICATE ARE SUBJECT TO RESTRICTIONS ON TRANSFER SET FORTH IN A LOCK-UP AGREEMENT, DATED AS OF JUNE 25, 2025, BY AND AMONG THE
ISSUER OF SUCH SECURITIES (THE &ldquo;ISSUER&rdquo;), A CERTAIN REPRESENTATIVE OF THE ISSUER NAMED THEREIN AND THE ISSUER&rsquo;S SECURITY
HOLDER NAMED THEREIN, AS AMENDED. A COPY OF SUCH LOCK-UP AGREEMENT WILL BE FURNISHED WITHOUT CHARGE BY THE ISSUER TO THE HOLDER HEREOF
UPON WRITTEN REQUEST.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)   For
the avoidance of any doubt, Holder shall retain all of its rights as a shareholder of Pubco with respect to the Restricted Securities
during the Lock-Up Period, including the right to vote any Restricted Securities, but subject to the obligations under the BCA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.   <U>Miscellaneous</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)   <U>Effective
Date; Termination of BCA</U>. This Agreement shall be binding upon Holder upon Holder&rsquo;s execution and delivery of this Agreement,
but this Agreement shall only become effective upon the Closing. Notwithstanding anything to the contrary contained herein, in the event
that the BCA is terminated in accordance with its terms prior to the Closing, this Agreement shall automatically terminate and become
null and void, and the parties shall not have any rights or obligations hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)   <U>Binding
Effect; Assignment</U>. This Agreement and all of the provisions hereof shall be binding upon and inure to the benefit of the parties
hereto and their respective permitted successors and assigns. This Agreement and all obligations of Holder are personal to Holder and
may not be transferred or delegated by Holder at any time. Pubco and SPAC may freely assign any or all of its rights under this Agreement,
in whole or in part, to any successor entity (whether by merger, consolidation, equity sale, asset sale or otherwise) without obtaining
the consent or approval of Holder (but the consent of the SPAC Representative shall be required). If the SPAC Representative is replaced
in accordance with the terms of the BCA, the replacement SPAC Representative shall automatically become a party to this Agreement as if
it were the original SPAC Representative hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)   <U>Third
Parties</U>. Nothing contained in this Agreement or in any instrument or document executed by any party in connection with the transactions
contemplated hereby shall create any rights in, or be deemed to have been executed for the benefit of, any person or entity that is not
a party hereto or thereto or a successor or permitted assign of such a party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)   <U>Arbitration</U>.
Any and all disputes, controversies and claims (other than applications for a temporary restraining order, preliminary injunction, permanent
injunction or other equitable relief or application for enforcement of a resolution under this <U>Section 2</U>) arising out of, related
to, or in connection with the BCA or any agreements or documents ancillary thereto, including but not limited to this Agreement, or the
transactions contemplated thereby (a &ldquo;<B><I>Dispute</I></B>&rdquo;) shall be governed by this <U>Section 2(d)</U>. A party must,
in the first instance, provide written notice of any Dispute to the other parties subject to such Dispute, which notice must provide a
reasonably detailed description of the matters subject to the Dispute. The parties involved in such Dispute shall seek to resolve the
Dispute on an amicable basis within ten (10) Business Days of the notice of such Dispute being received by such other parties subject
to such Dispute (the &ldquo;<B><I>Resolution Period</I></B>&rdquo;); <U>provided</U>, that if any Dispute would reasonably be expected
to have become moot or otherwise irrelevant if not decided within sixty (60) days after the occurrence of such Dispute, there shall be
no Resolution Period with respect to such Dispute. Any Dispute that is not resolved during the Resolution Period may immediately be referred
to and finally resolved by arbitration pursuant to the then-existing Expedited Procedures (as defined in the AAA Procedures) of the Commercial
Arbitration Rules (the &ldquo;<B><I>AAA Procedures</I></B>&rdquo;) of the American Arbitration Association (the &ldquo;<B><I>AAA</I></B>&rdquo;).
Any party involved in such Dispute may submit the Dispute to the AAA to commence the proceedings after the Resolution Period. To the extent
that the AAA Procedures and this Agreement are in conflict, the terms of this Agreement shall control. The arbitration shall be conducted
by one arbitrator nominated by the AAA promptly (but in any event within five (5) Business Days) after the submission of the Dispute to
the AAA and reasonably acceptable to each party subject to the Dispute, which arbitrator shall be a commercial lawyer with substantial
experience arbitrating disputes under acquisition agreements. The arbitrator shall accept his or her appointment and begin the arbitration
process promptly (but in any event within five (5) Business Days) after his or her nomination and acceptance by the parties subject to
the Dispute. The proceedings shall be streamlined and efficient. The arbitrator shall decide the Dispute in accordance with the substantive
law of the State of Delaware. Time is of the essence. Each party subject to the Dispute shall submit a proposal for resolution of the
Dispute to the arbitrator within twenty (20) days after confirmation of the appointment of the arbitrator. The arbitrator shall have the
power to order any party to do, or to refrain from doing, anything consistent with this Agreement, the other Ancillary Documents, the
BCA and applicable Law, including to perform its contractual obligation(s); provided, that the arbitrator shall be limited to ordering
pursuant to the foregoing power (and, for the avoidance of doubt, shall order) the relevant party (or parties, as applicable) to comply
with only one or the other of the proposals. The arbitrator&rsquo;s award shall be in writing and shall include a reasonable explanation
of the arbitrator&rsquo;s reason(s) for selecting one or the other proposal. The seat of arbitration shall be in the State of Delaware.
The language of the arbitration shall be English.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e)   <U>Governing
Law; Jurisdiction</U>. This Agreement shall be governed by, construed and enforced in accordance with the Laws of the State of Delaware,
without regard to the conflict of laws principles thereof. Subject to <U>Section 2(d)</U>, all Actions arising out of or relating to this
Agreement shall be heard and determined exclusively in the Chancery Court of the State of Delaware (or, if such court lacks subject matter
jurisdiction, in any appropriate Delaware State or federal court) (or in any appellate court thereof) (the &ldquo;<B><I>Specified Courts</I></B>&rdquo;).
Subject to <U>Section 2(d)</U>, each party hereto hereby (a)&nbsp;submits to the exclusive jurisdiction of any Specified Court for the
purpose of any Action arising out of or relating to this Agreement brought by any party hereto and (b)&nbsp;irrevocably waives, and agrees
not to assert by way of motion, defense or otherwise, in any such Action, any claim that it is not subject personally to the jurisdiction
of the above-named courts, that its property is exempt or immune from attachment or execution, that the Action is brought in an inconvenient
forum, that the venue of the Action is improper, or that this Agreement or the transactions contemplated hereby may not be enforced in
or by any Specified Court. Each party agrees that a final judgment in any Action shall be conclusive and may be enforced in other jurisdictions
by suit on the judgment or in any other manner provided by Law. Each party irrevocably consents to the service of the summons and complaint
and any other process in any other Action relating to the transactions contemplated by this Agreement, on behalf of itself, or its property,
by personal delivery of copies of such process to such party at the applicable address set forth in <U>Section 2(i)</U>. Nothing in this
<U>Section 2(e)</U> shall affect the right of any party to serve legal process in any other manner permitted by Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f)   <FONT STYLE="font-variant: small-caps"><U>WAIVER
OF JURY TRIAL</U>. EACH OF THE PARTIES HERETO HEREBY WAIVES TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW ANY RIGHT IT MAY HAVE TO
A TRIAL BY JURY WITH RESPECT TO ANY ACTION DIRECTLY OR INDIRECTLY ARISING OUT OF, UNDER OR IN CONNECTION WITH THIS AGREEMENT OR THE TRANSACTIONS
CONTEMPLATED HEREBY. EACH PARTY HERETO (A)&nbsp;CERTIFIES THAT NO REPRESENTATIVE OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE,
THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF ANY ACTION, SEEK TO ENFORCE THAT FOREGOING WAIVER AND (B)&nbsp;ACKNOWLEDGES THAT IT AND
THE OTHER PARTIES HERETO HAVE BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS
IN THIS <U>SECTION 2(F)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(g)   <U>Interpretation</U>.
The titles and subtitles used in this Agreement are for convenience only and are not to be considered in construing or interpreting this
Agreement. In this Agreement, unless the context otherwise requires: (i) any pronoun used in this Agreement shall include the corresponding
masculine, feminine or neuter forms, and the singular form of nouns, pronouns and verbs shall include the plural and vice versa; (ii)
&ldquo;including&rdquo; (and with correlative meaning &ldquo;include&rdquo;) means including without limiting the generality of any description
preceding or succeeding such term and shall be deemed in each case to be followed by the words &ldquo;without limitation&rdquo;; (iii)
the words &ldquo;herein,&rdquo; &ldquo;hereto,&rdquo; and &ldquo;hereby&rdquo; and other words of similar import shall be deemed in each
case to refer to this Agreement as a whole and not to any particular section or other subdivision of this Agreement; and (iv) the term
&ldquo;or&rdquo; means &ldquo;and/or&rdquo;. The parties have participated jointly in the negotiation and drafting of this Agreement.
Consequently, in the event an ambiguity or question of intent or interpretation arises, this Agreement shall be construed as if drafted
jointly by the parties hereto, and no presumption or burden of proof shall arise favoring or disfavoring any party by virtue of the authorship
of any provision of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i)   <U>Notices</U>.
All notices, consents, waivers and other communications hereunder shall be in writing and shall be deemed to have been duly given when
delivered (i) in person, (ii) by email, with affirmative confirmation of receipt, (iii) one Business Day after being sent, if sent by
reputable, internationally recognized overnight courier service or (iv) three (3) Business Days after being mailed, if sent by registered
or certified mail, pre-paid and return receipt requested, in each case to the applicable party at the following addresses (or at such
other address for a party as shall be specified by like notice):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 5.4pt; padding-bottom: 5.4pt; width: 54%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I></I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>If to Pubco prior to the Closing, to:</I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">c/o Minovia Therapeutics Ltd.<BR>
    3 HaSadna St.<BR>
    Tirat Carmel, 3902603, Israel<BR>
    Attn: Natalie Yivgi Ohana, Chief Executive Officer<BR>
    Telephone No.: +972-545833727<BR>
    E-mail: natalie@minoviatx.com</P></TD>
    <TD STYLE="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 5.4pt; padding-bottom: 5.4pt; width: 46%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>with copies (which will not constitute notice) to:</I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Bevilacqua PLLC<BR>
    1050 Connecticut Avenue, NW, Suite 500<BR>
    Washington, DC 20036<BR>
    Attn: Louis A. Bevilacqua, Esq.<BR>
    Telephone No.: (202) 869-0888 (ext. 100)<BR>
    E-mail: lou@bevilacquapllc.com</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>and</I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Gornitzky &amp; Co.<BR>
    Vitania Tel-Aviv Tower<BR>
    20 HaHarash Street,<BR>
    Tel Aviv, Israel 6761310<BR>
    Attn:&#9;Chaim Friedland and Timor Belan<BR>
    Telephone No.: 03-710-9191<BR>
    E-mail: friedland@gornitzky.com;<BR>
    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;timorb@gornitzky.com</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; padding-top: 5.4pt; padding-bottom: 5.4pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>If to Pubco or SPAC after the Closing, to:</I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Mito US One Ltd.<BR>
    3 HaSadna St.<BR>
    Tirat Carmel, 3902603, Israel<BR>
    Attn: Natalie Yivgi Ohana, Chief Executive Officer<BR>
    Telephone No.: +972-545833727<BR>
    E-mail: natalie@minoviatx.com</P></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-top: 5.4pt; padding-bottom: 5.4pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>with copies (which will not constitute notice) to:</I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Bevilacqua PLLC<BR>
    1050 Connecticut Avenue, NW, Suite 500<BR>
    Washington, DC 20036<BR>
    Attn: Louis A. Bevilacqua, Esq.<BR>
    Telephone No.: (202) 869-0888 (ext. 100)<BR>
    E-mail: lou@bevilacquapllc.com</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>and</I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Gornitzky &amp; Co.<BR>
    Vitania Tel-Aviv Tower<BR>
    20 HaHarash Street,<BR>
    Tel Aviv, Israel 6761310<BR>
    Attn:&#9;Chaim Friedland and Timor Belan<BR>
    Telephone No.: 03-710-9191<BR>
    E-mail:friedland@gornitzky.com;<BR>
    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;timorb@gornitzky.com</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>and</I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">the SPAC Representative (and its copy for notices hereunder)</P></TD></TR>
</TABLE>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; padding-top: 5.4pt; padding-bottom: 5.4pt; width: 54%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>If to SPAC at or prior to the Closing, to:</I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Launch One Acquisition Corp<BR>
    180 Grand Avenue, Suite 1530<BR>
    Oakland, CA 94612, U.S.A.<BR>
    Attn: Chris Ehrlich, Chief Executive Officer<BR>
    Telephone No.: (415) 994-0582<BR>
    E-mail: chris@launchpad.vc</P></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-top: 5.4pt; padding-bottom: 5.4pt; width: 46%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>with copies (which will not constitute notice) to:</I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ellenoff Grossman &amp; Schole LLP<BR>
    1345 Avenue of the Americas, 11th Floor<BR>
    New York, New York 10105, U.S.A.<BR>
    Attn: Matthew A. Gray, Esq. and<BR>
    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Stuart Neuhauser, Esq.<BR>
    Telephone No.: (212) 370-1300<BR>
    E-mail: mgray@egsllp.com;<BR>
    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;sneuhauser@egsllp.com</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>and</I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Goldfarb Gross Seligman &amp; Co.<BR>
    One Azrieli Center, Round Tower<BR>
    Tel Aviv, Israel 6701101<BR>
    Attn: Aaron M. Lampert and Daniel Kahn<BR>
    Telephone No.: 03-607-4444<BR>
    E-mail: aaron.lampert@goldfarb.com;<BR>
    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;daniel.kahn@goldfarb.com</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; padding-top: 5.4pt; padding-bottom: 5.4pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>If to the SPAC Representative, to:</I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Launch One Sponsor LLC<BR>
    c/o Launchpad Capital Management<BR>
    180 Grand Avenue, Suite 1530<BR>
    Oakland, CA 94612<BR>
    Attn: Jurgen Van de Vyver<BR>
    Telephone No.: (510) 200-8878<BR>
    Email: jurgen@launchpad.vc</P></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-top: 5.4pt; padding-bottom: 5.4pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>with copies (which will not constitute notice) to:</I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ellenoff Grossman &amp; Schole LLP<BR>
    1345 Avenue of the Americas, 11th Floor<BR>
    New York, New York 10105, U.S.A.<BR>
    Attn: Matthew A. Gray, Esq. and<BR>
    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Stuart Neuhauser, Esq.<BR>
    Telephone No.: (212) 370-1300<BR>
    E-mail: mgray@egsllp.com;<BR>
    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;sneuhauser@egsllp.com</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>and</I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Goldfarb Gross Seligman &amp; Co.<BR>
    One Azrieli Center, Round Tower<BR>
    Tel Aviv, Israel 6701101<BR>
    Attn: Aaron M. Lampert and Daniel Kahn<BR>
    Telephone No.: 03-607-4444<BR>
    E-mail: aaron.lampert@goldfarb.com;<BR>
    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;daniel.kahn@goldfarb.com</P></TD></TR>
  <TR>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; padding-bottom: 5.4pt; vertical-align: top; padding-top: 5.4pt; text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>If to Holder, to: </I>the address set forth under Holder&rsquo;s name on the signature page hereto, with a copy (which will not constitute notice) to, if not the party sending the notice, each of the Company and SPAC (and each of their copies for notices hereunder).</FONT></TD>
    </TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(j)   <U>Amendments
and Waivers</U>. Any term of this Agreement may be amended and the observance of any term of this Agreement may be waived (either generally
or in a particular instance, and either retroactively or prospectively) only with the written consent of the party against whom enforcement
of such waiver is sought; provided that any waiver by Pubco or SPAC hereunder will also require the written consent of the SPAC Representative.
No failure or delay by a party in exercising any right hereunder shall operate as a waiver thereof. No waivers of or exceptions to any
term, condition, or provision of this Agreement, in any one or more instances, shall be deemed to be or construed as a further or continuing
waiver of any such term, condition, or provision.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(k)   <U>Severability</U>.
In case any provision in this Agreement shall be held invalid, illegal or unenforceable in a jurisdiction, such provision shall be modified
or deleted, as to the jurisdiction involved, only to the extent necessary to render the same valid, legal and enforceable, and the validity,
legality and enforceability of the remaining provisions hereof shall not in any way be affected or impaired thereby nor shall the validity,
legality or enforceability of such provision be affected thereby in any other jurisdiction. Upon such determination that any term or other
provision is invalid, illegal or incapable of being enforced, the parties will substitute for any invalid, illegal or unenforceable provision
a suitable and equitable provision that carries out, so far as may be valid, legal and enforceable, the intent and purpose of such invalid,
illegal or unenforceable provision.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(l)   <U>Specific
Performance</U>. Holder acknowledges that its obligations under this Agreement are unique, recognizes and affirms that in the event of
a breach of this Agreement by Holder, money damages will be inadequate and Pubco (and the SPAC Representative on behalf of Pubco) will
have no adequate remedy at law, and agrees that irreparable damage would occur in the event that any of the provisions of this Agreement
were not performed by Holder in accordance with their specific terms or were otherwise breached. Accordingly, each of Pubco and the SPAC
Representative shall be entitled to an injunction or restraining order to prevent breaches of this Agreement by Holder and to enforce
specifically the terms and provisions hereof, without the requirement to post any bond or other security or to prove that money damages
would be inadequate, this being in addition to any other right or remedy to which such party may be entitled under this Agreement, at
law or in equity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(m)   <U>Entire
Agreement</U>. This Agreement constitutes the full and entire understanding and agreement among the parties with respect to the subject
matter hereof, and any other written or oral agreement relating to the subject matter hereof existing between the parties is expressly
canceled; <U>provided</U>, that, for the avoidance of doubt, the foregoing shall not affect the rights and obligations of the parties
under the BCA or any Ancillary Document. Notwithstanding the foregoing, nothing in this Agreement shall limit any of the rights or remedies
of Pubco, SPAC and the SPAC Representative or any of the obligations of Holder under any other agreement between Holder and Pubco, SPAC
or the SPAC Representative or any certificate or instrument executed by Holder in favor of Pubco, SPAC or the SPAC Representative, and
nothing in any other agreement, certificate or instrument shall limit any of the rights or remedies of Pubco, SPAC or the SPAC Representative
or any of the obligations of Holder under this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(n)   <U>Further
Assurances</U>. From time to time, at another party&rsquo;s request and without further consideration (but at the requesting party&rsquo;s
reasonable cost and expense), each party shall execute and deliver such additional documents and take all such further action as may be
reasonably necessary to consummate the transactions contemplated by this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(o)   <U>Counterparts;
Facsimile.</U>&nbsp; This Agreement may also be executed and delivered by facsimile signature or by email in portable document format
in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><I>{Remainder of Page Intentionally Left Blank;
Signature Pages Follow}</I></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>IN WITNESS WHEREOF</B>,
the parties have executed this Lock-Up Agreement as of the date first written above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt"><I>&nbsp;</I></FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt"><I><U>Pubco<B>:</B></U></I></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt"><B><I>&nbsp;</I></B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt"><B>MITO US ONE LTD.</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 35%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt"><I>&nbsp;</I></FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt"><I><U>SPAC<B>:</B></U></I></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt"><B><I>&nbsp;</I></B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt"><B>LAUNCH ONE ACQUISITION CORP.</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt"><I>&nbsp;</I></FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt"><I><U>SPAC Representative</U>:</I></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt"><I>&nbsp;</I></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt"><B>LAUNCH ONE SPONSOR LLC</B>,</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">solely in the capacity as the SPAC Representative</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><I>{Additional Signature
on the Following Page}</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>IN WITNESS WHEREOF</B>,
in addition to the signatures set forth above or in counterpart documents, the party below has executed this Lock-Up Agreement as of the
date first written above.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I><U>Holder</U>:</I></FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name of Holder:<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U STYLE="text-decoration: none">By:</U></FONT></TD>
    <TD COLSPAN="2" STYLE="padding-bottom: 1.5pt"><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="width: 32%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="width: 57%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Address for Notice:</U></FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Telephone No.:<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="width: 19%">&nbsp;</TD>
    <TD STYLE="width: 80%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><I>{Signature Page to Lock-Up Agreement}</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 9; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>4
<FILENAME>ea024761201ex10-2_launch.htm
<DESCRIPTION>FORM OF VOTING AGREEMENT, DATED AS OF JUNE 25, 2025, BY AND AMONG LAUNCH ONE, AND THE COMPANY, AND CERTAIN COMPANY SECURITYHOLDERS THEREIN
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Exhibit 10.2</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B><I>EXECUTION COPY</I></B></P>

<P STYLE="text-align: right; margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"><B>CONFIDENTIAL</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>FORM OF VOTING AGREEMENT</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Voting Agreement (this
&ldquo;<B><I>Agreement</I></B>&rdquo;) is made as of June 25, 2025 by and among (i) <B>Launch One Acquisition Corp.</B>, a Cayman Islands
exempted company limited by shares (&ldquo;<B><I>SPAC</I></B>&rdquo;), (ii) <B>Minovia Therapeutics Ltd.</B>, an Israeli company limited
by shares (the &ldquo;<B><I>Company</I></B>&rdquo;), and (iii) the undersigned shareholder (&ldquo;<B><I>Holder</I></B>&rdquo;) of the
Company. Any capitalized term used but not defined in this Agreement will have the meaning ascribed to such term in the BCA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>, on or about
the date hereof, (i) SPAC, (ii) Launch One Sponsor LLC, a Delaware limited liability company, in the capacity as the SPAC Representative
thereunder, (iii) the Company, (iv) Natalie Yivgi-Ohana, in the capacity as the Seller Representative thereunder, (v) Mito US One Ltd.,
an Israeli company limited by shares (&ldquo;<B><I>Pubco</I></B>&rdquo;), and (vi) Mito Sub Israel Ltd., an Israeli company limited by
shares and a wholly-owned subsidiary of Pubco (&ldquo;<B><I>Company Merger Sub</I></B>&rdquo;), entered into that certain Business Combination
Agreement (as amended from time to time in accordance with the terms thereof, the &ldquo;<B><I>BCA</I></B>&rdquo;), pursuant to which,
among other matters, (a) the Company will cause a Cayman Islands exempted company limited by shares (&ldquo;<B><I>SPAC Merger Sub</I></B>&rdquo;)
(1) to be formed by a Permitted SPAC Merger Sub Owner and (2) to execute and deliver a joinder to become party to the BCA, (b) Company
Merger Sub shall merge with and into the Company, with the Company continuing as the surviving company (the &ldquo;<B><I>Company Merger</I></B>&rdquo;),
and in connection therewith (1) the shares of the Company issued and outstanding immediately prior to the effective time of the Company
Merger shall be cancelled in exchange for the right of the holders thereof to receive Pubco Ordinary Shares (along with the contingent
right to receive Earnout Shares after the consummation of the transactions contemplated by the BCA (the &ldquo;<B><I>Closing</I></B>&rdquo;)),
(2) outstanding In-the-Money Company Options will automatically vest and be cancelled in exchange for the right of the holders thereof
to receive Pubco Ordinary Shares, (3) outstanding Company SAFEs will automatically be cancelled in exchange for the right of the holders
thereof to receive Pubco Ordinary Shares, and (4) all other Company Convertible Securities that have not been cancelled or converted prior
to the effective time of the Company Merger will be terminated, (c) immediately after the consummation of the Company Merger, SPAC Merger
Sub shall merge with and into SPAC, with SPAC continuing as the surviving company (the &ldquo;<B><I>SPAC Merger</I></B>&rdquo; and, together
with the Company Merger, the &ldquo;<B><I>Mergers</I></B>&rdquo; and collectively with the other transactions contemplated by the BCA
and the Ancillary Documents, the &ldquo;<B><I>Transactions</I></B>&rdquo;), and in connection therewith each issued and outstanding security
of SPAC immediately prior to the effective time of the SPAC Merger shall no longer be outstanding and shall automatically be cancelled,
in exchange for the right of the holders thereof to receive a substantially equivalent security of Pubco, and (d) as a result of such
Mergers, SPAC and the Company each shall become wholly owned subsidiaries of Pubco, and Pubco shall become a publicly traded company,
all upon the terms and subject to the conditions set forth in the BCA and in accordance with the provisions of the Cayman Islands Companies
Act, Israeli Companies Law and other applicable Law;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>, the Board
of Directors of the Company has (a) determined that the Transactions are advisable and fair to and in the best interests of the Company
and its shareholders (the &ldquo;<B><I>Company Shareholders</I></B>&rdquo;), (b) approved the BCA, the Ancillary Documents and the Transactions,
and (c) recommended the approval and the adoption by each of the Company Shareholders of the BCA, the Ancillary Documents and the Transactions;
and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>, as a condition
to the willingness of SPAC to enter into the BCA, and as an inducement and in consideration therefor, and in view of the valuable consideration
to be received by Holder thereunder, and the expenses and efforts to be undertaken by SPAC and the Company to consummate the Transactions,
SPAC, the Company and Holder desire to enter into this Agreement in order for Holder to provide certain assurances to SPAC regarding the
manner in which Holder is bound hereunder to vote any Company Ordinary Shares or other equity interests of the Company which Holder beneficially
owns, holds or otherwise has voting power (or which Holder will beneficially own, hold, or otherwise have voting power after the date
hereof) (the &ldquo;<B><I>Shares</I></B>&rdquo;) during the period from and including the date hereof through and including the date on
which this Agreement is terminated in accordance with its terms (the &ldquo;<B><I>Voting Period</I></B>&rdquo;) with respect to the BCA,
the Ancillary Documents and the Transactions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B></B></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>NOW, THEREFORE</B>, in
consideration of the premises set forth above, which are incorporated in this Agreement as if fully set forth below, and intending to
be legally bound hereby, the parties hereby agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.   <B><U>Covenant
to Vote the Shares in Favor of Transactions.</U></B> Holder agrees, with respect to all of the Shares, solely in Holder&rsquo;s capacity
as a Company Shareholder (and not, if applicable, in Holder&rsquo;s capacity as an officer or director of the Company):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)   during
the Voting Period, at each meeting of the Company Shareholders or class or series thereof, and in each written consent or resolutions
of any of the Company Shareholders in which Holder is entitled to vote or consent, Holder hereby unconditionally and irrevocably agrees
to be present for any such meeting and vote (in person or by proxy), or consent to any action by written consent or resolution with respect
to, as applicable, the Shares (i) in favor of, the approval and adoption of the BCA, the Ancillary Documents, any amendments to the Company&rsquo;s
Organizational Documents, and all of the other Transactions (and any actions required in furtherance thereof), (ii) in favor of the other
matters set forth in the BCA, and (iii) in opposition to: (A) any Acquisition Proposal or Alternative Transaction and any and all other
proposals (x) for the acquisition of the Company, (y) that would reasonably be expected to delay or impair the ability of the Company
to consummate the BCA, any Ancillary Documents or any of the Transactions, or (z) which are in competition with or materially inconsistent
with the BCA or the Ancillary Documents; (B) other than as contemplated by the BCA, any material change in (x) the present capitalization
of the Company or any amendment of the Company&rsquo;s Organizational Documents or (y) the Company&rsquo;s corporate structure or business;
or (C) any other action or proposal involving the Company or any of its Subsidiaries that is intended, or would reasonably be expected,
to prevent, impede, interfere with, delay, postpone or adversely affect in any material respect the Transactions or would reasonably be
expected to result in any of the conditions to the Company&rsquo;s obligations under the BCA not being fulfilled;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)   to
promptly execute and deliver all related documentation and take such other action in support of the BCA, any Ancillary Documents and any
of the Transactions as shall reasonably be requested by the Company or SPAC in order to carry out the terms and provision of this <U>Section
1</U>, including (i) any actions by written consent of the Company Shareholders presented to Holder, and (ii) any applicable Ancillary
Documents, customary instruments of conveyance and transfer, and any consent, waiver, governmental filing, and any similar or related
documents;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)   not
to deposit, and to cause their Affiliates not to deposit, except as provided in this Agreement, any Shares owned by Holder or its Affiliates
in a voting trust or subject any Shares to any arrangement or agreement with respect to the voting of such Shares, unless specifically
requested to do so by the Company and SPAC in connection with the BCA, the Ancillary Documents and any of the Transactions;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)   except
as contemplated by the BCA or the Ancillary Documents, make, or in any manner participate in, directly or indirectly, a &ldquo;solicitation&rdquo;
of &ldquo;proxies&rdquo; or consents (as such terms are used in the rules of the SEC) or powers of attorney or similar rights to vote,
or seek to advise or influence any Person with respect to the voting of, any capital shares of the Company in connection with any vote
or other action with respect to the Transactions, other than to recommend that the Company Shareholders vote in favor of adoption of the
BCA and the Transactions and any other proposal the approval of which is a condition to the obligations of the parties under the BCA (and
any actions required in furtherance thereof and otherwise as expressly provided by <U>Section 1</U> of this Agreement); and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e)   to
refrain from exercising any dissenters&rsquo; rights or rights of appraisal under applicable law or any preemptive rights granted to the
Holder under the Amended and Restated Articles of Association of the Company at any time with respect to the BCA, the Ancillary Documents
and any of the Transactions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>2.   <FONT STYLE="text-transform: uppercase"><U>O</U></FONT><U>ther
Covenants</U>. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)   <U>No
Transfers</U>. Holder agrees that during the Voting Period it shall not, and shall cause its Affiliates not to, without SPAC&rsquo;s and
the Company&rsquo;s prior written consent, (A) offer for sale, sell (including short sales), transfer, tender, pledge, encumber, assign
or otherwise dispose of (including by gift) (collectively, a &ldquo;<B><I>Transfer</I></B>&rdquo;), or enter into any contract, option,
derivative, hedging or other agreement or arrangement or understanding (including any profit-sharing arrangement) with respect to, or
consent to, a Transfer of, any or all of the Shares (provided, however, that Holder may transfer all or any of the Shares to one or more
of its Affiliates so long as each of such Affiliates agrees to become a party to this Agreement and be subject to the terms hereof applicable
to Holder pursuant to a joinder acceptable to SPAC); (B) grant any proxies or powers of attorney with respect to any or all of the Shares,
except as provided for in this Agreement; (C) permit to exist any lien of any nature whatsoever (other than those imposed by this Agreement,
applicable securities Laws or the Company&rsquo;s Organizational Documents, as in effect on the date hereof) with respect to any or all
of the Shares; or (D) take any action that would have the effect of preventing, impeding, interfering with or adversely affecting Holder&rsquo;s
ability to perform its obligations under this Agreement. The Company hereby agrees, to the extent permitted by applicable Law, that it
shall not permit any Transfer of the Shares in violation of this Agreement. Holder agrees with, and covenants to, SPAC and the Company
that Holder shall not request that the Company register the Transfer (book-entry or otherwise) of any certificate or uncertificated interest
representing any Shares during the term of this Agreement without the prior written consent of SPAC and the Company, and the Company hereby
agrees that it shall not effect any such Transfer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)   <U>Changes
to Shares</U>. In the event of an equity dividend or distribution, or any change in the capital shares of the Company by reason of any
equity dividend or distribution, equity split, recapitalization, combination, conversion, domestication, exchange of shares or the like,
the term &ldquo;Shares&rdquo; shall be deemed to refer to and include the Shares as well as all such equity dividends and distributions
and any securities into which or for which any or all of the Shares may be changed or exchanged or which are received in such transaction.
Holder agrees during the Voting Period to notify SPAC and the Company promptly in writing of the number and type of any additional Shares
acquired by Holder, if any, after the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)   <U>Compliance
with this Agreement; Efforts</U>. Holder agrees to not during the Voting Period take or agree or commit to take any action that would
make any representation and warranty of Holder contained in this Agreement inaccurate in any material respect. Holder further agrees that
it shall use its commercially reasonable efforts to cooperate with SPAC to effect the Transactions, the BCA, the Ancillary Documents and
the provisions of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)   <U>Registration
Statement</U>. During the Voting Period, Holder agrees to provide to SPAC, the Company and their respective Representatives any information
regarding Holder or the Shares that is reasonably requested by SPAC, the Company or their respective Representatives (including Pubco)
for inclusion in the Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e)   <U>Publicity</U>.
Holder shall not issue any press release or otherwise make any public statements with respect to the Transactions or this Agreement without
the prior written approval of the Company and SPAC, except as may be required by applicable Law, by obligations pursuant to any listing
agreement with or rules of any national securities exchange or by the request of any Governmental Authority, in which case, to the extent
legally permitted, Holder will give SPAC a reasonable opportunity to review and comment upon such public statement, and Holder will consider
such comments in good faith. Holder hereby authorizes the Company and SPAC to publish and disclose in any announcement or disclosure required
by the SEC, Nasdaq or the Registration Statement (including all documents and schedules filed with the SEC in connection with the foregoing),
Holder&rsquo;s identity and ownership of the Shares and the nature of Holder&rsquo;s commitments and agreements under this Agreement,
the BCA and any other Ancillary Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.   <B><U>Grant
of Proxy</U>. </B>Holder, with respect to all of the Shares, hereby irrevocably grants to, and appoints, SPAC and any designee of SPAC
(determined in SPAC&rsquo;s sole discretion) as Holder&rsquo;s attorney-in-fact and proxy, with full power of substitution and re-substitution,
for and in Holder&rsquo;s name, to vote, or cause to be voted (including by proxy or written consent, if applicable) any Shares owned
(whether beneficially or of record) by Holder, and revokes all prior proxies given in connection with any of the matters set forth herein.
The proxy and power of attorney granted herein is granted in consideration of SPAC entering into this Agreement and the BCA and incurring
certain related fees and expenses, and shall be deemed to be coupled with an interest, shall be irrevocable during the term of this Agreement
and shall survive the bankruptcy, insolvency or dissolution of Holder, but shall expire at the end of the Voting Period. Holder shall,
from time to time as reasonably requested by SPAC or the Company, execute and deliver such further instruments, agreements or other documents
and take such other actions as may be necessary or advisable to give effect to, confirm, evidence or effectuate the purposes of the proxy
and power of attorney granted by this Section 3. Holder agrees, until this Agreement is terminated in accordance with <U>Section 5(a)</U>,
to vote its Shares in accordance with <U>Section 1</U> above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.   <B><U>Representations
and Warranties of Holder</U></B>. Holder hereby represents and warrants to SPAC and the Company as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)   <U>Binding
Agreement</U>. Holder (i) if a natural person, is of legal age to execute this Agreement and is legally competent to do so and (ii) if
not a natural person, is (A) an entity duly organized and validly existing under the laws of the jurisdiction of its organization and
(B) has all necessary power and authority to execute and deliver this Agreement, to perform its obligations hereunder and to consummate
the transactions contemplated hereby. If Holder is not a natural person, the execution and delivery of this Agreement, the performance
of its obligations hereunder and the consummation of the transactions contemplated hereby by Holder has been duly authorized by all necessary
action on the part of Holder. This Agreement, assuming due authorization, execution and delivery hereof by the other parties hereto, constitutes
a legal, valid and binding obligation of Holder, enforceable against Holder in accordance with its terms (except as such enforceability
may be limited by bankruptcy, insolvency, fraudulent transfer, reorganization, moratorium and other similar laws of general applicability
relating to or affecting creditor&rsquo;s rights, and to general equitable principles). Holder understands and acknowledges that SPAC
is entering into the BCA in reliance upon the execution and delivery of this Agreement by Holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)   <U>Ownership
of Shares</U>. As of the date hereof, Holder has beneficial ownership over the type and number of the Shares set forth under Holder&rsquo;s
name on the signature page hereto, is the lawful owner of such Shares, has the sole power to vote or cause to be voted such Shares, and
has good and valid title to such Shares, free and clear of any and all Liens of any nature or kind whatsoever, other than those imposed
by this Agreement, applicable securities Laws or the Company&rsquo;s Organizational Documents, as in effect on the date hereof. There
are no claims for finder&rsquo;s fees or brokerage commission or other like payments in connection with this Agreement or the transactions
contemplated hereby pursuant to arrangements made by Holder. Except for the Shares set forth under Holder&rsquo;s name on the signature
page hereto, as of the date of this Agreement, Holder is not a beneficial owner or record holder of any: (i) equity securities of the
Company, (ii) securities of the Company having the right to vote on any matters on which the holders of equity securities of the Company
may vote or which are convertible into or exchangeable for, at any time, equity securities of the Company or (iii) options, warrants or
other rights to acquire from the Company any equity securities or securities convertible into or exchangeable for equity securities of
the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)   <U>No
Conflicts</U>. No filing with, or notification to, any Governmental Authority (except for filings, if any, under any securities Laws or
the Israeli Companies Law), and no consent, approval, authorization or permit of any other person is necessary for the execution of this
Agreement by Holder, the performance of its obligations hereunder or the consummation by it of the transactions contemplated hereby. None
of the execution and delivery of this Agreement by Holder, the performance of its obligations hereunder or the consummation by it of the
transactions contemplated hereby shall (i) conflict with or result in any breach of the certificate of incorporation, bylaws or other
comparable organizational documents of Holder, if applicable, (ii) result in, or give rise to, a violation or breach of or a default under
any of the terms of any Contract or obligation to which Holder is a party or by which Holder or any of the Shares or its other assets
may be bound, or (iii) violate any applicable Law or Order, except for any of the foregoing in clauses (i) through (iii) as would not
reasonably be expected to impair Holder&rsquo;s ability to perform its obligations under this Agreement in any material respect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)   <U>No
Inconsistent Agreements</U>. Holder hereby covenants and agrees that, except for this Agreement, Holder (i) has not entered into, nor
will enter into at any time while this Agreement remains in effect, any voting agreement or voting trust with respect to the Shares inconsistent
with Holder&rsquo;s obligations pursuant to this Agreement, (ii) has not granted, nor will grant at any time while this Agreement remains
in effect, a proxy, a consent or power of attorney with respect to the Shares and (iii) has not entered into any agreement or knowingly
taken any action (nor will enter into any agreement or knowingly take any action) that would make any representation or warranty of Holder
contained herein untrue or incorrect in any material respect or have the effect of preventing Holder from performing any of its material
obligations under this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>5.   <U>Miscellaneous</U>.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)   <U>Termination</U>.
Notwithstanding anything to the contrary contained herein, this Agreement shall automatically terminate, and none of SPAC, the Company
or Holder shall have any rights or obligations hereunder, upon the earliest to occur of (i) the mutual written consent of SPAC, the Company
and Holder, (ii) the Closing (following the performance of the obligations of the parties hereunder required to be performed at or prior
to the Closing), and (iii) the date of termination of the BCA in accordance with its terms. The termination of this Agreement shall not
prevent any party hereunder from seeking any remedies (at law or in equity) against another party hereto or relieve such party from liability
for such party&rsquo;s breach of any terms of this Agreement. Notwithstanding anything to the contrary herein, the provisions of this
<U>Section 5(a)</U> shall survive the termination of this Agreement.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)   <U>Binding
Effect; Assignment</U>. This Agreement and all of the provisions hereof shall be binding upon and inure to the benefit of the parties
hereto and their respective permitted successors and assigns. This Agreement and all obligations of Holder are personal to Holder and
may not be assigned, transferred or delegated by Holder at any time without the prior written consent of SPAC and the Company, and any
purported assignment, transfer or delegation without such consent shall be null and void ab initio. Each of the Company and SPAC may freely
assign any or all of its rights under this Agreement, in whole or in part, to any successor entity (whether by merger, consolidation,
equity sale, asset sale or otherwise) without obtaining the consent or approval of Holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)   <U>Third
Parties</U>. Nothing contained in this Agreement or in any instrument or document executed by any party in connection with the transactions
contemplated hereby shall create any rights in, or be deemed to have been executed for the benefit of, any person that is not a party
hereto or thereto or a successor or permitted assign of such a party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)   <U>Arbitration</U>.
Any and all disputes, controversies and claims (other than applications for a temporary restraining order, preliminary injunction, permanent
injunction or other equitable relief or application for enforcement of a resolution under this <U>Section 5(d</U>) arising out of, related
to, or in connection with the BCA or any agreements or documents ancillary thereto, including but not limited to this Agreement, or the
transactions contemplated thereby (a &ldquo;<B><I>Dispute</I></B>&rdquo;) shall be governed by this <U>Section 5(d)</U>. A party must,
in the first instance, provide written notice of any Disputes to the other parties subject to such Dispute, which notice must provide
a reasonably detailed description of the matters subject to the Dispute. The parties involved in such Dispute shall seek to resolve the
Dispute on an amicable basis within ten (10) Business Days of the notice of such Dispute being received by such other parties subject
to such Dispute (the &ldquo;<B><I>Resolution Period</I></B>&rdquo;); <U>provided</U>, that if any Dispute would reasonably be expected
to have become moot or otherwise irrelevant if not decided within sixty (60) days after the occurrence of such Dispute, then there shall
be no Resolution Period with respect to such Dispute. Any Dispute that is not resolved during the Resolution Period may immediately be
referred to and finally resolved by arbitration pursuant to the then-existing Expedited Procedures (as defined in the AAA Procedures)
of the Commercial Arbitration Rules (the &ldquo;<B><I>AAA Procedures</I></B>&rdquo;) of the American Arbitration Association (the &ldquo;<B><I>AAA</I></B>&rdquo;).
Any party involved in such Dispute may submit the Dispute to the AAA to commence the proceedings after the Resolution Period. To the extent
that the AAA Procedures and this Agreement are in conflict, the terms of this Agreement shall control. The arbitration shall be conducted
by one arbitrator nominated by the AAA promptly (but in any event within five (5) Business Days) after the submission of the Dispute to
the AAA and reasonably acceptable to each party subject to the Dispute, which arbitrator shall be a commercial lawyer with substantial
experience arbitrating disputes under acquisition agreements. The arbitrator shall accept his or her appointment and begin the arbitration
process promptly (but in any event within five (5) Business Days) after his or her nomination and acceptance by the parties subject to
the Dispute. The proceedings shall be streamlined and efficient. The arbitrator shall decide the Dispute in accordance with the substantive
law of the State of Delaware. Time is of the essence. Each party subject to the Dispute shall submit a proposal for resolution of the
Dispute to the arbitrator within twenty (20) days after confirmation of the appointment of the arbitrator. The arbitrator shall have the
power to order any party to do, or to refrain from doing, anything consistent with this Agreement, the other Ancillary Documents, the
BCA and applicable Law, including to perform its contractual obligation(s); provided, that the arbitrator shall be limited to ordering
pursuant to the foregoing power (and, for the avoidance of doubt, shall order) the relevant party (or parties, as applicable) to comply
with only one or the other of the proposals. The arbitrator&rsquo;s award shall be in writing and shall include a reasonable explanation
of the arbitrator&rsquo;s reason(s) for selecting one or the other proposal. The seat of arbitration shall be in the State of Delaware.
The language of the arbitration shall be English.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e)   <U>Governing
Law; Jurisdiction</U>. This Agreement and any dispute or controversy arising out of or relating to this Agreement shall be governed by
and construed in accordance with the laws of the State of Delaware, without regard to the conflict of law principles thereof. Subject
to <U>Section 5(d)</U>, all Actions arising out of or relating to this Agreement shall be heard and determined exclusively in the Chancery
Court of the State of Delaware (or, if such court lacks subject matter jurisdiction, in any appropriate Delaware State or federal court)
(or in any appellate court thereof) (the &ldquo;<B><I>Specified Courts</I></B>&rdquo;). Subject to <U>Section 5(d)</U>, each party hereto
hereby&nbsp;(i) submits to the exclusive jurisdiction of any Specified Court for the purpose of any Action arising out of or relating
to this Agreement brought by any party hereto and (ii)&nbsp;irrevocably waives, and agrees not to assert by way of motion, defense or
otherwise, in any such Action, any claim that it is not subject personally to the jurisdiction of the above-named courts, that its property
is exempt or immune from attachment or execution, that the Action is brought in an inconvenient forum, that the venue of the Action is
improper, or that this Agreement or the transactions contemplated hereby may not be enforced in or by any Specified Court. Each party
agrees that a final judgment in any Action shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in
any other manner provided by Law. Each party irrevocably consents to the service of the summons and complaint and any other process in
any other action or proceeding relating to the transactions contemplated by this Agreement, on behalf of itself, or its property, by personal
delivery of copies of such process to such party at the applicable address set forth or referred to in&nbsp;<U>Section 5(h)</U>. Nothing
in this&nbsp;<U>Section 5(d)</U>&nbsp;shall affect the right of any party to serve legal process in any other manner permitted by applicable
law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f)   <U>WAIVER
OF JURY TRIAL</U>. EACH OF THE PARTIES HERETO HEREBY WAIVES TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW ANY RIGHT IT MAY HAVE TO
A TRIAL BY JURY WITH RESPECT TO ANY ACTION DIRECTLY OR INDIRECTLY ARISING OUT OF, UNDER OR IN CONNECTION WITH THIS AGREEMENT OR THE TRANSACTIONS
CONTEMPLATED HEREBY. EACH PARTY HERETO (i) CERTIFIES THAT NO REPRESENTATIVE OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE,
THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF ANY ACTION, SEEK TO ENFORCE THAT FOREGOING WAIVER AND (ii) ACKNOWLEDGES THAT IT AND THE
OTHER PARTIES HERETO HAVE BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS&nbsp;<U>SECTION
5(f)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(g)   <U>Interpretation</U>.
The titles and subtitles used in this Agreement are for convenience only and are not to be considered in construing or interpreting this
Agreement. In this Agreement, unless the context otherwise requires: (i) any pronoun used shall include the corresponding masculine, feminine
or neuter forms, and the singular form of nouns, pronouns and verbs shall include the plural and vice versa; (ii) &ldquo;including&rdquo;
(and with correlative meaning &ldquo;include&rdquo;) shall be deemed in each case to be followed by the words &ldquo;without limitation&rdquo;;
(iii) the words &ldquo;herein,&rdquo; &ldquo;hereto,&rdquo; and &ldquo;hereby&rdquo; and other words of similar import shall be deemed
in each case to refer to this Agreement as a whole and not to any particular section or other subdivision of this Agreement; and (iv)
the term &ldquo;or&rdquo; means &ldquo;and/or&rdquo;. The parties have participated jointly in the negotiation and drafting of this Agreement.
Consequently, in the event an ambiguity or question of intent or interpretation arises, this Agreement shall be construed as if drafted
jointly by the parties hereto, and no presumption or burden of proof shall arise favoring or disfavoring any party by virtue of the authorship
of any provision of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(h)   <FONT STYLE="font-size: 10pt"><U>Notices</U>.
All notices, consents, waivers and other communications hereunder shall be in writing and shall be deemed to have been duly given when
delivered (i) in person, (ii) by email, with affirmative confirmation of receipt, (iii) one Business Day after being sent, if sent by
reputable, internationally recognized overnight courier service or (iv) three (3) Business Days after being mailed, if sent by registered
or certified mail, pre-paid and return receipt requested, in each case to the applicable party at the following addresses (or at such
other address for a party as shall be specified by like notice):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 5.4pt; padding-bottom: 5.4pt; width: 55%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I></I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>If to SPAC, to:</I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Launch One Acquisition Corp<BR>
    180 Grand Avenue, Suite 1530<BR>
    Oakland, CA 94612, U.S.A.<BR>
    Attn: Chris Ehrlich, Chief Executive Officer<BR>
    Telephone No.: (415) 994-0582<BR>
    E-mail: chris@launchpad.vc</P></TD>
    <TD STYLE="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 5.4pt; padding-bottom: 5.4pt; width: 45%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I></I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>with copies (which shall not constitute notice) to:</I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ellenoff Grossman &amp; Schole LLP<BR>
    1345 Avenue of the Americas, 11th Floor<BR>
    New York, New York 10105, U.S.A.<BR>
    Attn: Matthew A. Gray, Esq. and<BR>
    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Stuart Neuhauser, Esq.<BR>
    Telephone No.: (212) 370-1300<BR>
    E-mail: mgray@egsllp.com;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;sneuhauser@egsllp.com</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>and</I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Goldfarb Gross Seligman &amp; Co.<BR>
    One Azrieli Center, Round Tower<BR>
    Tel Aviv, Israel 6701101<BR>
    Attn: Aaron M. Lampert and Daniel Kahn<BR>
    Telephone No.: 03-607-4444<BR>
    E-mail: aaron.lampert@goldfarb.com;<BR>
    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;daniel.kahn@goldfarb.com</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; padding-top: 5.4pt; padding-bottom: 5.4pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>If to the Company, to:</I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Minovia Therapeutics Ltd.<BR>
    3 HaSadna St.<BR>
    Tirat Carmel, 3902603, Israel<BR>
    Attn: Natalie Yivgi Ohana, Chief Executive Officer<BR>
    Telephone No.: +972-545833727<BR>
    E-mail: natalie@minoviatx.com</P></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-top: 5.4pt; padding-bottom: 5.4pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>with copies (which will not constitute notice) to:</I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Bevilacqua PLLC<BR>
    1050 Connecticut Avenue, NW, Suite 500<BR>
    Washington, DC 20036<BR>
    Attn: Louis A. Bevilacqua, Esq.<BR>
    Telephone No.: (202) 869-0888 (ext. 100)<BR>
    E-mail: lou@bevilacquapllc.com</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>and</I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Gornitzky &amp; Co.<BR>
    Vitania Tel-Aviv Tower<BR>
    20 HaHarash Street,<BR>
    Tel Aviv, Israel 6761310<BR>
    Attn:&#9;Chaim Friedland and Timor Belan<BR>
    Telephone No.: 03-710-9191<BR>
    E-mail: friedland@gornitzky.com;<BR>
    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;timorb@gornitzky.com</P></TD></TR>
  <TR>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; vertical-align: top; padding-top: 5.4pt; padding-bottom: 5.4pt; font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt"><I>If to Holder, to: </I>the address set forth under Holder&rsquo;s name on the signature page hereto, with a copy (which will not constitute notice) to, if not the party sending the notice, each of the Company and SPAC (and each of their copies for notices hereunder).</FONT></TD>
    </TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i)   <U>Amendments
and Waivers</U>. Any term of this Agreement may be amended and the observance of any term of this Agreement may be waived (either generally
or in a particular instance, and either retroactively or prospectively) only with the written consent of SPAC, the Company and the Holder.
No failure or delay by a party in exercising any right hereunder shall operate as a waiver thereof. No waivers of or exceptions to any
term, condition, or provision of this Agreement, in any one or more instances, shall be deemed to be or construed as a further or continuing
waiver of any such term, condition, or provision.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(j)   <U>Severability</U>.
In case any provision in this Agreement shall be held invalid, illegal or unenforceable in a jurisdiction, such provision shall be modified
or deleted, as to the jurisdiction involved, only to the extent necessary to render the same valid, legal and enforceable, and the validity,
legality and enforceability of the remaining provisions hereof shall not in any way be affected or impaired thereby nor shall the validity,
legality or enforceability of such provision be affected thereby in any other jurisdiction. Upon such determination that any term or other
provision is invalid, illegal or incapable of being enforced, the parties will substitute for any invalid, illegal or unenforceable provision
a suitable and equitable provision that carries out, so far as may be valid, legal and enforceable, the intent and purpose of such invalid,
illegal or unenforceable provision.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(k)   <U>Specific
Performance</U>. Each of Holder and the Company acknowledges that its obligations under this Agreement are unique, recognizes and affirms
that in the event of a breach of this Agreement by such party, money damages will be inadequate and SPAC will have not adequate remedy
at law, and agree that irreparable damage would occur in the event that any of the provisions of this Agreement were not performed by
Holder or the Company in accordance with their specific terms or were otherwise breached. Accordingly, SPAC shall be entitled to an injunction
or restraining order to prevent breaches of this Agreement by Holder or the Company and to enforce specifically the terms and provisions
hereof, without the requirement to post any bond or other security or to prove that money damages would be inadequate, this being in addition
to any other right or remedy to which such party may be entitled under this Agreement, at law or in equity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4.5pt; text-align: justify; text-indent: 1in">(l)   <U>Expenses</U>.
Each party shall be responsible for its own fees and expenses (including the fees and expenses of investment bankers, accountants and
counsel) in connection with the entering into of this Agreement, the performance of its obligations hereunder and the consummation of
the transactions contemplated hereby; provided, that in the event of any Action arising out of or relating to this Agreement, the non-prevailing
party in any such Action will pay its own expenses and the reasonable documented out-of-pocket expenses, including reasonable attorneys&rsquo;
fees and costs, reasonably incurred by the prevailing party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4.5pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4.5pt; text-align: justify; text-indent: 1in">(m)   <U>No
Partnership, Agency or Joint Venture</U>. This Agreement is intended to create a contractual relationship among Holder, the Company and
SPAC, and is not intended to create, and does not create, any agency, partnership, joint venture or any like relationship among the parties
hereto or among any other Company Shareholders entering into voting agreements with the Company or SPAC. Holder is not affiliated with
any other holder of securities of the Company entering into a voting agreement with the Company or SPAC in connection with the BCA and
has acted independently regarding its decision to enter into this Agreement. Nothing contained in this Agreement shall be deemed to vest
in SPAC any direct or indirect ownership or incidence of ownership of or with respect to any Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4.5pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(n)   <U>Further
Assurances</U>. From time to time, at another party&rsquo;s request and without further consideration, each party shall execute and deliver
such additional documents and take all such further action as may be reasonably necessary or desirable to consummate the transactions
contemplated by this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(o)   <U>Fiduciary
Duties</U>. Notwithstanding anything in this Agreement to the contrary: (i) Holder makes no agreement or understanding herein in any capacity
other than in Holder&rsquo;s capacity as a record holder and beneficial owner of the Shares, and not in Holder&rsquo;s capacity as a director
or officer of the Company or any of its Subsidiaries, if applicable, (ii) nothing herein will be construed to limit or affect any action
or inaction by Holder or any Representative or Affiliate of Holder, as applicable, serving on the Board of Directors of the Company or
any of its Subsidiaries, or as an officer of the Company or any of its Subsidiaries, acting in such person&rsquo;s capacity as a director
or officer of the Company or such Subsidiary, and (iii) no exercise of fiduciary duties or action or inaction taken in such capacity as
a director or officer of the Company or any of its Subsidiaries shall be deemed to constitute a breach of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(p)   <U>Entire
Agreement</U>. This Agreement (together with the BCA to the extent referred to herein) constitutes the full and entire understanding and
agreement among the parties with respect to the subject matter hereof, and any other written or oral agreement relating to the subject
matter hereof existing between the parties is expressly canceled;&nbsp;<U>provided</U>, that, for the avoidance of doubt, the foregoing
shall not affect the rights and obligations of the parties under the BCA or any Ancillary Document. Notwithstanding the foregoing, nothing
in this Agreement shall limit any of the rights or remedies of SPAC or the Company, or any of the obligations of Holder under any other
agreement between Holder and either SPAC or the Company, respectively, or any certificate or instrument executed by Holder in favor of
SPAC or the Company, and nothing in any other agreement, certificate or instrument shall limit any of the rights or remedies of SPAC or
the Company or any of the obligations of Holder under this Agreement. This Agreement shall not be effective or binding upon Holder until
such time as the BCA is executed by each of the parties thereto (other than, for the avoidance of doubt, SPAC Merger Sub).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(q)   <U>Counterparts;
Facsimile</U>. This Agreement may also be executed and delivered by facsimile or electronic signature or by email in portable document
format in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the
same instrument.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><I>{Remainder of Page Intentionally Left Blank;
Signature Page Follows}</I></B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>




<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B></B></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>IN WITNESS WHEREOF</B>, the parties have executed
this Voting Agreement as of the date first written above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I><U>SPAC:</U></I></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>LAUNCH ONE ACQUISITION CORP.</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 40%">&nbsp;</TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 35%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I><U>The Company:</U></I></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>MINOVIA THERAPEUTICS LTD.</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><I>{Additional Signature on the Following Page}<BR STYLE="clear: both">
</I>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><I>{Signature Page to Voting Agreement}</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B></B></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>IN WITNESS WHEREOF</B>,
in addition to the signatures set forth above or in counterpart documents, the party below has executed this Voting Agreement as of the
date first written above.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 40%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I></I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I><U>Holder</U>:</I></P></TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Name of Holder:&nbsp;<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Number and Type of Shares</U>:</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </U>Company
    Ordinary Shares</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Address for Notice:</U></FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;</U></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Telephone No.:<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:</FONT><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><I>{Signature Page to Voting Agreement}</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 12; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>5
<FILENAME>ea024761201ex10-3_launch.htm
<DESCRIPTION>SPONSOR AGREEMENT, DATED AS OF JUNE 25, 2025, BY AND AMONG THE COMPANY, THE SPONSOR, PUBCO, AND THE SELLER REPRESENTATIVE
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Exhibit 10.3</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B><I>EXECUTION COPY</I></B></P>

<P STYLE="text-align: right; margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"><B>CONFIDENTIAL</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Launch One Sponsor LLC<BR>
<FONT STYLE="font-weight: normal">c/o Launchpad Capital Management<BR>
180 Grand Avenue, Suite 1530<BR>
Oakland, CA 94612</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">June 25, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Mito US One Ltd.<BR>
c/o Minovia Therapeutics Ltd.<BR>
3 HaSadna St.<BR>
Tirat Carmel, 3902603, Israel<BR>
Attn: Natalie Yivgi Ohana, Chief Executive Officer</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Natalie Yivgi Ohana<BR>
Minovia Therapeutics Ltd.<BR>
3 HaSadna St.<BR>
Tirat Carmel, 3902603, Israel</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Re:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Sponsor
Letter Agreement</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dear Natalie:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">Reference is hereby made to
that certain Business Combination Agreement, dated as of the date hereof (as it may be amended from time to time in accordance with the
terms thereof, the &ldquo;<B><I>BCA</I></B>&rdquo;), by and among (i) Launch One Acquisition Corp., a Cayman Islands exempted company
limited by shares (&ldquo;<B><I>SPAC</I></B>&rdquo;), (ii) Launch One Sponsor LLC, a Delaware limited liability company, in the capacity
thereunder as the SPAC Representative, (iii) Minovia Therapeutics Ltd., an Israeli company limited by shares (the &ldquo;<B><I>Company</I></B>&rdquo;),
(iv) Natalie Yivgi-Ohana, in the capacity as the Seller Representative thereunder, (v) Mito US One Ltd., an Israeli company limited by
shares (&ldquo;<B><I>Pubco</I></B>&rdquo;), (vi) Mito Sub Israel Ltd., an Israeli company limited by shares and a wholly-owned subsidiary
of Pubco (&ldquo;<B><I>Company Merger Sub</I></B>&rdquo;), and (vii) upon the execution of a joinder agreement to the BCA after the date
hereof, a to-be-formed Cayman Islands exempted company limited by shares (&ldquo;<B><I>SPAC Merger Sub</I></B>&rdquo;). Any capitalized
term used but not defined herein will have the meanings ascribed thereto in the BCA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">In connection with the transactions
contemplated by the BCA, Launch One Sponsor LLC, a Delaware limited liability company (the &ldquo;<B><I>Sponsor</I></B>&rdquo;), has agreed
to enter into this Agreement with Pubco and the Seller Representative relating to certain of the 5,750,000 SPAC Class B Ordinary Shares
(together with any Pubco Ordinary Shares issued in exchange therefor in the SPAC Merger, the &ldquo;<B><I>Founder Shares</I></B>&rdquo;)
held by the Sponsor that were initially purchased by the Sponsor in a private placement prior to the IPO.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24pt">For good and valuable consideration, the receipt
and sufficiency of which are hereby acknowledged, Sponsor, Pubco and the Seller Representative hereby agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in">1.</TD><TD STYLE="text-align: justify">The Sponsor hereby agrees that, upon and subject to the Closing, the Sponsor will subject 1,293,750 of
the Founder Shares (the &ldquo;<B><I>Sponsor Earnout Shares</I></B>&rdquo;) to the vesting, forfeiture and transfer restrictions set forth
in this Agreement. Notwithstanding anything to the contrary herein, if at or prior to the Closing the Sponsor transfers any Founder Shares
to any third-party investor who provides Transaction Financing, the number of Founder Shares so transferred shall reduce the number of
Sponsor Earnout Shares hereunder. Unless otherwise agreed in writing by the Sponsor and the investor receiving such Founder Shares, any
such transferred Founder Shares shall not be subject to the terms and conditions of this Agreement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in">2.</TD><TD STYLE="text-align: justify">The Sponsor hereby agrees that from and after the Closing until the date that it is finally determined
in accordance with Section 1.13 of the BCA that a Triggering Event has occurred and the Eligible Earnout Recipients are entitled to receive
the Earnout Shares (an &ldquo;<B><I>Earnout Release</I></B>&rdquo;), it will not (i) lend, offer, assign, sell, contract to sell, sell
any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, or otherwise
transfer or dispose of, directly or indirectly, any Sponsor Earnout Shares, (ii) enter into any swap or other arrangement that transfers
to another, in whole or in part, any of the economic consequences of ownership of the Sponsor Earnout Shares, or (iii) publicly announce
the intention to do any of the foregoing, whether any such transaction described in clauses (i), (ii) or (iii) above is to be settled
by delivery of Sponsor Earnout Shares or other securities, in cash or otherwise (any of the foregoing described in clauses (i), (ii) or
(iii), a &ldquo;<B><I>Prohibited Transfer</I></B>&rdquo;). The foregoing sentence shall not apply to the transfer of any or all of the
Sponsor Earnout Shares owned by the Sponsor (I) by gift, will or intestate succession upon the death of the Sponsor, (II) to any Permitted
Transferee (as defined below), (III) pursuant to a court order or settlement agreement related to the distribution of assets in connection
with the dissolution of marriage or civil union or pursuant to a domestic relations order, (IV) to Pubco in accordance with the requirements
of the BCA, or (V) required by virtue of the laws of the Cayman Islands or the State of Israel, as the case may be; provided, however,
that in the of cases of clauses (I), (II) or (III) it shall be a condition to such transfer that the transferee executes and delivers
to Pubco an agreement stating that the transferee is receiving and holding the Sponsor Earnout Shares subject to the provisions of this
Agreement applicable to the Sponsor, and there shall be no further transfer of such Sponsor Earnout Shares except in accordance with this
Agreement. As used in this Agreement, the term &ldquo;<B><I>Permitted Transferee</I></B>&rdquo; shall mean: (A) the members of the Sponsor&rsquo;s
immediate family (for purposes of this Agreement, &ldquo;immediate family&rdquo; shall mean with respect to any natural person, any of
the following: such person&rsquo;s spouse, the siblings of such person and their spouses, and the direct descendants and ascendants (including
adopted and step children and parents) of such person and his or her spouse and siblings), (B) any trust or charitable organization for
the direct or indirect benefit of the Sponsor or the immediate family of the Sponsor, (C) if the Sponsor is a trust, the trustor or beneficiary
of such trust or to the estate of a beneficiary of such trust, (D) if the Sponsor is an entity, as a distribution to limited partners,
shareholders, members of, or owners of similar equity interests in the Sponsor.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in">3.</TD><TD STYLE="text-align: justify">Upon the occurrence of an Earnout Release, all Sponsor Earnout Shares shall vest in full and all restrictions
of the Sponsor under this Agreement with respect to the Sponsor Earnout Shares shall cease and become null and void and be of no further
force or effect.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in">4.</TD><TD STYLE="text-align: justify">In the event that it is finally determined in accordance with Section 1.13 of the BCA that the Earnout
Period has ended and no Triggering Event has occurred during the Earnout Period and the Eligible Earnout Recipients no longer have the
contingent right to receive any Earnout Shares under Section 1.13 of the BCA, the Sponsor shall, promptly after such final determination,
surrender the Sponsor Earnout Shares to Pubco for cancellation and the Sponsor Earnout Shares will be cancelled by Pubco promptly after
its receipt thereof.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in">5.</TD><TD STYLE="text-align: justify">Until and unless the Sponsor Earnout Shares are surrendered to Pubco for cancellation in accordance with
<U>Section 4</U> above, the Sponsor shall have full ownership rights to the Sponsor Earnout Shares, including the right to vote such shares
and to receive dividends and distributions thereon.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in">6.</TD><TD STYLE="text-align: justify">Notwithstanding anything to the contrary contained in this Agreement, in the event that the Minimum Cash
Condition set forth in Section 7.2(d) of the BCA is not satisfied as of the Closing, but the Company and Pubco provide a written waiver
of such Minimum Cash Condition and the Closing nonetheless occurs (the foregoing, a &ldquo;<B><I>Minimum Cash Condition Waiver</I></B>&rdquo;),
then, unless otherwise agreed in writing by the Company, Pubco and the Sponsor, at the Closing, the Sponsor will deposit in escrow with
Continental Stock Transfer &amp; Trust Company or another escrow agent reasonably acceptable to the parties (the &ldquo;<B><I>Sponsor
Earnout Escrow Agent</I></B>&rdquo;) a number of Sponsor Earnout Shares (the &ldquo;<B><I>Escrowed Sponsor Earnout Shares</I></B>&rdquo;)
equal to (i) $23,000,000 minus the Net Cash, divided by (ii) the Redemption Price, up to a maximum of all of the Sponsor Earnout Shares.
The cost of establishing and maintaining the escrow with the Escrow Agent will be paid by Pubco. Pubco agrees that in the event that a
Minimum Cash Condition Waiver occurs, Pubco will use its reasonable best efforts to enter into the CCOD as promptly as practicable after
the Closing, and reasonably cooperate with Sponsor in the Sponsor&rsquo;s efforts to arrange the CCOD facility. If Pubco enters into the
CCOD, upon the registration statement for the CCOD becoming effective with the SEC, the Escrowed Sponsor Earnout Shares will be released
from escrow and returned to the Sponsor, but will still be subject to the vesting, transfer restrictions and forfeiture requirements applicable
to the Sponsor Earnout Shares, if such vesting requirements have not yet been met at such time.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in">7.</TD><TD STYLE="text-align: justify">No party hereto may assign either this Agreement or any of its rights, interests, or obligations hereunder
without the prior written consent of the other parties; provided, that in the event that the Sponsor liquidates and distributes to its
members all securities of Pubco that it owns in accordance with its organizational documents, Sponsor may, without obtaining the consent
of any other party hereto, transfer the Sponsor Earnout Shares and its rights and obligations under this Agreement to its members so long
as such members agree in writing to be bound by the terms of this Agreement that apply to Sponsor hereunder. Any purported assignment
in violation of this <U>Section 6</U> shall be void and ineffectual and shall not operate to transfer or assign any interest or title
to the purported assignee. This Agreement shall be binding on the undersigned and their respective successors and permitted assigns.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in">8.</TD><TD STYLE="text-align: justify">This Agreement (including the BCA to the extent incorporated herein) constitutes the entire agreement
and understanding of the parties hereto in respect of the subject matter hereof and supersedes all prior understandings, agreements, or
representations by or among the parties hereto, written or oral, to the extent they relate in any way to the subject matter hereof. This
Agreement may not be changed, amended or modified as to any particular provision, except by a written instrument executed by all parties
hereto. No provision of this Agreement may be waived except in a writing signed by the party against whom enforcement of such waiver is
sought. No failure or delay by a party in exercising any right hereunder shall operate as a waiver thereof nor shall any single or partial
exercise thereof preclude any other or further exercise of any other right hereunder.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in">9.</TD><TD STYLE="text-align: justify">Any notice, consent or request to be given in connection with any of the terms or provisions of this Agreement
shall be in writing and shall be sent in the same manner as provided in Section 10.3 of the BCA. Unless otherwise specified in writing
by the Sponsor, notices to the Sponsor shall be sent to the address of the SPAC Representative set forth in the BCA.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in">10.</TD><TD STYLE="text-align: justify">This Agreement shall be construed, interpreted, governed and enforced in a manner consistent with the
provisions of the BCA. The provisions set forth in Sections 10.2, 10.5 through 10.10, and 10.14 through 10.16, of the BCA, as in effect
as of the date hereof, are hereby incorporated by reference into, and shall be deemed to apply to, this Agreement as if all references
to the &ldquo;Agreement&rdquo; in such sections were instead references to this Agreement, and the references therein to the &ldquo;Parties&rdquo;
were instead to the parties to this Agreement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in">11.</TD><TD STYLE="text-align: justify">This Agreement shall terminate at such time, if any, as the BCA is terminated in accordance with its terms
prior to the Closing, and upon such termination this Agreement shall be null and void and of no effect whatsoever, and the parties hereto
shall have no obligations under this Agreement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>{Remainder of Page Left Blank; Signature Page
Follows}</I></P>




<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Please indicate your agreement to the foregoing
by signing in the space provided below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Launch One Sponsor LLC</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 35%"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ <I><U STYLE="text-decoration: none">Chris Ehrlich</U></I></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: </FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chris Ehrlich</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><B><I>Accepted and agreed, effective as of the date
first set forth above:</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><B><I></I></B>&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Mito US One Ltd.</B></FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 35%"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="text-decoration: none">/s/ <I>Natalie Yivgi-Ohana</I></FONT></FONT></TD>
    <TD STYLE="width: 60%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: </FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Natalie Yivgi-Ohana</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U STYLE="text-decoration: none">/s/ <I>Natalie Yivgi-Ohana</I></U></FONT></TD>
    <TD STYLE="width: 60%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Natalie Yivgi-Ohana</B>,</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">solely in the capacity as the Seller Representative under the BCA</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><I>{Signature Page to Sponsor Letter Agreement}</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>lpaa-20250625.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.1a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: /qpZs7xRiXgen8uBYXYsWaWKKaPtyJ1xeYkxuG97fWkq7yklxkb2rSBi13bWMR0M -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:srt-types="http://fasb.org/srt-types/2025" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:LPAA="http://launchoneacquisitioncorp.com/20250625" elementFormDefault="qualified" targetNamespace="http://launchoneacquisitioncorp.com/20250625">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://launchoneacquisitioncorp.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="lpaa-20250625_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="lpaa-20250625_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="lpaa-20250625_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" />
    <import namespace="http://fasb.org/us-gaap/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd" />
    <import namespace="http://fasb.org/us-types/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2025" schemaLocation="https://xbrl.sec.gov/country/2025/country-2025.xsd" />
    <import namespace="http://fasb.org/srt/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd" />
    <import namespace="http://fasb.org/srt-types/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd" />
    <element id="LPAA_UnitsEachConsistingOfOneClassOrdinaryShareAndOnehalfOfOneRedeemableWarrantMember" name="UnitsEachConsistingOfOneClassOrdinaryShareAndOnehalfOfOneRedeemableWarrantMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="LPAA_ClassOrdinarySharesParValue0.0001PerShareMember" name="ClassOrdinarySharesParValue0.0001PerShareMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="LPAA_WarrantsEachWholeWarrantExercisableForOneClassOrdinaryShareAtExercisePriceOf11.50PerShareMember" name="WarrantsEachWholeWarrantExercisableForOneClassOrdinaryShareAtExercisePriceOf11.50PerShareMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>7
<FILENAME>lpaa-20250625_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.1a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="lpaa-20250625.xsd#Cover" roleURI="http://launchoneacquisitioncorp.com/role/Cover" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://launchoneacquisitioncorp.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="lpaa-20250625.xsd#LPAA_UnitsEachConsistingOfOneClassOrdinaryShareAndOnehalfOfOneRedeemableWarrantMember" xlink:label="loc_LPAAUnitsEachConsistingOfOneClassOrdinaryShareAndOnehalfOfOneRedeemableWarrantMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_LPAAUnitsEachConsistingOfOneClassOrdinaryShareAndOnehalfOfOneRedeemableWarrantMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="lpaa-20250625.xsd#LPAA_ClassOrdinarySharesParValue0.0001PerShareMember" xlink:label="loc_LPAAClassOrdinarySharesParValue0.0001PerShareMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_LPAAClassOrdinarySharesParValue0.0001PerShareMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="lpaa-20250625.xsd#LPAA_WarrantsEachWholeWarrantExercisableForOneClassOrdinaryShareAtExercisePriceOf11.50PerShareMember" xlink:label="loc_LPAAWarrantsEachWholeWarrantExercisableForOneClassOrdinaryShareAtExercisePriceOf11.50PerShareMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_LPAAWarrantsEachWholeWarrantExercisableForOneClassOrdinaryShareAtExercisePriceOf11.50PerShareMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement_50" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport_50" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport_50" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport_50" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport_50" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate_50" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate_50" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate_50" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus_50" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus_50" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate_50" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber_50" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName_50" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey_50" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber_50" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber_50" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode_50" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1_50" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2_50" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3_50" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown_50" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince_50" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry_50" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode_50" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion_50" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode_50" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber_50" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="loc_deiExtension_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension_50" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications_50" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial_50" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer_50" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer_50" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle_50" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag_50" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol_50" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName_50" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle_50" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation_50" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm_50" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements_50" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer_50" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers_50" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus_50" xlink:type="arc" order="45" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent_50" xlink:type="arc" order="46" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory_50" xlink:type="arc" order="47" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness_50" xlink:type="arc" order="48" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany_50" xlink:type="arc" order="49" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod_50" xlink:type="arc" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber_50" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany_50" xlink:type="arc" order="53" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat_50" xlink:type="arc" order="54" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent_50" xlink:type="arc" order="55" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding_50" xlink:type="arc" order="56" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock_50" xlink:type="arc" order="57" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>8
<FILENAME>lpaa-20250625_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.1a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="lpaa-20250625.xsd#LPAA_UnitsEachConsistingOfOneClassOrdinaryShareAndOnehalfOfOneRedeemableWarrantMember" xlink:label="LPAA_UnitsEachConsistingOfOneClassOrdinaryShareAndOnehalfOfOneRedeemableWarrantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LPAA_UnitsEachConsistingOfOneClassOrdinaryShareAndOnehalfOfOneRedeemableWarrantMember" xlink:to="LPAA_UnitsEachConsistingOfOneClassOrdinaryShareAndOnehalfOfOneRedeemableWarrantMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LPAA_UnitsEachConsistingOfOneClassOrdinaryShareAndOnehalfOfOneRedeemableWarrantMember_lbl" xml:lang="en-US">Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant</link:label>
      <link:loc xlink:type="locator" xlink:href="lpaa-20250625.xsd#LPAA_ClassOrdinarySharesParValue0.0001PerShareMember" xlink:label="LPAA_ClassOrdinarySharesParValue0.0001PerShareMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LPAA_ClassOrdinarySharesParValue0.0001PerShareMember" xlink:to="LPAA_ClassOrdinarySharesParValue0.0001PerShareMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LPAA_ClassOrdinarySharesParValue0.0001PerShareMember_lbl" xml:lang="en-US">Class A ordinary shares, par value $0.0001 per share</link:label>
      <link:loc xlink:type="locator" xlink:href="lpaa-20250625.xsd#LPAA_WarrantsEachWholeWarrantExercisableForOneClassOrdinaryShareAtExercisePriceOf11.50PerShareMember" xlink:label="LPAA_WarrantsEachWholeWarrantExercisableForOneClassOrdinaryShareAtExercisePriceOf11.50PerShareMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LPAA_WarrantsEachWholeWarrantExercisableForOneClassOrdinaryShareAtExercisePriceOf11.50PerShareMember" xlink:to="LPAA_WarrantsEachWholeWarrantExercisableForOneClassOrdinaryShareAtExercisePriceOf11.50PerShareMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LPAA_WarrantsEachWholeWarrantExercisableForOneClassOrdinaryShareAtExercisePriceOf11.50PerShareMember_lbl" xml:lang="en-US">Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>9
<FILENAME>lpaa-20250625_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.1a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="lpaa-20250625.xsd#Cover" roleURI="http://launchoneacquisitioncorp.com/role/Cover" />
    <link:presentationLink xlink:type="extended" xlink:role="http://launchoneacquisitioncorp.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="lpaa-20250625.xsd#LPAA_UnitsEachConsistingOfOneClassOrdinaryShareAndOnehalfOfOneRedeemableWarrantMember" xlink:label="loc_LPAAUnitsEachConsistingOfOneClassOrdinaryShareAndOnehalfOfOneRedeemableWarrantMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_LPAAUnitsEachConsistingOfOneClassOrdinaryShareAndOnehalfOfOneRedeemableWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lpaa-20250625.xsd#LPAA_ClassOrdinarySharesParValue0.0001PerShareMember" xlink:label="loc_LPAAClassOrdinarySharesParValue0.0001PerShareMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_LPAAClassOrdinarySharesParValue0.0001PerShareMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lpaa-20250625.xsd#LPAA_WarrantsEachWholeWarrantExercisableForOneClassOrdinaryShareAtExercisePriceOf11.50PerShareMember" xlink:label="loc_LPAAWarrantsEachWholeWarrantExercisableForOneClassOrdinaryShareAtExercisePriceOf11.50PerShareMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_LPAAWarrantsEachWholeWarrantExercisableForOneClassOrdinaryShareAtExercisePriceOf11.50PerShareMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Jun. 25, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 25,  2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-42173<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">LAUNCH ONE ACQUISITION CORP.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0002015502<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">98-1781481<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">E9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">180 Grand Avenue<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 153<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Oakland<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94612<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">510<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">692-9600<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Elected Not To Use the Extended Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=LPAA_UnitsEachConsistingOfOneClassOrdinaryShareAndOnehalfOfOneRedeemableWarrantMember', window );">Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">LPAAU<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=LPAA_ClassOrdinarySharesParValue0.0001PerShareMember', window );">Class A ordinary shares, par value $0.0001 per share</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Class A ordinary shares, par value $0.0001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">LPAA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=LPAA_WarrantsEachWholeWarrantExercisableForOneClassOrdinaryShareAtExercisePriceOf11.50PerShareMember', window );">Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">LPAAW<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=LPAA_UnitsEachConsistingOfOneClassOrdinaryShareAndOnehalfOfOneRedeemableWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=LPAA_UnitsEachConsistingOfOneClassOrdinaryShareAndOnehalfOfOneRedeemableWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=LPAA_ClassOrdinarySharesParValue0.0001PerShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=LPAA_ClassOrdinarySharesParValue0.0001PerShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=LPAA_WarrantsEachWholeWarrantExercisableForOneClassOrdinaryShareAtExercisePriceOf11.50PerShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=LPAA_WarrantsEachWholeWarrantExercisableForOneClassOrdinaryShareAtExercisePriceOf11.50PerShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>4</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>3</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="ea0247612-8k425_launch.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://launchoneacquisitioncorp.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="ea0247612-8k425_launch.htm">ea0247612-8k425_launch.htm</File>
    <File>lpaa-20250625.xsd</File>
    <File>lpaa-20250625_def.xml</File>
    <File>lpaa-20250625_lab.xml</File>
    <File>lpaa-20250625_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="30">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>17
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "ea0247612-8k425_launch.htm": {
   "nsprefix": "LPAA",
   "nsuri": "http://launchoneacquisitioncorp.com/20250625",
   "dts": {
    "inline": {
     "local": [
      "ea0247612-8k425_launch.htm"
     ]
    },
    "schema": {
     "local": [
      "lpaa-20250625.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "lpaa-20250625_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "lpaa-20250625_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "lpaa-20250625_pre.xml"
     ]
    }
   },
   "keyStandard": 24,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 3,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "contextCount": 4,
   "entityCount": 1,
   "segmentCount": 3,
   "elementCount": 66,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 30
   },
   "report": {
    "R1": {
     "role": "http://launchoneacquisitioncorp.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2025-06-25",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0247612-8k425_launch.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-06-25",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0247612-8k425_launch.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://launchoneacquisitioncorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://launchoneacquisitioncorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://launchoneacquisitioncorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://launchoneacquisitioncorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://launchoneacquisitioncorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://launchoneacquisitioncorp.com/role/Cover"
     ],
     "auth_ref": []
    },
    "LPAA_ClassOrdinarySharesParValue0.0001PerShareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://launchoneacquisitioncorp.com/20250625",
     "localname": "ClassOrdinarySharesParValue0.0001PerShareMember",
     "presentation": [
      "http://launchoneacquisitioncorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class A ordinary shares, par value $0.0001 per share"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CountryRegion",
     "presentation": [
      "http://launchoneacquisitioncorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://launchoneacquisitioncorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://launchoneacquisitioncorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://launchoneacquisitioncorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://launchoneacquisitioncorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://launchoneacquisitioncorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://launchoneacquisitioncorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://launchoneacquisitioncorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://launchoneacquisitioncorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://launchoneacquisitioncorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://launchoneacquisitioncorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://launchoneacquisitioncorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://launchoneacquisitioncorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://launchoneacquisitioncorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://launchoneacquisitioncorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://launchoneacquisitioncorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://launchoneacquisitioncorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://launchoneacquisitioncorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://launchoneacquisitioncorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://launchoneacquisitioncorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://launchoneacquisitioncorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://launchoneacquisitioncorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://launchoneacquisitioncorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://launchoneacquisitioncorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://launchoneacquisitioncorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://launchoneacquisitioncorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://launchoneacquisitioncorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://launchoneacquisitioncorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://launchoneacquisitioncorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://launchoneacquisitioncorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://launchoneacquisitioncorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://launchoneacquisitioncorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://launchoneacquisitioncorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://launchoneacquisitioncorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://launchoneacquisitioncorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://launchoneacquisitioncorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://launchoneacquisitioncorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://launchoneacquisitioncorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://launchoneacquisitioncorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://launchoneacquisitioncorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Extension",
     "presentation": [
      "http://launchoneacquisitioncorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://launchoneacquisitioncorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://launchoneacquisitioncorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://launchoneacquisitioncorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://launchoneacquisitioncorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://launchoneacquisitioncorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://launchoneacquisitioncorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12gTitle",
     "presentation": [
      "http://launchoneacquisitioncorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://launchoneacquisitioncorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://launchoneacquisitioncorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://launchoneacquisitioncorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://launchoneacquisitioncorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementLineItems",
     "presentation": [
      "http://launchoneacquisitioncorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementTable",
     "presentation": [
      "http://launchoneacquisitioncorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://launchoneacquisitioncorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "LPAA_UnitsEachConsistingOfOneClassOrdinaryShareAndOnehalfOfOneRedeemableWarrantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://launchoneacquisitioncorp.com/20250625",
     "localname": "UnitsEachConsistingOfOneClassOrdinaryShareAndOnehalfOfOneRedeemableWarrantMember",
     "presentation": [
      "http://launchoneacquisitioncorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant"
       }
      }
     },
     "auth_ref": []
    },
    "LPAA_WarrantsEachWholeWarrantExercisableForOneClassOrdinaryShareAtExercisePriceOf11.50PerShareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://launchoneacquisitioncorp.com/20250625",
     "localname": "WarrantsEachWholeWarrantExercisableForOneClassOrdinaryShareAtExercisePriceOf11.50PerShareMember",
     "presentation": [
      "http://launchoneacquisitioncorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share"
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://launchoneacquisitioncorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>18
<FILENAME>0001213900-25-060421-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001213900-25-060421-xbrl.zip
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M5,EYJZNWG77[\4O[\ZNFYTTO@K/%D4OWGCN=%Q=R?MXB7)=V:?:*D(A[/;,
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M;%670C2T'X$^;WTK3E]MZ@C.,H$ODFGHQ2@^FQ<]"<I$-"9-'Z8=Q.X((4$
M(;UBX9LX/LP=C]P>60G9Z^9->FFBWY>><SWSKHJ#/CO3Z.!4Y48@*ZMXG^(H
ML-4;&UOS>%<Q9E@,)4J9F^*_453R826&29=>+;QRI,78D^%ZNI&ZW0J3^&T>
M+ 4:*97,"(>66L)%@?<1H7![/1D@J9,51PL>9>]U$1+)A.00LE41<5&7#\8O
MKE/Q\B+1$H9HS6?G3HZ=%Q;#$5Q3VAK;XV)>F01HRZN>'"LP^Q0@MF!^6FR?
MA9PYRIECY#T0"DKEBIRQG0 4]N8LO<(+IVT'*$^YF0"#GMW,; "R5?Y3QXB]
M."P7N,W,C46"I#<6(T@01'0V,&4Z[V1CZ09!U",57$W"EVT^SUE.[E4L^@6"
M?AI/1)MY^@[.KP+YG@A*J[J_F""&18@!>L&-0/+M0406,#08G@ALJK@CFK';
M]7M/!(9\,Z@.(P1 /1?XH[^BV+;?(4GW*??;WADMAJJL 1\%LH>L#IPH11MY
MN>NC%X+2*)"$QB5@N31@T1[=BK8%6HZ.&>.B:_R>GFJ7J!5\TU;'](-S\)4$
MKSQ:4K5/KRM#V?<IVJ4G8URJ'D6'X]CN'Q7B$IIW>R"#<<2.95',6M QL]2[
M='28$B@WE2PXK>F!- R\JD6NPA)/<46<A]$EZ,H#:44.J=@>71!- =H*B&$H
M8.!/R+'$:! H#8C6N_'\!,4--"9A>WAO$N3V7[6-0>6KSUFO5<B.M9Z1!+99
M<5#F&@([5M9WP(:Q AW9) SX0&A#"19VP4Z$"CWO@_13X7:8%1'U0%FD**:*
MT+618N7692$%H\^'+K!I^/TRF@0>2!PN# MBUA09L[P:<V@Z^KE ,>' =@ 2
MP#>8*A#FC%;H!C019Z[:OYK2R&U=96]$8T<BT<:N8RQ\U.?X.LB8S?)X@D-_
M#"^!\,QB#_R=[>R$XO;/<(0$+U23,O>26,Y"X37R8W#5BI$<%33)_T'>^4P6
M![G)/9?DX&/?JR1PT:Y57$AAE,@4 9]1H' .\G8C?-W$)Q0RGAL6JG-9:[-Y
MQ)=<Z\+V0Q#6<"$BU'NLZV;NHJ$PV;6KWF[>Q4]&9 _"C#399''D>K($+"6$
MU[$(K[)56LZ7^>258Q.,"T[;]8QIIH+&9-1:V$^%C;>3V=N.YH$H'KBA_X6I
M$PZ;HVLJ.,4$ V8_PJ_N!'3AV/KQ8D7DL1IC$0:@R,4AN[65CX>>P !AI)1-
M%XD)#W(!(SO954IT"B-_@]/"#1A16:QE_VHE(P0\4(\>P.]N-Y%*3S$G0?2)
MGL,P2 D&>NE7M$N,O_1-K(\3N)?\,CZ4W,(,^%* -!1_ALW)\,*/(]H=+ '6
MDI(G;OGJ8H5"2\EW.&$5'=:-)!2>X>R@X,:Y#W 28-23V"5B2K^@N<2]0GH%
MT\&FNG%TKMZ'?Z%*0YC -*$P"^XQYZ!D[VL?NPP@)^9W\"6J:TC$'_4H;/<"
MVD^/XS$4[:17X6"2"=I"]!(0 LKV@/E&$Z"D43RU=X5P0/2&8X[C"1O+-%@)
M#GZ(6JZN,,I"!;(7>@S/^Q0-PI*'VCT'E%PI^%C,5:C5>:RUW6MX]+=E 2_=
M<E[:+Q"H4:291/*08#HW(I@B3S!SPN@MT$TFF^S>)PD@L T&)L9[9X9TBN\G
MG:6$TD$26DXG5^S\5YS>I-!9C2&+ 1.M7,"L:CG"G\\GNBO.0FK*%[% /?4U
M1[*E10A!EH!$TRQ%Q:\TD6.ZK DMOU8@NPY3:D7G?)G1YW(^@'"]C@A>+*)"
M%^4T"!="]&D><=/$R:+G"(DR:D7C$D%/XPE:_#B1\D[#Y7]>FJ!NL%(T;>7S
M9E*5,TLD2N-BBK)0-F].X9U+2=![4/[41#?J%)B9D,992:P0-+5R0T(E,D*U
MB%(Z/YZ.H2CHS*-C&(L4HP*&^QTQ%')1("8(8)DO719G8"S$)1AC2%/Y!>;[
M6';QU8V<(URPU1_-$UGH20'^%1L#B=K%<E6[\7H GQ!+660V \?2T;V(<J$X
M]DWFCQ^'"B.>FQ1K7/ X2E(S..YT%&;-=;-F4DE5M,-@JCRF>@F$9R:<Q9FU
MO73)=Z/B;6=]DF1>+UTKH3BIK/-FL^+[,'$\$/T):OQFNJIS8F"B,\2(:Z!+
M)9J@UN\.T+B%!S;%6D6%/(-9$]*#R4':TS!]V&;,0E1#1O4-3CEH$U*19AP+
M0.J(\3(I(HOHJ4U"%$W4!QQ#&<&EL/H*?MCWJ3$UV0?YUG*TD!N&P)![6B("
M/%2UKM!HWQM*^@VN,-$KH5SB%;'_/^YH_*1=O)(J3E.-K02PB@Z##+C>:H7=
MV[@(';(/,E*F66']!MRB+3"8$"[V<BI7\BS$*KF[0==QEC-DK]]I+X(;R"%9
M?P*['T&Q7\'W]">XJ2_HNH8H9<U0<#]KN[?>)H4*2FP]VGZ2JQMT-]U!V)F0
MR4U \!']T.YH++EHR =,5+>*$W@IJT,+-\[17K/]#.0%S^<@Z!"M(F4JA] !
M%'T_P> &BHGA(B7[LD?%FL1ZG1(.-^B"%']=UR96P7-BJ1)Y289P5!%&I=:E
M++O-O\(HIG2HXW!X:LIS7*]QGJ.5GY-7KWC"YWK\0M"/2_[_T3@-T'/BC%%+
MX1:;%F,MR)E5T33!2L&T8L=AZ#HM&(,Y)\PR'<;19##,,^:T<)I.X:@$;1\G
M SDPAG4%3 W5F4U"?8@@C&)<BP5$$K#<@)3 9"AE.I/>IX\F9[%6L'?L'<V>
MM=X,&:%9L' #B85F>,7V>M5(,+F%192GEIFPD6SBHGR.=75)MV R+9W\LHV<
MUQOZLF^A+3='CJLSY;M,[2ZGZ)]55&:6QORF>S\;W<L$?0Q)LEP>KK[S((PG
MPVBL76XZZEE?1;14:DF95#(DGBC'<F&#Z%+UA.56?^C401?@)$E(&Y$4V#1K
MOF#./HY2EE8T*_^-A \2"4\L88WPQ_ 04"K'NN$'R)%6AG*GM4=Y0@,3#.D8
M*HW^0>I1_'QU8S9R/?M"F.J1^22#R'2TLH+*DLP2R3HCAZLAP85%!JYJ(A;U
M'6.,*83 DRU/*_$L(<?1U33C+OGH_LS=GJKDR,)6CNCK\CT OZ%X>*HWPI)T
MDG7;Q'F)*R$;RF4/Y-(&M,"@9'*U;Y=<V>2%QDS"W"?_%2.I[C2]"S@<@.Z/
M ]&&\UD)D;B(4!0(\[X\HP+8)FW\N^VLI40Q1!K-?LL/MF(E>3DJ!)99O1>-
MX:E%\8H+-*8==,9C33CL]QV2FB4Y#P8-M@HC*:T'"QY@CJX.\ZO7_J-7%TU2
M*AE'M>,X;,_8=>S,[EGS@U%TJ(X)Q0VC[4 !V HT4&H.'4PA-A;'P.UQZBYM
MM!O!6E$&\/P8 (#9X#G2W66'F3*WLR3,W?(\!C'AZNRA:A@O.COZ41OLU&D7
M\QZ?X?HPSM.:LU (@\-$75P9G$?,,@YHN),>)7)[$[JL5C _ W? ]A@.!\Y*
MT^C< +K]6/F/?N4L6TO>3*(L_E<#)Q1EJT6&"LPS ,2F( Q>X\I=\+"?*X1R
M_7>T9"Y:LO$[6O+KHR6OO0"_Q;>?27S+V4Z0Z^<% R,6Y T$PC(06#GXY:R<
MO $J3SNK>8*LY :V&LJD(JW\&F;E%/C2;Y7CP>(L2U\D"(F<(#3'!Z3:$^*[
ME&7F+#]>R;ZJ:)$7L#M*.-F$;<W)CL JP":[+)O(DZA&V^44]#W*9:08NQ9V
M\D8GT'(]&\69'427XBH?A#Q_/5!S+B.QW)B_G&8@K\2+6$Z3-#KGB_8*[N,S
M]WR8#'W<'HHV^.?RU8I#63%C=ZK\PV-,*RN:QHR6099_2Z%"XWXB.=++LJ)R
M8&Q)?2K?+IY33#AGW\#RE//PWOJA/YJ,Q!YF@.]EH:P4 LT%&$VY++2  -%)
M^N0#;<*5^13%*C*5#)<&4NJ'N1ADG S.#!:QYYFH'_H$QI(< ]:WW%W:Y8P\
M)!3*;Q)CK#1+\/:\)KM>]+ M (<UZT<$&0"4L[R^PL_Y4++9V-0HXPNVN<*[
M M\ED[0J,:-O@X_'X9,]!I_815JH@<J!->QROI>GPC7'O+"BAPJF9G:7>GJ:
MF2MZV$7CF@5?,S(L(!N9$$0/?BNCXXO9^'Q(^IN26ZXN*&J"Z%N&<20'1L\N
MZC?_>;#\9[;8D27 X%5&BP&[874A(<LQ1:IFW"-4=*P/+:$GD?)<%8SD>D2J
M6I0*D^>)@<*NUSB[V2I:9\J79:IO171C'Q-$K&H86: #A1/KT"4@V:#J*@\*
MAI_0Y4*C05E=02Z7Q/X.,FW 51A-4DZ.L*P:E6*56E7I'XC?),P,(52J9P@J
M304]=.X4R_)860R@@I-A"Y/D38T0*TA&E2@IEJ2B4&&3^IWETY,)#&-?N"Z
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MQ#5F"Y5:+/<X:C(FDW_=4&?JS+#J^0'%B&29H O"O.;'X:BMYF(6<I%NZ&3
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M.MZ>!&8@;H?--QOK<4GT#0!.E)C&R9Q'DN(45AQD.# 1>_&^&,(V)IH+\JL
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MY?B%:H%6)CR6+W@_M1)$>,PG?\%NF+V!??<#)K=498@VM'\+NT.31YUBM4A
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M:*;)/-X]5GI;:>NJ\PM8OQ5*9?6**07D<R&LSQ3.[)'E9H=PQ#5*;Q#9K@@
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M(>I"%4Z TN%,@)7$;'*%GDIFB:D#H,Q\]N4 =OT9@:!W2P/M&O*&?)$B=)&
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M_*1KFIY@6Y92ZBZ']2?!C!( 8:54U:L7R/U,2IQ!6DN3FE>N<9HX?A+JZ$;
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MI$P(PR(/Y?;,4!OIY:8ZTH@LB7J77IZG6\<7.M?+)TFR#' SG$8%L\"(KU+
ME==GM$&\1]'ZVO)+M/32GC3C2;'D]ERF,LM9,Y:!>:85MQ4F6E^3F8@,J2NX
M:MEBJ[BBN]>,JS1.=;G 6T63MQ8D8%.ODO(<@ !3=U=';(5N%RRNOM U<)JR
MU@#.YTT%]ZZJ$/KC--=(YM;7/#(+(-;P6PQO3\MBIFI 5+QT]"\,H">3HHQU
M/DG@IM87=!YX%RN&/^)9AP;!_>RN<=Z45:-A2AC\ZB*=7.#Y$$TN<"2X$S6,
M"W=D0P?XP@1BHH&<=(BR^B2:O *4ZVL;NYNXPG$"XDHYXY&T.H$=IS4.W!I
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MO(C! W4B4]8KFHASNQ[8)NVD(X!;L*ME4/=D,38_L-ELO. ;A.YL9J96-[<
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M.GU,0!+<^$]!AG9G^I"8$C\X>#"*#F^"B]D$MOLQOXD+>MV;X"0:QTPO4*A
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MAXN-*KJO<1G:\^Z-;(_&A^!S7.23X/<X&^:+O<(KX>7NO2 $AN%T4,%MO41
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M%D'])C#E2%=@GU]S_RQ< *8+/#(D@F")U3 I!QC($ 1GJJ$WYM@$HRW#.-,
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MO'O&"3IDJ9,0=)4.2XJJM**GGL_-[$K46SQ6C,6ZXF]#0V"R05?[ A<WR^3
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M#1@T F\9X+H>\<UO/YR>7-BOVRJ3_\;\3D)B>A&\_0=^YF=4R^1 UPTAVTB
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MM"$7&^[%B4)L93O/:.-/+?6EA:=2XXF]DJ%VP<E"(*22EI6%7:?FKG!]S3U
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MCD(H(6[[$JL*,X8%%D/$_$'(2"D,\+ZTYU@*U O7PVD85&P*^(JD5-R-RH?
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M7+W,9Y#9]<W=-#\L$['HT_7=Q8U]=;_,^%0DB_@)/ ::1)X$!%0$H+2]?:R
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M>QQ'JO?@ N-ST\(NRRG-./7MESN[NULOP!C=V&.H AN;Q\'BH>*?4(8T4D=
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M:EE?*K[FED4SU,X=OJ=[)-VY;($9R[;Y1H1;;9:M&N)0Z(D-+9(CE X[&>5
MA1L#J<=G3X9XA'(<H$&B2V>D@\#R<@>5S'W ,0_-*0^"NC'WNASY-Y&"*R/9
M.0YCSUIH#&F<A5+'9UHV&TSTQD HM!<RZEFAK&PE;N<\T-A%P@CW2_]@3O(3
M5>Y(?]4XZQ#.2_/ 0W(S-Z*+*$M@-3]D-F)!ECD-/[+UKM2T]U0V05S@FGE*
M<XX"JVPG"KA*REL;A;%4$_A26IA!T@W\L-&N*.*^4OLGLN.M$($U$ 0Q>[F^
M0KK4"0N*YI%W=%GUX^H&C0(ERND1- V0RTOI9F#1 ,*]"&0:3M<;P:TA\!85
M!\!_:P(:&2#1J62,(SWQ+Z-HG(#]Y*9ZZE!KH0HJP OS@BO!>!8(]8KB-';Z
M[CBG"E2P54;8Q M7#Q.*P<;!WS8;Y31V=8H"FG.IS/..EN#./?)]H*$5QQH1
M%\4/VX*]035O7Y2M1@V4L06S.^!GJH0"!9W%+F:^4C6\ZJ?U-7F("4VK+_<Y
M^2>E&MA=<A6E(T$[ONW5KC71DMG@R*&7(D^//P@'\$-"V,(<.'Q7Y%_@!V=\
MJPZX?CH-/N-GL>S/3'['4)[8:KU+R0\Z$^:Z(@,O]<C7/KTYI,YQF8%DG31.
M68ZQ4I+A+%*.&9/W2=\#,R ,^)M&+J@*2/%Y"0F<&]PIILQR[-.T/\C#EF:U
MO+"DF L@8W1*VQS96Z?5]1'\4LH$;=5!?AQ?!7T'-&[\,G!I5X7*_G.%BJI0
M^?&Y0F5)IF+N4I>P= :OK^F.UT\2L7J*L=N3.*EH[('RZ9S9B6>QV(D12KO2
MTLD4T2.9Q-"H& 29JK))!N1'C3'-N-')@=F'=5\F(ZI=Q\N'IR$E)=+F:+Z&
MN<&LI%X  ]N$1:H5UZ]P%_#,JCP5$#3YO@J+8MDQW"2@"/EX^1B+Y >2T9;
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MT&[&? >TEF=ZHF9QQ:-CVMBS/HHA64ZQDQ[ OJQ^6=0<B<UC0;7(T*EH+I!
M7I(70W\[>(7$1M":,>*9KIBFCG9&EV)0,BXA4]U1I3)-.$=N6,(O(*_#K#Y;
M(UQWIQ)' 9<=$DGX+<U=:F3)A;EPWX\8$?AE%JZG@_JF"Q=+?-NP=?^;+-SQ
M:!"P^-$+M[MDT5KW4B?B@$0+CD8HS958L7RG(1[%IP0KB!X!+_+2[Z+@0LP,
MM:7.")U_0ZNH:3<6_\)X!G?(/HI&>#5A:<P^FJ012=2NR=+X12PL[=YOO5"_
M@(6%)FCV/C/GCV":8%EA Y6S/':YM'[AP1O0"WLTG[NS7]B4_X=I-&:%6X+6
MQ2K >>, H,(L?A14]OV-=.2"M1H<]$1,9:/J0]DJ!VDWR^Y65K9-U8?=L@0Q
M[F+ K7=).!&3VS4)_VM)*8?J^D]NZ_I2UW]P6]?_+BA''EZ+V/03XXN/XAA-
M,0"JR>\RCGD:$G_6F"/(HR@/(!#M%G7WZ42EN$MZ"3S>R),G>L4R86P;(B#E
M&N3U6="V86P]-)!:5]@'$R5@^>!(0'']())2R30E.$HCCZ+;I$A3%$_W +%L
M7XX@-^41TRDHV0-J\F,6@=3(.B^N]2X(]>](!3EJVSUH)>1[F%%CCK[@4;X"
M8VB'9*^',/3Z>^A:C*'77>[(3F/6^^>@]K0W5(;/?02?PTH@G5E =KLTR>>G
M<7Q:C4\:C)CC$]W6?"_59X".2'%][MO(O6R?63_9ISVC=/=W[4A.R&7G+S'*
MGF87R*EA0K> !RY+DF7 CV8%=LQ@@L(Y!L@-,2^)RP11OQ@B)OL"W_4N=>P'
MG#NGESN:BPKV2BX1+)I ZLWDEGRP^&&:&K^Z#9L F)*H0,.!#[?_N1+=WOV6
M$53GX XTG-=Y?>I79@*$L#4]V<] Q57A#"<>"V(7 D%RVKR0FUI!1.(#=1F=
MX%)XF4.>DA;1']0@JU\=J(10+=%9-D.<+9_%O=Q:3S")#A-ANQ> #,(VN__P
M/V03<:LN>54"\4]24'B#;V@RN[I#,6:H$,+@[CL7Q*(-S?@9[CDRN13;?0?Q
MUE?UE>_W,,A\U:<Y_D:C@/<%%^[4*QSU+:CHQ$WRL'CBG)ZM0MNP9Z'CSH8B
M!$Y&!^:8K,3!.89)'O??)_F3QX_S1T\?]]T]]R<E-V3S><H/!&DE_SSN\([9
M4\)'NA:OBY#([-_H\5,SA1"5!(:?**01EHHJY8N6!<$:VA))8HZ";AIDBA0R
M#Q@:7TBNUS:U-AZY+>-6#.P1>*?:W4E/%N+Y0D"T!QDSKP -.Y)V63:=/I,Z
M\,I*+S0>)?A"E+TC\,>1:F %$.6YJ2,>&E&0<];++ )L4WYR#YC1H;>+5GT<
M6^FNHVE"0I5,^%2 7\X2JF3$L;)-I^9VS>P<RBMT$.>>TB_@#\D[;"/HN;6S
MIJ(#G'_&W,S5JG)^ZWA$?Y60.TH$?D1\EE]OPFJ6L!V,YJ*(QCD W:_45!8S
M,P[#SBEGFSL13J:\ITD[)T]"T$_JWYD>T119TQ:2^[OFZB:=1RZ8?@>UK,0T
ML65-[;&WIR^>M[UV*P.S-9V0B#5-<\^G[/A1 ZJVV0J[O(99Z,05RQWM*7=F
MJ=L)B!NW/MP.@G/*/]"6NP@7"C\U??CR8[;8_<ZFQ+9\AG@V+HX%B3FB#KC#
M0OJI "-DJ&./[QX?B\@W1[5Q?T>K[CBT_T"F?F69 $Y7^-YNOO[R4#T!A%I4
M\[,R>T'M,ERSQNO2I"FM#AHZ=Z0[CQR""0+3R&$67V62&Q*EWL0 A:_62P&1
MF3FU\$"E9M^ AR/JISQV3WA8B/)UH7Q0[/%HNW;,W84#()QREL$$J':)$-3'
M$G#AAP_OYP]/[@\_KO/FOO0*R Y< %@+_D(KX"YP)!*NEHIA5!EKP.1&A3$?
M1?D;ANU57&;[]I9VJ-[T]+;>)/6FA[?UIF];;Z+3>A:=UM3ZYJ(,2%,]' X'
MB8I F/.@FK)P\0.FNTQ:#W)K]57)?C-FG9?;8MUUEH/CP'[PG#RKUTMX:Z;Q
M+*($89C_&<@SWLU>+83[O"\?1*^/J"W_?IW (WRNHP\3M[\?Y\</3B)^1?0Y
M=4S#:T);H1)!0T"L]?H@E-5'W7 X>G0UR>[GCQ_<3]W+%/W3H2K1()>>%;;S
M'-$-(8IP(<@.NX?. &Z;BL3" <'4X+\FV?'3I_GQ\4-YP*9<(>V#JGDNL),"
M(3C%I9NM%JJ$G(\<O 4+,-B5ZSLR!'41G"T*P4@>+O;:^'4H5>*7"I]]V[6E
M+4CF(K*8NH86+I1@FZ:"V=Y+(X7*(.2[V5MWH%NW=D9N+?8QJ2,Z&*H3>09$
MM*E0EN?3])($G%%P<9Q?3-/D-@6Q=?;<YQEH#2.WOQD,KESA,G(^=U/-2OGC
MIA*DL&!@X'FPCQ:21_S.$^"KI:2,G1GR@[[]V?[U[/)\PC44A/&X@,9%[%/B
MZ?$N7VLC'QA2]Y%?-#DW_@T&57/^:I!6DV%_1IY<A7RK)G^-[36'DYABKQ3^
MP1T0L$RPF[ IY::F;MM2EU6UE6XZ0Y]'B#)/'=L3-@#E&B^?_Y*^\DZBK:^+
M*2Q/- %FC0K&V([+<M*%<C1#3Z4?GNAFTJI7-T02ZO<EAA<FG6EV+ R13])R
M<@$*2.6LDEZO<[=1ZY5\"+Y^D,!)LTMI^C/5=W+H"N$"".JF(4E!_0&[$LWX
M&:OI"6,H-^3-J?L[F@YY[?0C\]W"<=4S/DZ\I-],T.G7PB&DIV;&BW4'2]N@
M5KK8RJ:4/!T04LS=6P?@1[>W9UCSMGFE;DZQ,0DLVCSGS+ EMY(CF1KG3*\\
MKX-0L2(>8N0UX-OZ.Q&[]7#.NW?1FPB-GRVGS0__T5(F;2Y719I-D1(2\2!W
M[X&<K9EBWR*JL: E.4=H0\D'>:?,UJ+6!@J1"+V30=5H5>5:XGENM>S+"PLA
MOTGSRE0E.$<)NB+7TC;6EI.^V/2L39*TQ?HGQHB#A#A<J-G"FU9G9UA1/1*S
M1:0'?%(3* (.>"[UYQ+O2_.MO>KD)AW997AD4UM=J;@!F8 70CO3'G(^EVQ]
M6R2[_D>QWD&D<IQG)_=.'D3]<0PR9ZV9.5I=+BY<!12&Q,T&>X5@#6(+^BR0
M-($07%U,VEQL&M?>="FQ49L'YV-_T4N2I_NQ9?(, 56]8MJ52^W&5<%1I,Z*
M2+"*2KB8'J0B"82Z"[I<+Q'W"7#/0G1NQ+]!JIYN0Q&L0W_&DAX/?,W,XMY:
MRE' 7#[AZ!(5?6S6?:@T35Y(7U62UR!'4NH! I3*QUIA+30X(.WM.D=I8H!C
MMAH\$O;K,.11S3#28$B/$T;ZW=-7P3.L :QB?@<<P$P])2(JR'0)VE&^CZ;3
MB#*@#A&2VV.]UZO,2N%7A,W\&.[UX2:1?ZU11KJ@J.P&!'2S1.!M-Q 8<%1-
M=!TXRLQ+ *[R1,8IY2I@::%_J418U:&F$<4D^LL=''/4DFQ2?T/BBMRX\&$]
MN37N0+AJZL9&=GX"PG?MH(F#@==F\_%( (Y$LCYX#7(+I1PBWBRN=(PHYQC(
M^M+Z_AF)D228B$H/Z0&!FXA $"YT5FVTJXS#.7$-Q<MG:HW.\VAP@RT^_0."
MC0+N?Y?N\DJ-PL[>U,?B1M(QKN9SJZ:@/85#-?8SR.2*I]%RK"%CHM \)+LI
MZ*7FY11D-$0&(-5SVR&HZ?.V[8DX'D$W&54"$\=BZ$FI0A.0O6&XQ4)-)IPB
M'Z<7+]"WDG)_"J&O](RXWW,3G_4T:!5^?:Q5'.1/Y^]L,U"SW,'#P#=4!L2O
M'Y-%,;L?\":'QK5%_$#0S,'2B(L=S6U.G#*\#DQU_(@]8&S]P(LMZP)5+Q$J
MQ@3XQC<U7(S5VJ)*>(!NFG^'.GF1GBSW((048D5KEE8G:>C7_$-:\W0DMDS
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MT8/G-DND5B1AFLOZ1+NQ "?WZ.&$8&AYD$T]A @0PL1BJ2T<"VE_V?L:O:^
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M"5),=D?)SODWYKZON_WS<'2X62/*18U3H.,'F6!,UN!'E;-C7!\?SOA=4VC
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MZE+-Y17)V9X7ZM6VW2 8OHZNB?$49' 85&(2H)Q*3:\V1D"P/>GZ<<8/2U^
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M1&  KMY9PTVE>&"89T0["<\8ZEAT!K=/,QN=_8KF-8"I:Z>PT@K&PK$V,MD
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M4M:!@FV#Z^(4B[R6^PBMH!N7:ZQ-6)9:35;@'%G[*^NT%O-YQ<XT46FW8EJ
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MWI0=-<RX8^TA4O\#S@B+387O<L*R"C="H9Y9?]S)1\,&PHXV0-9BC_4<Z?B
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M$3O'J_H7M[80K'C_&-"*)_>S:;'$W=Z>E^56I)75NL%7?G#_[R0[92(*0T6
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MX^=[>*AX@JQQ-Y*GDR K%"7"U.$UYXTFO,@)[&"9T:<N",&AL39#!ICHC+$
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M+Q="VLUE3OV!'&.SD#V3ZI^<JI<F^"[\P\5LMJV',_PLB,8$4G&K_F_5&HD
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M#)WD>U.3'LJ,>^V<3B9'BP]QWPKF/JM%T&]6+WXDC75PS1 1Y%ON*>_%?6/
MCVL;RC#?MT9[[K7&HX/&=I6%/638[".&6_O'J''*YR6=>SUK*DL;?-63L>$M
MCI5ON]]^HH( ]LK4+<$U? <^8JQ1(:.:6=DA=RL8"@#[0(WG)T[K=ZX"^'*,
M*J!Q$-_L)P8Y7$R(\, =I;NUOO4^!0=#$LA("&Y"W")@TRTD2F+-30T@;=R2
M@EQ^XP;HAF^_XP8JPP_NW5:&I3+\Z+8R_)U4A@^WVF1=@ZX\^[$/NHOYBE.@
MW-O ;78#3*-!"H\;4L$]\P _[ N*2/830L\>TL85 N]T46["\\!++ZU7^4.;
M9C")#*B!=&UA-!;A#GT"C&REU[5!W;A0?3>K(*TRWVVO@N8_L<<*<@)/@LUB
M3E@92D@-%+,,.#B%TF+]53"PGLFPJ5"]IU^'2N:0W.+)3W@04"(JJ$?DQ-*S
M6]FRH];PHD,4^[.*\ JY;S&K&P'D36()3<L2ADN&VN Z"]%K/3 I*OS0/3P?
M8GX N,;AW;[=FGW7X;5-XNC\\YQX3,19UIXA)&-%,=MD7>'EBS=OM9^T*1<B
M#MHG>\LG\06MD^3S<;S18EP/0653%U3A<S/04 ^L1(N)J3,M SQSR#2R9!>:
M7)H^U]S=@3H% H^Z%]05EADT,S9OBDNW-$A$I,\["F1J?3'-PAOK2UHT7(TQ
MU8JX/34F<)/ZS7!EHD+?[=L[&E^U=#"D<Z"Q;!Y8VR@ZJR,^7:H.T=?#8(Z:
MW)$PB[7;_0:#[4V@ P,S,#8FY.VKA"R"<8,&T+LU4HQ&''-:(H" 9;^5/QEL
M2<Y?,>*\B&&=TRF7@3U=*FZIZ6LUB#1W'AP_<*$3-K&Z_[?"X!2X=76I$M(
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M. YO0C45$45P<Z3/P!2179\HPB!C_T"FB.P&1!%HSGX&IHCL(**(N(<EVOG
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MCK1YD-#*;W/.,Z3/DF$(U^X5<-^Y/?%T]S)0L]F)78EV,MX-WX%3P=,+(<M
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M+#.1 >-@9T"K%^]R*G::[0F=(@O <.ST-+VR'NCGLQQE:+Z+]:F7,%=DF3B
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MDHZLF/[G++"H36S01;)M*\H6(GNQR6J10:M?$?VM,R7."1R.[ ,21/>)#TZ
M*G?ZT/KA:MD4;"X5&NXFH=YU<M%#Z[ILZ*%Y5,I5]IJ6AXJ>[0ZF6 -43>#:
M4)ON"KMV<:.@9?7!&?074(Z!PN 7:SS"U3J^J.4CB%J^U7(]=9<2L.X?8B_U
M#>;%BN41!CH/8QCJ23/1T0U3R F*.?;%L1,>YB0L54=</X%A5P5[IN#Z0UN;
MXDQ)?+V7PJ,3] PIFOM)\B0]X7-[B?>VFK2(R\\.FASL%".HJ0BM?V:( ]:;
M8<_0A54ZX]ZH/H]/104(JRUWC.&5"J7$WFE(YJ#I=%8[9C .6V:&%?Y"%(MA
M$BRJ*?V;L2'DS\5O2"UJ\5\E7&HS,1O^LT8A]/R QW3VIQ/ABAR/E"PRI'!X
MI%UV>U*^$ECRN5XL8]W+HION@P3AB&XC)$OS$:GM=[NIAG#"KK9;P8C[%XD8
MP>!9HP"X;]$4JZBH@\<1K\44U\+7<>?.0_@(Q/VY=R,";E<^"UBOAJ^AX]&I
M7/;8>H/P(O2'%E3PB"UKKT1?% .;W VN %D3[@P-:UM,ILE_'([^G7%Y.\CW
MP)XMT5'!=KO:RX-0>P-+Q2+C9KN\FE CU %2S81("'D(TX\ZU4.!T0U?U] 4
M'+_][Z5SF#]FRV)]OG->["09HX^$QU/-V #+#,@)+. UXK3M7B\2K?4V1%P!
M7U-S$,YWI5B9Q$M[\,W@7C*#DN;P+LK8@/'=!O1W<G4W7O(A%WCR2/ 6<E])
MVCR*1B<O%R(@DGV1[DY^0'XY!$I)8^8:9;@V4&4[_]']OXI0RM08*.\ 1&2X
M6D.#XX[H#\&5TL+"SJH4332$GC7*J7,FT"A@- ZK?#TQ A92^0%# 0H)+/L2
MT7NSC^@<3K4ZFP*NJ;TII#\'[H2\ CUNAG.EGL_?)WAWN''1M,R.>@0KE;GA
MDL@CFH2.-='?Z/L=O8L!Z:TE^EG60B<=,OV85P&R2-[5>2*L@(8U\"(Z^>3.
MU$=W%!^"!%?NU/+Q7Y<?6^G<J46G5_V[4UUG<TZN)J0R-O5FMW1_U+=IM;M;
M?SJVIKU&/Z8W[YY'$7 D"+ 2OD^N^O;]!V24X/<LZITS"1_'YTC/OU 9\X.5
M+3%^^=#I:>%*T!.#G<-59%9NK_#>\%S8K$BAH&%;K+<037\FLB_^_DG1,C]
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M2.,D[+;[1QP]!7GZ8\:8K4Z@_O<>L^MVRHX3\ ,-B(;/8G; 44P^*5>4;M@
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MAH>!\8E492H?.CE#_:=N7>M@4GHAN&<4#;>J+SE(!Q%?C#XXC8-Q\N25(L/
M0RSQ0(Q?'/QN[MOM*V[UEZ"95FLJF,0H@>U\27$&[C1"3<)"2NF \8C]3WKP
M,=F:Z2(+-5780%&+I<_6+-5H5[SED-$)/[%&'HNZ4VY49CN[J,I%]Z&XG?29
M:3A.G^4FQK($=*6\WA)[=%6"W"ZH88"JS R+ E?Z";UH0GP^1:=[04@@DK*)
M=FMW3;9Y"+<JJ0^"#R3)\^#ZQU8Z-3*0H3THY/ET0\-%R%8:A%&);)(BY/4R
M+I'*+="5?T7Q#;I04UW/85M*I3B!AWYA_O7; /3\%CS75Z&J02LN=%O%6?TA
M>P]\/Z_6')T^=N?58#H1[4_Y3@S[SW;+32$>;*3*X::G&CCI%%**I5]^XHLU
MYA*5*HF:@LQEXV];"BA:W=0Y<*;9)A\EP[:H8?<WWBO"TT$Y#GU1[M71JEQ-
MD2.Q<:M58MYRX?2*TUG0Q@E+&^DPNCM\4TN?.$B_KMT[+JI-GOV&AQX2$+NF
MY"=!WGG=,L<%/4"(A)P>6SNO%[F!J-<"!-B<+H(H,BE=0S2."Q"P!YD5*.SD
MNS[^\W\M5IL?7F=Z+,#*)_^EX^87K<\'D3H-X^&AA>*,*#%18!R<JL06TH&$
MY#QKR=+32K35J@*.,K4$@*9W^Q%)ML$I[!UV)O'F4"3$?(E6I-O4&/Z-1JPG
M8-N6W;(JH1-RNN%28^-25D/]C)UD[U#G+G90_U,W"):8"P5(#R-IN*1($!Z%
M-GQRH5.#2PP:-F/=0M8K._DVS%FC3Q_&AF+85J^]Z>]C37+A&L#,H[[NN H0
MKC=,GU#K!A4S>-ZI=#>FNC3ZA)SZ2*74BT&MXIXP(-49<=@TI2'"P'@9':#T
M;DOL:6!-.G130VHI.)0]NYLHL:92OI@VM9,B_A9SUL/R"0N %"ASS?4*\['H
M'IP3R*NFM0CP4A(#\U78MV]HR9/9,_BWM.T,$D+'=,<ZH_TE XO,ND>QGM]U
MX>6:][7'/,A1BHW+5PA+B<G/0Z>R':8-G?=XXOT&]/$7.^B5RP?D/5QLV=D,
M@ %;*>J,29^D]U*YJG8KQMA(RP1G<?%] ]$:MKRR#3"3"\B!KB#(R%^63<'%
M^KL-@I](W]U#YYJ5(*!Q"*5!_V8L1JHG$5O6H)_<XJUW<.WC!<^ZLR5JL$0S
M(UH*/%@=QP2&A]@#MWDSL&S@C[VQUO3U#)8HY"[5%(T9>I$/JA4/F8,W$ ._
M+):E]*.:QV7'VT@7*TGS^3ET>B.:R'6LVB+L>@AE\0!=,>YX\Q"GM>@?H=]M
MW=@*HI-F=^B40(Q-_@:86_HRMCGT^/2#;B@NAG8_48I^N^#>]._>XFPDY,%E
MSPWOUKPB%D>X-4UH3%/30\8'7!5\]J .UG2KV105H0GX++4!/X4R*:?G]-75
M[.?,D'ZE_DQ4^A,G8ZSB996JRIV/2Z#CY6_+JIA62ZKE%$$DT)E>R%'*S]SP
M8%9A5HYXM@%_(M<QN#P2+>F_9;R$=I(J)V' L_\9:&>^=^OI3"U-NPTJ2S"Z
MT>;E<R5\?N:5[:S><')MA=>,>Y%H@8F)+I)IX7OS8=FYT[N@UNC2F6F+#V!#
M<[/DJN)E1<U+UY(64:I;:!<BKLGLH@!Z!"<T3BAFG559.D4$0Q-J-N<$[MQ7
MY]5,XP[:U%#L(&PR1>V##U_^SOK>ALC.$*[EZ1VN17 MC^]P+;<%U_(4>\:#
M_3H>B0$+Q\^T*G>+@;%JI'W ?IZ$: D85FR8+ TFZ+>8<_D)=M@ "QCL-AZ,
M,P#(V11'373FV]*Y7!M?9\'X/!R?DFM"L$"]!'0)6 M?I6>8*V]) RL"'!TM
MN8KD!$S"<BPWR :8SB2+;],+P1?GPD,=Y_M?O7G-Z%#^ C<CSA8E/ X0#53J
MM:P+<'T_TIRDFE.R;@(!U,<;;=EY]R27#CUS:.Q&_:$NJ9D:\TS(8PSJ -';
M 56#N%@ 9Z&0GE\'X9$6?H@9H KD:J]*WV]=J:93UG2\OM08%_JK@&RT:*)_
M+)=+2O6;Z2L(01$Q=1/B4\60G"JX^,K?_YZQ+3>N(]J=@4]W"MR%5URG0#FE
M]L+_8M=:"=3>C='-A9OWL6X^T ,V%3!:P)?/G6L,<%<)L):FN_GS3F7(>"34
M@-4BV?@/\RF$'([2)08!S#!MJ#!POUU@EE*AH] TET>0)ZLCJ'"IR,ZAP=VB
M  /#O;I::7BIC*O&:Z! 1L 2+J]N(,S?BDL"W.4E'('WQ7*FQ'M;JCU&^F.#
MJ)V7X&G;3D":S3.<14R=-8<@V%Q:(I..800\ GV+:H5@[:L@DH-T_A^14(_$
MO$$KS:F7+75(2[:0Y'40]F\*-F\".$HGWO64E'!7$+(]<H##,(+03=W=3 BH
M,IJRW0,"T.EF,B $-]GT[. ]#Z8['GVV?>_M')K:=B!S.&3?SUI2+WBAAC'Z
M()8BBQD%3\*&XM3;8[>]5R_N;>K9!R!3+Q-7"5Z-91E=$NB)8$E,+M=V@=JY
M6E^ZW<=0\K18?T#*(I_XYIO._PV\G'K7S$"PX.'-EO->6&FRQ(=2O(OXF7S1
M Q?4@4AX7M&)O;WT1W2)59A9P8LLL3E(X\F5%=Q\H""&H?^1-)>GU\JS=7E>
M;RM)ZWA2ND9*+#U]6ER<"0/O%F?JVWF&4CZ!5^EX)#1/X1@3M:+V;:?8-<XF
M'.C<ZV&+!,)4;:@!D1")\0CE <5]A<45*,S%E>W%A1$@T#C"8X4&#11EH#1-
MK#&$;%OQ5 I/J><.[50JC.51:H  M)8MA:]A3__UY>M?WLOK\ OS<L:IT>_=
MO;(NO;4/7_VR 1MO]'\'*N7'IIJ?.\E6V_>'[#6::DG#^%AA &HA*>C%W"T
MYR1HED]08(AI=W@U(!1Z4O&^MI6*>@L8QLN^K&SIFWNKOL3*/,L][.Z5V07F
M>S6[? *^ ,2FE2O19)XU*^W5LWYZ KA2:<Z0#%UQW!V_ #K0_<);Y?B<N+^0
MYK S)DQ41;F/,1'H'M.4B=W< HF]\6E]%]$TU>3,W4,%9:VQU0O>N7"OU4V8
M%E% 7M3,STYL_W!>R;,[HR$?SV0IS/7*,4&4 /-F=XL#U HO3<AZ%,[I?@FN
MWL].2F&[?SU]YTS(&JX?I]7_]"2_?_\^_-\$OH\LI?=6;B6O)$9X62QW 1F!
M5F(NLC\]>'A??L];J)+#0(W!J7?82(](W22;NKIU!8UP'C?T$( !&PC5>I H
MOFO>^TR,+T*D1/4A/$!&UR04 U2R:#]5_2.]/]C],]\([8"SB'8@5+N<4P=Z
MU<8#QSGQTH-./9XS/60:4@(S!'8'#]$+@($!+*?G(#UXZD\2<'R8P/6S9Z^?
M<\<T?#^U)^35D*WN3*NC:Z&C7;.;;6GC3SY>T,+('P78M6FJ2YP&M%L3T B\
MW3V0SC2R05]"YQ;J3JO&7N+3>3FU:"6]6Y!+5;^%LH'1.LP=, X#D7.HB688
MDHE'X88;YM&=O72OT2 ?U3;//CC=N!'">KVG"FH4MQ(,B68TUJ7S0F>43DKL
MPR0@R6-H/*&"<;4Q-%:>N]'Y]2O.\:W*\%O,+G#PJ48#@B*)F*>O>[_U\G6?
MS)S$><SPP"$;CWK,NM K//"4)5YUR..A(14Y%6W=HW5ZK"1KX/B-UFB9>Z>3
M$\S#-5ER\Q<*!4F4=H$H)-4 @2?:@=3=W@I[]/"\KDLN$Y>\ 9(A.+YRW.!_
M[RVK#V40F/1N.<R\<#9#A>L' 8PB?9;E-4[@F-<8#D\"'-<YSL%A-8%2IL"F
M$TT EP1C3F0M(/X0FPD#D0FNZ]3]YVY;8HC%^;Q0I^Y$UB889A_6]<=E"7+H
M>78@,UFNS]V9G&<_U9 %S?Y>+#_@K]88;_CIIY39]4:/\QD<YU3O9P*/%\@G
M4\QC!:#IB'2BQ.B:]!><[58O$?L@]J4W*G%ZV "4M_M*BZ=BJ\OP6HC"I1]B
M'&4>AO<D6<"_"JOQCLK<FDT2\.'8+KH^KU]<$Q6N<(ZT?T:_SVI*A9>&=ALO
MH_Z(X1ZKR<;JW,6K5UW,'U2NX9"Z]2SH$D78=@7#A,$P7$H$4FK5.%U?%_/V
MHO[8$H]^(LW ,C<YS5X0N5D?D'<3U5N2;<,B;I3C6=<G11HP)M@?2&P8STM0
MF[^O6P8FP>3Z938;FN2BMKQ>ILNI4.G0X:QW2VSH!USM3H3QRG-[UF#O GU1
ML61F^VJU$0Z5M3L#\B,W#$59:3^]#BJ23GX_A]A^SP &"DE/=X?LN)#87[[>
M_92$'!LQ-OE*[] AV9=Y;'Q"E"D&BV^E92BJQIN1:4 H;@Z]:N^SL52<1)%B
MG5!V*!^NZKG'7=.<D*X>SJ_R5C5,MPE7&%&?P2&"6"8174EJ1*Y 2"C <P,L
MJ?E0N9@FN>2RI<.C,FHQE*Z6-DUZ*3$6V\M?\OB$N/\\B]J;0CCK?*V\@7!O
M+;"^PW! ;<GC1#OK$S8Q">C/MIPI.9$22WCN8M=0X%H7.0^7N-;&KE+*V#,4
M71.G7*QD16;WC?Q:$S3KO]=[VJFF=/%7B$#_@![2>>/.XOR><PWJYGO0=]OR
M]X2FAS!-W]UAF@33].0.TV1D\S/(X6TX1=^</KP/N9,76KMEU2LE9M\DJ4G2
MV@D95+TV0I2W54E:EB3D&KYZI\8NU^]F%^Z2A) S#(T8$D,;-+;];E2:''K@
MIG+-QOVZ?K5?IH%X6U2,-LCGDRR+OV80/M>2.N(A)#8'*9KV)M _B_Z^#:-W
MPOD Q)6 Q>/13U0DP0>&J-=3\3,^*KA1U\BIX;G9W]9M**?V?08IP( _2CD_
MEESB8=L9H2G N.ENN('G"PW Y1?=;H,]/4W>6SY.J+2 @.H42T+9__DA@_R!
MDA4070\139I*.AF]*=V (<ED#"DMQ1EH,LQJ-"-\GG!R..T">0CL;=X:KX$:
M^F9_)QQ,SW#159+7>K3Y21>A8ZJPX^@/8<W;+ME,/ 2EWR8*'N4U"A4T.*OL
M()I. .I7J!M)\JA2)62T XV^G,B6RX5"VDW;VV27KL"-UH  :BG?J]W');PS
M;)4@IJ5YHSG$D(41!L8?\?-Z),_VD,-J.&SHI4&HA%!W5C%YJ#5%?L!1!N_3
M7X.)5^9 Y^ND"SH-8NR:Z(2Q$QC5.9'++&$;TYK-BKP]*5N"W3"?&/P.B7M"
M;6+6VR@6;EL&50W.<KTLF49V1>]0QQCCR2SWX#M"*'1;+!91A[C4? W+F*96
M$E_CP@_VPNE5!S2ZY*SMDB/;:P-L2/KP4FX[!3^Z=RC*3^K^Z*%/ZG%O/9!+
M%MLW*>Y9M;!Z6C;,4KEWY9P5.2 .*P(*H._-#51_3]]4XOFG=Y,:DQU,G+8B
MZ.!<;X"_>K>NJ-$A=9/DL[ORRV//UG[/5S<9&&H7L2+1D6 &@# M;HF!L9P[
M5NO:FR4W80?B8+#;L; ;BF$ZO]E:R=\GS3IF@9(*SW$P6 )C4*,3&*8]V\X2
M8LE!ITL,//V];3^>(./-)88& G^!.3 8%\\;@2Y^!?WG, 2?Z. 5B\OZ^R:>
MDNI<*OPKUG>\#'X5=(=J H;_ 2_M-'VE+U7:KU. M;[RG6/G0Q+8G83=2^ED
M4:T4%JP1V?[;15^EWUU X6'7E @,@MA:H7@>MZB_:Q=Y&&3PX4-D$2(NT?$H
M).#^(7MU=G:$ ,$N8@=DAZLV.$T:8+>_(P<=>\P,Y9U0*FN46R^7I/7[;W#+
MK-B'$R2+KA1KSEB%K]Z=(;C,G#;&FY6?!(%!0769SH,GSQ6WRQRS[PP@Q,E%
M'ILSV-K%TIGH+]V<4'GM6KIFEDB02[B&>%Q\_]!#V16 X2,[.A+'*$4;MZYV
MOE7+\R#-YU\7&H%PI]<E425LF^K\G&+.R>]VO3Q8D1>R6ET>(<#LH$5Y4+OQ
M'DJ6#IU!'VI4E78W-]3Q9U(YR8Y>CW-#*?DQG32\V+A%Y65:UYP-4U07[V6O
M"Q(W'V>&CV? 3CDO!8 ?2 2-A?IRP(;73*<D*!OB!EPK>7%Q#CUFMA0,&/"(
M%-:F8](<1T>PK=#TI RZ9P94*:#GHB":?/&-/C(!VO&CTW5/8'1@85XO%B4F
M!/LD-<0 F=1T(-X]3]?/.V$^*A>-DI21'-H<>S(HBNZ5^ AZAJRSH 2L))!S
M0^@B?_5C#,;D!;Q#:A09J#5WTX1PPD9M2JNBPI<&"X=JM=LZ-6'X6S]_MT%]
M$'24X)H;-$^)<-%IRWK3;Q$6D2DEEKYS/F9<0Q6<YYXS&3^&' @8/;<*8Z8J
MQE[)N$W73QRW$CX0%$89IU"*HV'%+.<IUSN./72Q';; <2^T0T;9"]I(2%;W
M;)'6!ZBL7PRRHKU1C'5)ON0UW-V^59*X0KQW'!GG2ARDDA:Z+E+[5;?;RC7V
MFAU%O?B3DSXF,W :UHFH!3=$VIK[=D:PAJ_. $.(CE8M?[D-#L9 XO>;^W>)
M7TG\?G.7^+TE9!8/'P5.ZOOB4_9V!Z',8^S <@:=N6I0VWVQZKW.1BIK#:8R
M0)3QCA+3U%?_<DDO&MV^$AAOP '?\_U9KEQC:<=7[V^])Z-WDR7B=ER&\#VZ
MV:'K2)%H_^^6&9$:E!*,/Y.\<.]:0LMU/IV(JQFXH+).[*((Q75+Q0DFHI2=
M VW3FKDNU9V^__C'V)\&":;PU9KYUQAIY6D]*&"&%HY/8-C?IPS!E!>%'4:@
M])?]RSFQ2U'^@/BS:1UP&'&)NI&9'G\GY.\<F#4=7#]MTT&A0#H\ 8-I'0J"
MU:_PRXN:J4:$_I"^,:=22,%.*",XSBAG3"C/CW-RSHCZ3>CD/+N6*7!LRO/=
MLF@HWU;/JD+;?Q*"39[7C1-XQ93L(<-YI\#F)78"G^VS>X5)8GUD'H=+#A;Y
ML[1<EY]F%U!L ]OTRMU.%^6]GZ$DT-L\KS<&X0I'W._N0_VP]I&C1W RY>^^
M,".55HX'8)],7QN/^I\P+S?.X-)]@8?9![QG9FO-_! 4A;A$"2$).:)MM87*
MA"*[K.IE4/S8R9F;I^=A0@F[]4E1EM-3E.>\E) .K;;;1,G,;S60OMEP"LJ>
M8G(<4I/.D5"#$^DAW!-?TK/6V*_GH-4Z&3@MF3TL6!1VS=.2JM@5;482D_6?
M'O3J_@+@WA\G$@?1;CQTF;T06<*RCUQD+'3]N,)+F:(,UGI;4S80^H);+:MA
MAY1J%3H$8E#2,\Q. )7J1%!XO//X6:#2W-*YNU[/Y9HEP(P,B4<I>BIW="6=
M2/)HWN0)]LW;/>RB_D@OD,DBDD%R)P0><_O7W2L<]]_-C_IWZY0<)ZNY[-W7
MV6W5!P/O\-1+6OH$^?@V$:PRFZ=&8C# KVXO_I,QA<:><A3[ZPG#])N8&,'R
M-B9% =EV+,/T,-A=EUPU1S%!T$T!,L8'9?*DR93&PICD97C!QE8<BYB$[Z,G
M:E97LLE8I%4L322';U=6MZ:?#;![DI+ E1':%1N9ZHX#>-1486^E]$;)=D1I
M)U((R>+Q 0BK#](BF5)$Y0M_!/H^[=33:L!L7G>^/7=F!WT9R^+;?<O0Z1._
M+#ZV^Q<G2+)A2Q_C--G((872PJ"L/,][0MS; Y+(5 B)L=JJ=?=DJTP96F)E
MG2(B^.&L!@!<3L>CERQ<Q65=S24S,J]WTVUWFV \Q+)CSDJ%U(FI7L14E23)
MD3":+2/J,"U3O_HMX09DM'6O_$O*A)K&G2-;EC00NY&;MQ]+DRN01L+>!(PB
MQ[=Q3G PV9,;%(CUL(_D>L\>MBU-<EO*M8#2;KI$H.Y,@9^$CV\H@[<*6/P/
M#XM^C @!MYWCD6F.\3+H'/]_:GA@H[QO?<EC7W.H,1U.QYQTTL8!$[] @R.
MY]ORG,E!W4#>0>YB)1EG$L<7SR:I&)'':UHSEIM^4,N-E7==GQ57*T0"+ L@
MB/6D@YR1):Y!['4"A=Y<A14_70X:^?L6,WV:_1WPH146OM.K\\[ U&YT$G/O
MPNU40[W)9F@MGSRX?__/DZS^"+@_'J#0>KH+(63T)*R9;>6H39407Z!] \-2
M[I.@>-33!T1UZ[Y/2CR%UVYTG::T=%VA=U(1AZZ1J^V%$\KS"YN:Z%D8VU$5
M1^>$7JA% %S1[@ H87P8I^_+[-'TWF.9DG= 9ML.XLRN T/4R&1?E2MWF-?S
M';,O@ Y;,OZ/W4A*J;+@D\CX61K.43LIWZ4SE#T1^"9Q8 1GP?U E8_NN8(M
M<"YT(*)\D$$Q)TX$NU,X0TT,<>-DA8S^1CK D(;P(:!ZF.VV@$H@)0Q$TL@7
MGRZJ:>7D]P6VQNEZ:ZI88J&Q6XGW80X,4V#O;JEBE.RDM+! (&GJM/ *8B:$
MON0PH2F6,M4]<RZYU,0QN._,)XWZ8@JJ4_#P:*GFAEP363]P6(D60>9]!M]=
M=T^/-,SN@&TX"N-$?%7:#G#X6M/J(GA^9V5,'PQ5G]"4$:-706\-[+>R<)JB
M<JH.@?'K8F68GAC^/;&BDD39EQ #,M1T9C@^V3RO-XP65\-(()B=E< XHP5&
M7J,:2T;9I4N)2*XP:!2S7"4X3DE5.!^_Y$8ET8"[>V!:M A#ISEQ5]U)<R^)
M5>DTQ$V>5<K%[?G)]XRX2RJ;P37(M+)75(0N[-^VNU]XEKK;YR>2?$5VP!O4
M*I!78.>(0Z9/*)N>8],5SO115#,<2=E]D2!E!ZXQ%@9M9@%FTURXZV'Y5!(V
M$M1>^63M3'<'=W!BB^OWRA(3V0)Q)-GVC&AC%]I9&QPSR*6J/JJV*+82N6YE
M2BT=*E4 ]J(Y<(L8<'/]AP4>EN('D7Z)>:83$BU /HH>QQ.',].9^>?R7 AB
MD/)%*%7E5.3WV6X#UF31@L_RH[HD[A8^O-K^FP=WH L!77Q[![KX@P7OJP_M
MC(S[\>@_7[URQNM??WSK!O;LI]?O7OWRM^S9ZU^>OWK_ZO4O[\"4_?SCOZ6%
M&-^>8AGU,PW18@P.<8\ABO"UOV)]KY;HWBWU9\/T)ZWWCMLP:DR5QH6T=O*T
M;T*0\Q&L5@(M.,6,+0/[")HZO$D^#OW]U\[$?%GDCG/,WO(MR'[*.Q]+@'HH
MO%;!::-M37V:_<P<\9J3IQI-0Q=_6?N>#"9883JS^,X8;ASF)3]3H+ /Z>&<
M^T]7)EY$TI.H V=1P"L?$L][A^3<%-.MXQI#PN\_<]_?H@45M)=5WR8>=]=?
M/G!;CIC$.%@D.>/]XON"L!9Q051J9V,I@LC[OMH*;;&#Y4BQA^R594]_XUR)
MPKHQ3AR(--Z$<)];'>Q@XIZTJG=MB@&S I1((-=N_,NJW%'-",?? 8Y48I_B
M$(K2/2JY?WC3J9],K&78MP'G0BG($@ &+97MEMALK__Q0B$JACH.E\(O$8;A
MT&4.81$3N\#2=0->HVJ#DY0P,M1F.:.$V'O*O>O$B+F!%AP8=Z&R 7)?NLTX
M6@V"!>M:X7*9A>!@5>$+CC%NI1B31'^.Z)H=4CC[SM*QZIP9ZIRS];;:4A,[
M=]"!>NW5OV5GQ-1'W7BY*[($8DIM6<:!QTD4P$MO6" [GF-07P_W22O]A%""
MRT\;:3^&:DM9_N;'M$MS?S. ]AJ/WB(<;%N[<R92W-*5<.;._C,ZW9VSI?H6
M _C(8#HO?77>WQ!7"WOCU,L9J0YL(YNAQ]NU<@-2;&LK];!L9<[^=G,QC>;]
M?21C.Z9M+>-ME8WSQND-MQ+*6>?<NC<[L3R5/;L\L=N,L;E>;R:QS55WF\O.
M-N,]$>RUC/N8]GR!>_Y+32:56X#7#:>0(+;?=P;M,JZA?3" 4Y&" :$[J]T2
MFBW,H9,-)D2(R!UB""4I;*R-%4L#Z!CJAG$_)41RUQB1Y1Z/Q=K]<J)C4Y-E
MBWG@M29:@+0%[_4+1@CR!T[5K[ 5*26<K.S86&;$#('>3)@_<)8$XCS ,\87
M>?#G!ML>4\FY6P!,U+5)$Z&?BZ+SQF.2PW.Z^#>;NEHS";'TSJB+9NXUT*I<
M37UC[NQ-W6[O2;:;@&SX@XY"+Y?4E)",7W@+P;=#3D+<,FB<;8 15-;N204B
M%H@'WQQ;.=(%[14$XL&6%0AZVAV@G4NS:%K@(3D(]$RN36VW>"[@)/4]7>A?
MULX3HY3EENC'-)?.^\NCS88'>TR[6.$NOB3TA]M%[BSSBM ?$#?9M:<9;)\4
M8B<#?6;WE(Y(<]4F>:S!13 2M>2!PI5:R# >1756$3@ENRXVI7O"CVF+?V.#
MSN.^QB,-B'F5V@,,BS7HO(2ZA7)NTK4<\GOWXID!5U#[Y$'F5P(H0-D#M/^A
M:QVB%>[J=Z_@/VB8VM_Q*2AW>O3'M,T?R(:+R5AE>V_.FY7(&AS*_YFC0I;L
M @+F )+(%&00/6/:E:^^4?]D=1E+%(9TU;1(1 K*?>< _]O)BM;NW1DTGK7,
M-[QL =O,W8JY%5OCBBFQ+L- WC3UIFXE*W FK2H7U0(XK9X(IY7U(I?%!MI?
M>P!I6)$3/=BK*,T)>+0GH]_DK1TJK<'7#@5FT;'$K19+Y[;S>CR\@Y@(Q.3I
M'<3D5O!Z?'OZ,(%Y>!UB&<Q)C)EQ/=*,H1"ONNTV3<T;F(K@3\PE*,@VSK>G
M#XB]<1LB*>*>; .OWP>SX#1]'\(B2P L0C0%*3)\_^0.4!$"*BSDE2L=F2/>
MW04^]:"5_<'W*5:H7U>(1!!![F=JA!9_U.U(J[XQ?$>9S[6[(MP-L]"GJK/*
M:'[U:[;-KN3T9]-@I)(KVO;A?Q%U&W]7(EC/L8B#8.<8A9>&8N;SW+8YHW1]
MW>Y=)HJTS^?0)HJK!*&\G"J7B"<12SJ &0"'/AX)N\#P@SNNQ6RV(])*?"Z&
M"N;22HOQ\MB)JJB6.^_,=-83!RR]J\:C<Z)!9E^2 =H<<)!J7_1E5I4.%)\M
ME<?<Q>UG*40^F[NM=^OV I^(K4^D\<CRBKN(P=)K^^$<)TGL'Q<%Q;E\#SD3
M+<&R_ U%+*7K0M'WX@S!LDWL'5-!QS%9HX18\;UI2"\\D]H2!JD8UNN0A""L
MH[52R:@#)M-9IMH0%*1M(%@9U)$0 >1F64&H='\3 V&?]%D)X>ZA\I@DFI[$
MWP\2"U?IG?1D=Z]4J%XP/5%A,5[=T0K')"HSS7OU'"I-@?4=.@L< GW5R&*;
M^!3=*M6:FRWVE7. CD128]/(!;9]MYY![^!CVA>"%OQ<K:O5;C4>/0/R)[45
M:4]^W80W6MX)1$-B63N^<R]+*)O%LKV66#7Q/R"OXQR[DILI2J.MQ0[*!RF.
MB> JH64*&IJ?D-?8N57( G7'K]3JCTUQ)>42]M"]U7;H$Z;SP:L-&Z"X>]:#
M.W4VR ;D&]@O>SI0VYZ4F$.+&GY//,QKH+MG7 FKMV\U$7;R.?3T1'%U0\%M
M>.&NK344>9@A!/7M<Z%RT6\*8=B;UUPJPU_@BO=L41KZ*/Q'_5'79CR*FC]W
M*^H);U#*ZZHUG];]44^S8MW'H@0M*^=O+IDD73/:\YW8+K8AMW8GXH[Q:[>T
M7CIG2Z@HA76;Y&+B\&HGV)E_@6UQ ^CPDD-9IL8^2K!N8*'>?W0K<W7O_064
M8?Y<+9<PN5]/WYUFSVO Q[G7_NGAH_S^_?OP?TS;Y+LK=0WCP)5ZR"B:Q#@'
M3O*Q8MP(9O.,^H2/1PF(H@&#<X_OGTKDY(@+Z"@Y@D2+G<+3'C M=676^EPY
M?=HL_IAV@L O//'QZ#GY<NXHGY)\?LD!?;5:%'XSYX-?$[6!$P?OY)(XQI>L
M]WP3G1DY:&)=Y1S-GWG"%W6O);PUXCRGV"%".UI"0(;9%MAF5U+Q8E/,G$N6
M\UN03ZUHT[$6I>W9$QAJ49T5K,[<W^&?4_PG>1/\IQGAR5(&WQ<^05]?<$AR
MW (VY1:!6W^X['C*BU;>XOE"N\U/O3Q@((3Z?,^95@$M1F+'W)C@SUY<.U;R
MKTU9?R+NXJYKPQ1N25E"BH(7FAN'/8#[_L<)!ZK:>KD+:JEU8%/$-0$_%'..
MM JH%X>!<K)B]24P]"3#!X/HL[T8>N)AL2CYJ^"3 ="\AEKWM6>27\-_NZ5Z
M-O$ $Z4U%6A]MY:HF[WQ=1Y@8#V?4*D F(6KJ7OJ5;C&R.V"<M6: @;+]!&M
M7RTH\GC9_*J1'HM+#M I#VL./,(0%_+X5 OIEK_5]1RA*UC$_SMTRKE[4*9D
M %;#G!C\R=R?>5]%L*BE;^=ONZ9JYQ4)[$0[@,CC%%=8D,._=I)2-,M*,,^=
MA.0F 8XC=:+,-LR'9^&XSG)4/&ZL*NP(R0OQ.LU3")G.%<$/G)8+Q51 6;BT
M<R>CPI8#&"WD/$&05@EU$U<)N$_8$CKL_H$GN'=;VBR]+8TVYH+H\V7A/D?*
M.+$-@BTZNE-SB8>FKZNYQ_)W*N T&( XNE2[[VLU[8[);+3N*6K:S>*RKRMZ
M)DW1S9$^P3@%I.,J=^TV5UH E)M^X*F9C$?ND5>>_%9HT6D0QR8RER&D-\#4
MO26J%UVYPR3(=U.R\-O!!_?(%N"O#Q N'Z7J;"S%M;;&GY;?0,SI5PBI0R:V
M;&X[GN/1'9Y#\!S?W>$Y;@F>X]%^/ <<P,^!UM"8P# 4PWD]-\)BP*/OD!>?
M&7EQ(-AF#S:#<JL#X(PLQF8DWHNVA*&RN@%RH\.K%@WUI)NGCQFT\@0 Y&!&
MM F#0Q@$F8Y2?%%P"(9@4NB0[(N#0X01/8$.Z:;Q/BLX!*%":71(]D7 (8'X
M2PU7)/_'E HX"#KROJ,R\HZ>4D1)N5RZO_U>3(GHD["-0A_"I/]1%F#2>=P!
M:!/+]7H(W,2]8V4!)ZGPQC')UY?!F]BPE[912N-/[(9RP/8.?R+XDZ'D++&1
M]-8^%ME/]>S#O5\WYM+WT3;XK)S#IUIH0 VCK[)_IW UWDKSBI0^.[&DC(0A
M./6&8MLY:=Y<2'0"]+&1[K,Z[K,:95#3=<@D/,@.!M)Y@U&2-TYOD[UW>'[[
M&,L_"6C0Z49@:,)/>]A;O;7%*MY7=U*L/1 1(YQX /@%$>OY,:W\';#@(&!!
MF\[DV!ABG ,. WW2@Z_KPC"!6P0F\)T;%F$_\<^.*7@48@H>,:: M"K_B3 %
MI\8)MM'QP!GN27M)'_M#4!?I%0K@%J9&_VLMD %=/.H#7?AA'EO8?A!ZT>NT
MI.,KU)VH0/Z<_7)U&"+#2U-26B[=).>8,EP;5@',+$*?LD',QB K2 35\$5=
M!V$UXMZ_AZ(U8$@ID ;=G4K;Z$3ZNK"-ZU ?#N$. K0&QB"N26K(,99G-/\0
M,H&E#S= 2J2L['C(^[@9[W 2O3B)GD1=]WP/).$/!D>$B?<)=?-%L8RAY%\5
M+(%B'0SHCX9.=-\0 "FX)V*(I%"V&^?5;+CKF5&JGP%=@2K@8'A%ED97=&F<
MKBM;SJ^\@7!E*EMN0?HOMFL)VGCT>R4M"P0-A^7[\W2'QY_%8@<;<R.Y2R<R
M]F%X!B5O//KJP!Z1O A[=71JGF :[YET5C"4HF">U>M+6&%8,([(5'M]K!17
M5P)D0>D=U&+(&(19IMU6MM8S&J<'88GXF 6;OH>N@'N)-I^/:(H.M\M H#P=
M+_2,X<P.9@5M ^_<UV,UV4]<P,/((7<0;H-4#8% 'M^!0!@$\LW].Q#(UP6!
MA/BQ(<1AKP+Z/%!#D]O\ZE!##)>Z6_0.:HBB4ET;:S@4(+PU($.3#XY0A?KC
MMV_/^E(F1V?+7+++VC%F*/4&=L06FB'_D?8+;2 _M_?LCT<0:UQ,<(BH ZKU
M9;V\Y/:!2?^QH@KEOS@5T;?!WI-[6U)URQM10E'.Q5LQ9,2 K[+8-?A;G_D/
MC9>^06VU5>EMP+9^45PB]N)^"27[C;65)1A-L?;>_J6^'22U:HT;1D)K28Z-
MKPIHP@F,+]S#EY!'Z&R2[1F743.C -51<Z>T#!JE@;11<(LBZ1@JYT"\//9C
MT5+W86VY9%YH0O80,P/-MP J/0WCV."Y9P&)0"V!\U@W_8"6"2$OW:5W14\F
MSG;6KQH6](B2N@G *XD5^>STY_^\??9\H[WW+][^_.J7,VBQEYW]\CQ[\5]O
M7OSR[L5QM]M[2NWVS(V#.L"M5AB6AO,\+8T:U@M\;Z4B_[28NE_46&)(_N<6
M'-1D0*EH&5E\;&!BX$M;[;9 4)%HKI4RNK["0+\F'A$62%:&>9.EE7,=DI56
M"VN8F'QK)&MQAY3XYE'X*9HA>@-1+\A"6&*>.],+>C!D#Q_GV</[#Y\D.EV]
MWFTAWH+ATICKXP?J[#Z'_B 7]<?R$IKXJ7V&C:5QX'+\LK@/A^' ,C4"[G1+
M4CUH0>R#B #JE70V+15$ F9X:5U6]9+,*O'.]EVBX#$DT;0WN$394@B1T+GV
M\<[U @WO3\)G I(AY)-B1 0:"9A)K1'NN5M2N"V/C08K(\#6#?!"!F]2E 2_
M8??TF([BK.\H<B2S[T0.I 7 8BHQ2AY$\8TCH&%6SXX/#;+7U.B/_ B&66B/
MG.45-LUHB+4*FN_\5N-_AAE2Z4^3[(@SW)$F9Z<9(O$ZKF P5&3OY@<,SI"4
M)Z+_];W"62T%GL/?>?ZCQH2 9(VTP.R:6D!.PJ$G?P^,_O>8S["YN#IMNDF=
M<A@4F>EW$I[TH!$*:BE_\$U_=9UN6DR/Z83/^TZX/=(<2<A!:KC#J9,9LR%\
MF41W=(I9LK;W=0C%CXIA((VAI3!YZ$=%G:O(6>UX42@25>I^P:H0OF$\!:Z-
M1> QWJVI= 8+5J3X)E<N7&QF2KE'*E8A><// T^XCTXL8A(C%!B,+?I \&"Q
M>WRR=>NNRBS,TTKBV*F,3=U24YF!XJRZP=T%Y=?DP1?Q*;3!5&<T'FDG66]$
MR/K,,-E?K0$L!RK'/6!:8E!AQ\TCW<>@F.C?</*Y%DA2TL!6>.8>C[1MV<E#
MR4D3EUPHJ!C7, /LCD3TK4;#(M&&.B^&- 67O%'4)GYFH214JW3)[1>OK[MC
M XZ[,8*\;FE.Z#E=S[R"F')PWG S?%$,ES7H<L5R\-55WS]92Y)RT)>)K>?]
MZO5W&=MX6@[5OMEG4[[L4WGMJY9'I^;1:.'L<RAA#+T%RO91GQ96V/+G4\*P
M, =KX>QS*F&4E(.U<'8=)6P5J;$7DDH8*5^M%C;WM%6_-["<8^U;IK4O#X\0
M\RE[YA]-OP["*Y[<P2L$7O'@#E[QE>$54DUTO?N3[LY.X?Q B7AL#A+BP5->
M&"W<#3=)]:B<>ZHAEDK2KW_:OV@7V^LYDC?8*=STY,YT;M*[G=&=N4CN3%Q2
MI@Z2IFJ(*U(6NI]<4@+*W?*/KF<-ON.$Z#>*[!GU*G7WYUNP] #"HMXY6C=@
MOI'50(3JI?!&O&GJ3U>F7R=5I(3/6/AA=X>&AM^BN$2&2_IB:FH_$YG',4E+
M=8.0+^MABH96B[2\_%R6:"6[,WGA;BY+DH]4E?/?ZAW%XC"37K?;3;WFTRQP
M,SS%X!BYDXP",<]#]D=;;&3J=2]K;,FN8*3]C*F02  34PA3CTD$?ON#1"!N
MO8#^D!+T_^F)<.[#J3YOZA8=!>KP$-[LX]$%;P?>$9[N:MY-U6 Q0U5N+Z!P
MYJ_O?GWS;]N+O_X%_A<]F(.NCT[TIV*B^#]L1LPXH=,@MXK\CK#L!W(<5>T&
M@@H;2^;@N^21Q#5K^(!XD+G"/U.9976GLF6]AB@"4.Q T0-KWKT>%2-INB[5
M;^A2_>#VYXC.SH=K&*P@5O#G_]U2/XK*.37+I5M!  90?<T6,%2[=5LNW;8O
MJF:%7N?R2A5@V]?*X^7[U^/1ZXV[P+&(IEA>M57K8YGN\?/=C (ZVW)VL:Z7
M]7DOE@YYN9!X!5-M-E.68^&*02 NJP\P0$,/!:F8:KUH*KCMG4Z'=Z[@O&(1
M+)5OKI'E@K)4[@#,[U%](Z[+FV)+H.B/9#*"D,OSR SGP$\?392&A,:C0SV!
M/#XG.9]10E_"V4\95*0:&6@-7YT'K'DYFC3$$[C!AJX0O*+P"[2(!>UV\N!)
M$&O!%VZV>KSI=3D&M)R]T\QPA?WLRVSEWL59<K='"-\3=C):.TBPMKDT7\+O
M8(GI (KT-'O)&M\93=5<*G'G]6ZZS>.XS'55B/L2NU:1"OE 41F(1/%9P>DO
M&-YI.0Q@-W!7))@5%4_Z5C0]&9" 5(71IV8XW[CA<&B0K@1HR<[S;<OR@QRZ
MC,]<+E&M4&_[$>A1-#^";; 5A$2=GRL.TC/?072MW7]M'!GR]2EU6'W!/#EN
MDV/$6Y8 O&$?QQ#UQG[&K&IFNQ7!Y&%GVEE333L4G4^)HI,JU4V<L1 5@5T/
M04<$K(QXF'RI)Z7> SLJ^K320PL1[);SB.A[%:#<-=R\]9.VO;W0A E2[(E)
M$,*(WQ(]#,03?#?D,L5P\67I6WN1-K=?[QZRP&CHOCV/OT\Z!2=*]&J4$@ 5
MI!I:HPA3+&TUP' :)-PDDG=6? .E0="*"O,@87R7J_[AZ0U54V#U7TC#BN85
M/9D&XBZR5KDDO\><CF7\<*KDL?)]N'\\P7\@EN/IZ2/]Y#M9$P-7^R\5M*ZZ
M?&B@'^VNN:PX.#ZX(R:7X&3T NL9&?5-3VJ<R);86$Y6#Q6:7^4%KR9HP\5N
M:4+?-\=U93%-&[_C95/LYMFS95$YE7KN'+-V:W K5)/+-9:X QYV.BB5)T$M
M;]B0S&2\BZD;<F[)=,WZ\VY-3K._<_$E\F6*HP'^R7F-UCC:.T0S6IC<2$0+
MPY*0VNOQ2#;[9+K;#H]'8$L!_Z^F2_#BJM:_[=;"<<$T-;.0<D,+\9W?3&8!
MBL4B245F!O'@_NEWN"J4S&(E)H7?;;V4L23QP3'@"%-&0]*EB)%8O$B;ZGX/
MI"V)%(A^H,HBA7P:@HYUXL2>/5=6'^]TK]_S@Y-77:5Y='<\LFZ_+$MF*I5F
MBG2_OTN=!M2Y3_UYL-H5=N;%80T2.ZPSL2",1REDO.[^IJCTYA=N*7@? I1!
MC4FCQA],RE3SGFG'G9 !2,@#C((5V>SNGB](-8-;@=;@##7=D_M_-IA;4RRH
MG2:U6>0)F+;>>BA-STKQ24$MNT\QV,L'%/VV">@'JN+BXP)(0D!C+C@ 9]ZL
M8=QN25*D.8T.<5KGP[K^Z#R,<S:EPPQOF?W[NV<=<L6<PB;PT1NWZK-J4RPY
M3HC: =T563FT/#JKHA+2PZO=*4-;A)$R"56.1[^N*Q 2G#YR20EA@'K\4'_[
M[.SUCX;!@I<[.YG5&"K :$"B^:0(R?,29>>,^HFV,2 ]IR.$"TB55IT)JY<S
MA1A_LXZ3.H9!W 0&0Z-**X>!!] -AKQA\%MSC:V)UB?7)O I(_&&%76;I )2
M=MC4-1[\JFT*=U/)DN;9;D.6^:KX!,TY31/2/SW\%N-W4A3#GQ@Z3HHXPZ4=
MMGM%MNJ*#5"0..2'4/(Z:@.:Q5U ;TL557^!UQ!4X)L[J(! !1[>007^:2L+
M7_V7UA7^_>S5?[YX^PYK"M^6$/$GD^-H:PJ_HYK"OV/3$*HP!L<,;"3RS+!G
M.%EE;Z&Q-1X+#B'(+0U\ 6^:&F^*71NR)^_CFS])=9.P?+^@[B%J<;T.$KWX
M2;'GU.L(&C:T&A>$9)4[W7,R-L(9,KDXY"?!R&F-?0<_*UMPKZKV@ME!PK;K
M[+?(Q6?[H<N;9 )0V. NKGI+"51C710S3GYR4D+ORIVG;6@][=:,20F<AW8)
MKLE&6HZWS,6.QJN[X99N/F6]:Z6>0T;D\[S@+;J'NSF"S]A D0^A$!#G7"O>
MN2GK]43MIFFY+A>55D;J<#<[MU"S,.-K<LK! F2)^8]'0PLP253VO:$WFGQQ
MQY[*Q)K*C8OOZX^"""(OT'CDI8.M'@A*SJMVNH/TQ*HF,U+P&J%(0.SR^PR*
M2H5RNCM(>1E%Z]Q_767EDH^,6PAG&I/%QHU:W2ENW2'N\%&=*#@J_@1/F2;]
MZ?Q-^A)3<<XRV (GW%"\X_9&.-IF]6HJD9N3HO4Q203WM,%2FG/F]B_8NQ_E
M><_\\SJ;1XU)_* Y"U XI0' $F'G'.J9.[=]8I$.;AY^?^X4@W.%RJAO4Y&E
M1IAG4 U+V9&>K>6T".:5#GJF9D@0VGMO4>^<-_'P\00$S;E>)DTQ$XM<U4L.
M-/CJ7^/T6JZG"E9(9&%O9V$WP=DD&>A155$6S9H2_1@P1ZN\A2#E4K<^.!*Y
M?,?9XC,W=Z0K,EX=@!6*3VRVDSOPIP<^;>_.G3#;J@]$N9SYQ%/BX!H!+ACR
ML)H7[97Q]$Y03@V&05+G:=HT68^F"Z)FUI)E#R,0"T]5B(2#\+=+9YACD"ZB
M?F.4%&83*2H(E+65D-@J9$Y:#WL/>YX'%%)[+N;Q*'DS9Y_]8D8?OO4^.1HE
M[B7E<D'+'!8UDIY>]]&@1*PGJ1*'-6:S]RV*TZM@K@R59K@G24ZBZSV;(<]K
M]\V/6.J(?JGE6(!%(,&D@ 9$>"C4B*G8W%R_T+8&@^@<"?I0D1!2#!;^PK=.
MZH#!M^80OJFF3 "-=S9<4'A05L4'>OLLB-/K<\8C>5 $ >MYZ"2'2%71S)?$
MC@TP (S/$BL[O:2IN+RBD&P_E(0FKB"L!U]BP88V3OM87&&G]'0W:PH&4U\O
M"A\>.IQIT9+FFC'S$H1Y&[ -((XN>2@GI?A[]_]JDORE>_XR6VJ*95^PA]T1
MSHQTC))#K6J6TR]]>(,0&IU6BDI%QY4/>>6T[64]0YP",C.TN$O1&F3*VAG6
M-1MF'O-H,+@X"OA[A57.)Y^<Q6X+!4@:(E*X ,!5T;[KO#)+OW$\ZGVEW&N$
MX' "66S;NL16COX1]"6(:I;G Q4JH=3[G D*!3E8G?+P@R5LP&^[@8"-1P=*
M&-\+F,GUEUIKPIY>J$KI@HF.*D.%TG>OY,JDV!R[@.'0!>^5NG0 S#S?S4I%
MA.$=G[I=XC88!ZUKP,WQ!Y_<-EY8H6:#BP6<V<BYY:9)O*!4.(<H@3R;5G+;
MAN"O;E8W6(9H,2E9;& 2/Q4?3[/W'3+FH.-)[_H-7M"'W<\$09^Q3O(=5ME5
MQTN';@78B=0%E>OUA!C\!N\2M,)WBF*@NRCXHH3>88$Z$ :R[/P84 .U:!"X
MSR +2PH+<C<Y7/W4U()RO+HE@Z^XMIR:\\]^Y^<W#^W91V5 >H'C-FWJU@ES
MU>Y@SDT^3U9FL0/A1X^DYOI%;2!A%7J8:B%3P:/F@,RDVC+%R)X+ZX0_(1Y%
M>A0*R3J44KQ8+XERW&VPV\\=?[B:^ ::?Z"M)D,6'\RGVK<$*XFP0W%Q?;]/
M\8>>SC/F ;G1471CN>E9[#N*6?(D1@>P(U" 2SEX5WHB"+G:KV*Q (&AFQRH
M ??$8E6<B_P03N12T!^Y7G).DZ240M$&$ <]-Q8<"G80W [=%E<WZ3(JZ<Q>
M&>@,"H,*SN6?59BR)]-;LZ"SNMTF(=9J69(DY6&,+;"3]BV+^_02HS?28X(>
MR5#%+J0GAG@-0IL6$*0PMJ$I@X.4YKQ<0,C-N15WE)/72@SYO-#/K]X]>_'3
M3V>_O'C]ZVT@F>S.9NZ.&,6 OL>(A4\:?;5!/KA/R:-W*,3%4MDH#VV;+C"0
M(2@7J=(BZHR.?W5JDIHM]?9)U\99\J8.@T ,[T+7SN NM5.(YE)"%+A^'L!:
M$NHK)G5I8PH$[/G=84EN<XPJ<:!([_@IZCOJ/U$K>1F .YIZ!U@\N6X,KR*/
M3B[A0<1L%,VE_O'4B\G3B*CU1;%RS @:8)2&GM+[.1X=LJ']&V9!T1HF:U.6
MMO>2R61+\Z! 6'Q8!$Q;>6HIW[L4'?)E13GC@A1;7J>*6G[054*68E,*1530
M8#NV*[HB*.WHHSEVH<3*W&IO$6>(5$ML57OE7]S7I%:&/?DJJ,5_%-V(50R_
MU.M[;SE*U,_6*\4+[$3/Y?@R<%V//81\F2I/S[RQ?D/9SS5,*J0M,4\-BL-!
MG, RP$B]D-I#2[ 2'PPJR<I/H$T@B[PN5H2VBG3CFAZ9)")5^'*2:5N.U$ 7
MS>P%G=2PH9.P)IZ$0PB^I!=&<@P8J4 :RXAKL:/FH,EB 6%$=UAAF5BYPHYP
M,%&JV'/I.>CT"_;>*,'(IK[2Z-Q+2ROXZ@J):W/4 &OX#Y,XS[V!["3AG()/
MVRV _:#NC;"#)!*QUZ4_#"LLL*A@"K, ).KOF$;V!\W"&<'7F@;OI8)/+5$%
M?&Z"\\9_ZH_S*P: &P/B.TPI)+_O,!:NW%X8BF\/JE(:'2$;3=T7<E*9#Y=A
M%C8W[@+WB\?+]@,G-:ZG,\0#M1TU;P-P?0CC^.T=QE$PCH_N,(Y?EP[)VP:/
MR#: >L*6S8(S,CWA+[DPR:/N $N82]:VU'ENM=JMP6Q&+:$-4BS*62MI?>/[
M*2"7(/:I(4/D84!JC7-H6PPQI/5XY&UO*)RJUMSF*:?Z,B"06!75,N<(BJ]G
MAS'S/RB(P2@%_*'[)>@M!5 \=S8%6;#$:=>20;_ _\#B&Z=$=UN*K:P+ 9IC
MH.E\C6UYD?47ZX[ N@+24></7594Z82M!K<73F]E)X\FP7O;X,4K9*>QK^:*
MBI)(]M1+<?^B>3O=?@]K0"B)[&[!M0(RH,%OV6)!?:JS9*=0E,.FGLZ"2[PE
M.,Q!9L:&2/TWJG)Y0NNWUW<GGU(%/\O3Y,MV9DCKZ/=G/_[T(H,@"\357OWR
MM__O7^[_"_[[S=GSY_+O:X_N8S7?7L!7[_]9E30DVHM-Z[25_->_H)+YZ_NW
M\@)L\3@KEC(3I\G^1131^^?RK8U;<;<KI.>>G#XV%P'^B6\!N0/Z;@G_.8_V
MR4,W6'FX?!F?KX/XO1OU+P I  S!JX4'/!$I3Z)*#TP=%I(_Z.UV]_^@1_Y4
M[-;N,+QV>N0,X)\M\8 ^<Y8E!?'@/0^>WL_^UL#1/',J;>>TQSMGO979@R>/
M[OMOO2X^+ OH&_[L+/ON\3</'N9(4G%VZK]RMMVZ5S^[<.91]N*B<>?VPGW]
M D+Y+Z0]?/::;%[_J_?ELMQ<@*K[I3[]/CMY##P0WWWW^-[])T\?^J^]N >Z
MQ,DG//[_7^+$G#R<7L[H6GS__,L)X^.G7TX8\<Z8U1NP53E<H8 *N/*<'[G;
MJMKZ1Q#*%\MEN7:NCQ.ZNFW=][-_+58;9X'.,&#CM)N1S4>/G[!8FI9_C=-#
M[O$/'KBE>;FL:R--,(C_6S<?<OTO-\0']Y_T22LPG5VX;YZ=PAEP7M^+]K]/
MX9[R7Z0EN-G_?[?=0>3IEW)W\?_:>]>NN)$L;?0[:_$?]-:9G@7K" IP^5;N
MZ35IP&6F,7  5TU]5*:4H+)2RM8%3)]U_OO9UXC0+0$7MC,K\UWS=IE,I12*
MV+%C7Y\'@Q YW[]?^/=V]S:]9R]WMG:?[>RTA7]R!6/\[^BJ2)+I-A@U;YYF
ME.[_%JF.U7G.O(L4[!5<,JK_>MK;ZF"?^,Z_@.<^#O(A[P',Z<57=B?L9R(B
MI+C_#99:$GO[Y.SX<'LP7;W+[%:5*,@0;)'XQI>N/W#@=G9!Z/E;%O-!D(/>
M_[#M'<,#HIQ3\@?8J)EX_PRN4W,G5QIWGFV]V'FY]1/\/_Y>Q3# NVTG?*O_
MOI)W<03RJ821_S>D<6Y_@G'6'F84/_S/^9.;*[V'P#=2_$\MR6S5F&Z%>O9"
MK)F%V3^.87/!$3,X-_:M-AS]F'G':B-X^\$T+@G6,@T8.NM/6S_-<^1_JOP*
M_,%?80^'D??KW<TL$^?Y[LZFM[>SL_7JU<M7CI;GW?4'W>K/FSA_-0'^$DMH
M801Z911]J5&TLHF6RR8B=?P0NTA$:89M9"7^8?91AW"V;"377+_73GI*(9UE
M)3W=ZJ],KB\RN126Y-YXTL+LU@]QFMW$ =:WY,$TJF#E"^^X#)U=^LQ['UP$
M81IX%Z6KWN,<IF$_R"<(3/+L]<[>BYUGND&;&_,D ,,MCKS?XYNKV#N]!@ON
M\3&E__OUR[VMYS\]?_7LV<N]E^U]FO)#_GO"[U1^KGD7BR'!*V/KX7=^&]W$
M"?;#!]Y9S6T FV@'L6JHY!6$R_@$)[^I7_#<-4%^"PILF2PQUW.PCR;]LQ=-
M"3[.*DP(;WOVJ?<:/#M@\+QZ\7IKY]6K5]Y&]+G<QG#]9EMRDZSZ[Z&Y[S1)
M1BO3Y*N8)GD:E__^=-<T1GX%OS)%+1@E6VAGN/;'W@[HO_=!COA'%V4>1:7?
M&[!YL?ML=\<-V.Q?8\W!.S!QPH0+FD(<(AP;;R/XH"]>\W)W9^OU[NO=>KQF
MK+<!PT!>Y*L%:TH<Y+#^H*;5 /_!U%8COV;FW&&LFU6F\&K9BQ-^^EK%"4]?
MA]"UMO.5WL0';!7QOR-^RAOO8=;LS'12ZYX/M1)<RZ+3<G#SHG-L13@QQZZN
ME0?8O"_GZ!3HL$7MB?S5[>&O:]-^;SG^Z=4\R_%36\/S)-7+:PP_?A6^DRT\
M3^+2:PKC_6>9P_A]KTG<$ZMSS&(K0P\RC;M#=77SV)6=V2;R4\;I'FXF/Z%]
MTJNI6[=]L.I^VO ;6PH&45?C90[#\[<.G6$*<8F#7(LB.'_13./J5%Z=RJM3
M^2]W*N^?8K#CY+]^V/OAH8JV2Z_V*M^&HJWU?39^Y!R[#1B:AQRUM?0X%MQK
MI7W@]AT*.(3 U6R;YM*GM7'FY2AJV#!HOW"?/[8I&"J N\Y6^(7*GWR(X3T_
M7E :?CFLH7D1L54@8F7RK$R>E<GS]4V>)Q. MOEDLG_?% +C>\!N/"2-^7IF
M&O,OE[1\ONJHGEMF$WWF]T_.?OW IYL_U1E'+?4$$; 9&:XE/*>7H[)]\1K]
MOJBT?66IK@K;'UK8_K"V/;<6;%G.V=V=[9\0S>0M@X&OKS%Q^QMO4!3P:VI0
MZR)M5TIN48V&TIP131"L3W$M%&:<\*29:06AIR28YU!+U5 .&;.P$XL14360
M52837!4&;2X)J S'7+0&:Y$!&7D1+A*TR:G#]G(<W-9@H@@C):L$N9Q#D,(F
MKP@O2A)30\HU!?:"DMO 238T\@H.%YB9UB<J"B _0V=R?2VM$J8D1?+U-[AL
MRE%+H+0$X)8*EIISUSJ+N*#MPI>X*@)RS>C6+GR5 ::9!XBH;[LAGN/,@@CE
M(8. QTIL?.A"2$:*62FBVV"T!>$-(YQE(I.^S0S66F%HPK*BW%(X1P[5OLV"
M7.#[7=3A%]N[+S:"3>&HE^<=D,X^]8[@ZDG*R#&,1=X(>]=O]-)0FL-]%%GS
M\)<+WZV-PZWP+B9H2X5ZEM;6YMC6UQ!']@7S.',4L(:EZE $&Y1-%V00,<K@
ME8FR6)3!B$EJVTC*1!1$O$ MR-D&4;U@SCJ8I$B8(XQ7 FC/&L#P)?=QI=T+
ML,B[:P1>81D)SC/+19P2'EL/<I,91)MDSW=QY1D9OR#MI;!!HASYA_K/P.I%
M0H=LJD6#H"IW6;Y]_0+E=I /8Z&]5N@NT=6XC&%<3*M2,+S*'%&J"L6]'#&K
MS892!2&3"T-"L7 PL!/*1Y8S=P/R:S-7)/EOA#Z5($L <UDQECN&AG&M@I00
M+.W'%E:0, P)>$K@Z+/<?30]6<!'%3.0.)B41,T!%G24 <X(3L%F"T7080[W
M6XQ\G4SL#T4CW0CJM$D'/-\M&D!C/5P14)A01?:]P;8WD$T\J8K2 ,&/X[PH
M20D@_JVOA.[F$.?4A"(SRE",>N:IGXHB$\X]0O>E7227J]*3>^'SS7,"07PG
MGJ0P*@FL3 @HIQ8L/A(" _,0'8$\@H&;=2!Q>I,E-X+NZXY$L8*1V8A _0N\
MSKT14U-XP410S(9!$1>&BQ F9 /! .IH:S)".U6U1Q(*&Z*]C2(P;4*#J]HY
M=UYCZCKH/<^MS(+ZB[.P*1@MH\<7!3EF4&J]]6U6):$[_4,Z<6 4-3T,+@"R
M>V9EW?!#*J(DND'@:K@Q:MXP&N$3=;**^#/"CKZ Z0HM)AU)S8BY"$<1'=1U
M42'86E+95L#!7FN]=3<ZKA&'@976VO$@2PXB5N5*4&OO#;8,WQP1@>,)'$@(
MMLI3DR,W<,Y30U#IL0+VR1WQI+2*LX'K34*6;D6?XX)0"Y&5/8QQIL^09 -&
M@RG" (DWQW$JHDL!E<' N633(:^91/D(69\<;>V=5PG>IR4T];NT&47'^BR>
M.3WM^[813@](+/+ N'M'WA0?1A2?3&.BSH]0B;B2T%K5+E8DO2<QT.I4L<U5
M=[?R2+3P&+2^(#<S^'B;<$(L$CK $M8>[N(9T8,KPFHDAA!ZVWH56A!I1I06
M_*6^.;SI9(HTFQO#JE0KB_DV9&>,T<79>-Y0(YO.O-#<%H6C_CJFF-$9=?>"
M635"RYNT%M)UH=G*Z]BM,E4KVQ=R&(-X\5B^DN#V#L9%^PUNA2<%DM^2KLAC
M6F$S=:CIU#Y0VBL'R<[B =>GW.+_TSMXN%;PV36S9F5Q6AJ'>AA=R<ZH;3:4
M#)C(VN0;XL1'S+[S9%E=)762Z<77E=7NT-WM(\G*O:+O(XYE"0LW2<@Z)]XP
M83@M>Z:%56M-$+IQZ^T"P4LFZ*RS^%R4 AI] &;++>P41&D'FQ'5HER"H)QP
M*^'(FR4Y!G&?%$" [SC-"N2C(6AELZ6[1==Y.5X1L!>(XQ=3]K6SH@FW*@"C
M1AST(W/#GMFC@XP6#(-R3))$DFDT'3JBF<^ \6@6C-$F93*,,!-RC#OC5A4(
MGJI<@TWWBW8G.+A)@@:L81!F$:HQP+GT#LC\RYP$S/"E"-T5S*J-.&P4<+CK
MR>Y;Y=BUA=&&EH.<WA:?TCR2+&PXS\P&82:ILQ5@!"704SK,JF&IY$ATQTV!
M A<K@&<205VG)GKC,@AMRIDP509BPJ87K&]K3-I@&<E42U$H5S/HNUL,!,R&
M!.89KIF99.0D05H7J];]Y0<PY30A!5&1,W=9?<3K:SI6'FH1!>Q==!TGHKK:
MVY%^"J.ZJC"-V1A5[1:'Z542%]?SX)K.R)._W%FADFL._<4JASXOJ.0OT3?Z
MA8&UT58!-?P&P>#B(HQ')M[1'1MW/&VP !C!O,PK/<*5V*3G8(8G%;VG,1P]
M&M9FTF:'U9N,6:);QCM,.7J:1,*;EXVWL5953VGK^!>P2W:?F4 F?*&1 )^B
M. .YJA[7H"/0)0GL-)N'R%6)HV2R2Z9V@U>//H.V+8C^637=_C5. YR$^UF5
ME[T3@.<&0Y1S5!^N75_#O6ZM*V$P_,-9+%_-:SAE0 ?GQ(QA;BD/R;UQA.3R
M"=]VDXXH^[LHP> +?Z=3NMGA05TH]/CZ&KU*!WWUH]>!;/1:N-*$@#;%O#*A
M%C.WM1F@HYDJEPTR.D^T'N)PY$^SP@1PA%"R02$U>\V5$4<BP;7Q"H$*6-HM
MNFO?Y2Y%UQLO)T8OO!-RF1-[(Z\C>+U16D2U$(-9W1J!H67X$#Y4]>Q-](G1
M_,DWE[ES9\R<K4/8RUM,WD.+7VB8I"0W E.E=WCOZ',$+@6%^)"5(!*.M+*$
MQ=.XGJ%_M4894I+2\^ 6.H/T/D05DX)'$@OQ835Q3+EZ,86Y0SSA(?EL>M#%
MCPHN<K90N(XDR^>J+ S"WW5)DO@#@L7O,-$&' &!R0VO: BR6C)HUX-6R24*
M3AQ \^%D^;FK5'"8#$/]J2RA/,5N7B6\3],H-U8Q_H[8E9U1N[*IM!,4I"2'
M22D5A!6IFDR4SH^,57 $2I.&E)B=.)NU<<AKU_?1K&BOQ&J=K(S?Q3'O*T6K
MRJ2/OU09KU$-2Z&YAM1TF#7F*"5D<%P1:04!][0G(X9L'GPNGDAN2=F@ZA>]
M=&@_ TJ1VQ1@G7<)AP3S'@F/:7U"0:?55M;D:'1I811X6A)YM\;PC"OC$ZE'
M(]]>X_MQ8LF-%QXP;:9WA"^"*>V@E)\:+4RO5=5\AWKSJV_3_BHL.HIV%*J#
M3JP69$6VC3CG+$/#_N@W*J3"Q-+8.J?R(V[ +T*4*/79) [Y1T^G]\#9=)J;
M[I]*-Z7YT+GT[I_*_> ."WZ."BSL+AXTDV1*]MQ@VQ9J_D7-ZE=>NW7M!HR,
M "\K)C!]6Z-@6H!K\O$?OPV.?CT\7U\[?>?]S\?SW[W+\Z/!L=0.#/;?>_#Y
MY?M#[VQP?GET>.&]/SP_O#RE_[S]W:,?7WCP 5[S[N/Q\>'%I7?XOY>'\/2S
MP_,/1Y>7AP<>7#DX.SL^VJ>RV./!;][@Y'?O_.B7]Y?>T:7W8?"[]W[PZR'<
M!R2(1X"_H?'\=G3YWCL_O#@[W+_$!^$O!_N71Z<GWL'1.7QX_+MW>NX=G9B_
M!N='%T<GOWBG'R]A]+[W\>3@\)RO\?9/3TX.^==TX\OW1Q?>X)?SP\,/.&2X
M"%_D\GQP<L$/N0#[$J;R\,/9\0!?A5]<Y@8GY7>=DHW!IK=_"+/T#N?I\OW@
MTCLYA9&?P>#AWH-+F"J<37R!4WC*N?Y\<&&O.CSP8?KPCPM^+[KRMZ.+0_!)
MZ)X7'W%1G-__=OKQ^  >=>GC"^+P#W^E=WGGS!5(U>'A/W'^#D_>G9[O'_(
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MBLZ9J-?S\DUSU'H9GSN3H!A56%'O>^-H@C$G,N32J"(%B/Z%E"3=@E(HU =
M>ZF"(Z]Y$$L;#L>%_=ISIV"22@B$*D>P_S%X@V50=D$T5BL-JO)SK+&@Z"Q]
M:BJ-&[WZTJ'O#3$,@TU;)BCO6ZN\XDAOU^]0%&I%$QW^(69)W*':@6(]/TK)
M"&?%PS#5"&-HE/H.J=G!O$ ]9*:7PDR,>$4Q<U"E7 V# 3):61PI"IT1A?4U
MG>OVHDNTJVV7>-=!49-2@UB@U2[TQ([TQ2^#P1G>]^C=^46C0AUD=A@4%$'A
M[6/'[Y1=TEN(H^/F2VA*X.7#32T<-!(E)8)47^\))F3.E4(W]A5JOXJTK'!]
M#;\O'/'4; 15^*O?=!6E6.,HX4Z68-M#B5Y+%,IN)K'AO^Q,68U@>['1P\*X
M!\:_M0)E#!9,=FMG@#>3#+TV,M(5\A;PZM%F^WHQCG1ZG$_!QM5/<63.-\,[
M^8*-3Y8]OBL&&^')*+<Q-AB7L\+T'>\HO1]1WE$$R=XC02"I!/,69XTKVT5U
MN\T#5<,P[O/<8%;&=E;,^H_=-Y_]?K?8+$D"R5/IM!CUO%_'$DZO<_Q2'D\/
M92UC%^^*ATF2(M=AIP0/D^73_OQ'\Q6LT<8UZX*:NFG?*^1^;RS$+%3T<1:[
M+Z"HN71OZ<5_6GB;C3W3@-J4,>T\BNQ4Q*+;K#JUMC_]&PX'?,TIV)>C.U\1
M4T[1$+6JKM>ST,+D.E*#";EH*VO'CWD9&+W@GL&!S':,#F6<:ELI-H?+A/\U
M\68;7\YKL6?WY-R04Y6D#?60=6?J3M(FUP!S,(;#5H6ZT,V;@.]3,MY 'N%9
M+4Y@3JXN[C0</-]13D39;1A.D_RY.2IGWHV&PK>3[DH16HI@40C%E/U*_;U$
M\5S_K^9YE[PZ(#A_8/R3NAMAGIT^:C!?1@%G] B!1A_9$6#5O5.36]$Y32TJ
M)J=\ZINK)4C0H5T/.9A@OLDEHQ.**VM4HU:V^VK7HG%M@P]PQT.-2[04*4S$
MI[8R.4 DP;QH;_S_J"F9];6/*36U4:EB 2XX_8S?8B/9;,P@/CVM)D-<3LXW
MYB(Q;HZ> 0-ZSPEC^_)FH[M;A -S>[*;$*RF*#/P,0NP"TH,0$R&DBQ$>0,3
M*48<ZW_+)RB.HM"=$A?&'&C8)AR\M5JT ]/%L>.,:6D!=1K]<'"S281C-RFZ
MQB^OM$G&H_"/5D"W1F#GC&:E-8*,D;^[!B!6Y!AL.S+AW.YBC(_(U,"TQ@;"
MPQGJ Z:DWW[L&FKA9CU(5<!2ZM_MX3O&7W:;BI!1F(QJ*'#_@NA$15DTYI@:
M&VY!DV.U ;[5A-O_3,P,"X78JHBGI$7^P)Y7VU231E<93))I30[S8%R:X%O=
M,]M'S8HQ@Y+*;VI50P1T,8RO*LF;PV6%>GB2S&U[?]@[PFFL[@WCM$45Z*K0
MX)QWT'K9>H30%[,*3=6BFDS5C!I6H(YI0. ?FJ(!&H,W#FZR7(S:,"[,G[;.
M')YU$^>E[:@(*K!0\^(ZGHJ9[";K.V:O XT [[XO[;F^B0+"7D><TS'I\L:A
M3>>UQ"G% Y(HI50CRXQH]DT*E.%PI,X8R1[Y-N>'V=X I? F@!U","5W;O[.
MYXZ.D*6+1>]10^;0I<%AZL)FFC$\?,'&^)2U0GH9ZEF%PN\=XOI:_[0ZS=TT
M(E2_MBB=^G7S+(U'7AB4H%MBPJV(-=922X.ZN<\VUA0-G=V-CL%S4 =?KN^"
MQJ01DD!1= QT++I&(D+&0XM32H^6RUD<05!S^^B)@QH*J/-N1GV$P0SCWD1-
MO6Y8(Q7VRC@8T>EB&\[<9:"S6/ W-FDK<2QIDN74*&@&(J$4V7Q@'M-15'8D
M/PJJY"R;/]?24Z&&N'8QSYH.#6N% #=V?$6=5X@O(OB2= /8M<$G1,_1Q(X!
M.='R(0(PD9@DU7P9 WT)Y8J@SHZQ&&E][;R61R(!^Z;#VOU.TT'/Q0CLI7LD
MVR)D@A-L)^F#D1R&!(K8!YB+DG9Z%2.P!#?$;")\M+>A\LFE,/4N6]*T!EJQ
M!52D==2^I3LRI#QJ8+AGK:W7Z:JXX6 %?RW8C348-^[*;L5/>U*E9F==.N7J
M;-=@M%*R[P\<F^^.BLX>&6D=YM76%74!T&EC5BW9V1R?&8 %M*2JPZ$;16:S
M<7UM7)55CNF&+DXD^W8/>BOOBU^(S%BWVED@/=%E#4*,QT>&VLDWAH<MC^][
M9"L)H$A&3? _;9A6_+^6V>C:8@[LK27M<E!#NZFV;Z\S>A\$(U+\&BXDX8/
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MZ_/\I#7 %)6 5\1?KZ\IUD(8,5 3V:\S/<4&"O]#7,6:O]+A+HK%.-MPKY$
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M\GZ/;Z[BK=/K( WZDX#=:DV^Q4Y_&D@2W*+K01E 'EDS"=C(K!3-!&#QI1E
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M48P.HILHR::F..XR&EVG3.$1U 11=.Z1*%JV>)Z__.FGK=W7KW[R3=<^C-K
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M3-VK+U!^?&HRT0%([CC.L28V&E<%6@S,P4QGX&<XE(1MAQ@J\/ <59-ASG7
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MN+9FY*J7I&M>%9J_I_AO-L(L1PNZP63\>FQ>$5T,.)%"N^B!AQ$FXK2NW3"
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MB$':'26V,;*)("NS=D/\ZHYEW[8%Q%LA@\P[RF9C:+=H,PZT$V1.XKW9U0(
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MKWG%49?>"YIZFM29DF'UR;4,E-]%=+F:475Q>WB(5Q-9'AD;#&H#XXK""T9
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MZ[J!:+4]E/PFI,0^Q.=^O9D%@'TOXEHK=60")1HW"Z[$=6YNK=2*$G= 'UI
MF<5-;:M0G9G8.VDG9>Q./]^+A+(5E&#<'-6%[MR=L]UJJ9V]PMYE\*(]W*[W
M&,^9^?RF6&P\&,DH2D3^/L@Q@><PA?*,FUAZ<9Z9\YGD+&!VF\TGX[EBA%<3
M7F4'91LWC70C/#/54T6MY-0,W],5:W:;MIHL%J[>V6</I1XWBZQ'C"O!6.N$
MJE.%J"@%E0,WH82B/W<71(/$](C;P<7\P7YPP-$!E:R@I.,FDRYT9R;YLWQ0
MQ'X29;:-YI*[=]94&D*IQDT=/1C/S/:!']4\'YE &<;-&2MQ(747-YM@1<22
MNA=C5%M"F<;-(7THT?KG):A_7I[8/^/FDBYT2"1G:^?MKO<Y9TOBWI_G+0#>
MJ]0(ZCV8S[T],MTV93^MI:+4CUMS4,V_PQ3*//)65!_.<W.>A"RF8>;2+1-$
M!"9'V\%PO "H+P55 GFO*A ]RKS#-\KYKT(^BQDE6@H:9BF#;^K!600J1Q/F
M/6MPHVCQ5?+$T*72U;#*<5<X3*'<-V&^TX$39P%JMM9[]WS*OK/HH]Y5 JI
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M:"YH=&U02P$"% ,4    " !8AN%:])[AO_ L   OZP  '
M@ $ 1@  96$P,C0W-C$R,#%E>#$P+3%?;&%U;F-H+FAT;5!+ 0(4 Q0    (
M %B&X5HB?:H;9SD  & @ 0 <              "  2IS  !E83 R-#<V,3(P
M,65X,3 M,E]L875N8V@N:'1M4$L! A0#%     @ 6(;A6K0NIT3X%0  #&L
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MR@( ;'!A82TR,#(U,#8R-5]P<F4N>&UL4$L%!@     )  D =P(  &[3 @
!  $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>ea0247612-8k425_launch_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:LPAA="http://launchoneacquisitioncorp.com/20250625"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2025"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="lpaa-20250625.xsd" xlink:type="simple"/>
    <context id="AsOf2025-06-25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002015502</identifier>
        </entity>
        <period>
            <startDate>2025-06-25</startDate>
            <endDate>2025-06-25</endDate>
        </period>
    </context>
    <context id="From2025-06-252025-06-25_custom_UnitsEachConsistingOfOneClassOrdinaryShareAndOnehalfOfOneRedeemableWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002015502</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">LPAA:UnitsEachConsistingOfOneClassOrdinaryShareAndOnehalfOfOneRedeemableWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-06-25</startDate>
            <endDate>2025-06-25</endDate>
        </period>
    </context>
    <context id="From2025-06-252025-06-25_custom_ClassOrdinarySharesParValue0.0001PerShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002015502</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">LPAA:ClassOrdinarySharesParValue0.0001PerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-06-25</startDate>
            <endDate>2025-06-25</endDate>
        </period>
    </context>
    <context id="From2025-06-252025-06-25_custom_WarrantsEachWholeWarrantExercisableForOneClassOrdinaryShareAtExercisePriceOf11.50PerShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002015502</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">LPAA:WarrantsEachWholeWarrantExercisableForOneClassOrdinaryShareAtExercisePriceOf11.50PerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-06-25</startDate>
            <endDate>2025-06-25</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2025-06-25" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2025-06-25" id="Fact000004">0002015502</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2025-06-25" id="Fact000009">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2025-06-25" id="Fact000010">2025-06-25</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2025-06-25" id="Fact000011">LAUNCH ONE ACQUISITION CORP.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2025-06-25" id="Fact000012">E9</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2025-06-25" id="Fact000013">001-42173</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2025-06-25" id="Fact000014">98-1781481</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2025-06-25" id="Fact000015">180 Grand Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="AsOf2025-06-25" id="Fact000016">Suite 153</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="AsOf2025-06-25" id="Fact000017">Oakland</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2025-06-25" id="Fact000018">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2025-06-25" id="Fact000019">94612</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2025-06-25" id="Fact000020">510</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2025-06-25" id="Fact000021">692-9600</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2025-06-25" id="Fact000022">true</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2025-06-25" id="Fact000023">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2025-06-25" id="Fact000024">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2025-06-25" id="Fact000025">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="From2025-06-252025-06-25_custom_UnitsEachConsistingOfOneClassOrdinaryShareAndOnehalfOfOneRedeemableWarrantMember"
      id="Fact000026">Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="From2025-06-252025-06-25_custom_UnitsEachConsistingOfOneClassOrdinaryShareAndOnehalfOfOneRedeemableWarrantMember"
      id="Fact000027">LPAAU</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="From2025-06-252025-06-25_custom_UnitsEachConsistingOfOneClassOrdinaryShareAndOnehalfOfOneRedeemableWarrantMember"
      id="Fact000028">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="From2025-06-252025-06-25_custom_ClassOrdinarySharesParValue0.0001PerShareMember"
      id="Fact000029">Class A ordinary shares, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="From2025-06-252025-06-25_custom_ClassOrdinarySharesParValue0.0001PerShareMember"
      id="Fact000030">LPAA</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="From2025-06-252025-06-25_custom_ClassOrdinarySharesParValue0.0001PerShareMember"
      id="Fact000031">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="From2025-06-252025-06-25_custom_WarrantsEachWholeWarrantExercisableForOneClassOrdinaryShareAtExercisePriceOf11.50PerShareMember"
      id="Fact000032">Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="From2025-06-252025-06-25_custom_WarrantsEachWholeWarrantExercisableForOneClassOrdinaryShareAtExercisePriceOf11.50PerShareMember"
      id="Fact000033">LPAAW</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="From2025-06-252025-06-25_custom_WarrantsEachWholeWarrantExercisableForOneClassOrdinaryShareAtExercisePriceOf11.50PerShareMember"
      id="Fact000034">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2025-06-25" id="Fact000035">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="AsOf2025-06-25" id="Fact000036">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
